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During pancreas development Neurogenin-3 (Ngn3) plays a pivotal role 
positioning itself at the beginning of the differentiation pathway to endocrine-committed 
cell fate. Ngn3 activity is required during a proliferative stage at the interface of first and 
second transition. The specification of different islet cell types and the completion of the 
differentiation process require Ngn3 to regulate expression of a series of downstream 
transcriptional regulators. Transcription factors like NeuroD1, IA1, Pax4 and Nkx2.2 are 
known direct targets of Ngn3. Here, with a ChIP-cloning strategy, new direct targets of 
Ngn3 were identified in AR42J cells ectopically expressing Ngn3. One novel target was 
the zinc-finger type transcription factor OVO-like 1 (OVOl1). OVOl1, originally 
implicated in hair formation and spermatogenesis, is suggested to promote the transition 
from a proliferating, less-differentiated state to a post-mitotic more-differentiated state. 
Published data suggest that OVOl1 is activated by LEF1/β-catenin complex and then 
down-regulates proliferation by inhibiting expression of c-myc. By RT-PCR, Western 
Blot and immunostaining analyses we show that OVOl1 is expressed in islets, pancreatic 
ducts and in pancreatic cell lines INS-1 and AR42J. Furthermore, we show that Ngn3 
negatively regulates the expression of a -1100 bp OVOl1 promoter:-luciferase reporter 
construct in an E-box dependent fashion. We suggest that Ngn3’s ability to inhibit 
OVOl1, a regulator that promotes transition from proliferation to differentiated cells, may 
permit Ngn3 to control the balance between proliferation and differentiation of endocrine 
progenitors. The identification and characterization of both positively and negatively 
regulated targets of Ngn3 will be key to understand the molecular mechanism regulating 
conversion of progenitors into endocrine cells. 
 
Accepted Poster for the American Diabetes Association (ADA) meeting, 2008 
(S.Francisco, CA, USA) 
 TABLE OF CONTENTS 
ABSTRACT ...........................................................................................................................................................1 
RIASSUNTO..........................................................................................................................................................2 
1 INTRODUTION .................................................................................................................................................3 
1.1 THE PANCREAS ........................................................................................................................................3 
1.2 THE PANCREATIC -CELL.....................................................................................................................4 
1.3 PANCREAS DEVELOPMENT .................................................................................................................5 
1.3.1  EARLY PATTERNING OF THE ENDODERM..................................................................................5 
1.3.2  EMBRYONIC PANCREAS DEVELOPMENT ...................................................................................6 
1.3.3  PRIMARY AND SECONDARY TRANSITION DURING EMBRYONIC PANCREAS     
DEVELOPMENT ..................................................................................................................................................7 
1.3.4  THE MESENCHYME CONTROLS THE EXOCRINE AND ENDOCRINE PANCREAS    
FORMATION ........................................................................................................................................................9 
1.3.5  NOTOCHORD SIGNALS ARE REQUIRED FOR PANCREAS DEVELOPMENT.....................11 
1.4 HIERARCHY OF TRANSCRIPTION FACTORS IN PANCREAS DEVELOPMENT ....................15 
1.4.1  HEPATOCYTE NUCLEAR FACTOR (HNF) 3BETA/FORKHEAD BOX (FOX) A2 .................16 
1.4.2  HEPATOCYTE NUCLEAR FACTOR (HNF) 3ALPHA/FORKHEAD BOX (FOX) A1 ..............17 
1.4.3  HLXB9 ...................................................................................................................................................17 
1.4.4  PANCREATIC DUODENAL HOMEOBOX 1 (PDX1)/INSULIN PROMOTER FACTOR 1    
(IPF1) ..................................................................................................................................................................18 
1.4.5  HEPATOCYTE NUCLEAR FACTOR (HNF) 6 ................................................................................19 
1.4.6  NEUROGENIN3 (NGN3) ....................................................................................................................19 
1.4.7  HAIRY ENHANCER OF SPLIT-RELATED PROTEIN (HES1).....................................................21 
1.4.8  PANCREATIC TRANSCRIPTION FACTOR 1 (PTF1-P48) ...........................................................21 
1.4.9  NEUROD1/2 CELL E-BOX TRANS-ACTIVATOR 2 (BETA2)...................................................22 
1.4.10   PAIRED-BOX HOMEOBOX GENES (PAX4/PAX6).......................................................................22 
1.4.11    NK CLASS HOMEODOMAIN PROTEIN NKX2.2 AND NKX6.1................................................24 
1.4.12 ISLET 1 (ISL1) .....................................................................................................................................24 
1.4.12 INSULINOMA-ASSOCIATED FACTOR 1 (INSMA/IA1).............................................................25 
1.4.13    BRN4 BRAIN 4 ....................................................................................................................................26 
1.5     ENDOCRINE FATE COMMITMENT ..............................................................................................26 
1.5.1  NGN3 THE MASTER-SWITCH OF -CELL DEVELOPMENT....................................................26 
1.5.2  NOTCH SIGNALING PATHWAY IN ENDOCRINE DIFFERENTIATION ................................30 
1.6     GLUCOSE HOMEOSTASIS: .............................................................................................................33 
1.7     DIABETES............................................................................................................................................34 
1.7.1  TYPE 1 DIABETES MELLITUS ........................................................................................................36 
1.7.2  TYPE 2 DIABETES MELLITUS ........................................................................................................38 
 1.7.3  MATURITY ONSET DIABETES OF THE YOUNG: ......................................................................40 
1.8     GLUCOSE RESPONSE IN ISLET CELLS .......................................................................................41 
1.9     INSULIN SECRETION: ......................................................................................................................42 
1.10   INSULIN BIOSYNTESIS ....................................................................................................................43 
1.10.1   TRANSCRIPTION FACTORS BINDING THE INSULIN GENE PROMOTER REGION AND    
ACTIVATING ITS EXPRESSION:...................................................................................................................44 
1.10.2  ORGANIZATION OF THE INSULIN PROMOTER REGION AND TRANSCRIPTION 
FACTORS   BINDING SITES: ..........................................................................................................................45 
1.10.3  TRANSCRIPTION FACTORS REGULATING INSULIN GENE EXPRESSION IN MATURE 
-CELL: 47 
3 MATERIALS AND METHODS .....................................................................................................................51 
3.1 CELL LINES CULTURE. ........................................................................................................................51 
3.2 (BIO)CHEMICALS...................................................................................................................................52 
3.3 BUFFER AND SOLUTIONS ...................................................................................................................54 
3.4 PLASMID MINI-PREP.............................................................................................................................60 
3.5 PLASMID MIDI-PREP.............................................................................................................................60 
3.6     PLASMID MAXI-PREP ...........................................................................................................................61 
3.7 GEL EXTRACTION. ................................................................................................................................62 
3.8 BACTERIA TRANSFORMATION.........................................................................................................62 
3.9 RNA EXTRACTION AND REVERSE TRANSCRIPTION .................................................................63 
3.10   REAL-TIME RT-PCR ..............................................................................................................................64 
3.11   AGAROSE-FORMALDEHYDE ELECTROPHORESIS .....................................................................65 
3.12 PROTEIN QUANTIFICATION.............................................................................................................65 
3.13 MICROARRAYS ANALYSES .............................................................................................................66 
3.13.1  CELL CULTURE AND DIFFERENTIATION. ...............................................................................66 
3.13.2  SYNTHESIS OF AMINOALLYL-AMMINOHEXIL-UTP SSDNA. ............................................66 
3.13.3  HYDROLYSIS AND NEUTRALIZATION OF THE REACTION ...............................................67 
3.13.4  PURIFICATION OF THE CDNA .....................................................................................................67 
3.13.5  ETHANOL PRECIPITATION OF CDNA........................................................................................68 
3.13.6  FLUORESCENT DYE LABELING OF CDNA ..............................................................................68 
3.13.7  PURIFICATION OF LABELED CDNA ..........................................................................................68 
3.13.8  ASSESSING LABELING EFFICIENCY .........................................................................................69 
3.13.9  PANCHIP 6.0 ARRAY SLIDES........................................................................................................69 
3.13.10 PRE-HYBRIDIZATION OF THE ARRAY SLIDES .....................................................................71 
3.13.11 HYBRIDIZATION OF THE ARRAY SLIDES ..............................................................................71 
3.13.12 WASHING OF THE ARRAY SLIDES............................................................................................72 
3.13.13 SCANNER PLATFORM FOR CHIP READING ...........................................................................72 
3.13.14 TECHNICAL CHARACTERISTICS VERSARRAY CHIPREADER
TM
......................................72 
 3.13.15 SCANNING ........................................................................................................................................73 
3.13.16 SPOT DETERMINATION ................................................................................................................73 
3.13.17 SOFTWARE FOR MICROARRAY STATISTICAL ANALYSIS................................................75 
3.13.18 COMPARISON OF THE SIGNALS ................................................................................................76 
3.13.19 NORMALIZATION OF THE DATA...............................................................................................77 
3.13.19.1 TOTAL NORMALIZATION .........................................................................................................77 
3.13.19.2 LOWESS NORMALIZATION ......................................................................................................79 
3.13.19.3 VARIANCE REGULARIZATION ...............................................................................................80 
3.13.19.4 REPLICATE FILTERING..............................................................................................................81 
3.13.19.5 AVERAGING OVER THE REPLICATES EXPERIMENTS.....................................................82 
3.13.19.6 SIGNIFICANCE ANALYSIS OF MICROARRAY (S.A.M.) ....................................................83 
3.14 IMUNOHYSTOCHEMISTRY...............................................................................................................84 
3.15 PROTEOMIC ANALYSIS .....................................................................................................................84 
3.15.1  CELL CULTURE AND DIFFERENTIATION. ...............................................................................84 
3.15.2  PROTEIN EXTRACTION .................................................................................................................85 
3.15.3  FIRST-DIMENSION: ISOELECTRIC FOCUSING ........................................................................85 
3.15.4  SECOND-DIMENSION: SDS-PAGE ...............................................................................................86 
3.15.5  SILVER STAINING ...........................................................................................................................87 
3.15.16 GEL DIGESTION, PROTEIN REDUCTION, ALKYLATION AND TRYPTIC DIGESTION.87 
3.15.17 PEPTIDE ANALYSIS .......................................................................................................................88 
3.16 PREPARATION OF THE REV-NGN3 VIRAL PARTICLES............................................................88 
3.16.1  CLONING THE MOUSE NGN3 CDS INTO THE PREVTRE VECTOR.....................................88 
3.16.2  SELECTION OF STABLE VIRUS-PRODUCING PT67 PACKAGING CELL LINE ................93 
3.16.3  DETERMINING THE VIRAL TITER ..............................................................................................93 
3.16.4  ESTABLISHING STABLE REGULATORY TET-ON-F9 CELL LINES.....................................94 
3.16.5 ESTABLISHING A DOUBLE-STABLE, INDUCIBLE TET-ON/TRE-NGN3-F9 CELL    LINE .95 
3.16.6  DOXYCYCLINE-INDUCED EXPRESSION OF NGN3................................................................95 
3.17 PREPARATION OF AN NGN3-TETRACYCLINE-INDUCIBLE SYSTEM (T-REX SYSTEM).96 
3.17.1  CLONING THE MOUSE NGN3 CDS INTO THE PCDNA5/TO VECTOR ................................96 
3.17.2  ESTABLISHING A DOUBLE-STABLE, INDUCIBLE 6TR/5TO-NGN3-F9 CELL LINE......100 
3.17.3  DOXYCYCLINE-INDUCED EXPRESSION OF NGN3..............................................................101 
3.17.4  DIFFERENTIATION PROTOCOL.................................................................................................102 
3.18 PREPARATION OF AN NGN3-RHEOSWITCH

 INDUCIBLE SYSTEM...................................103 
3.18.1  CLONING THE MOUSE NGN3-CDS INTO THE PNEBR-X1 HYGRO VECTOR.................103 
3.18.2  CLONING THE MOUSE NGN3-CDS INTO THE PNEBR-X1-PURO VECTOR ....................106 
3.18.3  REMOVAL OF AN ASPECIFIC ATG CODON FROM THE PNEBR-X1-HYGRO-   NGN3 
VECTOR ............................................................................................................................................................109 
 3.18.4  CLONING THE IRES AND DTOMATO SEQUENCES INTO THE PNEBR-X1-   HYGRO-
NGN3/2 VECTOR .............................................................................................................................................110 
3.18.5  ESTABLISHING OF INDUCIBLE RHEOSWITCH

 F9 CELL LINE .......................................116 
3.18.6  CLONES SELECTION.....................................................................................................................116 
3.18.7  GAUSSIA LUCIFARASE ASSAY...................................................................................................117 
3.18.8  ESTABLISHING OF INDUCIBLE RHEOSWITCH

F9-R1-NGN3 CELL LINE......................118 
3.18.9  TRANSFECTION AND ACTIVATION OF STABLE CELL LINE NIH-3T3-47 .....................118 
(GENERAL PROTOCOL)................................................................................................................................118 
3.18.10 WESTERN-BLOT ANALYSIS ......................................................................................................119 
3.19 PREPARATION OF THE ADNGN3-EGFP AND ADNEUROD/BETA2 VIRAL  PARTICLES 120 
3.19.1  CLONING THE MOUSE NGN3 CDS INTO THE PSHUTTLE-IRES-HREGFP2    VECTOR
 120 
3.19.2  TRANSFORMATION OF THE BJ5183AD CELLS TO PRODUCE RECOMBINANT AD-
PLASMID...........................................................................................................................................................126 
3.19.3  PREPARATION OF PRIMARY ADENOVIRUS STOCK...........................................................128 
3.19.4  AMPLIFICATION OF THE PRIMARY VIRAL STOCK ............................................................129 
3.19.5  PLAQUE ASSAY..............................................................................................................................130 
3.20 CHROMATIN IMMUNOPRECIPITATION CLONING (CHIP-CLONING).................................130 
3.20.1  CELL CULTURE AND INFECTION. ............................................................................................130 
3.20.2  IN VIVO CROSSLINKING AND LYSIS........................................................................................131 
3.20.3  IMMUNOPRECIPITATION (IP) OF CROSSLINKED PROTEIN/DNA ...................................131 
3.20.4  ELUTION OF PROTEIN/DNA COMPLEXES..............................................................................132 
3.20.5  REVERSE CROSSLINKS OF PROTEIN/DNA COMPLEXES TO FREE DNA.......................132 
3.20.6  DNA PURIFICATION USING SPIN COLUMNS ........................................................................133 
3.20.7  BLUNTING REACTION, LIGATION AND BACTERIA TRANSFORMATION. ...................133 
3.20.8  BIOINFORMATICS ANALYSIS....................................................................................................134 
3.20.9  CONFIRMATION OF THE RESULTS ..........................................................................................135 
3.21 PREPARATION OF THE OVOL1-PROM1-LUCIFERASE REPORTER  SYSTEM AND 
TRANSACTIVATION EXPERIMENTS ........................................................................................................135 
3.21.1 CLONING OF THE RAT 1.1 KB OVOL1 PROMOTER INTO THE PGL2-BASIC    VECTOR.135 
3.21.2  SITE-DIRECTED MUTAGENESIS ...............................................................................................139 
3.21.3  TRANSACTIVATION EXPERIMENTS........................................................................................141 
3.21.4  IMMUNOHISTOCHEMISTRY.......................................................................................................142 
3.21.5  WESTERN-BLOT ANALYSIS .......................................................................................................144 
3.22 IDENTIFICATION OF THE -CELL SPECIFIC INSULIN GENE  COATIVATOR A2.2..........146 
3.22.1  NUCLEAR PROTEIN EXTRACT FROM HIT T-15 CELLS ......................................................146 
3.22.2  ELECTROPHORETIC MOBILITY SHIFT ASSAY (EMSA) .....................................................147 
3.22.2.1 OLIGONUCLEOTIDES LABELING ...........................................................................................147 
 3.22.2.2 GEL MOBILITY SHIFT ASSAY..................................................................................................148 
3.22.3  PURIFICATION OF A2.2 COACTIVATOR .................................................................................149 
3.22.4  COLLOIDAL GOLD PROTEIN STAINING .................................................................................150 
3.22.5  WESTERN-BLOT ANALYSIS .......................................................................................................150 
3.22.6  TCA PROTEIN CONTENTRATION..............................................................................................152 
3.22.7  MASS SPECTROMETRY ANALYSIS..........................................................................................152 
4 RESULTS ........................................................................................................................................................154 
4.1 MIMICKING THE DIFFERENTIATION PROGRAM OF THE PANCREAS AND IDENTIFY 
NEW  GENES INVOLVED IN ENDOCRINE DEVELOPMENT ...............................................................155 
4.1.1  AR42J-B13 DIFFERENTIATION .....................................................................................................155 
4.1.2  MICROARRAY ANALYSIS .............................................................................................................159 
4.1.3  PROTEOMIC ANALYSIS .................................................................................................................164 
4.2 MIMICKING THE EXPRESSION OF NGN3 DURING THE DIFFERENTIATION PROGRAM168 
4.3 PURIFICATION AND CHARACTERIZATION THE -CELL INSULIN TRANSCRIPTION    
FACTOR A2.2 (ALL INFORMATION ARE UNPUBLISHED PROPRIETARY OF JOSLIN DIABETED  
CENTER) ............................................................................................................................................................192 
4.3.1  CHARACTERIZATION OF THE TRANSCRIPTION FACTOR A2.2.........................................193 
4.3.1  PURIFICATION OF A2.2 TRANSCRIPTION FACTOR...............................................................195 
5 DISCUSSION .................................................................................................................................................204 
5.1 ARE THE TRANSIENT EXPRESSION OF NGN3 AND THE ENDODERM PATTERNING A    
PREREQUISITE TO HAVE THE PROPER MOLECULAR CONTEXT TO ACHIEVE -CELLS    
DIFFERENTIATION IN VITRO? ...................................................................................................................209 
5.2 WHICH ARE THE DIRECT DOWNSTREAM TARGETS OF NGN3? ...........................................213 
5.3 IDENTIFICATION OF THE TRANSCRIPTION FACTOR A2.2 .....................................................226 
5.3.1  CHARACTERIZATION OF A2.2 .....................................................................................................229 
5.3.2  PURIFICATION OF A2.2 ..................................................................................................................231 
6 CONCLUSIONS.............................................................................................................................................234 
ACKNOWLEDGEMENTS...............................................................................................................................260 
 
Abstract 
________________________________________________________________________ 
 1 
 
ABSTRACT 
 
Type 1 or “juvenile” Diabetes is an autoimmune disease in which the insulin 
secreting -cells, essential for glucose homeostasis, are destroyed by a target immune 
attack. To date, patients with type 1 Diabetes can rely only on exogenous insulin injection 
to control the glucose levels, but, unfortunately, the related chronic and devastating 
complications cannot be prevented. Identification of -cell-specific genes playing critical 
roles during the development will help to create new sources of -cells from 
stem/progenitor cells. Interestingly, endocrine cell fate appears to be governed by the 
“peaked” expression of the transcription factor Ngn3. However, Ngn3’s targets are still 
not well identified. As for pancreas development also insulin gene regulation lacks 
important information. Therefore the aims of this Thesis work have been to test an set-up 
an efficient system for the transient expression of Ngn3, mimicking its physiological 
behavior; identify the major factors that lie directly downstream the Ngn3 expression and 
characterize a novel -cell specific insulin gene regulator. As result from this work, an 
innovative system mimicking pancreatic differentiation and Ngn3 pulsed expression has 
been developed.  Furthermore, a novel Ngn3’s downstream target, the zinc-finger protein 
“OVO_like 1, has been identified opening a new, and interesting, scenario of Ngn3 
gene’s regulation. Last, but not least, the -cell-insulin-gene regulator A2.2 has been 
characterized and a reproducible purification system has been developed. 
Riassunto 
________________________________________________________________________ 
 2 
RIASSUNTO 
 
Il Diabete di tipo 1 è una malattia autoimmune caratterizzata dalla distruzione 
della popolazione di cellule  del pancreas, compromettendo in questo modo il corretto 
controllo dei livelli di glucosio nel sangue. Attualmente, i pazienti colpiti da diabete di 
tipo 1 possono essere trattati solamente mediante somministrazione di insulina esogena. 
Tuttavia questa soluzione non è una cura al problema in quanto non previene le altre 
croniche e devastanti complicazioni legate alla patologia. Un approccio promettente è 
quello di creare una nuova popolazione di cellule  a partire da cellule staminali 
embrionali o adulte. Tale soluzione è però limitata dalla conoscenza dei fenomeni 
molecolari alla base dello sviluppo del pancreas e più in particolare delle cellule beta. 
Molti gruppi di ricerca si sono concentrati nell’identificazione di geni coinvolti nello 
sviluppo embrionale del pancreas. Da tali studi è emerso come il destino delle cellule 
endocrine sia regolato dall’espressione, tempo e spazio specifica, del fattore di 
trascrizione Ngn3 (neurogenina 3). Alla luce di questo, risulta di fondamentale 
importanza l’idenfiticazione dei geni target di neurogenina 3 ancora sconosciuti. Come 
per la regolazione dello sviluppo embrionale, anche la regolazione beta-specifica del gene 
dell’insulina manca di informazioni fondamentali. Per questi motivi, lo scopo di questa 
tesi di dottorato è stato quello di: settare un sistema per  l’espressione transiente di Ngn3 
in modo da mimarne l’espressione in vivo; identificare nuovi target a valle di Ngn3; 
purificare e caratterizzare il cofattore A2.2 responsabile, assieme a MafA, della 
regolazione dell’espressione del gene dell’insulina nelle -cellule. E’ stato quindi 
sviluppato e testato un nuovo sistema per l’espressione di Ngn3 che permette di mimarne 
l’espressione fisiologica. Il gene ovol1 è stato identificato come target di Ngn3 nelle beta 
cellule, rivelando un nuovo ruolo di neurogenina 3 nella regolazione dell’espressione 
genica. E’ stato inoltre caratterizzato il fattore di trascrizione A2.2 e il sistema usato per 
la sua purificazione è stato reso riproducibile per ulteriori studi. 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 1 
 
 
INTRODUCTION 
Chapter 1 Introduction 
 
 3 
1 Introdution 
 
1.1 The Pancreas 
 
 The pancreas is located next to the duodenum and serves two main functions: 
controlling blood glucose homeostasis and facilitating nutrient uptake.  
 The organ consists of three major distinct populations of cells: exocrine, 
endocrine and ductal cells. In the exocrine compartment the acinar cells are organized 
into small lobules (acini) that constitute most of the pancreas (90-95%), and synthesize 
digestive enzymes that are secreted through the highly branches system formed by the 
duct cells into the duodenum. This secretion of about twenty different enzymes (e.g. 
amylase, trypsin, chymotripsin, lipases and nucleases) results in digestion of proteins, 
carbohydrates, nucleic acids as well as fats in the small intestine (Slack 1995). In 
addition, the duct cells secrete mucins and bicarbonate to neutralize the stomac acid.  
 The endocrine cells, which represent 2-5% of the adult pancreas, are clustered 
into small groups known as Islets of Langerhans. Isolated islets consist of approximately 
70% -cells, 25% -cells, and <5% each of -cells, PP-cells as well as smaller numbers 
of gherlin-positive endocrine cells, microglial-like cells and vascular endothelium.  
 In the mouse the insulin producing -cells, are located in the inner core of islets. 
These islets are surrounded by a mantle of glucagon producing -cells, somatostatin 
producing -cells and PP-cells that produce pancreatic polypeptides.  
 The hormomnes, produced by the endocrine cells, are secreted into the 
bloodstream and are transported to their target tissues to control blood glucose 
homeostasis. In addition the pancreas in innervated by autonomic nerves that regulate 
hormone secretion during feeding and fasting (Fig.1). 
Chapter 1 Introduction 
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1.2 The pancreatic -cell 
 
 Within the islets of Langerhans, the -cells are by far the most abundant. Through 
secretion of appropriate quantity of insulin in response to the glucose levels, the -cells 
are mainly responsible for the maintenance of the body’s glucose levels within a very 
narrow range.  
 Like the other pancreatic endocrine cells, -cells develop from endodermal 
progenitor cells. The identity of the progenitor cells and of the transcription factors 
involved in the generation of functional -cells is of enormous interest and considerable 
research effort is spent in this field (Edlund 2001).  
Fig.1: the pancreas is located in the abdomen adjacent to the duodenum. The endocrine portion, islets 
of Langerhans surrounded by acinar tissue, secrete its hormones production into the bloodstream to 
control glucose homeostasis. Image modified from http://academic.kellogg.cc.mi.us/. 
 
 
Chapter 1 Introduction 
 
 5 
 The most significant increase in growth of -cell mass occurs at a period of late 
fetal life. Unfortunately, assessment of -cell mass is not a straightforward method and 
caution must be taken when looking at such data. Any limitations on -cell replacement 
are thought to have direct consequences for glucose homeostasis. Throughout the lifetime 
of a mammal, low levels of -cell replication (2–3% per day) seem to balance -cell loss 
by apoptosis (Habener and Stoffers 1998). This results in a slow increase in mass 
(Bonner-Weir 2001). Interestingly the most significant increase growth of -cell mass 
occurs at a period of late fetal life.  
 
 
1.3 Pancreas development 
 
1.3.1  Early patterning of the endoderm 
 
 During the embryonic development the process of gastrulation subdivides the 
embryo into three groups of cells or germ layers: the ectoderm that will form the skin and 
the central nervous system (CNS); the mesoderm that will form blood, the bones and the 
muscles; the endoderm that will form the respiratory and digestive tracts. The definitive 
endoderm is recruited from the epiblast during the gastrulation. Following ingression 
through the primitive streak, it displaces the visceral endoderm to the extra-embryonic 
yolk sac (Tam and Beddington 1992). The definitive endoderm forms the epithelium of 
the primitive gut tube from which the epithelial lining of the respiratory and 
gastrointestinal tract as well as liver, lungs, pancreas, thyroid and thymus develop (Wells 
and Melton 1999).  
 At embryonic day 7.5 (e7.5), the endoderm layer in mice is a cup of 
approximately 500-1000 cells enveloping the mesoderm and ectoderm, both of which 
send instructive signals to the endoderm making it competent to respond to subsequent 
permissive signals that will establish the organ domains along the anterior-posterior axis 
(A-P) (Wells and Melton 1999; Wells and Melton 2000).  
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 For example, Fibroblast Growth Factor(s) (FGF) signaling is required for 
establishing and maintaining gut tube domains along the A-P axis. FGF4 is expressed in 
the mesoderm and ectoderm adjacent to the developing midgut and hindgut endoderm, 
and has been demonstrated to promote a posterior gut cell fate and to repress an anterior 
endoderm cell fate. Patterning of the early endoderm by FGF4 is necessary to define a 
window of competence to pancreatic cell fate.  
The first sign of pancreatic morphogenesis is the elongation of the endoderm cells 
so that they assume a columnar shape within the region of incipient development. All 
three-cell lineages of the pancreas (ducts, acini, islets) develop from a common pool of 
pancreatic duodenal homeobox 1-expressing (Pdx1/Ipf1) progenitor cells. Pdx1 is a 
parabox homeobox-containing transcription factor that is turned on right after the 
endoderm begins to form a primitive gut tube by day 8.5 (e8.5).  Also, at this time the 
region destined to become the pancreas receives signals from two mesoderm-derived 
structures: the adjacent nothocord and the dorsal aorta, which leads to the expression of 
Pdx1.  
Several cell fate choices are important for the development of the nearly 
homogeneous progenitor cell population into the distinct cells of the complex organ of 
the mature pancreas. It has been shown by Gu et al. (Gu, Dubauskaite et al. 2002), using 
lineage tracing, that cell fate choices occur in Pdx1 positive cells at e9.5-e11.5, assigning 
cells to either a ductal fate or an exocrine/endocrine fate. This window was the only time 
when ductal differentiation was observed, whereas at e8.5 or e12.5 and anytime later only 
islets and acini cells are formed.  
 
 
1.3.2  Embryonic pancreas development 
 
After e10.5 the pancreatic tissue expands rapidly from a compact structure of 
tightly packed cells and grows several folds in size, forming a branched structure into the 
surrounding mesenchyme (Guz, Montminy et al. 1995; Miralles, Battelino et al. 1998; 
Miralles, Czernichow et al. 1998). The branching morphogenesis produces a ductal tree 
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out of the pancreatic epithelium. This is made through intraepithelial lumen formation in 
which multiple microlumens eventually coalesce to form continuous lumen from which 
the ductal network is established (Hogan and Kolodziej 2002; Jensen 2004).  
The fusion, at e16.5-e17.5 in mice, of the dorsal and ventral buds made up to the 
definitive pancreas. In humans and in some other species (rabbit, pig, cat and sheep) the 
ventral pancreas is formed also from the fusion of two lateral buds. The dorsal and 
ventral pancreatic genetic program is not completely synchronized. This is due to the fact 
that they are two independent endoderm domains that receive distinct signals from the 
surrounding tissues (Fig 2). 
 
 
1.3.3  Primary and secondary transition during embryonic pancreas   
  development 
 
 Rutter et al., in the 1970s (Pictet, Clark et al. 1972) proposed a model for 
pancreatic differentiation in which two successive regulatory transitions occur: the 
primary transition refers to the start of the pancreas budding and expansion of the 
progenitor cell pool, while the secondary transition describes the formation and 
differentiation of endocrine hormone expressing cells (Fig. 2).  
 During the primary transition (e8.5), the only differentiated cell type present is 
glucagon producing -cells, neither exocrine nor -cells are identified at this time. These 
early glucagons expressing cells are Pdx1-indipendent. Mesenchymal cells accumulate 
around the primitive gut and form a blanket over the pancreatic diverticulum.  
The secondary transition starts at e13.5, peaks at e14.5 and ends at e15.5, during 
this period the first population of fully differentiated -cells appears, but there is also an 
increase of exocrine proteins production. After the secondary transition few progenitor 
cells are left (Fig.2).  
Double Glucagon- and insulin-positive cells have been observed in early 
pancreatic buds. Nevertheless studies by Chiang and Melton (Chiang and Melton 2003) 
showed that insulin-positive cells have never active the glucagon gene and vice-versa, so 
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double positive cells are different compared with the mature endocrine cells. Furthermore 
studies by Herrera et al. (Herrera, Orci et al. 1998) shown that mature insulin positive 
cells have the PP-gene turned on, pointing out the possibility that insulin positive cells 
and PP-cells could develop from a common progenitor cell type.  
It has been shown that endocrine cell fate choice occurs temporally with glucagon 
expressing -cells being the first to develop, thereafter -cells (e13.5) -cells (15.5) and 
PP cells (e17). Once differentiated, the endocrine cells delaminate from the squamous 
epithelium and migrate into the extracellular matrix, recognizing each other and 
aggregating into a defined structure that is the Islet of Langerhans. This clusterization of 
endocrine cells and the subsequent Islet formation begin right before the birth (e18.5 in 
mouse). Finally the formation of capillary networks occurs inside islets due to newly 
formed islets producing VEGF-a (vascular endothelial growth factor) that ensure that the 
islets are close to capillaries for the secretion of the hormones into the bloodstream.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 2: Schematic diagram of the pancreas development in mouse. The pancreas develops at the 
foregut/midgut junction from a pre-patterned region of the primitive endoderm. The first morphological 
indications are around day 9.5 with the emergence of two evaginations, the pancreatic buds, first the 
dorsal bud, and subsequently the ventral bud (first transition). The pancreatic epithelium proliferates 
invading the surrounding mesenchyme (second transition) and around the e18 they are going to fuse, 
after the rotation of the ventral portion and give rise to the mature organ (third transition). Hebner et al, 
2005 
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1.3.4  The mesenchyme controls the exocrine and endocrine pancreas  
  formation 
 
It was long suspected that the pancreas, like other organs such as the lung of the 
kidney, develops by interactions between the epithelium and its surrounding 
mesenchyme.  
Insulin expressing cells developed in vitro from embryonic pancreatic epithelium 
in the presence of mesenchyme are immature, whereas those developed without 
mesenchyme become mature (Miralles, Czernichow et al. 1998; Miralles, Czernichow et 
al. 1999). The cells developed in the presence of mesenchyme resemble to insulin-
expressing cells developed in vivo before e15 in rat embryos but those developed without 
mesenchyme resemble to cells developed in vivo at a later stage (Roberts, Smith et al. 
1998). Thus, it seems that different factors control the development of these cell 
populations. So, it is important to redefine whether a relationship exists between insulin-
expressing cells developed before e15 and those that appear after.  
Many studies have confirmed such hypothesis showing that signals derived from 
the mesenchyme are implicated in the control of pancreatic cell differentiation into 
exocrine or endocrine tissue.  
It is now clear that the differentiation of the epithelium into acinar tissue is 
mesenchyme-dependent (Pictet, Clark et al. 1972; Gittes, Galante et al. 1996; Miralles, 
Czernichow et al. 1998; Miralles, Czernichow et al. 1999). Amylase- or carboxpeptidase 
A-expressing cells develop normally from pancreatic embryonic epithelium growth in 
vitro in presence of mesenchyme but in its absence their growth is strongly repressed. In 
vitro this effect has been shown to be reproduced by the ligands of FGF1, FGF7, and 
FGF10. Nevertheless, it is still unclear whether FGF1, FGF7, FGF10 induce the 
differentiation of precursor cells into amylase-expressing cells or act as growth factors for 
pre-existing amylase-expressing cells. Recently experiments on hamster diabetic models 
have shown that FGF1 has the highest effect on exocrine cells during the post-natal 
period.  
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The implication of signals from the mesenchyme in the control of endocrine tissue 
development is more controversial. It was showed that when adult ductal epithelial cells 
are grafted into immuno-incompetent mice in the presence of fetal mesenchyme, insulin- 
and glucagon-expressing islets develop, whereas such islets did not develop in the 
absence of mesenchyme.  
 These experiments strongly suggested that the mesenchyme is necessary 
for the development of endocrine tissue from epithelial cells, at least during postnatal life 
(Dudek and Lawrence 1988; Dudek, Lawrence et al. 1991) even though some other 
evidences shown that the presence of mesenchyme tissue seems not necessary during the 
embryonic development (Gittes, Galante et al. 1996). Therefore it is possible that the 
mechanisms controlling endocrine cell differentiation during prenatal and postnatal life 
could be different. 
On the contrary, other experiments have showed that the mesenchyme could be 
not necessary for the pancreas development, whereas it seems to act as a repressor of 
endocrine tissue development (Miralles, Czernichow et al. 1998). Based on these data 
(Gittes, Galante et al. 1996; Miralles, Czernichow et al. 1998) it has been proposed that 
the default pathway for the epithelial primordium leads to islet and extrinsic signal would 
exist to exert a negative control on the proportion of endocrine tissue to be generated. A 
search for specific repressing endocrine-cells differentiation factors expressed in the 
mesenchyme has been done.  
The hypothesis was that the epithelium would produce factors, such activins or 
bone morphogenic proteins (BMPs), which would act in an autocrine manner to favor 
differentiation of pancreatic precursor cells into endocrine cells. The hypothesis is 
supported by the fact that 1) activin and BMP-7 have been found to be expressed in the 
pancreatic anlage, 2) transgenic mice expressing mutants forms of the activin receptors 
suffer of hypoplasia of the endocrine portion of the pancreas, 3) AR42J cell line, that is 
considered the election model of pancreatic precursor cells, needs activin A and HGF or 
Betacellulin to promote the differentiation onto insulin positive phenotype (Furukawa, 
Eto et al. 1995; Ritvos, Tuuri et al. 1995; Mashima, Ohnishi et al. 1996; Mashima, 
Shibata et al. 1996; Yamaoka, Idehara et al. 1998; Shiozaki, Tajima et al. 1999). The 
possible involvement of activin(s) in the control of the differentiation of precursor cells 
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into endocrine cells was tested indirectly by investigating the role of follistatin 
(Nakamura, Takio et al. 1990) in the regulation the relative proportions of endocrine and 
exocrine tissue during pancreatic development.   
It has been shown that exogenous follistatin increases the development of 
immature pancreatic epithelial cells into amylase-expressing cells while repressing the 
development of insulin-expressing cells (Miralles, Czernichow et al. 1998). Exogenous 
follistatin, thus, mimics the effects of the mesenchyme. On the other hand, because mice 
deficient in follistatin are normal (Edlund 1998), other factors with a function identical to 
that of follistatin should be implicate in the control of endocrine pancreas development.  
  
 
1.3.5  Notochord signals are required for pancreas development 
 
The notochord is an axial structure of mesoderm origin and its presence during 
embryonic development defines members of the Chordate phylum. The notochord is one 
of the earliest embryonic structures to be formed and functions as structural support for 
the entire organism, either transiently (higher vertebrates) or persistently (some lower 
vertebrates). Many different studies have shown that in addition to its structural function, 
the notochord plays a critical role in the patterning of ectoderm and mesoderm tissues 
such as the neural tube and somitic derivates.  
Experiments using chick embryo have provided strong evidence that the 
notochord plays a role in development of the dorsal pancreas at the 6-13 somites stage 
(Wessells and Cohen 1967; Spooner, Walther et al. 1970; Dieterlen-Lievre and Beaupain 
1974; Sumiya and Mizuno 1987). In chick embryo, premature separation of the 
notochord from endoderm abolishes expression of pancreatic marker genes, while co-
culture of isolated notochord with endodermal epithelium restores marker expression. 
Interestingly, the notochord is only capable of inducing pancreas marker in the anterior 
but not posterior endoderm, indicating that the endoderm is already pre-patterned at this 
early stage (Kim, Hebrok et al. 1997).  
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Studies by Wells and Melton (Wells and Melton 2000) support this pre-patterning 
hypothesis by showing that factors produced in the overlying mesoderm and ectoderm 
regionally specify endoderm at the late gastrulation stage. At the time when pancreas 
formation is initiated, the notochord secretes a variety of potent inducing molecules 
including the TGF- family member activin-B and FGF2 (Fig. 3).  
Tissue culture experiments with chick embryos have revealed that both ligands 
can mimic the notochord effect and induce transcription of pancreatic marker genes in 
isolated endoderm. Isolated notochord, or purified activin and FGF activate pancreatic 
gene expression by repressing expression of Sonic hedgehog (Shh), a secreted protein of 
the Hedgehog family in the dorsal pre-pancreatic epithelium (Hebrok, Kim et al. 1998). 
The notochord also produces Shh and induces Shh expression in overlying floorplate 
cells in the neural tube. The apparent embryologic paradox that notochord both induces 
and represses Shh expression may be explained by the evidence that dorsal endoderm and 
ventral neural tube have different competence for Hedgehog, FGF and TGF- signals 
(Briscoe, Pierani et al. 2000) (Fig. 3). For example expression of activin receptor IIB has 
been detected in chick endoderm and dorsal neural tube but not ventral neural tube (Stern, 
Yu et al. 1995) just before morphogenesis. Previous studies have established roles for 
activin and Hedgehog signaling in patterning foregut gene expression and organogenesis 
in mice using mutations of the activin receptors (Kim, Hebrok et al. 2000). The pattern of 
malformations in these mutants was consistent with an anterior transformation of organ 
fates in the foregut and correspond with antero-posterior shifts in expression genes 
including Shh and Isl1.  
The role of Shh in establishing pancreatic development has also been tested 
extensively. In the mid gestational mouse embryo, Shh is expressed in nearly all 
epithelial cells lining the alimentary canal (Echelard, Epstein et al. 1993; Bitgood and 
McMahon 1995; McMahon 2000; Ramalho-Santos, Melton et al. 2000), with the 
important exception that Shh is excluded from the oral epithelium primordium of the 
anterior pituitary and from pancreatic epithelium (Hebrok, Kim et al. 1998; Treier, 
Gleiberman et al. 1998; Apelqvist, Li et al. 1999). In mouse and chicks, ectopic 
expression of Shh in embryonic pancreatic epithelium results in loss of pancreas marker 
expression and transformation of pancreatic mesenchyme into the gut mesoderm 
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(Hebrok, Kim et al. 1998; Apelqvist, Li et al. 1999). Inhibition of hedgehog signaling on 
isolated endoderm foregut, induce pancreatic gene expression (Hebrok, Kim et al. 1998). 
Thus, spatially restricted expression of Shh provides permissive condition leading the 
appropriate organogenesis along the A-P axis.  
Anterior-posterior patterning in mesoderm and ectoderm is regulated by spatially 
restricted expression of Hox transcription factors (Krumlauf 1994) that are encoded in 
defined genomic regions, the Hox clusters. In the hindgut, endodermal Shh activate 
expression of Hox genes in overlying mesoderm (Roberts, Johnson et al. 1995; Roberts, 
Smith et al. 1998). However few Hox genes are expressed in endoderm-derived 
epithelium and mutations in Hox genes have not yet been shown to result in A-P 
transformations of endoderm-derived organs in vertebrates. A set of Hox-related genes 
that are expressed in endoderm make up the ParaHox cluster, first identified in 
Amphioxus (Brooke, Garcia-Fernandez et al. 1998). The expression of Ipf1/Pdx1, a 
ParaHox member, is not restricted to the pancreatic tissue, and a dorsal-ventral bud 
outgrowth is initiated in Pdx1 mutant animals (Offield, Jetton et al. 1996), suggesting that 
other factors are required to specify the pancreas anlage.  
A potential candidate is Hlxb9, a homeobox transcription factor that is expressed 
in the dorsal bud before Ipf1/Pdx1 and whose function is required for the dorsal but not 
ventral bud morphogenesis (Harrison, Thaler et al. 1999; Li, Arber et al. 1999). 
Expression of Shh and Ihh (Indian Hedgehog) in the pancreas is not affected in the Hlxb9 
mutants (Li, Arber et al. 1999) but remains to be determined if Hlxb9 expression is 
regulated by endodermal Hedgehog signals.  
While some progress has been made in understanding the signaling pathways that 
regulate early stages of dorsal pancreas development less is known about the 
development of the ventral pancreas. The notochord does not touch the lateral endoderm 
that will give rise to the ventral portion of the future pancreas. Nevertheless, Shh 
expression is repressed in that portion of lateral endoderm (Kim, Hebrok et al. 1997). 
During dorsal pancreas formation, Shh remains excluded from dorsal pancreatic tissue 
even after notochord and endoderm have been separated by the fusion of the paired dorsal 
aorta (Kim, Hebrok et al. 1997; Hebrok, Kim et al. 1998; Apelqvist, Li et al. 1999). Thus, 
separate mechanisms may initiate and maintain Shh repression in dorsal pancreatic 
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endoderm (Fig 3). The ratio of endocrine to exocrine cell mass is approximately 100:1 in 
mice and in human, but varies in other species, suggesting that genetic mechanisms 
regulate this ratio. Early studies (Golosow and Grobstein 1962; Wessells and Cohen 
1967) showed that pancreatic exocrine development require mesenchymal signals that 
can be replaced by cell free extracts (Golosow and Grobstein 1962).  
Conclusions about the role of cell interactions in endocrine differentiation were 
limited in these studies because of their dependence on morphogenic markers of 
development. Soon after, other studies using molecular markers of endocrine and 
exocrine cells showed that the removal of pancreatic mesenchyme impairs the exocrine 
development but on the other side promotes the endocrine development (Rutter, Pictet et 
al. 1978; Gittes, Galante et al. 1996; Miralles, Czernichow et al. 1998). These data 
support the hypothesis that the epithelial-mesenchymal interactions regulate the 
appropriate balance of endocrine and exocrine development.  
More recent experiments showed that intercellular signaling of TGF-, Notch and 
hedgehog pathway are important for appropriate specification of endocrine and exocrine 
development. TGF- signaling is a major regulator of pancreatic endocrine and exocrine 
development. TGF- signaling components (Massague and Chen 2000) including the 
TGF- ligands activin and TGF-1, the corresponding receptors, antagonist including 
follistatin, noggin and gremlin, and intracellular Smads proteins like Smad2 and Smad4 
are expressed in embryonic pancreas epithelium and mesenchyme (Ogawa, Abe et al. 
1993; Furukawa, Eto et al. 1995; Manova, De Leon et al. 1995; Verschueren, Dewulf et 
al. 1995; Crisera, Maldonado et al. 2000; Tremblay, Hoodless et al. 2000). It has been 
shown that in vitro exposure of embryonic mouse pancreas to activin of TGF-1 
promotes the development of endocrine cells and in particular of -cells and PP-cells 
(Sanvito, Herrera et al. 1994) but repress the epithelial branching and acinar formation 
(Ritvos, Tuuri et al. 1995).  
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1.4 Hierarchy of transcription factors in pancreas development 
 
The transcription factors involved in pancreas development belong to three 
different families: the homeodomain family, the basic helix-loop-helix (bHLH) family 
and the windged helix family of proteins (Schwitzgebel 2001). Several recent gene 
disruption studies in mice have helped to elucidate the hierarchy of transcription factors 
in pancreas development. The following paragraph describes each transcription factors, 
its onset of expression, its function and the studies done in mice knockout models (Fig. 
4). 
 
Fig. 3: Signals from mesodermal derived structures such as nothocord, dorsal aorta, cardiac 
mesoderm and septum transversum regulating early dorsal and ventral pancreas development. 
Kim&McDonald, Current Opinion in Genetics & Development, 2002. 
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1.4.1  Hepatocyte nuclear factor (HNF) 3beta/Forkhead box (Fox) a2 
 
 HNF-3, also called Foxa2, belongs to the winged helix family of transcription 
factors and it is first expressed at e5.5-e6.5 in the anterior part of the early primitive 
streak and later in the definitive endoderm (Ang, Wierda et al. 1993; Monaghan, Kaestner 
et al. 1993; Sasaki and Hogan 1993). Homozygous inactivation of HNF-3 in mice 
results in defects in foregut morphogenesis. The embryos die around e11 in utero (Ang 
and Rossant 1994; Weinstein, Ruiz i Altaba et al. 1994) precluding detailed analysis of 
the role of HNF-3 in pancreas formation. Recently a specific knockout of Foxa2 in 
pancreatic -cells was described. The Foxa2 animals showed hyperinsulemic 
hypoglycemia revealing that the gene is important for the maintenance of normal 
 
 
 
Fig. 4: Simplified  hierarchy of 
transcription factors during pancreas 
development. The model is based on 
onset of expression of each factor and 
function analyzed by experiments of 
targeted disruption of the 
corresponding gene. Murtaugh et al. 
Development, 2007. 
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pancreatic histoarchitecture and the preservation of a normal physiological response to 
glucose. Furthermore it has been suggested for Foxa2 gene an essential role in glucagon-
cells development (Sund, Vatamaniuk et al. 2001; Lee, Sund et al. 2005). 
 
 
1.4.2  Hepatocyte nuclear factor (HNF) 3alpha/Forkhead box (Fox) a1 
 
 HNF-3, now know as Foxa1, belongs to the same family of transcription factors 
as HNF-3. Its expression in the endoderm starts at e7.5. Targeted disruption of the 
HNF-3 gene leads to a 70% reduction of glucagon mRNA levels with no reduction in 
the number of -cells in the pancreas (Kaestner, Katz et al. 1999). Therefore it has been 
concluded that the decreased glucagon level is most likely caused by reduced 
transcriptional activity of the glucagon gene.   
 
 
1.4.3  Hlxb9 
 
 The Hlxb9 gene is a homeobox gene encoding the HB9 protein. The earliest 
expression of Hlxb9 is detected at e8 in the notochord and gut endoderm (Li, Arber et al. 
1999). By e12.5, the expression level decrease but one day later the expression increase 
again in the dorsal and ventral portion of the pancreas (Harrison, Thaler et al. 1999). 
Later, by e17.5, the expression of HB9 protein is detectable only in -cells. Deficiency of 
Hlxb9 in mouse pancreas causes failure of the dorsal pancreas formation, Pdx1 and Ils1 
dorsal expression while the ventral portion forms at the expected time but with a reduced 
-cell population (Li, Arber et al. 1999). On the other hand experiments using the Pdx1 
promoter to drive expression of Hlxb9 in the pancreas resulted in severely perturbation of 
pancreatic organization and impaired differentiation. This notion is evidenced by the 
detection of more elongated, tube-shaped intestinal-like structure in the pancreatic area 
and decreased insulin-, amylase-, carboxypeptidase A-expressing cells (Li and Edlund 
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2001). It further confirms the necessity of tightly-controlled temporal expression of 
Hlxb9 during pancreas development. 
 
1.4.4  Pancreatic duodenal homeobox 1 (Pdx1)/insulin promoter factor 1  
  (Ipf1) 
 
 The Pdx1 (Ipf1) gene belongs to the homeodomain family of proteins and it was 
the  first gene shown to be cell-autonomously required for formation of the pancreas in 
mice (Jonsson, Carlsson et al. 1994) and humans (Stoffers, Zinkin et al. 1997). Initially it 
was isolated by different groups as A1-element binding protein of the insulin promoter 
(Ohlsson, Karlsson et al. 1993) and the TAAT-binding factor of the somatostatin 
upstream enhancer (Leonard, Peers et al. 1993; Miller, McGehee et al. 1994), only later it 
emerged as a developmental regulator, in particular when its expression has been deleted. 
Expression of Pdx1 begins in epithelial cells of the dorsal and ventral pancreatic anlage at 
the 10 somites stage (e8.5). Lower expression is observed in adjacent duodenal and 
posterior stomach cells. Pdx1 expression persists in a homogenous way as the pancreatic 
epithelium branches. The early glucagon-producing cells are not Pdx1 positive. As the 
secondary transition starts, Pdx1 expression appears more evident. Insulin-positive cells 
up-regulate Pdx1 expression while differentiating exocrine cells gradually lose the Pdx1 
expression, although continuing to express the protein at low level. Ductal-cells also 
down-regulate Pdx1 and only -cells and a subset of -cells express Pdx1 at levels 
readily detectable using standard histochemical techniques (Oster, Jensen et al. 1998). 
Pdx1 has been shown to be important for the transactivation of several pancreatic genes 
including insulin, glucagon, somatostatin, islet amyloid polypeptide (IAPP) and glucose 
transporter GLUT-2 (Ohlsson, Karlsson et al. 1993; Miller, McGehee et al. 1994; 
Waeber, Thompson et al. 1996; Watada, Kajimoto et al. 1996). In Mice Pdx1
-/-
 the 
pancreas is absent, despite the initial formation of the pancreatic bud (Ahlgren, Jonsson et 
al. 1996; Offield, Jetton et al. 1996; Johansson, Momma et al. 1999). More recently 
transgenic animals have been generated to study specifically the absence of Pdx1 in -
cells. Such study has demonstrated the role of Pdx1 in the maintenance of -cell identity 
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and glucose sensing machinery (Ahlgren, Jonsson et al. 1998). Finally a selective 
knockout mouse has been created to study the role of Pdx1 at different times during 
pancreas development. Such model suggested that Pdx1 expression is essential for the 
maintenance of -cell functions, correct pancreatic structure as well as exocrine 
development in the adult pancreas (Hale, Kagami et al. 2005; Holland, Gonez et al. 
2005). 
 
 
1.4.5  Hepatocyte nuclear factor (HNF) 6 
 
 During pancreas development, HNF6 is detected at e9.5 in the epithelial cells and 
is later restricted to the exocrine and duct cells (Rausa, Samadani et al. 1997). In HNF6
-/-
 
embryos, the exocrine pancreas develops normally however the endocrine phenotype is 
severely inhibited. At birth, fewer endocrine cells were found and the islets of 
Langerhans are absent. Interestingly, the islets reappear with changed architecture at a 
later stage (Jacquemin, Durviaux et al. 2000). Therefore, the pancreatic epithelial cells 
can be committed in the absence of HNF6 but they may fail to give rise to the expected 
precursor endocrine pool. This notion is supported by the reduced expression of Ngn3, a 
potential marker of endocrine precursor cells, in HNF6 null mice (Jacquemin, Durviaux 
et al. 2000). 
 
 
1.4.6  Neurogenin3 (Ngn3) 
 
 Ngn3 is a transcription factor that belongs to the bHLH transcription factor 
family. Its expression starts at e9.5 (in mice), peaks at e15.5 and diminishes to 
undetectable levels before the birth (Apelqvist, Li et al. 1999). Experiments using 
knockout models have shown that those animals lack the endocrine population before 
birth, on the other end persistent expression of Ngn3 drives the formation of additional 
Chapter 1 Introduction 
 
 20
endocrine cells (Apelqvist, Li et al. 1999; Gradwohl, Dierich et al. 2000). For that Ngn3 
is thought to be responsible for the pancreatic endocrine commitment. A broader 
discussion of this fundamental transcription factor will be done in a separate section of 
this Thesis. 
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1.4.7  Hairy Enhancer of Split-related protein (Hes1) 
 
 Hes1 also encodes a bHLH protein expressed at e9.5 in pancreas. The detection of 
pancreatic endocrine cells excess in Hes1
-/-
 animals has suggested that Hes1 may have a 
role in repressing endocrine cell development through the Notch signaling pathway 
(Jensen, Pedersen et al. 2000). The elevated expression of Ngn3 in the stomach, small 
and large intestine in Hes1
-/- 
mice confirmed that Hes1 and Ngn3 have opposite effects on 
the determination of endocrine cell fate (Sumazaki, Shiojiri et al. 2004). Based on the 
pro-endocrine action of Ngn3, impaired expression of Hes1 would be predicted to 
increase differentiation of pancreatic endocrine cells, in fact conversion of the developing 
biliary system to pancreatic tissue in Hes1 deficient mice has been described and further 
support that idea (Burke, Shen et al. 2004; Sumazaki, Shiojiri et al. 2004). The 
experiments also claimed out that the conversion from biliary system to pancreatic like 
cells might be through the re-activation of Ngn3 that is initially restrained by Hes1. 
 
 
1.4.8  Pancreatic transcription factor 1 (PTF1-p48) 
 
 The bHLH transcription factor PTF1-p48 was first described as a DNA-binding 
subunit of the hetero oligomeric transcription factor PTF-1 that governs the expression of 
genes in the exocrine pancreas (Krapp, Knofler et al. 1996). Recent results have revised 
the role of PTF1-p48 to include also the involvement in both exocrine and endocrine cell 
lineage development. Furthermore a participation in endocrine spatial organization has 
been shown by several studies in murine and zebrafish models (Krapp, Knofler et al. 
1998; Kawaguchi, Cooper et al. 2002; Lin, Biankin et al. 2004). 
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1.4.9  NeuroD1/2 cell E-Box trans-activator 2 (BETA2) 
 
 NeuroD1, also called BETA2 (-cell E-Box trans-activator-2), is a bHLH 
transcription factor which expression start at e9.5 and goes throughout the development 
of -cells (Naya, Stellrecht et al. 1995) and can be induced by Ngn3 (Huang, Liu et al. 
2000). The essential role of NeuroD/BETA2 during pancreatic development has been 
shown by detection of severely reduced endocrine phenotypes in homozygous mice at 
birth. NeuroD/BETA2 null mice die after birth because hyperglycemia due to impaired 
islet formation along with a depletion in -cell population (Naya, Huang et al. 1997; 
Chae, Stein et al. 2004). Recently it has been shown that NeuroD/BETA2 activate the 
insulin promoter in -cells and represses the somatostatin promoter in human pancreatic 
-cell line (Itkin-Ansari, Marcora et al. 2005). 
 
 
1.4.10  Paired-box homeobox genes (Pax4/Pax6) 
 
 The paired homeobox genes encode key transcription factors involved in the 
organogenesis of many tissues including eye, brain and endodermal-derived organs such 
as pancreas and thyroid gland (Mansouri, Goudreau et al. 1999). Among them, Pax4 and 
Pax6 are associated with pancreatic endocrine cell differentiation (Marsich, Vetere et al. 
2003; Smith, Gasa et al. 2003).  The expression of Pax4 and Pax6 starts at e9.5 and e9.0, 
respectively (Turque, Plaza et al. 1994; Sosa-Pineda 2004). Targeted disruption of Pax4 
results in the absence of - and -cells in the newborn mice. On the other hand it has been 
observed, in the same model, an increase in -cell population (Sosa-Pineda 2004). Insulin 
and glucagon expressing cells were detected in mutant mice at e10.5, although insulin is 
no longer detected by e13.5. Thus, Pax4 seems to play a role in maintenance of -cell 
differentiation and maturation rather than to initiate it. On the other hand, Pax6 seems to 
be more crucial for the development of the -cells (St-Onge, Sosa-Pineda et al. 1997; 
Sosa-Pineda 2004). Double knockout of Pax4 and Pax6 have also been generated and 
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shown the complete loss of endocrine cells types (St-Onge, Sosa-Pineda et al. 1997), so 
Pax4 and Pax6 probably act cooperatively to regulate islet cell identities. 
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1.4.11 NK class homeodomain protein Nkx2.2 and Nkx6.1 
 
 Nkx2.2 and 6.1 belong to the NK class of homeodomain proteins. The expression 
of the two proteins starts respectively at e9.5 and e10.5 (in mice). For both the proteins 
the early expression is broadly spread but then became more restricted to defined cell 
types, in particular during the development the expression of Nkx2.2 become restricted to 
-, - and PP cells while the Nkx6.1 expression become  restricted to insulin producing 
cells in the adult pancreas (Oster, Jensen et al. 1998; Sussel, Kalamaras et al. 1998; 
Wang, Elghazi et al. 2004). More recently, Prado et al. (Prado, Pugh-Bernard et al. 2004) 
found that -cells were replaced by -cells (ghrelin-producing cells) in both Nkx2.2-/- and 
Pax4
-/-
 animal models (Prado, Pugh-Bernard et al. 2004). Nkx6.1 null animals display an 
important decrease in the -cell population after e12.5 (Sander, Sussel et al. 2000), 
therefore Nkx6.1 seems to be required for the expansion and final differentiation of -cell 
progenitors. The phenotype of the Nkx2.2 and double (2.1 and 6.1) knockout animals is 
very similar (Sander, Sussel et al. 2000). Since Nkx2.2 is still present in the Nkx6.1
-/-
 
model this indicates a possible common pathway with Nkx2.2 expressed upstream of 
Nkx6.1. 
 
 
1.4.12  Islet 1 (Isl1) 
 
 Isl1 encodes a transcription factor of the LIM homeodomain family and is 
involved in the early formation of the pancreas (Ahlgren, Pfaff et al. 1997). The Isl1 
expression starts at e9.0 in the dorsal pancreatic epithelium and in the mesenchyme 
surrounding the dorsal, but not the ventral, evagination of the gut endoderm. Isl1 is 
particular in that regard because is expressed in fully differentiated cells. In fact, at e9.5 
all the glucagon positive cells express Isl1 then later it is detectable in all the islets cells. 
Mice mutant for Isl1 do not develop after e9.0. The dorsal pancreatic mesenchyme is not 
formed, endocrine development is abolished and the exocrine component of the dorsal 
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pancreas is strongly depleted. The importance of the role of Isl1 has been understood by 
experiments of co-culture of tissue from Isl1 mutant mice with mesenchyme from wild 
type embryos. In these conditions the endocrine development can be partially restored but 
not the exocrine one. Furthermore Isl1 has been shown to bind the promoter region of 
several genes such as glucagon, insulin and somatostatin, suggesting that the Isl1 is also 
necessary for the maintenance of the islet function in the adult (Brink 2003). 
 
 
1.4.12  Insulinoma-associated factor 1 (Insma/IA1) 
 
 The insulinoma-associated 1 (Insm1/IA1) gene encodes for a zinc-finger protein 
well conserved during the evolution and was first identified in a subtraction library from 
an insulinoma (Goto, De Silva et al. 1992). Subsequently it was found to be expressed in 
a large number of insulinoma, neuroendocrine tumors as well as during nervous system 
and pancreas development (Goto, De Silva et al. 1992; Zhu, Breslin et al. 2002; Breslin, 
Zhu et al. 2003). To IA1 has been attributed, for long time, the role of transcription 
repressor; however recent studies have showed that it can act also as activator of the 
transcription during pancreas development (Gierl, Karoulias et al. 2006). Activated by 
Ngn3 (Mellitzer, Bonne et al. 2006) IA1 is expressed in all the cell types of developing 
and adult pancreatic islet (Gierl, Karoulias et al. 2006), nevertheless its role during 
pancreas development has not been assessed yet. Generic analysis performed using IA1 
mutant mice model shown that the protein is essential for the correct differentiation of the 
-cell population. IA1 mutants showed that most of the -cell precursor are maintained 
but do not express any hormones. The phenotype of IA1 mutant mice differs from that of 
Nkx2.2, Nkx6.1 and Pax4 mutant mice (Sander, Sussel et al. 2000; Prado, Pugh-Bernard 
et al. 2004). Moreover immunohistological and microarray analysis of those animals 
reveal a down-regulation of Nkx6.1 and Pdx1 in the pancreas, indicating that IA1 affects 
the transcriptional network that determines -cell differentiation. 
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1.4.13  Brn4 Brain 4 
 
 Brn4 (Brain 4/Pou3f4) belongs to a POU-homeodomain transcription factor 
family and directly regulate the glucagon promoter (Hussain, Lee et al. 1997). Its 
expression starts at e10 in the pancreas just before Pax6, which also appears in the 
glucagon expressing cells. It was suggested that Brn4 was the first and only gene 
specifically expressed in glucagon-expressing cells in the pancreas, nevertheless a Brn4 
null mouse showed that its expression is not essential for glucagon cell fate determination 
since this mouse had normal endocrine formation (Heller, Stoffers et al. 2004). 
 
 
1.5 Endocrine fate commitment 
 
1.5.1  Ngn3 the master-switch of -cell development 
 
 Neurogenin 3 (Ngn3, atoh5) belongs to the bHLH transcription factor family and 
has the role of proendocrine factor in the development of the pancreas (Gradwohl, 
Dierich et al. 2000). Ngn3 is expressed in endocrine precursors of both the pancreas and 
gastrointestinal tract (Jenny, Uhl et al. 2002). Mice deficient for Ngn3 fail to develop any 
endocrine cells and die 1-3 days after birth because diabetes, whereas exocrine cells 
develop normally (Gradwohl, Dierich et al. 2000).  
 Ngn3 has been demonstrated to be necessary and sufficient to drive the formation 
of islet cells during pancreatic development (Apelqvist, Li et al. 1999). Also using in ovo 
electroporation of early chick endoderm, Ngn3 was shown to induce endocrine 
differentiation in entire gut epithelium (Grapin-Botton, Majithia et al. 2001).  
 Ngn3 expressing cells in the pancreas are transient endocrine progenitor cells 
committed to an endocrine fate. Lineage tracing studies have shown that Ngn3 expressing 
cells do not give rise to exocrine cells and very rarely to duct cells but give rise to all 
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endocrine cell types (Gu, Dubauskaite et al. 2002). Ngn3 protein can be detected in very 
few cells in the early pancreas (e10.5-e12.5), while from e13.5 and onward, a major peak 
(between e14.5-e15.5) of expression is observed (Apelqvist, Li et al. 1999; Jensen, Heller 
et al. 2000). Ngn3 expression is only observed as a transient expression in the pancreas 
and is completely turned off in postnatal mice, as shown by immunohistochemistry 
(Jensen, Heller et al. 2000).  
 However, Gu et al. (Gu, Dubauskaite et al. 2002) has detected Ngn3 expression 
by RT-PCR in handpicked islets from 8-week old mice. In addition, using double 
transgenic Ngn3-Cre.ER
TM
;Z/AP mice they observed, upon administration of Tamoxifen 
(TM), induction, in three or eight-weeks old mice, of Ngn3 expression in 15 out of 25 
pancreata (identified by Human Placental Alkaline Phosphatase HPAP staining cells) in 
islet cells many of which co-express insulin (Gu, Dubauskaite et al. 2002). These data 
could suggest that Ngn3-expressing cells act as islet progenitor cells not only during 
embryogenesis but also in adults. This Ngn3 expression is transient and the new Ngn3-
positive cells are formed from Ngn3-negative cells during development as showed by the 
fact that positive staining for Ngn3 disappeared in HPAP+ cells (Gu, Dubauskaite et al. 
2002).  
 In conclusion the majority of Ngn3+ cells are endocrine progenitors that 
differentiate into endocrine cells without self-renewing (Gu, Dubauskaite et al. 2002). 
This, suggested also by Jensen et al., shows that once cells enter the endocrine pathway 
and start to express Ngn3, their proliferation rate decrease (Jensen, Heller et al. 2000). 
Premature expression of Ngn3 in pancreas (Apelqvist, Li et al. 1999) and endoderm 
(Grapin-Botton, Majithia et al. 2001) gives rise to endocrine cells consisting mostly of -
cells and it was suggested that -cells are the default endocrine cell type to be formed. 
However, an in vitro system in which Ngn3-expressing adenovirus was used to infect a 
mouse pancreatic duct cell line showed that Ngn3 turns on the islet differentiation 
program in these duct cells (Gasa, Mrejen et al. 2004). Both the genes that act early in 
differentiation, and those necessary for fully differentiated islet cells were switched on. 
All islet hormones, with the exception of glucagon, are turned on, although in much 
lower level that regular islets or TC3 cell line. This could be explained because the duct 
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cell line lack positive regulators that allows -cell differentiation. In fact, Brn4 has not 
been induced, in that system, by the expression of Ngn3.  
 An alternative explanation of such results could be the competency of the cells; in 
particular the duct cells could be not able to respond to Ngn3 as a pancreatic progenitor 
cell does. Insulin gene expression has been also achieved in a similar study by Vetere et 
al. (Vetere, Marsich et al. 2003) where pluripotent cells were transfected with an Ngn3-
expressing vector (Vetere, Marsich et al. 2003). Interestingly, only after induction of 
endoderm differentiation the overexpression of Ngn3 has been able to induce insulin gene 
expression along with many other endocrine transcription factors (Vetere, Marsich et al. 
2003).  
 It is now accepted that Ngn3-positive cells could adapt their responses to specific 
microenviromental inductive signals that changes during pancreatic development, and 
this give rise to the fact that the different endocrine cell types adopt their fate at different 
time points. This was partly confirmed using pancreatic explants in which forced 
expression of Ngn3 around e9.5 favors -cells, whereas at e 12-e13 it favors -cells 
(Dominguez-Bendala, Klein et al. 2005). This increase of Ngn3 expression level was 
achieved by transducing pancreatic explants with a TAT/Ngn3 fusion protein. This 
TAT/Ngn3 fusion protein was taken by cells by endocytosis and remains in the cells for a 
short period before to be degraded. Interestingly this short burst of Ngn3 activity, 
mimicking in some way normal behavior of Ngn3 expression, has been demonstrated to 
be essential to activate the transcription factors cascade downstream Ngn3 protein. 
Furthermore it has also been suggested that several other TF are required to deviate from 
the adult -cell fate. The Ngn3 gene expression is turned off before terminal 
differentiation and in the normal pancreas, Ngn3 protein has never been observed co-
expressed with mature markers such as insulin. Ngn3 positive cells exit the cell cycle, 
turn off Ngn3 expression and differentiate into mature endocrine cells. Interestingly, in a 
recent study by Lee et al., it has been demonstrated that pancreatic transcription factors 
that are seen to be expressed during the development are re-expressed also during the 
regeneration, with the only know exception of Ngn3 (Lee, De Leon et al. 2006).  
 Though Ngn3 protein, which marks all the proendocrine cells during 
development, is not seen during mouse pancreas regeneration, functional neo-islets are 
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generated by 4 weeks after 70% pancreatectomy (Lee, De Leon et al. 2006). The 
explanation for such phenomenon has been given only recently by Joglekar et al. 
(Joglekar, Parekh et al. 2007). In particular they showed that, after pancreatectomy only 
transcription factors upstream Ngn3 are activated and expressed at protein level with a 
pattern of expression similar to that observed during pancreas development whereas both 
Ngn3 and its direct downstream target (NeuroD/BETA2 and Nkx2.2) were never 
expressed even though the transcript for Ngn3 could be detected. The hypothesis that 
comes out from this study is a post-transcriptional regulation of Ngn3 protein by 
microRNA (Joglekar, Parekh et al. 2007). They carried out microRNA analysis during 
different stages of pancreatic development and regeneration and identified that, 
microRNAs that can potentially bind to Ngn3 transcript, are expressed at least 200-fold 
higher in the regenerating mouse pancreas. Inhibition of these miRNAs in regenerating 
pancreatic cells using anti-sense miRNA-specific inhibitors induced expression of Ngn3 
and of its downstream players: NeuroD/BETA2 and nkx2.2.  
 Furthermore Johansson et al. (Johansson, Dursun et al. 2007) have generated an 
inducible form of Ngn3 fusing the mutated form of the estrogen receptor (ER
TM
) that can 
be activated by Tamoxifen (Hayashi and McMahon 2002) under the transcriptional 
control of the mouse pdx1 promoter in order to specifically express this inducible protein 
in the pancreas. An addition of IRES-nGFP sequence allowed direct tracing of cells 
expressing the pdx1-ngn3-ER
TM
-IRES-nGFP transgene (Johansson, Dursun et al. 2007). 
Transgenic mice expressing the Tamoxifen-inducible Ngn3 fusion protein have been so 
generated. This work shows how the time of Ngn3 activation is important to differentiate 
cells into the different endocrine cell types. Early activation almost exclusively induced 
glucagon
+
 cells, while depleting the pool of pancreas progenitor cells. A activation at 
e11.5, Pdx1
+
 cells became competent to differentiate into insulin and PP cells. 
Somatostatin cells were generated from e14.5 while the competence to generate 
glucagon+ cells was dramatically decreased.  
 Altogether these data show how the timing for Ngn3 expression is important for 
the development and differentiation of the endocrine components of the pancreas.  
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1.5.2  Notch signaling pathway in endocrine differentiation 
 
 Notch signaling has been shown to play two major functions in the pancreas 
development: an early role in maintaining progenitor cells into an undifferentiated state 
and a later role in controlling the lateral inhibition, allowing selection of endocrine cells 
from non-endocrine cell population. As for the early role it seems that Notch signaling 
controls directly and indirectly Ngn3 expression. In fact it is know that Ngn3 expression 
appears to be dependent from positional signals that direct it to the gut and to the 
pancreatic endoderm and local signals that limit it to specific cells (Fig. 5).  
As for the lateral inhibition the mechanism is more straightforward and it has been 
recognized to be an almost “general” regulator for cell-fate decision in a variety of 
organisms and tissues (Kageyama and Ohtsuka 1999; Appel, Givan et al. 2001). Lateral 
inhibition, through the notch signaling pathway, prevents Ngn3 expression in all but a 
few scattered cells within the pancreatic epithelium (Schroeter, Kisslinger et al. 1998; 
Apelqvist, Li et al. 1999; Gradwohl, Dierich et al. 2000; Jensen, Pedersen et al. 2000; 
Schwitzgebel, Scheel et al. 2000). As expected, FGF10 deficient mouse embryos show a 
hypoplastic pancreas attributed to loss of the proliferative phase of the pancreas epithelial 
progenitor cells (Bhushan, Itoh et al. 2001). 
In the pancreas, all components of the Notch pathway have been shown be 
expressed (Jensen, Pedersen et al. 2000; Lammert, Brown et al. 2000). The Notch 
receptors Notch1 and 2 are expressed in pancreatic epithelial precursors, Notch3 in the 
surrounding mesenchyme, and Notch4 in the endothelial cells. The Notch ligands 
Jagged1, 2 and Delta1 (Dll1) are also expressed in pancreas. In addition the Notch in 
concert with the DNA-binding protein RBP-J activate the expression of the target gene 
Hes1 in the pancreatic bud and later in the pancreatic epithelial precursor cells 
(Apelqvist, Li et al. 1999).  
Interestingly, Hes1, a dominant repressor, dramatically and specifically inhibits 
the Ngn3 promoter (Lee, Smith et al. 2001). This is achieved when Ngn3 expression in a 
committed cell activates the Delta1 notch ligand, which in turn activates the receptor 
Notch1 in the surrounding cells by an intercellular cleavage of the intracellular domain of 
the Notch receptor. This domain interacts with RBP-J activating Hes1 expression and 
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subsequently downregulates the expression of Ngn3. Hes1 is co-expressed in exocrine 
precursors but not in amylase expressing acinar cells, along with Ptf1a (Esni, Ghosh et al. 
2004). Overexpression of Hes1 repress acinar cell differentiation, but not Ptf1a 
expression, in a cell-autonomous manner in explant cultures of e10.5 mouse dorsal 
pancreatic buds. Ectopic Notch activation also delays acinar cell differentiation in 
developing zebrafish pancreas.  
Further evidence of a role for endogenous Notch in regulating exocrine pancreatic 
differentiation was provided by examination of mutated zebrafish embryos in which 
Notch signaling is disrupted. Notch-deficient embryos display accelerated differentiation 
of exocrine pancreas relative to wild-type controls.  
Using transient transfection assays involving a Ptf1-responsive reporter gene, it 
has been showed that Notch target genes directly inhibit Ptf1 activity, independent of 
changes in expression of Ptf1 component proteins. These results define a normal 
inhibitory role for Notch in the regulation of exocrine pancreatic differentiation 
(Apelqvist, Li et al. 1999). This has been confirmed also by the observation that a forced 
expression of constitutively active Notch1 (Notch1-1C) using the pdx1 promoter 
represses both pancreatic endocrine and exocrine differentiation (Hald, Hjorth et al. 2003; 
Esni, Ghosh et al. 2004).  
The pancreatic epithelium appears disorganized with reduced numbers of 
endocrine cells. Subsequent branching morphogenesis is impaired and the pancreatic 
epithelium forms structures with ductal phenotype containing a few endocrine cells but 
completely devoid of acinar cells; on the other hand defects in Notch signaling has been 
shown to accelerate the endocrine differentiation program leading to a depletion of the 
precursor cell population (Apelqvist, Li et al. 1999; Jensen, Pedersen et al. 2000; Hald, 
Hjorth et al. 2003; Hart, Papadopoulou et al. 2003). Mice Hes1
-/-
 have showed ectopic 
expression of Ngn3 in the biliary epithelium and subsequent differentiation into 
pancreatic-like tissue (Sumazaki, Shiojiri et al. 2004). Interestingly, Hnf6 null mouse, 
show a highly reduced expression of Ngn3 and a consequent depletion of endocrine cell 
population. Nevertheless the level of Notch1, 2, 3 and Hes1, are normal. This suggests 
that the expression of Ngn3 could be regulated not only by Notch pathway.  
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The maintenance of Notch activation was proposed to derive from the pancreatic 
mesenchyme and mediated by FGF10 (Gittes, Galante et al. 1996; Norgaard, Jensen et al. 
2003; Miralles, Lamotte et al. 2006). Persistent expression of FGF10 in the pancreatic 
epithelium resulted in hyperplasia and impaired pancreatic differentiation of pancreatic 
progenitors caused by a maintained Notch activation. In fact, the FGF10-positive 
pancreatic cells expressed Notch1 and Notch2, the Notch-ligand genes Jagged1 and 
Jagged2, as well as the Notch target gene Hes1 resulting in impaired expression of Ngn3 
(Hart, Papadopoulou et al. 2003; Norgaard, Jensen et al. 2003). While FGF10 is 
expressed in the mesenchyme, its receptor FGFR2 is expressed in the pancreatic 
epithelium during the embryonic life (Orr-Urtreger, Bedford et al. 1993; Scharfmann 
2000). This is consistent with the hypothesis that FGF10 is the mesenchymal factor 
responsible for the maintenance of the Notch signaling in the self-renewal of progenitor 
cells (Miralles, Lamotte et al. 2006).  
In conclusion the Notch signaling pathway can be considered as a “suppressive 
maintenance”; the Notch target gene Hes1 activation leads to “suppression” of 
differentiation and “maintenance” of the precursor population. This produces ubiquitous 
expression of the Notch system in contrast to the scattered expression in the lateral 
inhibition model.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5: Lateral inhibition is caused by cell-cell signaling between epithelial neighbors. Cells in which Notch1 
is activated by the ligand Delts express high levels of Hes1, which in turn repress the proendocrine gene 
Ngn3. However, in ligand expressing cells, hes1 is not regulated, thus allowing robust Ngn3 expression and 
differentiation toward the endocrine lineage. Jensen J., 2004 
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1.6 Glucose homeostasis: 
 
Normal glucose homeostasis in the human body represents a balance between 
glucose appearance and tissue glucose uptake and utilization. This balance is tightly 
regulated. Therefore, plasma glucose concentrations are maintained within a range of 60–
110 mg/dl for the normal fasting state and <140 mg/dl for 2-hour post-glucose-load. 
 Three physiologic processes need to interact in a highly coordinated way to 
maintain glucose homeostasis: -cell insulin secretion, tissue glucose uptake, and hepatic 
glucose production. In the fasting state, hepatic glucose production via glycogenolysis 
and gluconeogenesis is almost exclusively responsible for the plasma glucose levels. 
 During fasting, tissue glucose uptake is predominantly insulin-independent and 
occurs mostly in those tissues that require glucose such as the central nervous system. In 
order to maintain fasting glucose concentrations constant, the rate of tissue glucose 
uptake dictates the rate of hepatic glucose production.  
Following a meal (absorptive state), plasma glucose levels rise and promote 
hepatic glucose uptake. Elevated glucose levels stimulate the release and production of 
insulin by the -cell, which acts as a glucose sensor, then the hepatic glucose production 
is suppressed by increased plasma insulin concentrations. Peripheral glucose uptake, 
mostly in the muscle, is also stimulated by insulin through GLUT4, a member of the 
GLUT family of glucose transporters (Foster and Klip 2000). In this way, hyperglycemia 
is minimized and the return of mealtime glycemic levels to pre-meal values is ensured 
(Porte and Schwartz 1996).  
Once inside the cell, the glucose is converted into glycogen in muscle or 
converted to lipids in adipose tissue (lipogenesis) (Nonogaki 2000). Free fatty acid (FFA) 
metabolism also plays an important role in maintaining glucose homeostasis in the fasting 
and absorptive state. Elevated rates of fat breakdown (lipolysis) lead to an increased 
release of FFAs. These have a detrimental action on the uptake of insulin by the liver, 
which in turn results in increased hepatic gluconeogenesis. In addition, elevations of FFA 
inhibit glucose uptake and utilization in insulin-sensitive tissues. Increased plasma insulin 
levels after a meal inhibit lipolysis and FFA release from adipose tissue. 
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1.7 Diabetes 
 
 The diabetes mellitus is one of the most common endocrine disorders today, with 
180 million people affected in the world in 2003 to approximately 220 million people in 
2010 (Zimmet 2000; Zimmet, Alberti et al. 2001).  
 The diabetes is a group of disorders of multiple etiologies characterized by chronic 
hyperglycemia with disturbances of carbohydrate, fat and protein metabolism resulting 
from defects in insulin secretion, insulin action or both (WHO 1999). The two most 
common types of diabetes mellitus are type 1 and type 2. About the 90% of the patients 
with diabetes suffer from type 2 diabetes, which is characterized by insulin resistance and 
impaired insulin release.  
 Type 2 diabetes used to be called “adult onset diabetes”, but today children are also 
being diagnosed. Type 2 diabetic patients have chronically increased levels of blood 
glucose, which is toxic and further impairs insulin sensitivity and -cell function, leading 
to more severe type 2 diabetes. Chronic hyperglycemia is a major risk factor for the 
development of complications such as micro and macroangiopathy and neuropathy, 
which result in blindness, impotence, ischemic foot ulcers and amputations (Porte and 
Schwartz 1996). One of the possible molecular mechanisms responsible for these 
complications is the increased oxidative stress induced by chronic hyperglycemia (King 
and Loeken 2004). Briefly, persistent hyperglycemia drives insulin-independent tissues to 
assume glucose. The increased glucose inside of the cells will enter in the glycolisis 
pathway, Krebbs cycle and oxidative pathways (King and Loeken 2004). The increased 
flux will generate an excess of oxygen reactive species (ROS) and the accumulated ROS 
educes the increased oxidative stress and may interfere with normal tissue functions. For 
example the increased levels of ROS affect: blood flow to retina (Kowluru and Kennedy 
2001) (retinopathy) and contractility of vascular smooth muscle cells (Sharpe, Liu et al. 
1998) (vascular disorders). ROS decrease neural conductivity in peripheral nerves 
(Hounsom, Corder et al. 2001) (neuropathy).  
 Another major factor in the development of the diabetic complications could be the 
increased glycosylation of proteins. This effect can lead to the accumulation of advanced 
glycosylation end-products and lipoxidation end-products (AGEs/ALEs) (Wada and 
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Yagihashi 2005). AGEs/ALEs can induce cross-linking of proteins or induce specific 
cellular responses including the release of profibrogenic and proinflammatory cytokines 
thus causing diabetic retinopathy and nephropathies such as glumerulosclerosis, 
interstitial fibrosis, and tubula atrophy (Bohlender, Franke et al. 2005). In addition to 
ROS and AGEs/ALEs, VEGF in diabetic retinopathy (Aiello 2005) and 
microalbuminuria for cardiovascular and renal disorders in type 2 diabetes has also been 
shown (Lane 2004).  
 Patients with type 2 diabetes can often be treated with diet and exercise alone or in 
combination with insulin sensitizers, which act to reduce the insulin resistance in target 
tissues, or sulphonylureas which stimulate the -cells to secrete more insulin.  
 Type 1 diabetes is caused by an autoimmune reaction, which leads to destruction of 
-cells and subsequent insulin deficiency. These patients are treated with insulin 
injections to compensate for the absence of natural insulin production. Whole organ 
pancreas transplants have been performed in type 1 diabetic patients since the 1970s.  
 Now with the recent success of islet transplantation using the Edmonton protocol 
(Shapiro, Lakey et al. 2000), type 1 diabetic patients have been shown to maintain normal 
blood glucose levels without daily insulin injections. This procedure/cure unfortunately 
relies on islets available from pancreata from cadavers, a very limited supply. Each type 1 
diabetic patient needs islets isolated from 2-3 pancreata and could need several 
transplants before achieving insulin independence.  
 These results are promising, but a shortage of donors has lead to an explosion in the 
number of investigations of methods to generate islets surrogates suitable for 
transplantation. Some of the roads taken so far have been expansion of existing -cell 
lines, encapsulated islet xenografts, conversion of a stem cell population (either 
pancreatic or non pancreatic adult stem cells) to -cell, in vitro differentiation of 
embryonic stem cells to -cells (Soria 2001) or transdifferentiation from a different cell 
type (Nygaard Jensen and Jensen 2004). 
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1.7.1  Type 1 Diabetes Mellitus 
 
Type 1 diabetes mellitus (T1DM) results from an absolute deficiency of insulin 
due to autoimmune attack and destruction of the -cells. Type 1 diabetes mellitus usually 
appears suddenly in non-obese children or young adults. This is why is referred to as 
juvenile-onset diabetes. This occurs as a result of direct attack of an aberrant b-specific 
autoimmune antibodies (Narendran, Estella et al. 2005) with involvement of cytokines 
and T-lymphocytes specific for -cell  antigens (Nerup, Mandrup-Poulsen et al. 1988), 
which only became symptomatic when the -cell  mass is reduced by approximately 
90%.  
T1DM is a complex genetic trait, with multiple genetic loci contributing to 
susceptibility, but also with environmental factors playing a role in determining a risk. It 
Has been shown to exist a significant familial clustering of T1DM with an average risk in 
siblings of 6% compared to 0.4% in the general population (Karvonen, Tuomilehto et al. 
1993; Karvonen, Viik-Kajander et al. 2000). At least one locus that contributes strongly 
to this familiar clustering resides within the major histocompatibility (MHC) region on 
the chromosome 6p21.3. Other established T1DM risk genes include the insulin gene 
region on chromosome 11p15 and the cytotoxic T-lynphocyte associated 4 gene (CTLA4) 
region on the chromosome 2q33 (Pociot and McDermott 2002). Most attention to 
environmental factors has been paid to virus infections and early exposure to cow’s milk 
protein as triggers of autoimmunity in individuals genetically susceptible to T1DM 
(Dahlquist 1998; Jun and Yoon 2003) although no consensus has been reached for this 
hypothesis.  
Another epigenetic factor is the influence of the intrauterine environment on the 
-cell development and later development of diabetes. Low protein diet given to pregnant 
rats during gestation induces permanent changes in the offsprings (e.g. altered islet 
proliferation, islet size, pancreatic insulin, apoptotic rates and increased sensitivity to 
interleukin 1b (IL-1b) and nitric oxide (NO) (Snoeck, Remacle et al. 1990; Petrik, 
Reusens et al. 1999; Merezak, Hardikar et al. 2001). In the offspring of T1DM mothers, it 
has been suggested that the exposure to a diabetic environment in utero is associated with 
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increased prevalence of IgT and defective insulin secretory response in the adulthood 
(Sobngwi, Boudou et al. 2003).  
The present concept of the pathogenesis of T1DM is mainly based on evidence 
from studies on the animal models of human T1DM. The diabetes-prone BioBreeding 
(B-DP) rat spontaneously develops a diabetic syndrome with characteristics similar to 
the human T1DM. In the non-obese diabetic mice model (NOD) autoimmune diabetes 
can be transferred from a diabetic to a non-diabetic animal via T lymphocytes. This 
confirms that the T lymphocytes are the mediators of autoimmune diabetes in NOD mice. 
It seems that both glutamate decarboxylase-(GAD) and insulin-reactive T cells are 
diabetogenic in the NOD mice. Antibodies to the above antigens can be observed long 
before the manifestation of hyperglycemia. The major histocompatibility complex class II 
allele, HLA-DQ, is the major genetic element, conferring susceptibility to or protection 
from human T1DM.  
However, the mechanisms determining the contribution of the HLA-DQ allele 
remain to be elucidated (Moustakas and Papadopoulos 2002). Accumulating evidence 
suggests that the regulation of the gut immune system may be aberrant in T1DM, 
possibly due to environmental factors (Akerblom, Vaarala et al. 2002). Many 
autoimmune diseases are characterized by an overproduction of cytokines. In the case of 
T1DM, interferon-g (IFN), tumor necrosis factor-a (TNF) and interleukin 1- (IL-1) 
have been shown to contribute to the pathology. In addition, the quality of the immune 
reactivity is an important factor in beta-cell destruction. In the animal model, only 
infiltration of the islets by helper T cells of the subtype Th1, which secret high levels of 
INF, caused beta-cell damage (Healey, Ozegbe et al. 1995).  
According to the so-called “Copenhagen model” of T1DM , beta-cells are 
destroyed by cytokine-induced free radical formation before cytotoxic helper T cells 
and/or autoantibody-mediated cytolysis (Nerup, Mandrup-Poulsen et al. 1988; 
Freiesleben De Blasio, Bak et al. 1999). A consequence of this model is that 
proinflammatory cytokines induce both protective and deleterious mechanisms in all cells 
expressing cytokine receptors. In genetically predisposed individuals, T1DM 
development occurs because the deleterious events in the -cells prevail.  
 
Chapter 1 Introduction 
 
 38
1.7.2  Type 2 Diabetes Mellitus 
 
The glucose homeostasis deregulation in type 2 diabetes mellitus (T2DM) is 
mainly due to a combination of two physiological defects: impaired insulin secretion and 
reduced peripheral and hepatic insulin sensitivity (Beck-Nielsen and Groop 1994; Bajaj 
and Defronzo 2003).  
The development of T2DM is a gradual process, and the relative roles of the two 
defects in the etiology of the disease remain controversial. However, it is now generally 
agreed that overt diabetes arises when -cell s can no longer compensate for the insulin 
resistance, that because a prolonged exposure of pancreatic -cells to glucose. This 
eventually leads to -cells exhaustion and glucose toxicity. The effect of -cell 
exhaustion is the early form of the disease and could be reversible whereas the glucose 
toxicity occurs later in the disease and is less reversible (Rossetti, Giaccari et al. 1990). 
 Recently, a detrimental effect of elevated levels of free fatty acids on -cell s 
function has also been studied. The suggestion is that diabetes is not only the 
carbohydrate disease but also associated with disordered lipid metabolism (Unger 1995). 
 In addition, the deposits of islet amyloid present in T2DM diabetic pancreas may 
lower the functional -cell mass (Kahn, Andrikopoulos et al. 1999; Marzban, Park et al. 
2003). Several lines of evidence indicate that hyperglycemia induces -cell apoptosis by 
inducing apoptotic molecules including glucose-induced NF-B, apoptotic-associated 
protein caspase 3 and ROS. Once the apoptosis-related factors have accumulated, -cell 
mass is reduced, insulin secretion is impaired and eventually diabetes occurs (Mandrup-
Poulsen 2003).  
Insulin resistance and -cell dysfunction are two major clinical characteristics 
found in T2DM diabetic subjects. As will be described after, insulin acts to maintain 
euglycaemia and this process involves several steps. A significant disruption of any of 
these actions regardless of the presence of normal or even high circulating levels of 
insulin indicates the presence of “insulin resistant” phenotype (Reaven 1988).  
Insulin resistance is the first defect to be detected in T2DM and must be 
accompanied by -cell deficiency for full development of the disease (Martin, Warram et 
al. 1992). The early insulin resistance in insulin-targeted organs including liver, muscle 
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and adipose tissue starts to be detected during pre-diabetic stage and therefore elevated 
insulin is subsequently produced from -cell s to compensate the require of insulin to 
maintain glucose homeostasis. Over a period of time, however, overexpression of insulin 
does not match the requirement of insulin to uphold euglycemia and the next pathological 
condition, -cell failure, occurs. Furthermore the expansion of -cell mass (called islet 
hyperplasia), is another notable consistent feature associated with insulin resistance in 
T2DM animals (Tokuyama, Sturis et al. 1995).  
The working model for the -cell dysfunction in T2DM can be discussed using 
animal model, 90% pancreatectomy (Px) rats. It has been found that insulin secretion is 
enhanced (hypersensivity) during the period when the blood glucose is as stable as the 
level in control animals (within 2 weeks post surgery) in Px rats (Porte 2001). This can be 
explained by the idea that, in order to compensate for the demands of insulin, -cells 
overwork to produce sufficient insulin to reach normoglycaemia.  
Another effect that accompanies the hypersecretion of insulin from -cell s in Px 
rats is the increase of glucokinase activity, probably to increase glucose sensitivity. 
Additionally an increase in the low-Km hexokinase activity is also observed in 90% of 
diabetic rats in comparison with the non-diabetic control animals (Narendran, Estella et 
al. 2005). Higher activity of hexokinase results in increased sensitivity of -cell s even 
when the blood glucose concentration is low. Thus established hyperglycaemia and 
enhanced -cell hexokinase activity lead to very high level of insulin output (Fajans, Bell 
et al. 2001). Since the insulin targeted tissues are insulin-resistant, the hyperglycaemia is 
more serious in spite of constitutive insulin secretion. Finally overworked -cells become 
fatigued and insulin granules are depleted.  
The occurrence of dysfunctional insulin receptor (IR) and downstream kinase 
provided another mechanism to explain why insulin resistance occurs. In the peripheral 
organ (e.g. muscle and liver) of insulin resistant subjects, a defect or IR and insulin 
receptor kinase have been observed (Froguel, Zouali et al. 1993; Yamagata, Furuta et al. 
1996). Defects in IR function were originally determined by the detection of IR-specific 
autoimmune antibody, the mutation on IR and the decreased IR numbers (Horikawa, 
Iwasaki et al. 1997; Stoffers, Ferrer et al. 1997). However, this defect is unlikely to be 
significant contributing to the pathology of diabetes while the antibody titre is generally 
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low and large changes of insulin-IR binding have never been seen (Stoffers, Ferrer et al. 
1997). More attempts therefore were turned to investigate the effect of deficient IR kinase 
for the onset of insulin resistance. Insulin-IR binding activates insulin receptor substrate-
1 (IRS-1)-dependent phosphatidylinositol 3-kinase (PI3K) which activates atypical 
protein kinase C (aPKC or PKC or ) and protein kinase B (PKB/Akt) pathways and 
thereby regulates glucose transport (Malecki, Jhala et al. 1999).  
The results exhibiting the reduced Akt kinase activity in the skeletal muscle tissue 
of T2DM patients (Busch and Hegele 2001) and defective activation of aPKC in muscles 
and adipocytes of rats with T2DM (Guz, Montminy et al. 1995) suggested that IR-related 
kinase plays a major role for the development of insulin resistance.  
 
 
1.7.3  Maturity Onset Diabetes of the Young: 
 
MODY is a specialized type of T2DM since it is characteristic of an onset before 
the age of 25 years and usually in childood and adolescence (Fajans, Bell et al. 2001). 
MODY can result from the mutation in any one of at least six genes.  
One of them, MODY 2, encodes the glycolytic enzyme glucokinase (Froguel, 
Zouali et al. 1993). Whereas the other five types of MODY are associated with pancreatic 
transcription factors: HNF4 (related MODY1)(Yamagata, Furuta et al. 1996), HNF1 
(associated with MODY3) (Stoffers, Ferrer et al. 1997), HNF-1 (associated with 
MODY5) (Horikawa, Iwasaki et al. 1997), and NeuroD/BETA2 (associated with 
MODY6) (Malecki, Jhala et al. 1999). These genes are all expressed in pancreatic -cells 
and the disruption of each gene lead to -cell dysfunction, and eventually diabetes. In 
comparison to late-onset T2DM, the onset of MODY is more likely to be a genetic issue. 
 This statement is supported by the fact that the screening of family pedigrees of 
MODY diabetic patients showing a history of diabetes in three of four generations (Busch 
and Hegele 2001; Fajans, Bell et al. 2001). 
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1.8 Glucose response in islet cells 
 
During fasting carbohydrates are processed by digestive enzymes and absorbed 
through the intestinal epithelium. Insulin is then released, as said before, when the 
glucose level become elevated and the -cells are “turned on” to produce the hormone. 
 Glucose sensing is the first step leading up to the release of insulin from the -
cells. In this step, both the high-Km glucose transporter GLUT2 and the high-Km glucose 
phosphorylating enzyme glucokinase (GCK) are important (Efrat, Tal et al. 1994). 
 In order to respond to an elevated glucose concentration, glucose must enter into 
-cells. Glucose entry occurs by facilitated diffusion via GLUT2. GLUT2 was originally 
cloned from a rat liver cDNA library and is expressed specifically in liver and in 
pancreatic islets (Unger 1991). A parallel correlation has been shown between reduced 
GLUT2 levels and loss of glucose-induced insulin secretion in Zucker diabetic mice 
(Johnson, Ogawa et al. 1990). In addition, hyperglycaemia has been observed in 
transgenic mice over-expressing GLUT2 antisense RNA. This reveals that GLUT2 might 
be not only responsible for the transportation of glucose into cells but also essential for 
maintaining the glucose homeostasis.  
However, different observations were presented in other animal models. For 
example, in RIP-Hras transgenic mice (Hras protein is specifically expressed in insulin 
producing cells), there is a reduction of GLUT2 but this change did not affect glucose 
homeostasis (Tal, Wu et al. 1992). Furthermore, in human another member of the glucose 
transporter family, GLUT1, is more abundantly expressed than GLUT2 in pancreatic -
cells (De Vos, Heimberg et al. 1995).  
These results suggested the function of GLUT2 may be primarily for the transport 
of glucose into the cells (Schuit 1997). GCK is a member of the hexokinase family of 
enzymes and expressed in pancreatic -cells and hepatocytes. GCK catalyses the ATP-
dependent phosphorylation of glucose after glucose entry into the-cells (Weir, Sharma 
et al. 1997) generating glucose-6-phosphate (G-6-P) (Tirone and Brunicardi 2001). It 
functions as glucose sensor in -cells controlling the rate of entry of glucose into 
glycolysis and the tricarboxylic acid (TCA) cycle (Matschinsky, Glaser et al. 1998).  A 
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decrease in -cell glucokinase activity has been observed in several situations associated 
with decrease insulin release (Meglasson and Matschinsky 1986).  
It was also reported that the impaired GCK activity is related to one type of 
autosomal dominant mode inheritance mature-onset diabetes of the young, MODY2 
(Froguel, Zouali et al. 1993). This further confirms the importance of GCK for insulin 
secretion and glucose homeostasis. 
 
 
1.9 Insulin secretion: 
 
 The metabolism of glucose through the glycolytic pathway produce two 
molecules of ATP (MacDonald, Fahien et al. 2005). As a result of the increase of ATP 
production, the intracellular ATP/ADP ratio increased; this change leads to closure of 
KATP channels which results in depolarization of the cell membrane. Ca
2+
 accumulates in 
the membrane-depolarized cells via activation of the VGCC (Voltage-Gated Calcium 
Channel) or release of Ca
2 +
 from the ER. In addition to the KATP-dependent pathway, 
protein kinase A (PKA) and protein kinase C (PKC) pathways are activated by sensing 
the glucose metabolic signaling in a KATP-independent manner although the molecular 
basis is not yet known (Bratanova-Tochkova, Cheng et al. 2002).  
 A Biphasic insulin secretion has been observed in the pancreas following rapid 
and sustained stimulation of -cells with glucose (Henquin, Ishiyama et al. 2002). The 
immediate reaction, so-called first phase insulin release, is mediated by rapid release of 
the insulin granule pools in a Ca
2+
-dependent manner (Straub, Shanmugam et al. 2004). 
 The insulin granule populations are complex, consisting of three pools including a 
reserve pool, a docked pool and a ready releasable. The increase of the intracellular Ca
2+
 
concentration is accelerated not only by the closure of KATP channel but also by several 
KATP-independent mechanisms (Straub, Shanmugam et al. 2004). The orchestration of 
KATP-dependent and KATP-independent signals positively augments the pre-existing 
insulin granules to release insulin.  
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 Under prolonged exposure to high glucose environment, the demand of insulin to 
maintain normal physiological glucose homeostasis drives the next round of insulin 
biosynthesis. 
 
 
1.10 Insulin biosyntesis 
 
Insulin is synthesized in response to prolonged elevated blood glucose level. 
Briefly the sequence of events is as follow: 1) production of preproinsulin transcripts in 
the cell nucleus; 2) packaging of preproinsulin into proinsulin in the rough endoplasmic 
reticulum (RER): 3) synthesis of mature insulin from proinsulin in the Golgi apparatus 
and 4) precipitation of insulin protein in the secretory granules.  
The preproinsulin is the original single polypeptide used to form mature insulin. It 
consists of four regions, from N-terminal to C-terminal, a hydrophobic signal sequence 
(SS), B-chain polypeptide, connecting peptide (C-peptide) and A-chain polypeptide.  
To process the preproinsulin to folded proinsulin the transcribed mRNA moves to 
a ribosome and sequentially binds to the signal recognition particle (SRP) initiating 
protein translation. The translated SS peptide (also called nascent chain) tags onto the 
SRP and migrates to a high-affinity receptor for SRP named the SRP docking protein 
(SRPdp) that is located at the external surface of the RER (Gilmore, Walter et al. 1982). 
Subsequently, the ribosome dissociates from the SRP and SRPdp and is restrained by the 
ribosome receptor (RR) on the ER membrane. The natural hydrophobic property of SS 
(22 of 24 amino acids in SS are hydrophobic) facilitates and enhances the binding affinity 
between ribosome-mRNA complex and he phospholipids bilayer of the ER membrane 
(Do, Falcone et al. 1996).  
In addition to SRPdp, other membrane proteins such as translocating-chain 
associated membrane (TRAM) and Sec61 proteins are essential for directing the 
ribosome-mRNA complex to the ER membrane (High, Martoglio et al. 1993; Voigt, 
Jungnickel et al. 1996; Knight and High 1998). Through the joint interaction of 
membrane proteins the complex is placed at the site on the ER membrane termed 
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translocon (McCormick, Miao et al. 2003) where the SS peptide guides the extension of 
the preproinsulin polypeptide chain into the ER lumen. The SS peptide is excised by 
signal peptidase positioned on inner ER membrane and proinsulin is formed. The native 
proinsulin is then folded by a molecular chaperone (e.g. protein disulfide isomerase, PDI) 
by the formation of the disulfide bonds(Winter, Klappa et al. 2002). The vesicles filled 
with proinsulin the bud out from the RER towards the Golgi apparatus where the 
zinc/calcium environment around the Golgi favors the formation of the zinc-containing 
proinsulin hexamer(Dodson and Steiner 1998). Proinsulin passes through cis, medial and 
trans Golgi cisternae and is converted to insulin at the stage of vesicle formation. This 
transformation is driven by membrane-associated prohormone convertase enzymes (PCs). 
The catalytic sites targeted by PCs are called the dibasic sites (Goodge and Hutton 2000). 
Subsequently the granules are packed with mature insulin coupled with the precipitation 
of removed C-peptide and are maintained in the cytoplasm as an “insulin secreting 
vesicles pool”.  
Once the -cells sense certain physiological variations of glucose level (high 
glucose) the insulin will be secreted through the release of these primary granules in 
order to maintain the normoglycaemia. 
 
 
1.10.1  Transcription factors binding the Insulin gene promoter region and  
  activating its expression: 
 
Short-term regulation of insulin secretion, as can be in response to a meal occurs 
mainly at the level of exocytosis. However the maintenance of adequate intracellular 
stores of insulin on a long-term maintenance relies on the transcriptional and translational 
regulation of insulin biosynthesis. The two more important nutrients for the mammals, 
glucose and fatty acids, profoundly affect the preproinsulin gene under physiological and 
pathological (glucotoxicity and lipotoxicity) status.  
Insulin, synthesized by thee -cells of the pancreas, is of major physiological 
importance for metabolic homeostasis. While mature insulin consists of two polypeptide 
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chains joined by disulphide bridges, the gene encodes for a highly conserver single chain 
precursor (Chan, Keim et al. 1976). In most species preproinsulin exists as a single gene, 
whereas in the mouse and the rat two non-allelic insulin genes are present.  
The human insulin gene is located on the short arm of the chromosome 11 (p15.5) 
(Harper, Ullrich et al. 1981) the rat insulin I and II gene are colocalized on chromosome 1 
(Soares, Ishii et al. 1985) while the mouse genes are positioned on two different 
chromosomes: insulin I on chromosome 19 (Davies, Poirier et al. 1994) and insulin II on 
chromosome 7 (Duvillie, Bucchini et al. 1998).  
The structure and organization of the insulin gene has been reviewed in detail 
over two decades ago (Steiner, Chan et al. 1985), briefly the insulin gene in humans and 
the insulin II gene (in rodents) containing three exons and two introns while the insulin I 
(in rodents) lacks the second intron (Steiner, Chan et al. 1985). In adult islets the 
nonallelic genes appear to be coordinately expressed and regulated (Giddings and 
Carnaghi 1988; Koranyi, Permutt et al. 1989). 
 
1.10.2  Organization of the insulin promoter region and Transcription factors 
  binding sites: 
 
In mouse embryo, insulin mRNA was first detected at e9 in the foregut area from 
which the pancreas develop (Gittes and Rutter 1992). In humans, insulin-positive cells 
are already present by 8 weeks of embryonic development (Polak, Bouchareb-Banaei et 
al. 2000) during post-natal life, insulin gene expression is restricted to the -cells. Most 
studies using humans and rat genes have showed that the insulin gene expression is 
controlled by the 5’-flancking region of the gene (German, Ashcroft et al. 1995) (Fig. 6).  
A highly conserved region (340bp) immediately upstream of the transcription-
starting site confers both tissue-specific expression and metabolic regulation of the 
insulin gene. Many of the transcription factors act upon this region, forming a highly 
sophisticated network, ensuring the precise regulation of this gene. Deletion and 
mutational analyses of various insulin promoter regions, conducted in transfected cell 
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lines and transgenic animals, led to the identification of cis-acting elements necessary to 
specific insulin gene expression.  
Three are the more critical binding site identified in the promoter region of the 
insulin gene: A3, C1 and E1 (Poitout, Stein et al. 2004).  
Pancreatic/duodenal homeobox-1 (Pdx1) binds the region called A3 box of the 
promoter region of the insulin gene (Melloul, Ben-Neriah et al. 1993) and functionally 
interacts with proteins of the bHLH family that bind the E1 box (Peers, Leonard et al. 
1994). The E1 activator has been shown to be a heterodimer consisting of on ubiquitous 
class A member (E12/E47 and E2/5) and a cell restricted class B member (B2) member 
of the bHLH family (Aronheim, Ohlsson et al. 1991). The cooperation between PDX1 
and bHLH proteins and coactivators is forming then a unique network of protein-protein 
and DNA-protein interactions (Ohneda, Mirmira et al. 2000; Qiu, Guo et al. 2002).  
 Recently the C1 (RIPE3b) activator has been identified as MafA (Olbrot, Rud et 
al. 2002). Although a number of hepatic nuclear factors and Pax family members 
contribute to the general network of transcription factors that control the transcription of 
the preproinsulin gene. 
 
 
 
 
 
 
 
 
 
 
 
 
  
Fig 6: Schematic organization of the human insulin gene and rat insulin I and II genes. Highlighted 
are the cis-regulatory elements. 
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1.10.3  Transcription factors regulating insulin gene expression in mature - 
  cell: 
 
Glucose controls the steps of insulin gene expression including transcription, 
preRNA splicing and mRNA stability. The binding site A3, E1 and C1 are the majors 
glucose-responsive elements of the insulin gene. In addition to those, a more distal 
glucose-responsive element, present in primary islets, appears to bind the glucose-
sensitive complex, nevertheless it is still not identified (Sander, Griffen et al. 1998).  
The most studied cooperative interactions are those between the proteins binding 
the juxtaposed E and A elements. For that purpose, the rat insulin I promoter, and in 
particular a short part of the promoter region called Far-Flat region (FF), composed of an 
E2 motif and of the unique AT-rich A3/A4 sequence elements and considered the 
election region of such studies has been extensively used.  
Glucose promotes the binding of PDX1 to the A3 site and its transactivation 
efficiency (Melloul, Ben-Neriah et al. 1993; Petersen, Serup et al. 1994). Also it is now 
well accepted that PDX1 action on insulin promoter region requires the recruitment of 
p300. The role of the ubitous coactivator p300 and the close homologue CBP has been 
investigated extensively. Those are histone acetyltransferases that stimulate transcription 
of specific genes by interacting either directly or through co-factors with a number of 
transcription factors and with the basal transcription machinery (Imhof, Yang et al. 1997). 
 The Homeodomain-containing factor that bind to A3/A4 region interacts also with 
the E2A-encoded proteins in transfected islet cells. PDX1 has been demonstrated acting 
in a synergistic manner with E47 to activate transcription (Serup, Petersen et al. 1995; 
Catasti, Chen et al. 1996; Edlund 2001). Such synergism requires the DNA binding and 
activation domains of both PDX1 and bHLH proteins. It was also demonstrated that the 
synergistic transactivation activity results not only from the coexpression of both E2A 
and PDX1 but also of BETA2 involving its C-terminal activation domain and a region 
within the N-terminus (Glick, Leshkowitz et al. 2000).  
 The transactivation activity of PDX1 involves also, to form an activation 
complex, the recruitment of the high mobility group protein 1 (HMG1(Y)) that binds 
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himself directly to the A3/A4 region increasing the PDX1/bHLH transactivation activity 
(Ohneda, Mirmira et al. 2000). PDX1 stimulation of insulin gene transcription involves 
recruitment of coactivators such bHLH proteins but also proteins affecting chromatin 
structure through methylation and/or acetylation of the histones (Mosley and Ozcan 2004; 
Francis, Chakrabarti et al. 2005). Furthermore, glucose appears to promote the 
translocation and modification of cytoplasmatic inactive PDX1 form of 31kDa to the 
nuclear 46kDa active form (Rafiq, Kennedy et al. 1998). Even if this translocation 
requires phospholylation, the large increase in apparent molecular mass suggests that 
PDX1 undergoes through multiple post-translational modification like O-linked N-
acetylglucosamine or small ubiquitin-related modification (Gao, Miyazaki et al. 2003; 
Kishi, Nakamura et al. 2003). Many kinases have been proposed to mediate PDX1 
phosphorylation, e.g. p38 mitogen-activated protein kinase, phosphatidylinositol-3 kinase 
and extracellular signal-regulated kinases (Macfarlane, McKinnon et al. 1999; da Silva 
Xavier, Varadi et al. 2000; Khoo, Griffen et al. 2003). MafA (RIPE3b1) that binds the C1 
element and B2/E47, binding the E1 box element, are also stimulated by glucose. 
Nevertheless it is still unclear how B2/E47 is regulated and how MafA expression and 
binding activity are regulated in response to glucose (Sharma and Stein 1994; Zhao, Guo 
et al. 2005).  
Like the rat FF region, the C1 (RIPE3b) enhancer in rat insulin II promoter 
contains an E1 (ICE) box that cooperates with the RIPE3b1 element (Hwung, Gu et al. 
1990; Emens, Landers et al. 1992). In such context the E47:BETA2 heterodimers require 
the presence of the beta-cell specific RIPE3b1-Act/C1 complex to activate gene insulin 
transcription (Sharma and Stein 1994; Naya, Stellrecht et al. 1995). In the human gene as 
well the synergism E1-A1 or E1-A2/C1 has been reported between (Odagiri, Wang et al. 
1996).  
The mechanisms responsible for efficient activation of the insulin promoter are 
still not fully clarified. Importantly, PDX1, B2 and MafA are not acting in an isolated 
manner but interact to each other to induce a synergic transcription of the insulin gene 
(Zhao, Guo et al. 2005). Also no -cell specific activators and coactivators, beside MafA 
and a recently E2A interacting protein recently discovered (Thomas, Yao et al. 1999), 
have been identified.  
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Therefore glucose enhances insulin gene transcription by many complementary 
mechanisms that include transcription factors recruitment, histone modifications, and 
start of transcription.  
Tissue specific expression seems at the end to be dependent of different 
combinations and concentration of transcription factors, only some of which is -cell 
specific. Understanding of the molecular mechanisms underlying the insulin expression 
will then require detailed analysis of interactions between the various transcription factors 
and coactivators. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Chapter 2 
 
 
AIMS 
Chapter 2 Aims 
________________________________________________________________________ 
 50
 2 AIMS 
 
 
 Type 1diabetes is an autoimmune disease in which the insulin secreting -cells in 
the islet of Langerhans, that are essential for the glucose homeostasis, are destroyed by a 
target immune attack.  
 Patients affected by Type 1 diabetes are dependent of exogenous insulin, even 
though this is not a cure because the chronic and devastating complications cannot be 
prevented. Identifying and characterizing -cell-specific genes playing critical roles 
during the differentiation and insulin gene expression could allow to better control the 
use of stem/progenitor cells to create new -cells for diabetes treatment and improve or 
induce the expression of insulin.  
 Among the genes important for differentiation Neurogenin-3 (Ngn3) seems to 
play a pivotal role positioning itself at the beginning of the true differentiation pathway 
that discriminates an endocrine-committed cell fate from cells that are still (multi)potent. 
Nevertheless Ngn3’s targets are still not well identified.  
 As for insulin gene regulation, recent findings showed that two transcription 
factors, A2.2 (-cell specific transcription factor) and MafA bind the insulin promoter 
onto an overlapping region. The two transcription factors are not competing for the 
binding region so it has been hypothesized that they cooperatively activate the insulin 
transcription in -cells.  
Therefore the aims of my research work have been: 
 
1. to identify new genes involved in pancreas development  
2. to test if an ectopic transient expression of Ngn3, mimicking as much as possible 
its physiological expression, is sufficient to act as generic switch to specify the 
beta-cell fate;  
3. To identify the major factors that lie directly downstream the expression of Ngn3;  
4. To identify the transcription factor A2.2.  
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MATERIALS AND METODS 
Primer Sets Forward Reverse 
RevNgn3 5’-AAGGATCCATGGCGCCTCAT-3’ 5’-GCAAGCTTTCACAAGAAGTCTGAGAAC-3’ 
pRevTRE-SEQ 5’-TCCACGCTGTTTTGACCTCC-3’ 5’-CCCCCTTTTTCTGGAGAC-3’ 
mNgn3 5’-CACGAAGTGCTCAGTTCCAA-3’ 5’-GCAGGGTCTCGACCTTTGTA-3’ 
rTubulin 5’-ATTGACCTTGTCTTGGACAG-3’ 5’-GTCATAGATGGCCTCATTGT-3’ 
T-RexNgn3 5’-GAAGCTTGAAATGGCGCCTCATCCCTTGG-3’ 5’-
GGGATCCTCACAAGAAGTCTGAGAACACCAGTG
C-3’ 
GATA4 5´-CGCCGCCTGTCCGCTTCC-3´ 5´-TTCGGCTTCCGTTTTCTGGTTTGA-3´ 
NeuroD/BETA
2 
5´-CTTGGCCAAGAACTACATCTGG-3´ 5´-GGAGTAGGGATGCACCGGGAA-3´ 
Pax4 5´-GAGATCCAACACCAGCTTTGCACTG-3´ 5´-GGAGAAGATAGTCCGATTCCTGTG-3´ 
Pax6 5´-TGAAGCGGAAGCTGCAAAGAAA-3´ 5´-TTTGGCCCTTCGATTAGAAAACC-3´ 
Nkx2.2 5´-ATGTCGCTGACCAACACAAAG-3´ 5´-GGGAGTATTGGAGGCCCTC-3´ 
Isl1 5´-ATGGGAGACATGGGCGAT-3´ 5´-TCATGCCTCAATAGGACTGGC-3´ 
PDX1 5´-CTCGCTGGGAACGCTGGAACA-3´ 5´-GCTTTGGTGGATTTCATCCACGG-3´ 
Insulin 5´-AAGTCCCGCCGTGAAGTG-3´ 5´-TTAGTTGCAGTAGTTCTCCAGCTGG-3´ 
Glucagon 5´-ATGAAGACCATTTACTTTGTGGCT-3´ 5´-GGTGTTCATCAACCACTGCAC-3´ 
Somatostatin 5´-ATGCTGTCCTGCCGTCTCC-3´ 5´-CTAACAGGATGTGAATGTCTTCCAGA-3´ 
PRIMER TABLE 
AdNgn3 5’-GAGTACTGAAATGGCGCCTCATCCCTTGG-3’ 5’-
GCTCGAGTCACAAGAAGTCTGAGAACACCAGTG
C-3’ 
AdNeuroD 5’-GAGTACTGCCACCATGACCAAATCATACAGC-3’ 5’-GCTCGAGCCTAATCGTGAAAGATGGCATTG-3’ 
M13 (-20) 5´-GTAAAACGACGGCCAG-3´  
M13  5´-CAGGAAACAGCTATGAC-3´ 
OVOl1ChiP 5’-CGGGAGGCTCTGATGC-3’ 5’-GGACACGGGTTGCAACC-3’ 
OVOl1Prom1 5’-P-GGTACCGGACACGGGTTGCAACCGGC-3’ 5’-P-GAGCTCGAAAGAGTCGCCGAGGCGTG-3’ 
OVOl1EboxMu
t 
TACGTCCACCGATAGCCCAAGGTGCT TTCGCCAAGACTCTTCTGGTCAAAAACAGC 
NeuroDChiP 5’-CTGTCTTCTGCTGCCACAAA-3’ 5’-TCACCCCTCCCTAGAACTCC-3’ 
OVOl1 5’-CTTCTGCCCACCGCAGCCCTACCTCG-3’ 5’-CCTCGCAGGGTCCTGAGGCCACACCAT-3’ 
pGL2SEQ-5’ 5´-TGTATCTTATGGTACTGTAACTG-3´  
pGL2SEQ-3’  5´-CTTTATGTTTTTGGCGTCTTCCA-3´ 
Amilase rat 5’-GGTTGGGGTTTTGTGCCTACTG-3’ 5’-TGCCATCACTGCCAACATTTACTT-3’ 
GAPDH mouse 5’-ATGGCCTTCCGTGTTCCTAC-3’ 
 
5’-GGCCCCTCCTGTTATTATGG-3’ 
 
GAPDH rat 5’-CGCGAAATTCAAGAGAGTAGGGAG-3’ 5’-CGCGGATCCTGCCAAGTATGATGAC-3’ 
dTomato 5’-ATTCGTCGACACCATGGTGAGCAA-3’ 5’-CTGAGTCGACTTACTTGTACAGCTCGTCCATG-
3’ 
IRES 5’-TAATCTCCGAGCGCGTCGAGCATGCA-3’ 5’-
ATTCGTCGACGGGTTGTGGCAAGCTTATCATC-3’ 
HMG1 5’-GGGAGGCGCATAAGAAGAAG-3’ 
 
5’-TTTTCATAAGGCTGCTTGTCATC-3’ 
 
RNA cold 
inducible binding 
protein 
5’-CGCTGGAGCAGGTCTTCT-3’ 
 
5’-ACTGTAGCCACCACTCTGACTC-3’ 
 
Hystone deacet. 5’-GCGCGTTACCCACCCAGGAGGAA-3’ 
 
5’-CTGAAGTAGGTGGTGCCCGATTTG-3’ 
 
RNA binding 
protein 8 
5’-AACTTGTTTCTTCAGGCTCTTC-3’ 
 
5’-CTGCATCATCAATGTCAGAAATC-3’ 
 
WWDB 5’-GAGGGCGGCGGAGTGAT-3’ 
 
5’-GAGGGCAGGGGTACATTCCATT-3’ 
 
TEFB 5’-CTATGGTGGCTGTGAAGGAC-3’ 
 
5’-AGCCATCAGCAGTTCCAG-3’ 
 
WTAP 5’-AAAGTTATGGCAAGAGATGAGTTA-3’ 
 
5’-GGCTTGTTCCAGTTTGTCTTTAG-3’ 
 
PHD 
 
5’-CAGCGCTTAGCCACCTTACCC-3’ 
 
5’-TGCTGCAGCTCCTTTTACATCACT-3’ 
 
BATF 
 
5’-CAGAAGAGCCGACAGAGACAGACACAGAAA-3’ 5’-TGGCAGCACGGAGCACAGG-3’ 
p21SNFT 
 
5’-CCAGCCCGCAGAGCCCCAAGGACGAT-3’ 5’-GTTCATAGGACACAGCAGCAGCGGGCACAT-
3’ 
Csdc2 5’-AGGGTCTGGGAGCGGGGTGGTGTC-3’ 5’-AGGCCCGGGCTGTCGCTGAATAGGT-3’ 
CIRBP 5’-AGCAGCAGCAGAGATGA-3’ 
 
5’-AGCTGGCTCCATTGTTC-3’ 
 
RNATF 
 
5’-CGCTGGAGCAGGTCTTC-3’ 
 
5’-GCTGGCATAGTAGTCTCTGGA-3’ 
 
HMGB4 5’-GCCCCCATCCTCCTTCCTGCTCTTCT-3’ 5’-ATTCCCCTTCCTGCCTTGACATTGGTTG-5’ 
RIKEN 5’-GTGTCCACTTGCTTCAGAT-3’ 
 
5’-CTAGGACACCCGTAACAG-3’ 
 
-139-113 
 
5’-CCAGGCAAGTGTTTGGAAACTGCAGCT-3’  
-119-20m 
 
5’-CCAGGCAAGTGTTTGGAAAAGGCAGCT-3’  
-121-122m 
 
5’- CCAGGCAAGTGTTTGGACCCTGCAGCT-3’  
-124-125m 
 
5’-CCAGGCAAGTGTTTTTAAACTGCAGCT-3’  
-127-128m 
 
5’-CCAGGCAAGTGGGTGGAAACTGCAGCT-3’  
-139-101 
 
5’-CCAGGCAAGTGTTGGAAACTGCAGCTTCAGCCCCTCTG-3’  
-109.10LM 
 
5’-CCAGGCAAGTGTTTGGAAACTGCAGCTTCCTCCCCTCTG-3’  
-113.114LM 
 
5’-CCAGGCAAGTGTTTGGAAACTGCAGAGTCAGCCCCTCTG-3’  
-121.22LM 
 
5’-CCAGGCAAGTGTTTGGACCCTGCAGCTTCAGCCCCTCTG-3’  
-124.25LM 
 
5’-CCAGGCAAGTGTTTTTAAACTGCAGCTTCAGCCCCTCTG-3’  
-126-101 5’-CCAGGCAAGTGTTGTGAAACTGCAGCT-3’  
C/EBP 5’-CACACTTGGAATTAGCAATAGATGCAATTTGGGACTTG-3’  
C/EBPm 5’- CACACTTGGAATTAGCGCTAGATGCAATTTGGGACTTG-3’  
AP1 5’-CGCTTGATGAGTCAGCCGAA-5’  
CREB 5’-ACGCTGCTGCGTCAGCAAAT-5’ 
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3 Materials and Methods 
 
3.1 Cell lines culture. 
 
NIH/3T3, F9, HIT T-15, -TC, RIN and AR42J cell lines were from ATCC (Manassas, 
VA, USA).  INS-1 cell line was provided by Prof. CB Wollheim (University of Geneva, 
Switzerland). NIH/3T3-47 were from New England biolabs (Ipswich, MA, USA). PT67 
packaging cell line was from Clontech (Mountain View, CA, USA). 293Ad cell line was 
from Stratagene (La Jolla, CA, USA). MIN-6 cells were from Dr. J.-I. Miyazaki (Osaka 
University Medical School, Japan). NIH/3T3, F9 and 293Ad were maintained in 
Dulbecco’s Modified Eagle Medium (DMEM) containing 4.5 g/L glucose, 1 mM sodium 
pyruvate, 2 mM L-glutamine, 100 units/ml penicillin, and 100 mg/ml streptomycin, 
supplemented with 10% (v/v) heat-inactivated fetal bovine serum. NIH/3T3-47 were 
maintained in Dulbecco’s Modified Eagle Medium (DMEM) containing 4.5 g/L glucose, 
1 mM sodium pyruvate, 2 mM L-glutamine, 100 units/ml penicillin, 100 mg/ml 
streptomycin, and 800 μg/ml G418 supplemented with 10% (v/v) heat-inactivated fetal 
bovine serum. PT67 were maintained in Dulbecco’s Modified Eagle Medium (DMEM) 
containing 4.5 g/L glucose, 1 mM sodium pyruvate, 2 mM L-glutamine, 100 units/ml 
penicillin, and 100 mg/ml streptomycin, supplemented with 10% (v/v) heat-inactivated 
Tet System Approved fetal bovine serum. AR42J were cultivated in Dulbecco’s Modified 
Eagle Medium (DMEM) containing 4.5 g/L glucose and 1mM sodium pyruvate, 25 mM 
HEPES, 2 mM L-glutamine, 100 units/ml penicillin, 100 mg/ml streptomycin, 
supplemented with 10% (v/v) heat-inactivated fetal bovine serum, and maintained at 
37°C in 5% CO2.  RIN and INS-1 were cultivated in RPMI 1640 containing 4.5 g/L 
glucose and 1 mM sodium pyruvate, 2 mM L-glutamine, 10 mM HEPES, 50 mM -
mercaptoethanol, 100 units/ml penicillin, 100 mg/ml streptomycin, supplemented with 
10% (v/v) heat-inactivated fetal bovine serum and maintained at 37°C in 5% CO2. HIT T-
15 were maintained in Dulbecco’s Modified Eagle Medium (DMEM) containing 4.5 g/L 
glucose, 1 mM sodium pyruvate, 2 mM L-glutamine, 100 units/ml penicillin, and 100 
mg/ml streptomycin, supplemented with 5% (v/v) heat-inactivated fetal bovine serum and 
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15% (v/v) heat-inactivated horse serum. -TC were maintained in Dulbecco’s Modified 
Eagle Medium (DMEM) containing 4.5 g/L glucose, 1 mM sodium pyruvate, 2 mM L-
glutamine, 50mM -mercaptoethanol, 100 units/ml penicillin, and 100 mg/ml 
streptomycin, supplemented with 10% (v/v) heat-inactivated fetal bovine serum. MIN-6 
cells were maintained in Dulbecco’s Modified Eagle Medium (DMEM) containing 4.5 
g/L glucose, 1 mM sodium pyruvate, 2 mM L-glutamine, 100 units/ml penicillin, and 100 
mg/ml streptomycin, supplemented with 20% (v/v) heat-inactivated fetal bovine serum. 
 
 
3.2 (Bio)chemicals. 
 
Invitrogen (Carlsbad, CA, USA): DMEM, RPMI 1640, streptomycin/penicillin 
solution, sodium pyruvate solution, HEPES solution, glutamine solution, TOPO TA 
cloning kit, ZERO BLUNT PCR cloning kit, Lipfectamine2000 transfection reagent, 
OptiMEM medium, Trizol reagent, DEPC-treated water, UltraPure Agarose, Superscript 
Indirect cDNA Labeling System, Labeling Purification Module S.N.A.P. Columns, 
precast 10-20% Tris-glycine gel. 
Amersham Biosciences (Milan, Italy): Cy3
TM
 Mono-Reactive Dye Pack and Cy5
TM
 
Mono-Reactive Dye Pack, Mini Quick Spin Columns. 
Beta Cell Biology Consortium (www.betacell.org): PanChip 6.0 array slides, Anti-
Ngn3 antibody.  
Stratagene (La Jolla, CA, USA): AdEasy XL Adenoviral Vector System (containing 
pShuttle-IRES-hrEGFP2 vector), BJ5183-AD-1 Electroporation Competent Cells. 
Clontech (Mountain View, CA, USA): RevTet-On Gene Expression System (containing 
pRevTet-On, pRevTRE and pRevTRE-Luc vectors), Doxycycline, heat-inactivated Tet 
System Approved fetal bovine serum. 
Santa Cruz Biotechnology (Santa Cruz, CA, USA): Rabbit anti-Neurogenin-3, goat 
anti--actin, mouse anti-MafF/G/K (C-18), mouse anti-MafA, rabbit anti-C/EBP, rabbit 
anti-C/EBP 
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Vector Laboratories (Burlingame, CA, USA): Rabbit normal IgG, goat anti-rabbit-IgG 
HRP conjugate, rabbit anti-goat-IgG HRP conjugate, Vecstastain Elite ABC. 
Aviva System Biology (San Diego, CA, USA): Rabbit anti-OVOl1. 
Millipore (Billerica, CA, USA): EZ-ChiP kit, Immobilon-P PVDF membrane. 
New England Biolabs (Ipswich, MA, USA): Protein G magnetic beads, magnetic 
separation rack, the blunting enzymes mix (T4 DNA polymerase and T4 polynucleotide 
kinase), dNTP mix, T4 DNA ligase, competent E. coli cells, BamHI, HindIII, XhoI, SacI, 
PmeI, PacI, NotI, SalI, ApaI, BsteII, SOC, Phusion Site-Direct Mutagenesis kit 
TransPassD2, RheoSwitch Expression system, Blue Loading Buffer Pack. 
Cell Signaling Technology (Beverly, MA, USA): rabbit anti-HA tag, 20X LumiGLO® 
Reagent and 20X Peroxide, anti-biotin HRP-linked antibody, anti-mouse IgG HRP-linked 
anitbody, anti-rabbit IgG HRP-linked antibody, rabbit anti-NeuroD/BETA2 antibody. 
QIAGEN (Valencia, CA, USA): QIAprep miniprep, midiprep and maxiprep kits and 
QIAquick gel extraction kit. 
Promega (Fitchburg, WI, USA): GoTaq DNA polymerase, RQ1 (RNA-Qualified) 
RNase-Free DNase, M-MLV Reverse Transcriptase, random hexadeoxynucleotides, 
FuGENE6 transfection reagent, Passive Lysis Buffer, Luciferase Assay kit, Dual 
Luciferase Assay kit, pGL2-Basic, pRL-TK, Sequencing Grade Modified Trypsin”. 
Novagen (San Diego, CA, USA): CytoBuster Protein Extraction Reagent. 
BioRad (Hercules, CA, USA): 30% Acrylamide/Bis Solution, 37.5:1 mixture (30%T, 
2.67% C), BioRad Protein Assay reagent. 
Applied Biosystem (Foster City, CA, USA): SYBR Green PCR Master Mix, Western 
Lightning Chemiluminescence Reagent, Galacto-Light Plus System. 
Stop&Shop Supermarket (Brookline, MA, USA): Instant non fat dry milk. 
SIGMA (St Louis, MO, USA): Paraformaldehyde, Protease Inhibitor Cocktail and -
mercaptohetanol, agarose, ethidium bromide, phenol:chloroform:isoamyl alchol 
(24:25:1), 3 M Sodium Acetate pH 5.2 solution, chloroform, isopropyl alcohol, 
ampicillin, kanamycin, G418, hygromycin, blasticidin, LB medium, LB agar, 
hexadimethrine bromide (polybrene),  N,N,N',N'-Tetramethylethylenediamine (TEMED), 
ammoniun persulfate (APS), Tris base, HCl, Sodium dodecyl sulfate (SDS), Glycine, 
Retinoic Acid (RA), dibutyryl-c-AMP (db-cAMP), KOH, xylene, 100% ethanol. 95% 
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ethanol, methanol, Triton X-100, Tween-20, NaCl, KCl, 3, 3'-Diaminobenzidine (DAB), 
H2O2, Harris’s Hematoxylin solution, sodium borate, citrate, paraformaldehyde, 
polyornithine, glycin, Triton X100, goat anti-Rabbit FITC conjugated, CHAPS, protease 
inhibitor cocktail, Bradford reagent, urea, dithiotreitol (DTT), iodoacetamide, silver 
nitrate, sodium carbonate, formaldehyde, sodium bicarbonate, potassium ferricyanide 
trifluoroacetic acid (TFA), 3-(N-morpholino)propanesulfonic acid (MOPS), Sodium 
Saline Citrate Buffer (SSC), Sarcosyl, 3-[(3-Cholamidopropyl)dimethylammonio]-2-
hydroxy-1-propanesulfonate (CHAPS), Protease Inhibitor cocktail, trichloroacetic acid.  
Amersham Bioscience (Arlington Heights, IL): PD-10 desalt column, IPG buffer, 
Immobiline DryStrip pH 3-10 and pH 4-7, HiTrap Heparin HP columns, Cy3
TM
 Mono-
Reactive Dye Pack and Cy5
TM
 Mono-Reactive Dye Pack. 
PIERCE (Rockford, IL, USA): TrichromRanger Molecular Weight mix. 
Carlo Erba Reagenti (Rodano, MI, Italy): Acetonitrile. 
Roche Applied Biosciences (Indianapolis, IN, USA): Mini Quick Spin Columns. 
Strathmann Biotech AG (Dengelsberg, Germany): Activin A. 
RELIATech GmbH (Braunschweig, Germany): Hepatocyte Growth Factor (HGF). 
 
 
3.3 Buffer and Solutions 
 
Sorensen’s buffer pH 7.4  
50 ml dH2O 
40.5 ml 0.2 M Sorensen’s phosphate solution A  
9.5 ml Sorensen’s phosphate solution B 
Sorensen’s phosphate solution A:  
35.61 g Na2HPO4 · 2H2O in 1000 ml of dH2O 
Sorensen’s phosphate solution B 
27.6 g NaH2PO4 · H2O in 1000 ml of dH2O 
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Pre-hybridization buffer  
5X SSC 
0.1% SDS  
1%  BSA 
 
Washing buffer 1 
1X SSC 
0.25% SDS 
 
Washing buffer 2 
1X SSC  
0.1% sarcosyl 
 
Sample Buffer (SDS Reducing Buffer) 
3.55 ml dH2O 
1.25 ml 0.5 M Tris-HCl, pH 6.8 
2.5 ml glycerol 
2.0 ml 10% (w/v) SDS 
0.2 ml 0.5% (w/v) bromophenol blue 
9.5 ml Total Volume 
 
10% SDS 
Dissolve 10 g SDS in 90 ml water with gentle stirring and bring to 100 ml with dH2O 
 
1.5 M Tris-HCl, pH 8.8 
27.23 g Tris base  
80 ml of dH2O 
Adjust to pH 8.8 with 6 N HCl. Bring total volume to 150 ml with dH2O and store at 4°C.  
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0.5 M Tris-HCl, pH 6.8 
6 g Tris base 
60 ml of dH2O 
Adjust to pH 6.8 with 6 N HCl. Bring total volume to 100 ml with dH2O and store at 4°C.  
 
10X Electrode (Running) Buffer, pH 8.3 
30.3 g Tris base 
144.0 g Glycine 
10.0 g SDS 
Dissolve and bring total volume up to 1,000 ml with dH2O. Do not adjust pH with acid or 
base. Store at 4 °C.  
 
Streptavidin-agarose binding buffer 
12% (v/v) glycerol 
12 mM HEPES-NaOH, pH 7.9 
4 mM Tris-HCl, pH 7.9 
60 mM KCl 
1 mM DTT 
Store at -20°C upon addition of DTT 
 
Streptavidin-agarose elution buffer 
12% (v/v) glycerol 
20 mM Tris-HCl, pH 6.8 
5 mM MgCl2 
1 M KCl 
1 mM EDTA 
1 mM DTT 
200 μg/ml BSA 
Store at -20°C upon addition of DTT 
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10X Binding Buffer (EMSA) 
100 mM HEPES, pH 7.9 
1 M NaCl 
20 mM EDTA 
80 mM DTT 
50% glycerol 
1X Buffer A  
10 mM HEPES, pH 7.9 
1.5 mM MgCl2 
10 mM KCl 
0.5 mM DTT 
 
1X Buffer B 
20 mM HEPES, pH 7.9 
25% (v/v) glycerol 
0.42 M NaCl 
1.5 mM MgCl2 
0.2 mM EDTA 
0.5 mM PMSF 
0.5 mM DTT 
 
1X Buffer C 
20 mM HEPES, pH 7.9 
20% (v/v) glycerol 
0.1 M KCl 
0.2 mM EDTA 
0.5 mM PMSF 
0.5 mM DTT 
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Rehydration Buffer  
8 M Urea,  
2% CHAPS 
60 mM DTT 
IPG buffer pH 3-10 or pH 4-7 
0.0002% bromophenol blue. 
 
 
Reduction Buffer  
2% SDS 
50 mM Tris-HCl pH 8.8 
6 M Urea 
30% glycerol 
0.002% bromophenol blue 
65 mM DTT 
 
Alkylation Buffer  
2% SDS 
50 mM Tris-HCl pH 8.8 
6 M Urea 
30% glycerol 
0.002% bromophenol blue 
135mM iodoacetamide 
 
STE Buffer  
10 mM Tris pH 8.0 
50 mM NaCl 
1 mM EDTA 
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HiTrap Binding Buffer 
10 mM sodium phosphate, pH 7 
 
HiTrap Elution Buffer 
10 mM sodium phosphate, pH 7 
1-2 M NaCl 
 
Streptavidin-Agarose Binding Buffer 
12% glycerol 
12 mM HEPES-NaOH, pH 7.9 
4 mM Tris-HCl, pH 7.9 
60 mM KCl 
1 mM EDTA 
1 mM DTT 
 
Streptavidin-Agarose Elution Buffer 
12% Glycerol 
20 mM Tris-HCl, pH 6.8 
5 mM MgCl2 
1 mM EDTA 
1 mM DTT 
200 μg/ml BSA
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3.4 Plasmid Mini-Prep 
 
For the plasmid DNA Mini-Prep the QIAprep miniprep kit was used. The 
QIAprep miniprep procedure uses the modified alkaline lysis method of Birnboim and 
Doly (2). Bacteria are lysed under alkaline conditions, and the lysate is subsequently 
neutralized and adjusted to high-salt binding conditions in one step. After lysate clearing, 
the sample is purified on the QIAprep silica membrane. 
 Single colonies from the transformed bacteria plates obtained as above were 
inoculated into 3 ml of LB medium containing the appropriate antibiotic, and grown with 
vigorous shaking for 12–16 h. 1.5 ml of the bacterial cells were harvested by 
centrifugation at 6800 x g in a conventional, table-top microcentrifuge for 3 min at room 
temperature. After harvesting the pelleted bacterial cells were resuspended in 250 μl of 
Buffer P1. 250 μl Buffer P2 were then added and the tubes mixed thoroughly by inverting 
the tube 4–6 times. 350 μl Buffer N3 were then added, the tubes mixed immediately and 
thoroughly by inverting the tube 4–6 times and centrifuged for 10 min at ~17,900 x g in a 
table-top microcentrifuge. The cleared supernatants from step above were applied to the 
QIAprep spin column centrifuged for 1 min. The flow-through was discarded. The 
QIAprep spin column were washed by adding 750 ml of Buffer PE and centrifuged for 1 
min as above. The flow-through was discarded, and the column centrifuged for an 
additional 1 min to remove residual wash buffer. The QIAprep columns were placed in a 
clean 1.5 ml microcentrifuge tube and the DNA eluted adding 50 μl of water to the center 
of each QIAprep spin column, let stand for 1 min, and centrifuged for 1 min.  
 
 
3.5 Plasmid Midi-Prep 
 
For the plasmid DNA midi-prep the QIAprep midiprep kit was used. To 50 ml of 
LB medium containing the appropriate antibiotic, 100 μl of positive bacterial suspension 
were added and grown with vigorous shaking for 12–16 h. The bacterial cells were 
harvested by centrifugation at 600 x g for 15 min at room temperature. After harvesting 
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the pelleted bacterial cells were resuspended in 4 ml of Buffer P1. 4 ml Buffer P2 were 
then added and the tubes mixed thoroughly by inverting the tube 4–6 times and incubated 
5 min at broom temperature. 4 ml of cold Buffer P3 were then added, the tubes mixed 
immediately and thoroughly by inverting the tube 4–6 times, incubated 15 min on ice and 
centrifuged for 30 min at ~20,000 x g. The cleared supernatants from the above step were 
applied to the QIAprep column previously equilibrated with 4 ml of buffer QBT and 
allowed to enter the resin by gravity flow. The flow-through was discarded. The QIAprep 
column was washed by adding 2 x 10 ml of bufffer QC. The flow-through was discarded, 
the column placed in a clean 50 ml tube and eluted with 5 ml of buffer QF. The DNA was 
then precipitated by adding 3.5 ml of isopropyl alcohol at room-temperature and 
centrifuged immediately at 15,000 x g for 30 min at 4°C. The supernatant was carefully 
decanted and the pellet washed with 2 ml of 70% ethanol, centrifuged at 15,000 x g for 
10 min. The supernatant was carefully decanted and the pellet air dried and then 150-200 
μl of dH2O. The purified plasmid DNA was quantified by use of a ND-1000 
Spectrophotometer (NanoDrop Technologies). 
 
 
3.6 Plasmid Maxi-Prep 
 
For the plasmid DNA maxi-prep the QIAprep maxiprep kit was used. To 500 ml 
of LB medium containing the appropriate antibiotic, 100 μl of positive bacterial 
suspension were added and grown with vigorous shaking for 12–16 h. The bacterial cells 
were harvested by centrifugation at 600 x g for 15 min at room temperature. After 
harvesting the pelleted bacterial cells were resuspended in 10 ml of Buffer P1. 10 ml 
Buffer P2 were then added and the tubes mixed thoroughly by inverting the tube 4–6 
times and incubated 5 min at broom temperature. 10 ml of cold Buffer P3 were then 
added, the tubes mixed immediately and thoroughly by inverting the tube 4–6 times, 
incubated 15 min on ice and centrifuged for 30 min at ~20,000 x g. The cleared 
supernatants from the above step were applied to the QIAprep column previously 
equilibrated with 10 ml of buffer QBT and allow it to enter the resin by gravity flow. The 
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flow-through was discarded. The QIAprep column was washed by adding 2 x 30 ml of 
bufffer QC. The flow-through was discarded, the column placed in a clean 50 ml tube and 
eluted with 15 ml of buffer QF. The DNA was then precipitated by adding 10.5 ml of 
isopropyl alcohol at room-temperature and centrifuged immediately at 15,000 x g for 30 
min at 4°C. The supernatant was carefully decanted and the pellet washed with 5 ml of 
70% ethanol, centrifuged at 15,000 x g for 10 min. The supernatant was carefully 
decanted and the pellet air dried and then 150-200 μl of dH2O. 
 
 
3.7 Gel Extraction. 
 
For the DNA gel extraction the QIAquick gel extraction kit was used. After the 
run the bands were excised from the agarose gel with a clean, sharp scalpel, weighed and 
added with 3 volumes of Buffer QG (v/w). The gel slices were incubated at 50°C until 
completely dissolved, added with 1 gel volume of isopropyl alcohol placed onto 
QIAquick spin columns and centrifuged at 10,000 x g for 1 minute. The QIAquick spin 
columns were then washed with 750 μl of buffer PE and centrifuged as above. The flow-
troughs were discarded and the QIAquick columns centrifuged for an additional 1 minute 
at 10,000 x g. The QIAquick columns were placed into a clean 1.5 ml microcentrifuge 
tube and the DNA eluted with 50 μl of dH2O and centrifuged for 1 min at 10,000 x g. 
 
 
3.8 Bacteria transformation 
 
For bacteria transformation, to the competent E. coli cells, thawed on ice, up to 50 
ng of DNA (vector or ligation reactions) are added and the mixture incubated on ice for 
30 min. The cells were then heat shocked at exactly 42°C for exactly 30 seconds and 
placed on ice for 5 min. After addition of 950 μl of room temperature SOC into the 
mixture the cells were incubated at 37°C for 60 min with vigorous shake (250 rpm). Ten 
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μl for vectors and up to 100 μl of ligation reaction were plated onto a LB-agar plate 
containing the appropriate antibiotic and incubated overnight at 37°C. The plasmid DNA 
was then extracted as described above. 
 
3.9 RNA Extraction and Reverse Transcription 
 
The RNA was extracted by adding directly to the plate 1 ml of Trizol reagent and 
passing the cell lysate several times through a pipette. The homogenized samples were 
then transferred in a microcentrifuge tube and incubated for 5 min at room temperature. 
200 ml of chloroform per 1 ml of Trizol were then added and the tube vigorously shacked 
for 15 sec incubated at room temperature for 5 min and centrifuged at 12,000  g for 15 
min at 4°C. Following centrifugation, the upper aqueous phase is recovered and 
transferred in a new microcentrifuge tube. The RNA from the aqueous phase was then 
precipitated by mixing with 500 μl of isopropyl alcohol per 1 ml of Trizol Reagent. The 
samples are then incubated at room temperature for 10 min and centrifuged at 12,000  g 
for 10 min at 4°C. The supernatant is removed and the RNA precipitated washed once 
with 1 ml of 70% ethanol. The sample are mixed by vortexing and centrifuged at 7,500  
g for 5 min at 4°C. At the end of the procedure, the RNA pellet was briefly dried and the 
RNA pellet dissolved in DEPC-treated water and stored at -70°C. 
The purified DNAs were quantified by use of a ND-1000 Spectrophotometer 
(NanoDrop Technologies). 
Prior to proceed to the Reverse Transcription reaction the RNA extracted as above 
is DNase treated. In a 200 μl tube the following reagent were added: 
 
RNA         1.0 μl (1 mg) 
RQ1 RNase-Free DNase 10X Reaction Buffer    1.0 μl (1X final) 
RQ1 RNase-Free DNase       1.0 μl (1 Unit) 
DEPC-treated H2O                   To 10 μl 
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 The mixture is incubated for 1 h at 37°C. To the reaction 1 μl of RQ1 DNase Stop 
Solution is added to terminate the reaction and the mixture incubated at 65°C for 10 min 
to inactivate the DNase. 
 To the DNase-treated RNA 2 μl of a 50 ng/μl solution of random 
hexadeoxynucleotides were added and the solution incubated for 5 min at 70°C. The 
tubes were then rapidly cooled on ice and added with the following reagent: 
 
M-MLV 5X Reaction Buffer       5.0 μl (1x final) 
dNTP mix 10 mM        5.0 μl (2 mM) 
M-MLV RT         1.0 μl (200 Units) 
DEPC-treated H2O                     To 25μl 
 
The mixture is incubated for 1 hr at 37°C followed by incubation at 70°C for 10 
min to inactivate the M-MLV RT. 
 
 
3.10 Real-Time RT-PCR 
For the real-time PCR reaction the following mixture is prepared in 96-optical 
tube plate:  
SYBR Green Mix (2X)               12.5 μl 
cDNA           3.0 μl 
10 μM 5’-Primer       2.5 μl (0.5 nM) 
10 μM 3’-Primer        2.5 μl (0.5 nM) 
Sterile dH2O               To 25 μl 
 
For the quantification the comparative Ct method has been used. This involved 
comparison of the Ct values of the samples of interest (samples transfected) with a 
calibrator (samples transfected with the empty vector). The Ct values of both the 
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calibrator and the samples of interest are normalized to an appropriate endogenous 
housekeeping gene. 
The comparative Ct method is also known as the 2
–[][]Ct method, where  
[][]Ct=[]Ct,sample-[]Ct,reference. Here, []CT,sample is the Ct value for any sample 
normalized to the endogenous housekeeping gene and []Ct, reference is the Ct value for the 
calibrator also normalized to the endogenous housekeeping gene. 
 
 3.11 Agarose-Formaldehyde Electrophoresis 
 
RNA electrophoresis under denaturing conditions in 2.2 M formaldehyde is 
performed according to Maniatis et al., (1982) using the MOPS buffer system. RNA 
under these conditions is fully denatured and migrates according to the log10 of its 
molecular weight. Agarose has been prepared by melting the required amount of agarose 
in distilled water, cooling to approximately 60°C (hand hot) and adding 37% 
formaldehyde and 10X MOPS to give 2.2 M formaldehyde and 1X MOPS, respectively. 
RNA samples have been prepared by adding up to 25 μg of RNA in a maximum of 5 μl 
sterile H2O, to 15 μl RNA denaturation buffer. One μl of 10 μg/μl ethidium bromide is 
added to aid visualization of RNA after electrophoresis. Samples are loaded into the gel 
and electrophoresed at no more than 5V/cm, with occasional buffer recirculation, until 
the leading bromophenol blue dye front has migrated approximately three quarters of the 
length of the gel. Visualisation of RNA is achieved by irradiation with short wave 
(254nm) UV light. 
 
 
3.12 Protein Quantification 
 
For the protein quantification the BioRad Protein Assay reagent was used. In a 
96-well plate 5 and 10 μl of cell extracts and 10 μl of solutions containing 0.1, 0.2, 0.3, 
0.4 and 0.5 μg/μl of BSA were pipetted. To the well 200 ml of 1X dye reagent were 
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added, the plates incubated at room temperature for 5 min and the absorbance read at 595 
nm in a microplate reader. 
 
 
3.13 MICROARRAYS ANALYSES 
 
3.13.1  Cell culture and differentiation. 
 
Approximately 2 x 10
7
 AR42J cells were plated in 100 mm cell culture dish in the 
appropriate medium and treated with 2 nM Activin A and 100 pM of HGF for 2 days 
changing medium every other day. After the differentiation period the cells were washed 
with cold PBS. The cell were recovered by a cell scraper centrifuged and the pellet 
resuspended in 1 ml of Trizol reagent. The total RNA was then extracted as described 
above. 
 
 
3.13.2 Synthesis of Aminoallyl-Amminohexil-UTP ssDNA.  
 
For the synthesis of aminoallyl-amminohexil-UTP ssDNA the Superscript 
Indirect cDNA Labeling System has been used. In 200 μl RNAse-free tubes were mixed: 
 
1X Reaction mixture 1: 
Total RNA       up to 10 μl (up to 20 μg)  
Anchored oligo(dT)20 primer (2.5μg/μl)                         2 μl  
 
The mixture has been incubated 5 min at 70°C then the reaction was placed on ice 
for 1 min. At the same time the reverse transcription reaction mixture has been prepared 
as follow: 
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1X Reaction mixture 2: 
5X First strand buffer       6.0 μl   
0.1M DTT        1.5 μl 
10mM dNTPs        1.5 μl  
RNAse out (40U)       1.0 μl 
SuperScriptII        2.0 μl   
DEPC-treated H2O                      To 18μl 
 
The above mixture (Reaction mixture 2) was combined with the RNA solution 
previously prepared (Reaction mixture 1) and the final mixture incubated for 2 h at 46°C. 
 
 
3.13.3 Hydrolysis and Neutralization of the Reaction 
 
To the reverse transcription reaction from above, 1.5 μl of NaOH 1 N (fresh made 
from 10 N stock solution) has been added and incubated for 10 min at 70°C. Fifteen μl of 
1 N HCl have been added to neutralize the solution and gently mixed followed by 
addition of 20 μl of 3 M Sodium Acetate pH 5.2 and gently mixed. 
 
 
3.13.4 Purification of the cDNA 
 
For the purification of the cDNA the Labeling Purification Module S.N.A.P. 
Columns have been used. Five hundred μl of Loading Buffer have been added to the 
cDNA mixture previously neutralized, loaded on the S.N.A.P.
TM
 column and centrifuged 
at 14,000 x g at room temperature for 1 min. The column was then washed with 700 μl of 
Washing Buffer, centrifuged as above and washed again. After a further centrifugation, 
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the cDNA was eluted twice with 50 μl of DEPC-treated water. The purity cDNA was 
measured spectrophotometrically. 
 
 
3.13.5 Ethanol Precipitation of cDNA  
 
To the cDNA purified with the S.N.A.P. column, 10 μl of 3 M sodium acetate pH 
5.2, 2 μl of 20 mg/ml glycogen and 300 μl of ice-cold 100% ethanol have been added and 
incubated overnight at -80°C. The following day the mixture was centrifuged at 14,000 x 
g for 20 min at 4°C. The pellet was then washed with 70% ethanol, centrifuged again for 
5 min at 4°C and resuspended with 5 μl of DEPC-treated water. 
 
 
3.13.6 Fluorescent Dye Labeling of cDNA  
 
The Cy3
TM
 Mono-Reactive Dye Pack and Cy5
TM
 Mono-Reactive Dye Pack were 
resuspended with 10 μl of DMSO and 5 μl of each have been used for the labeling 
reaction. 5 μl of DMSO/dye and 5 μl of cDNA previously resuspended were combined 
and incubated in the dark for 1 h at room temperature. 
 
 
3.13.7 Purification of Labeled cDNA 
 
For the purification of the Cy3- and Cy5-labeled cDNA the Labeling Purification 
Module S.N.A.P. Columns have been used. Briefly 200 μl of 3 M sodium acetate pH 5.2  
and 500 μl of Loading Buffer plus isopropanol were added to the dye-coupled cDNA 
mixture, mixed by vortexing, loaded on a S.N.A.P. column and centrifuged at 14,000 x g 
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for 1 min at room temperature. The column was washed twice with 700 μl of Washing 
Buffer and the cDNA eluded twice with 50 μl of DEPC-treated water. 
 
 
3.13.8 Assessing Labeling Efficiency 
 
The sample, previously purified with S.N.A.P. column was assessed 
spectrophotometrically to confirm the labeling reaction. All the samples have been 
transferred into a cuvette and the absorbances measured at the following wavelength: 260 
nm, 280 nm, 310 nm, 550 nm 650 nm and 750 nm. The coupling efficiency has been 
calculated as follow: 
 
  Cy3
TM
 [pmol] = [(A550 – A650) x 55]/0.15 
   
  Cy5
TM
 [pmol] = [(A650 – A750) x 55]/0.25 
 
After the spectrophotometer reading, the samples were mixed (e.g.: Sample 
differentiated-Cy3 vs. Sample undifferentiated-Cy5), added with 12 μl of sodium acetate 
3M pH 5.2, 12 μl of 20 mg/ml of glycogen, 300 μl of ice-cold 100 % ethanol and 
incubated overnight at -80°C. The following day the labeled-cDNA was precipitated by 
centrifugation and the pellet resuspended with 1.17X Hybridization Buffer. 
 
 
3.13.9 PanChip 6.0 array slides  
 
The Mouse PancChip 6 provided by the Beta Cell Biology Consortium contains 
approximately 13,000 mouse cDNAs chosen for their expression in various stages of 
pancreatic development, many of which are not found on commercially available arrays. 
Many of these clone where chosen to represent every assembly found to be expressed in 
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the pancreas by sequence analysis of Consortium Libraries EPConClones. In addition, 
well characterized probes amplified from full-length sequence verified transcripts known 
to be involved in pancreas development and pathways relating to glucose homeostasis are 
included. The high level of homology between mouse and rat genes makes this array 
suitable for use with tissues or cells derived from the rat. The PanChip 6.0 has been 
printed with 306 spots per grid. As control each subgrid has a Cy3 anchor on the right 
bottom corner (Fig. 2).  
 
 
 
The PanChip 6.0 is supported with excel and text files containing all the information 
about the genes spotted on the surface: 
 
• Internal unique identifier for sample or clone 
• Data source for the External_Source_ID (e.g. GeneBank accession number) 
• EntrezGene gene symbol and unofficial symbols and description used for the gene 
and its products represented by the clone 
• EntrezGene description of the clone 
• Mouse Genome Information accession number for the clone 
• NCBI Reference Sequence collection ID associated with the 
Verified_EntrezGeneID for the clone 
Fig. 2: The Array has been 
spotted on Corning ULTRA 
Gaps slides at the University 
of Pennsylvania. Each Array 
consists of grid of 48 subgrids 
(12x4) while each subgrid 
consists of 306 spots (17x18). 
The anchor Cy3 control has 
been placed at the right 
bottom corner.  
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• Chromosome information 
• Map location 
• PCR failure flag to determine if the PCR reaction has failed 
• Sequence_Verified flag to determine if the spotted clone has been verified 
• GeneBank accession number for the 5’ sequence end of the spotted clone 
• GeneBank accession number for the 3’ sequence end of the spotted clone 
• DoTS (Database Of Transcribed Sequences) for the spotted clone and description 
• ID for mouse PromoterChip element corresponding to the Mouse PanChip genes 
• Description of the controls: 
 Cy3 Anchors: random 70mer oligo labeled with Cy3 
 SpotReport
TM
: positive (-actin) and negative (Arabidopsis thaliana PCR 
products) 
 
 
3.13.10 Pre-Hybridization of the array slides 
 
For the hybridization reaction the Pre-Hybridization Buffer has been warmed for 
30 min at 42°C and the microarray slides were submerged in the pre-warmed Pre-
Hybridization Buffer for 45 min. After incubation the microarray slides were washed for 
2 min with 0.5 SSC buffer and dried by centrifugation at 1,000 x g at room temperature. 
 
 
3.13.11 Hybridization of the array slides 
 
To the labeled-cDNA, 5μl of oligo(dT)-NoTI (5μg/μl) have been added in order 
to minimize non-specific hybridization. The mixture was first incubated at 95°C for 3 
min, centrifuged and then placed on ice. The microarray slides were placed into the 
hybridization chamber and the labeled-cDNA mixture spread on the spotted surface of 
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the slide. After covering the slide with a coverslip the hybridization chamber has been 
closed and incubated for 16 h at 40°C in a water-bath. 
 
 
3.13.12 Washing of the array slides 
 
The day after the microarray slides were removed from the hybridization chamber 
and washed with: Washing Buffer 1 (pre-warmed at 42°C) for 4 min, with Washing 
Buffer 2 for 5 min, with 0.2X SSC for 5 min, with 0.1X SSC for 5 min and then 
centrifuged at 1,000 x g for 1 min. The slides were then scanned and the intensity signals 
were acquired for the statistical analysis.  
3.13.13 Scanner Platform for Chip Reading 
 
The VersArray ChipReader System scanner is a dual-laser confocal system 
designed for rapid imaging of microarrays. The BioRad scanner as been chosen because 
it allows differentiating between a spot response and background level, and optimizing 
the signal on the bottom as well as on the top end of the range for increased sensitivity 
but also for its multi-cross platform properties. The VersArray ChipReader shows low 
background, enhanced weak signal detection, and virtually no photobleaching for a long 
dye lifetime.  
 
 
3.13.14 Technical characteristics VersArray ChipReader
TM
  
 
Chip Size: 2575 (13") or other similar sizes and depths. 
Scan Area: Up to 2265 mm (0.872.56"), defined by user; other scan areas can be 
selected. 
Read Time: Approx. 8 min per slide at 10 μm resolution (scanning speed 5-30 lines/sec). 
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Read Sequence: Simultaneous or independent. 
Scanning Resolution: 3 ㎛ model : 3 - 24 ㎛ in 3 ㎛ increments. 
Dynamic Range: 16 bits per pixel; linear detection over the entire range. 
Data Storage: 16-bit TIFF images. 
Number of Lasers: 2 standard. 
Excitation Wavelengths: 532 nm and 635 nm (standard). 
Laser Power: 10 mW for each channel; independently controlled from 0-100%. 
 
 
3.13.15 Scanning 
 
The first scanning of the microarray slides has been done at low resolution (40 μm 
per pixel). Such scanning allows setting all the parameters of the photomultiplier and the 
laser power in order to balance the signal between the two lasers and to optimize the 
system. In order to get that, the count ratio (ratio between the area under the curves in the 
gap of the histogram defined by the two vertical cursors of minimum and maximum 
considered) must be as much as possible close to the unit and the histogram must be as 
large as possible, without outclassing the sensitivity of the instrument. With the first low-
resolution scanning it is possible also decide the area that will be scanned with the high-
resolution scan.  
 
 
3.13.16 Spot Determination 
 
After the first scanning at low-resolution, the software VersArray Image 
Acquisition needed to be set with defined parameters for the spot position determination. 
Those parameters were the grid and sub-grid number and their position and the software 
has centered automatically the laser on the spots on the array. After that the array has 
been checked (Fig. 1a) and the laser position on each spot has been corrected (Fig 1b), if 
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necessary, so the laser was able to read exactly the spot surface without external 
interferences such as dust on the array surface (Fig. 1c) or be miss-centered because the 
wrong shape of the spotted cDNA (Fig. 1d). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Once that the parameters have been chosen a high-resolution scan (3 μm) has 
been performed and .tif images have been produced. The images are composed of two 
separated monochromatic images for both the channels that the software compare and 
analyse as a single, colored, image. The scan gives a .txt file as output with different 
information about the slide. The informations are: GridName, Column, Row, CentroidX, 
CentroidY, Signal Average, Signal Median, Signal Std, Signal Pixels, Background 
Average, Background Median, Background Std, and Background Pixels. The Signal 
 
 
 
a b 
c d 
Fig.1: after the low-resolution scan and after settled the grid and subgrid 
parameters the laser was not focused exactly on all the spots (a) that because 
sometime the shape (c and d) of the spots are not perfect but also because dust 
on the glass surface (white arrow). For that after the first scan the laser position 
needs to be adjusted (b). 
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Average and the Background Average have been used for the following statistical 
analysis. 
 
 
3.13.17 Software for Microarray Statistical Analysis 
 
TIGR-MIDAS (from TIGR-Software http://www.tigr.org/)  
 
R (from The R project for statistical computing, http://www.r-project.org/) 
 
mArray (from Bioconductor,  
http://bioconductor.org/repository/release1.5/package/html/index.html) 
 
S.A.M. (significance of microarray analysis, from Stanford Univeristy, http://www-
stat.stanford.edu/~tibs/SAM/) 
 
Several software tools that combine data normalization are currently available. 
Those software packages were analyzed by Dudoit et al. (Dudoit, Genteman et al. 2003) 
with particular emphasis on the TIGR-MIDAS microarray software suite, Bioconductor 
in R and BioArray software Enviroment (BASE) system. For this Thesis project the 
analysis has been done with the TIGR-MIDAS software suite, the Bioconductor in R 
packege and the S.A.M. package for Microsoft Excel. Briefly the TIGR Microarray Data 
Analysis System is a member of a suite of microarray data management and analysis 
applications developed at The Institute for Genomic Research (TIGR). TIGR-MIDAS is 
an application that allows performing normalization and other statistical data analysis 
such background subtraction, total normalization, Lowess normalization, and S.A.M. 
analysis. The Bioconductor in R (Genteman, Carey et al. 2004; Team 2007) is an open 
source language environment for statistical computing. The expression ratio for each 
element on the array was calculated in term of log2(Red/Green). The data were 
normalized by total and Lowess method using the Bioconductor package mArray 
Chapter 3 Materials and Methods 
________________________________________________________________________  
 76
(Genteman, Carey et al. 2004). The analysis was carried out with RNA from five 
replicate experiments at the same time point of treatment.   
Analyzing a microarray slide means to manage some thousands or tens of 
thousands different values for each parameter for each of the two colors used to label the 
different samples. That means that in order to analyze the data deriving from an array 
analysis it must be chosen a well-defined approach in order to get high-quality and 
reproducible measures of the hybridization intensities. For that purpose before comparing 
the levels in a “secure way”, a number of transformations must be carried out on the data 
to eliminate questionable low-quality measurements, to adjust the measured intensities to 
facilitate comparison and to select genes that are significantly differentially expressed 
between classes of samples. The first step has been the primary comparison of the signals 
(Red and Green).  
 
 
3.13.18 Comparison of the Signals 
 
The hypothesis is that we have data from an array of a certain number of spotted 
probes (e.g. from 1 to 100,000 and beyond). So the case is, the array has Narray distinct 
elements, and query elements and reference elements have to be compared. The 
comparison of those elements derives from the ratio of the corresponding element. If the 
query sample has been labeled with the green dye (G) and the reference sample has been 
labeled with the red dye (R) the ratio (C) will be: 
 
  
C
i
=
G
i
R
i
 
 
where i is the index for all the arrayed genes from 1 to Narray. Even if the ratio gives a 
measure of the expression change, it has the drawback to consider differently up- and 
down-regulated genes. In fact, genes up-regulated by a factor of 2 have an expression 
ratio of 2, whereas those down-regulated by the same factor have an expression ratio of -
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0.5. For that reason is required a further transformation, instead to use the simple ratio 
between the query and reference sample, a logarithmic transformation has been 
introduced: 
 
  
C i = log2
Gi
Ri
 
 
The base 2 logarithmic transformation ensure that all the expression changes are 
weighted in the same way. In fact the logarithms of the expression ratios are, in such way, 
treated in a symmetrical way: 2 fold up-regulation, the log2 (2/1) = 1, on the other hand if 
the query has a 2 fold down-regulation, the log2 (1/2) = 1. Furthermore, a first 
transformation has been applied to the data to adjust the individual hybridization 
intensities to balance them appropriately. There are many of reasons why the data must 
be normalized: quantities of starting RNA, differences in labeling or detection 
efficiencies between the fluorescent dye used, and also systematic biases in the measured 
expression levels. 
 
 
3.13.19 Normalization of the Data 
 
3.13.19.1 Total Normalization 
 
There are many approaches to normalize the expression levels; one of those is the 
Total Normalization, which is based on simple assumptions. The first is that the starting 
amount of RNA is the same between the samples, that the mass of each single molecule is 
the same, and therefore the number of molecules in the samples is the same; The second 
is that the spotted genes in the array are representing a random sampling of the gene 
organism or the gene pool of a particular organ. Based on these two simple hypotheses a 
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normalization factor can be calculated by the sum of the intensities of both channels in 
the following way: 
 
  
C total =
Gi
i =1
C array

Ri
i =1
C array

 
 
 
where the Gi and Ri are the measured intensities of the i
th
 elements of the array and Carray 
is the total number of the elements on the array. One or both intensities are properly 
scaled in the follow way: 
 
  R'K =C total RK  and   G'K =GK  
 
then: 
 
  
M
i
=
G
'
i
R
'
i
=
1
C
total
G
i
R
i
 
 
That expression corrects each ratio such that the mean ratio is equal to 1, which is 
as to subtract a constant from the logarithm of the expression ratio: 
 
  log2 M i( ) = log2 M i( )  log2 C total( )  
 
That result is a mean value of the logarithm ratio equal to 0. After the total 
normalization a second normalization called Lowess has been applied to the array values.  
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3.13.19.2 Lowess Normalization 
 
In addition to the total intensity normalization many other functions can be 
applied to the analysis of microarray data: Linear Regressions (Chatterjee and Price 
1991), Rank Invariant Methods (Tseng, Oh et al. 2001) and Chen’s Ratio Statistics 
(Chen, Dougherty et al. 1997), just to mention some of those. Nevertheless the main 
limitation of such approaches is that none of them consider the systematic biases that may 
appear in the data. In fact several reports have indicated that the log2 ratio values can 
have systematic dependence on the intensities (Yang, Chen et al. 2002; Yang, Dudoit et 
al. 2002), that is the most common cause of deviation from zero in spots with low-
intensity values. For that purpose a local weighted Lowess Normalization (or Linear 
Regression Analysis) has been applied after the total intensity normalization in the 
microarray analysis. Lowess uses a weight function that does not increase the 
contribution of data from array elements that are far from each point. The effects of the 
Lowess normalization are evident when the data from the array are plotted in log2(Gi/Ri) 
as function of log(Gi*Ri) also known as “R-I Plot”. (Figura dai grafici degli array). 
Basically when the values xi=log(Gi*Ri) and yi= log2(Gi/Ri) are assessed the Lowess 
normalization function estimates the y(xk) and then uses the function, point by point, to 
calculate a correct log2(ratio). In that way the corrected value became: 
 
  
log2 = log2 M i 
1
2
y (x i )
 
  
 
  
= log2
Gi
Ri
 1
2
y (x i )
 
 
 
 
 
  
 
so, as see before for the total intensity normalization, the transformation for the intensities 
is: 
 
  R' i = Ri  2
y (x i )  and   G' i =Gi  
 
after the normalization, a Variance Regularization has been done. 
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3.13.19.3 Variance Regularization 
 
Nevertheless with the total and Lowess normalizations the mean of the log2(ratio) 
has been corrected, some stochastic process can cause a variance of measured logarithmic 
ratio between the regions of the array or between different arrays. To avoid such 
situation, a possible approach has been proposed by Yang et al. 2002 and Huber et al. 
2002 (Huber, von Heydebreck et al. 2002; Yang, Dudoit et al. 2002). Considering a 
single array with distinct subgrids, as the array platform used for my study, after a local 
normalization there is a factor for each subgrid that can be used to scale all the 
measurements within that subgrid. In this case a good scaling factor is the variance for a 
particular subgrid divided by the geometric mean of the variances for all the subgrids. So, 
considering that each array slide has n-grids and considering that each subgrid has Q 
elements (spots) already adjusted to the mean of the logarithm ratio to zero, the variance 
of the n
th
 subgrid will be:  
 
  
 n2 = log2 M j( )[ ]
j =1
Q

2
 
 
if the number of subgrids in the array is Ngrids the best scaling factor for the k
th
 subgrid 
elements is: 
 
  
ek =
 k2

n=1
N grids
 n2
 
  
 
  
1
N grids
 
 
after that all the elements of the k
th
 subgrid are divided for the ekth value calculated for the 
same subgrid, equivalent to taking the ekth cause of the individual intensities in the k
th
 
subgrid: 
 
  
log2 M i
'( ) =
log2 M i( )
ek
;  
  
R
i
' = R
i[ ]
1
e k  and 
  
G
i
' = G
i[ ]
1
e k  
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The same kind of subgrid regularization can be used for the regularization 
between different arrays. When the array data are analyzed by an “R-I Plot” it can be 
noticed that the variability in the measured logarithmic ratio increase if the measured 
intensity values are decreasing. For that the relative error tends to increase for low 
intensities levels, because the signal is close to the background noise. A solution of that 
problem is to use a threshold baseline higher than the background signal or screen the 
signal intensities to use only those that are statistically different from the signal 
background, which is two standard deviations above the background level.  
 
3.13.19.4 Replicate Filtering 
 
Replication is essential for identifying and reducing the variation in an experiment 
and the microarray experiment is not an exception. Technical replicates include replicated 
elements within a single array, multiple independent elements for a particular gene within 
an array, or replicated hybridizations for a particular sample. One widely used technical 
replication in two-color array assay is the Dye-reversal or Flip Dye Analysis, which 
consists of duplicate labeling and hybridization by swapping the fluorescent dyes used for 
each RNA sample. So the analysis will be: 
 
  
M
1i
=
R
1i
G
1i
=
A
1i
B
1i
 and  
  
M
2 i
=
R
2 i
G
2 i
=
B
2 i
A
2 i
 
 
where A and B are two samples labeled respectively with red and green first and then the 
color swapped and labeled with green and red respectively. If we compare the samples 
we expect that the differences between the normalized samples is zero: 
 
  
log2 M1i M2 i( ) = log2
A1i
B1i
 B2 i
A2 i
 
 
 
 
 
 = 0  
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Therefore, the values expected to be “good values” are close to zero for the 
log2(M1i*M2i) while the “bad values” are far from the zero. Depending the stringency set, 
the values with a log2(M1i*M2i) will be within a certain number of standard deviations of 
the mean.  
 
 
3.13.19.5 Averaging over the replicates experiments 
 
To reduce the complexity of the data, an average of the replicate measures has 
been done. If the treated and untreated sample are A and B respectively, and ci the 
constant used to correct the array, the averaging between the replicates as been calculated 
in the following way: 
 
  
log2
A1i
B1i
 
 
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errors in the replicates experiments are corrected following the error propagation theory 
(Bevington and Robinson 1991): 
 
in general for a function f(x) the error will be: 
 
  
f x( )error  x2 =
f
x
 
 
because we are working with the array the function will be the logarithmic ratio of the 
intensities: 
 
  
f = log2
Ai
Bi
 
 
 
 
 
 = log2 Ai( )  log2 Bi( )  
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but for the logarithm properties: 
 
  
log2 x( ) =
ln x
ln 2
 
 
for the partial derivates properties: 
 
  

x
ln x( )( ) =
1
x
 
 
then the error for the average logarithm is calculated as follow: 
 
  

x
log2 x( )( ) =

x
ln x
ln 2
 
  
 
  
=
1
ln 2
 
  
 
  

x
ln x =
1
ln 2
 
  
 
  
1
x
=
1
x ln 2
 
 
and 
 
  

f
2
=

f

A
 
 
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 
 
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f

B
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The estimated error for A and B has been used to estimate the error for the ratio. 
 
3.13.19.6 Significance Analysis of Microarray (S.A.M.) 
 
The S.A.M. software (Tusher et al. 2001 implemented as in Chu et al. 2002), 
distributed under GNU public license and running on Microsoft Excel, pick-out 
significant genes based on differential expression between sets of samples. The a priori 
hypothesis is that some genes will have significantly different expression mean levels 
between different samples sets, as for example between different treated samples. A 
valuable feature of S.A.M. is that it gives an estimate of the False Discovery Rate (FDR), 
which is the proportion of genes likely identified by chance being significant. Moreover it 
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allows looking at the t-test and then let set thresholds for significance (delta parameter) 
after looking the distribution, rendering the data-miming process more sensitive. In 
particular for the microarray analysis the function “one-class” has been used, where it is 
possible to specify the value against which the mean expression of each gene will be 
tested. The gene expression is considered significant if the mean log2 of expression ratios 
is significantly different from the specified mean.  
 
3.14 Imunohystochemistry 
 
2 x 10
5
 cells were plated the day before the differentiation treatment on 
polyornithine coated glass coverslips in a 12-well cell culture plate. The cells were 
treated with medium containing 2 nM activin A and 500 pM HGF for 2 days.  After 48h 
the medium was removed, the cells were washed with PBS 1X and fixed with a 4% 
paraformaldehyde solution for 10 min. The cells were then permeabilized with a 0.1% 
TritonX100 solution in PBS at room temperature and then saturated with the same 
solution completed with 1 M glycine and incubated for 45 min at room temperature. After 
saturation the cells were incubated overnight with anti-insulin antibody (1:100) at 4°C. 
Following the overnight incubation the cells were washed and incubated for 30 min at 
room temperature anti-Rabbit FITC conjugated (1:200). The samples have been treated 
with DAPI and mounted with MOWIOL and analyzed with a Leica DC 300 microscope. 
 
 
3.15 PROTEOMIC ANALYSIS 
 
3.15.1  Cell culture and differentiation. 
 
Approximately 2 x 10
7
 AR42J cells were plated in 100 mm cell culture dish in the 
appropriate medium and treated with 2 nM Activin A and 500 pM of HGF for 2 days 
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changing medium every other day. After the differentiation period the cells were washed 
with cold PBS. The cell were recovered by a cell scraper centrifuged and the pellet 
extracted as bescribed below. 
 
3.15.2  Protein Extraction 
 
The cell pellet from above were washed with 5 ml of PBS and frozen at -80°C. 
After 1 h the pellet has been re-suspended with 2.5 ml of a PBS solution containing 2% 
CHAPS and protease inhibitors and sonicated three times for 30 sec. The protein solution 
was then centrifuged at 14,000 x g for 25 min at 4°C and the solution loaded on a PD10 
desalting. The flow-through was discarded and the proteins eluted with 3.5 ml dH2O 
collecting the flow-through.  The concentration of the eluted protein was determined as 
described above. The protein samples were then divided in 50 μg aliquots and freeze-
dried. 
 
 
3.15.3  First-dimension: isoelectric focusing 
 
Freeze-dried 50μg protein aliquot prepared as above were resuspended with 125 
μl of Rehydration Buffer for 1 h at room on both 13 cm pH 3-10 and pH 4-7 Immobiline 
DryStrips. The strips were positioned on the “EttanIPGphor” system and run for 12 h at 
50V. For the first dimension the following isoelectric focusing program has been used:  
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STEP Voltage V/h Mode 
Step 1 1000 V 100 V/h Gradient 
Step 2 6000 V 18000 V/h Gradient 
Step 3 8000 V 160000 V/h Step-n-Hold 
Step 4 10 V 100 V/h Standby 
STEP Voltage V/h Mode 
Step 1 500 V 500 V/h Gradient 
Step 2 3500 V 5250 V/h Gradient 
Step 3 8000 V 28000 V/h Step-n-Hold 
Step 4 10 V 100V/h Standby 
3.15.4  Second-dimension: SDS-PAGE 
 
Before the SDS-PAGE, two steps of equilibration have been performed. The first 
step was the reduction of the disulphide bonds using the Reduction Buffer followed by an 
alkylation of the thyol groups of the protein using the Alkylation Buffer. The second step 
was an equilibration step with the Running Buffer. The strips were then placed on the 
cathode side of an 8 % polyacrilamide running gel and run at 100V for 30 min and at 
200V for 4.3 h. 
 
Strip pH 3-10 
Strip pH 4-7 
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3.15.5  Silver Staining 
 
After the second dimension separation, the gels were washed with milliQ water, 
fixed for 30 min with a solution containing 45% methanol and 5% acetic acid and then 
washed with milliQ water for 1 h. Following the washes the gels were treated for 2 min 
with a solution containing 0.02% sodium thiosulphate and briefly washed with milliQ 
water. The gels have been then incubated with a 0.1% silver nitrate solution for 30 min 
and then washed with milliQ water as described before. The gel development has been 
performed using a 3% sodium bicarbonate/0.03% formaldehyde solution followed by a 
blocking treatment with a 1% acetic acid solution. The analysis of differentially 
expressed proteins was done using the ImageMaster system from Amersham Bioscience; 
the images have been processed and digitalized. 
 
 
3.15.16 Gel Digestion, Protein Reduction, Alkylation and Tryptic Digestion 
 
Individual differential expressed spot identified as above was excised from the gel 
and washed for 15 min with milliQ water, followed by a destaining step with 50 μl of a 
solution containing 15 mM potassium ferricyanide/50mM sodium thiosulphate for 10 min 
at room temperature. The gel slices were then washed with milliQ water and then with 
acetonitrile for 15 min at room temperature. The slices were then incubated for 15 min 
with 100 nM ammonium bicarbonate solution and washed for 15 min with 300 μl of a 
solution of 100 nM ammonium bicarbonate/acetonitrile (1:1) and incubated. Each slice 
was dehydrated with acetonitrile and dried using a vacuum-drier unit. The proteins in the 
gel slices were rehydrated and reduced for 1 h at 56°C with a solution of 10 mM DTT in 
100 mM NH4HCO3 and then alkylated for 30 min in the dark with a solution of 50 mM 
iodoacetamide in 100 mM NH4HCO3. The samples were then washed twice for 15 min 
with 100 mM ammonium bicarbonate solution and then with iodoacetamide in 20 mM 
ammonium bicarbonate (1:1) solution. After that the gel slices were dehydrated with 
acetonitrile and dried using a vacuum-drier unit. The slices were then rehydrated with a 
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100 mM iodoacetamide solution containing 0.1 μg/μl trypsin and incubated overnight at 
37°C. After trypsin digestion, the protein peptides were collected and the minced gels 
were subjected to a second extraction using a 60% acetonitrile/1% acetic acid solution for 
10 min. The supernatants from the two extractions were combined, vacuum-dried and 
stored at -80°C until the MS analysis. 
 
 
3.15.17 Peptide Analysis 
 
 For the peptide analysis has been used the LC/MS system (HPLC Surveyor unit 
connected to the LCQ Deca-Ion Quadrupole). Data analysis and protein identification 
were performed using the Turbo Sequest Search software connected to the Mascot Search 
(Matrix Science) Database. 
 
 
 
3.16 Preparation of the Rev-Ngn3 viral particles 
 
3.16.1  Cloning the mouse Ngn3 CDS into the pRevTRE vector 
  
The complete mouse Ngn3 CDS sequence has been amplified by PCR using a 
specific set of primers reported in Table 1 (RevNgn3 primers set) and pBS-Ngn3 as 
template. Typically the PCR mixture contained: 
 
5X GoTaq Buffer       10 μl (1X final) 
25 mM MgCl2        7.5 μl (3.75 mM) 
10 mM dNTP        2.5 μl (0.5 mM) 
10 μM 5’-Primer       2.5 μl (0.5 μM) 
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10 μM 3’-Primer       2.5 μl (0.5 μM) 
Template (100 ng/μl)       1.0 μl 
GoTaq         0.5 μl (2.5 Units) 
Sterile dH2O                      To 50 μl  
 
Following 28 cycles of amplification, 5 μl of PCR product was run on a 1% 
agarose gel and analyzed by ethidium bromide staining. To the PCR mixture 445 μl of 
TE buffer were added and the solution extracted with 1 volume of 
phenol:chloroform:isoamyl alchol (24:25:1). After centrifugation at 10,000 x g for 1 
minute the upper aqueous phase was collected added with 1/10 volume of 3 M Sodium 
Acetate pH 5.2 and 0.7 volume of isopropyl alcohol. The solution was then centrifuged at 
10,000 x g for 20 min. The pellet further washed with 500 μl of 70% ethanol and 
centrifuged once more at 10,000 x g for 20 min. The pellet was air dried and dissolved in 
10 μl of dH2O. The purified PCR fragment was used to perform a TOPO cloning reaction 
using the TOPO TA cloning kit. In a 200 μl tube were mixed: 
 
Purified PCR        4.0 μl 
Salt Solution        1.0 μl 
pCR2.1-TOPO vector       1.0 μl 
 
The reaction was mixed gently and incubated for 5 min at room temperature. The 
reaction was placed on ice and the transformation was performed as described above. 
Single colonies from the transformed bacteria plates obtained as above were 
inoculated into 3 ml of LB medium containing 50 μg/ml of kanamycin, and grown with 
vigorous shaking for 12–16 h. The plasmid DNA was then extracted as described. 
The DNA plasmid mini-preps were analyzed by restriction analysis. In 200 μl tubes 
were mixed: 
 
10X NEB Buffer 2       1.0 μl (1X final) 
100X BSA        0.1 μl (1X final) 
Mini-prep        5.0 μl  
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BamHI         0.3 μl (6 Units) 
HindIII        0.3 μl (6 Units) 
Sterile dH2O                       To 10 μl  
 
 The reaction was mixed gently and incubated for 1 h at 37ºC. The digestion 
products were run on a 1% agarose gel and analyzed by ethidium bromide staining. At 
least one positive colony containing the expected fragment size was used to set-up a 
DNA plasmid midi-prep as described before. 
The DNA plasmid midi-prep (pCR2.1-TOPO-Ngn3) was analyzed by restriction 
analysis. In 200 μl tubes were mixed: 
 
10X NEB Buffer 2       1.0 μl (1X final) 
100X BSA        0.1 μl (1X final) 
Midi-prep (100 ng/μl)       1.0 μl  
BamHI         0.3 μl (6 Units) 
HindIII        0.3 μl (6 Units) 
Sterile dH2O                       To 10 μl  
 
The reaction mix was gently and incubated for 1 h at 37ºC. The digestion products 
were run on a 1% agarose gel and analyzed by ethidium bromide staining. 
The Ngn3 CDS from the pCR2.1-TOPO-Ngn3 vector was subcloned into the 
pRevTRE vector by restriction digestion with BamHI and HindIII as follow. In two 1.5 
ml microcentrifuge tubes were added respectively: 
 
10X NEB Buffer 2       10 μl (1X final) 
100X BSA        1.0 μl (1X final) 
pRevTRE        20 μl (28 μg final)  
BamHI         1.5 μl (30 Units) 
HindIII        1.5 μl (30 Units) 
Sterile dH2O                 To 100 μl 
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10X NEB Buffer 2       10 μl (1X final) 
100X BSA        1.0 μl (1X final) 
pCR2.1-TOPO-Ngn3       20 μl (15 μg final)  
BamHI         1.0 μl (20 Units) 
HindIII        1.0 μl (20 Units) 
Sterile dH2O                 To 100 μl 
 
 The reactions were gently mixed and incubated for 1 h at 37ºC. 2 μl of the 
digestion products were run on a 1% agarose gel and analyzed by ethidium bromide 
staining. To the PCR mixture 348 μl of TE buffer were added and the solution extracted 
with 1 volume of phenol:chloroform:isoamyl alchol (24:25:1). After centrifugation at 
10,000 x g for 1 minute the upper aqueous phase was collected added with 1/10 volume 
of 3 M Sodium Acetate pH 5.2 and 0.7 volume of isopropyl alcohol. The solution was 
then centrifuged at 10,000 x g for 20 min. The pellet further washed with 500 μl of 70% 
ethanol and centrifuged once more at 10,000 x g for 20 min. The pellet was air dried and 
dissolved in 20 μl of dH2O. The digestion products were run on a 1% agarose gel, 
analyzed by ethidium bromide staining and gel extracted as described above. The purified 
DNAs were quantified by use of a ND-1000 Spectrophotometer (NanoDrop 
Technologies). 
The ligation reaction was set up at a 3:1 insert:vector ratio. In a 200 ml tube were 
mixed: 
 
10X NEB T4 DNA ligase Buffer     2.0 μl (1X final) 
pRevTRE BamHI/HindIII      1.0 μl (25 ng final) 
Ngn3 BamHI/HindIII       1.0 μl (7 ng final) 
T4 DNA ligase       0.3 μl (600 U final) 
Sterile dH2O variable                           To 20 μl  
 
The mixture was incubated at 16°C for 16 h. The reaction was placed on ice and the 
transformation was performed as described above. 
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Single colonies from the transformed bacteria plates obtained as above were 
inoculated into 3 ml of LB medium containing 100 μg/ml of ampicillin, and grown with 
vigorous shaking for 12–16 h. The plasmid DNA was then extracted as described. 
The DNA plasmid mini-preps were analyzed by restriction analysis. In 200 μl tubes 
were mixed: 
 
10X NEB Buffer 2       1.0 μl (1X final) 
100X BSA        0.1 μl (1X final) 
Mini-prep        5.0 μl  
BamHI         0.3 μl (6 Units) 
HindIII        0.3 μl (6 Units) 
Sterile dH2O                       To 10 μl  
 
 The reaction was mixed gently and incubated for 1 h at 37ºC. The digestion 
products were run on a 1% agarose gel and analyzed by ethidium bromide staining. At 
least one positive colony containing the expected fragment size was used to set-up a 
DNA plasmid midi-prep as described above. The purified plasmid DNA (pRevTRE-
Ngn3) was quantified by use of a ND-1000 Spectrophotometer (NanoDrop 
Technologies). 
The DNA plasmid midi-prep was analyzed by restriction analysis. In 200 μl tubes 
were mixed: 
 
10X NEB Buffer 2       1.0 μl (1X final) 
100X BSA        0.1 μl (1X final) 
Midi-prep (100 ng/μl)       1.0 μl  
BamHI         0.3 μl (6 Units) 
HindIII        0.3 μl (6 Units) 
Sterile dH2O                         To 10 μl  
 
The reaction mix was gently and incubated for 1 h at 37ºC. The digestion products 
were run on a 1% agarose gel and analyzed by ethidium bromide staining. 
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3.16.2  Selection of Stable Virus-Producing PT67 Packaging Cell Line 
 
The RetroPack PT67 Packaging Cell Line was cultivated in Dulbecco’s Modified 
Eagle Medium (DMEM) containing 4.5 g/L glucose and 110 mg/L sodium pyruvate and 
4 mM L-glutamine, supplemented with 10% (v/v) heat-inactivated Tet System Approved 
fetal bovine serum. The day before the transfection 8 x 10
5 
cells were plated into three 60 
mm cell culture dishes with 4 ml of medium. For the transfection in sterile 
microcentrifuge tubes 200 μl of DMEM (containing 4.5 g/L glucose and 110 mg/L 
sodium pyruvate and 4 mM L-glutamine), 6 μl of FuGENE 6 were added and incubated 
for 5 min at room temperature. 2 μg of pRevTet-On, pRevTRE-Ngn3 or pRevTRE-Luc 
DNA were added, respectively, and the mixtures incubated at room temperature for 15 
min. The FuGENE6/DNA complexes were then added to the cells in a drop-wise manner 
and the cells returned to the incubator. The culture plates were incubated at 37°C for 2 
days. After that the packaging cells transfected with pRevTet-On, pRevTRE-Ngn3 and 
pRevTRE-Luc plasmids are diluted 1:500 and plated in selection medium containing 300 
μg/ml of G418 (for pRevTet-On transfected cells) and 150 mg/ml of hygromycin (for the 
pRevTRE-Ngn3 and pRevTRE-Luc transfected cells), respectively. The culture plates 
were incubated at 37°C for 7–10 days, replenishing the growth medium when needed. At 
least 24 single colonies were obtained for each vector.  
 
3.16.3  Determining the Viral Titer 
 
This assay is used to determine the titer (pfu/ml) of the viral stocks. 5 x 10
5
 
NIH/3T3 cells were plated in two 6-well tissue culture plates overnight at 37°C. The 
retroviral stocks for RevTet-On and RevTRE-Ngn3, obtained as above were diluted in 1 
ml volumes over a 10-fold series from 10
-5
 to 10
-9
 in growth medium containing 4 g/ml 
of polybrene, respectively. Each dilution were then added to a separate well of the 6-well 
plates and incubated at 37°C for 48 h. 48 h post-infection, cells infected with RevTet-On 
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viruses were subjected G418 selection (500 μg/ml) and those infected with RevTRE-
Ngn3 were subjected hygromycin selection (300 μg/ml) for one week. The titer was 
determined by counting the number of colonies obtained with the highest viral dilution 
and multiplying that number by the dilution factor to estimate pfu/ml. The colonies 
showing a titer of about 1 x 10
8
 pfu/ml were expended. Ten high titer colonies producing 
RevTet-On viruses (average of 5 x 10
8
 pfu/ml) and 8 high titer (average of 3 x 10
8
 
pfu/ml) colonies producing RevTRE-Ngn3 viruses were obtained. 
 
3.16.4  Establishing Stable Regulatory Tet-On-F9 Cell Lines 
 
Approximately 2 x 10
6
 F9 cells were plated in 60 mm cell culture dish in the 
appropriate medium and infected with 5 MOI of RevTet-On viruses for 24 h in presence 
of 4 μg/ml of polybrene. The medium was replaced after 24 h with fresh one. The cells 
were maintained in culture for two days. The infected target cells were diluted 1:500 and 
plated in selection medium containing 300 μg/ml of G418 for 7 days, changing medium 
as necessary. An average of 15 healthy colonies were obtained and expanded.  
The expended stable colonies were assayed to detect those with the higher 
inducibility and the lower background. 
5 x 10
5
 RevTet-On-F9 cells were plated in 6-well tissue culture plates overnight at 
37°C. The cells were then infected with 5 MOI of RevTRE-Luc and incubated at 37°C 
for 24 h. After 24 h of incubation the medium was changed with fresh one containing 1 
μg/ml of doxycycline and incubated for further 48 h.  
As control to evaluate the background another set of the same cells were treated 
as above but with no addition of doxycycline. 
The cells were then washed twice with PBS and lysed with 250 μl of 1X Passive 
Lysis Buffer. The plates were then rocked several times to ensure complete coverage of 
the cells with lysis buffer. The cells were then scraped and all the liquid transferred to a 
microcentrifuge tube, vortexed and centrifuged at 12,000  g for 10 min at 4°C.  
For the Luciferase assay, 100 μl of Luciferase assay reagent for each samples 
were dispensed into luminometer tubes and 20 μl of cell lysates were added. Immediately 
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the tubes were read in a luminometer programmed to perform a 2-second measurement 
delay followed by a 10-second measurement read for Luciferase activity. 
The fold induction was calculated as follow: 
 
Fold-induction = +Dox RLU/–Dox RLU 
 
 The clones showing the highest fold-induction (highest expression with lowest 
background) were propagated. About 8 clones (Tet-On-F9) were obtained showing about 
a 15-fold induction. 
 
3.16.5  Establishing a Double-Stable, Inducible Tet-On/TRE-Ngn3-F9 Cell  
  Line  
 
Approximately 2 x 10
7
 Tet-On-F9 cells from one of the clone obtained above 
were plated in 100 mm cell culture dish in the appropriate medium and infected with 5 
MOI of RevTet-On viruses for 24 h in presence of 4 μg/ml of polybrene. The medium 
was replaced after 24 h with fresh one. The cells were maintained in culture for two days. 
Two days after infection the target cells were diluted 1:500 and plated in selection 
medium containing 150 μg/ml of hygromycin for 7 days, changing medium as necessary. 
An average of 20 healthy colonies (Tet-On/TRE-Ngn3-F9) were obtained and expanded.  
 
3.16.6  Doxycycline-induced expression of Ngn3 
 
Approximately 5 x 10
5
 Tet-On/TRE-Ngn3-F9 cells from ten of the clones 
obtained above were plated in 6-well tissue culture plates in the appropriate medium and 
tested for Doxycycline-regulated gene expression by assaying for Ngn3 expression in 
presence of 0, 2, 4, 6, 8 and 10 μg/ml of doxycycline for at least 48 h.  
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The cells were then washed twice with PBS and RNA extracted with 1 ml of 
Trizol reagent as described above. One μg of total RNA was then DNase treated and 
reverse transcribed as described above. 
Expression of Ngn3 has been evaluated by PCR using a specific set of primers 
reported in Table 1 (Ngn3 primers set).  
 
3.17 Preparation of An Ngn3-TETRACYCLINE-INDUCIBLE SYSTEM (T-REx 
System) 
 
3.17.1  Cloning the mouse Ngn3 CDS into the pcDNA5/TO vector 
  
The complete mouse Ngn3 CDS sequence has been amplified by PCR using a 
specific set of primers reported in Table 1 (T-RexNgn3 primers set) and pBS-Ngn3 as 
template. Typically the PCR mixture contained: 
 
5X GoTaq Buffer       10 μl (1X final) 
25 mM MgCl2        7.5 μl (3.75 mM) 
10 mM dNTP        2.5 μl (0.5 mM) 
10 μM 5’-Primer       2.5 μl (0.5 nM) 
10 μM 3’-Primer       2.5 μl (0.5 nM) 
Template (100 ng/μl)       1.0 μl 
GoTaq         0.5 μl (2.5 Units) 
Sterile dH2O                       To 50 μl  
 
Following 28 cycles of amplification, 5 μl of PCR product was run on a 1% 
agarose gel and analyzed by ethidium bromide staining. To the PCR mixture 445 μl of 
TE buffer were added and the solution extracted with 1 volume of 
phenol:chloroform:isoamyl alchol (24:25:1). After centrifugation at 10,000 x g for 1 
minute the upper aqueous phase was collected added with 1/10 volume of 3 M Sodium 
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Acetate pH 5.2 and 0.7 volumes of isopropyl alcohol. The solution was then centrifuged 
at 10,000 x g for 20 min. The pellet further washed with 500 μl of 70% ethanol and 
centrifuged once more at 10,000 x g for 20 min. The pellet was air dried and dissolved in 
10 μl of dH2O. The purified PCR fragment was used to perform a TOPO cloning reaction 
using the TOPO TA cloning kit. In a 200 μl tube were mixed: 
 
Purified PCR        4.0 μl 
Salt Solution        1.0 μl 
pCR2.1-TOPO vector       1.0 μl 
 
The reaction was mixed gently and incubated for 5 min at room temperature. The 
reaction was placed on ice and the transformation was performed as described above. 
Single colonies from the transformed bacteria plates obtained as above were 
inoculated into 3 ml of LB medium containing 50 μg/ml of kanamycin, and grown with 
vigorous shaking for 12–16 h. The plasmid DNA was then extracted as described. 
The DNA plasmid mini-preps were analyzed by restriction analysis. In 200 μl tubes 
were mixed: 
 
10X NEB Buffer 2       1.0 μl (1X final) 
100X BSA        0.1 μl (1X final) 
Mini-prep        5.0 μl  
BamHI         0.3 μl (6 Units) 
HindIII        0.3 μl (6 Units) 
Sterile dH2O                     To 10 μl  
 
 The reaction was mixed gently and incubated for 1 h at 37ºC. The digestion 
products were run on a 1% agarose gel and analyzed by ethidium bromide staining. At 
least one positive colony containing the expected fragment size was used to set-up a 
DNA plasmid midi-prep as described before. 
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The DNA plasmid midi-prep (pCR2.1-TOPO-Ngn3) was analyzed by restriction 
analysis. In 200 μl tubes were mixed: 
 
10X NEB Buffer 2       1.0 μl (1X final) 
100X BSA        0.1 μl (1X final) 
Midi-prep (100 ng/μl)       1.0 μl  
BamHI         0.3 μl (6 Units) 
HindIII        0.3 μl (6 Units) 
Sterile dH2O                      To 10 μl  
 
The reaction mix was gently and incubated for 1 h at 37ºC. The digestion products 
were run on a 1% agarose gel and analyzed by ethidium bromide staining. 
The Ngn3 CDS from the pCR2.1-TOPO-Ngn3 vector was subcloned into the 
pcDNA5/TO vector by restriction digestion with HindIII and BamHI as follow. In two 
1.5 ml microcentrifuge tubes were added respectively: 
 
10X NEB Buffer 2       10 μl (1X final) 
100X BSA        1.0 μl (1X final) 
pcDNA5/TO        20 μl (30 μg final)  
BamHI         1.5 μl (30 Units) 
HindIII        1.5 μl (30 Units) 
Sterile dH2O                To 100 μl 
 
 
10X NEB Buffer 2       10 μl (1X final) 
100X BSA        1.0 μl (1X final) 
pCR2.1-TOPO-Ngn3       20 μl (20 μg final)  
BamHI         1.0 μl (20 Units) 
HindIII        1.0 μl (20 Units) 
Sterile dH2O                   To 100 μl 
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 The reactions were gently mixed and incubated for 1 h at 37ºC. Two μl of the 
digestion products were run on a 1% agarose gel and analyzed by ethidium bromide 
staining. To the PCR mixture 348 μl of TE buffer were added and the solution extracted 
with 1 volume of phenol:chloroform:isoamyl alchol (24:25:1). After centrifugation at 
10,000 x g for 1 minute the upper aqueous phase was collected added with 1/10 volume 
of 3 M Sodium Acetate pH 5.2 and 0.7 volume of isopropyl alcohol. The solution was 
then centrifuged at 10,000 x g for 20 min. The pellet further washed with 500 μl of 70% 
ethanol and centrifuged once more at 10,000 x g for 20 min. The pellet was air dried and 
dissolved in 20 μl of dH2O. The digestion products were run on a 1% agarose gel, 
analyzed by ethidium bromide staining and gel extracted as described above. The purified 
DNAs were quantified by use of a ND-1000 Spectrophotometer (NanoDrop 
Technologies). 
The ligation reaction was set up at a 3:1 insert:vector ratio. In a 200 ml tube were 
mixed: 
 
10X NEB T4 DNA ligase Buffer     2.0 μl (1X final) 
pcDNA5/TO BamHI/HindIII      1.0 μl (25 ng final) 
Ngn3 BamHI/HindIII       1.0 μl (8 ng final) 
T4 DNA ligase       0.3 μl (600 U final) 
Sterile dH2O variable                             To 20 μl  
 
The mixture was incubated at 16°C for 16 h. The reaction was placed on ice and the 
transformation was performed as described above. 
Single colonies from the transformed bacteria plates obtained as above were 
inoculated into 3 ml of LB medium containing 100 μg/ml of ampicillin, and grown with 
vigorous shaking for 12–16 h. The plasmid DNA was then extracted as described. 
The DNA plasmid mini-preps were analyzed by restriction analysis. In 200 μl tubes 
were mixed: 
 
10X NEB Buffer 2       1.0 μl (1X final) 
100X BSA        0.1 μl (1X final) 
Chapter 3 Materials and Methods 
________________________________________________________________________  
 100 
Mini-prep        5.0 μl  
BamHI         0.3 μl (6 Units) 
HindIII        0.3 μl (6 Units) 
Sterile dH2O                     To 10 μl  
 
 The reaction was mixed gently and incubated for 1 h at 37ºC. The digestion 
products were run on a 1% agarose gel and analyzed by ethidium bromide staining. At 
least one positive colony containing the expected fragment size was used to set-up a 
DNA plasmid midi-prep as described above. The purified plasmid DNA was quantified 
by use of a ND-1000 Spectrophotometer (NanoDrop Technologies) 
The DNA plasmid midi-prep (pcDNA/5TO-Ngn3) was analyzed by restriction 
analysis. In 200 μl tubes were mixed: 
 
10X NEB Buffer 2       1.0 μl (1X final) 
100X BSA        0.1 μl (1X final) 
Midi-prep (100 ng/μl)       1.0 μl  
BamHI         0.3 μl (6 Units) 
HindIII        0.3 μl (6 Units) 
Sterile dH2O                       To 10 μl  
 
The reaction mix was gently and incubated for 1 h at 37ºC. The digestion products 
were run on a 1% agarose gel and analyzed by ethidium bromide staining. 
 
 
3.17.2  Establishing a Double-Stable, Inducible 6TR/5TO-Ngn3-F9 Cell Line  
 
The F9 cell line was cultivated in the appropriate medium. The day before the 
transfection 8 x 10
5 
cells were plated into three 60 mm cell culture dishes with 4 ml of 
medium. For the transfection in sterile microcentrifuge tubes 500 μl of OptiMEM, 20 μl 
of Lipofectamine2000 were added and incubated for 5 min at room temperature. Six μg 
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of pcDNA6/TR and 1 μg of pcDNA5/TO-Ngn3 DNA were added and the mixtures 
incubated at room temperature for 15 min. The Lipofectamine2000/DNA complex was 
then added to the cells in a drop-wise manner and the cells returned to the incubator. The 
culture plates were Incubate at 37°C for 2 days. After that, the transfected cells were 
diluted 1:500 and plated in selection medium containing 25 μg/ml of blasticidin and 150 
μg/ml of hygromycin for 7-10 days, changing medium as necessary. At least 15 single 
colonies (6TR/5TO-Ngn3-F9) were obtained.  
 
 
3.17.3  Doxycycline-induced expression of Ngn3 
 
Approximately 5 x 10
5
 6TR/5TO-Ngn3-F9 cells from the clones obtained above 
were plated in 6-well tissue culture plates in the appropriate medium and tested for 
Doxycycline-regulated gene expression by assaying for Ngn3 expression in presence of 
0, 2, 4, 6, 8 and 10 μg/ml of doxycycline for at least 48 h.  
The cells were then washed twice with PBS and RNA extracted with 500 μl of 
Trizol reagent as described above. One μg of total RNA was then DNase treated and 
reverse transcribed as described above. 
Expression of Ngn3 has been evaluated by PCR using a specific set of primers 
reported in Table 1 (Ngn3 primers set).  
 
 
Chapter 3 Materials and Methods 
________________________________________________________________________  
 102 
3.17.4  Differentiation Protocol 
 
Approximately 1 x 10
7
 6TR/5TO-Ngn3-F9 cells from the clones obtained above 
were plated in 100 mm tissue culture plates in the appropriate medium containing 0.1 nM 
Retinoic Acid (RA) and 1 mM dibutyryl-c-AMP (db-cAMP) for 72 h. Differentiation 
ratio was assessed by detecting GATA4 expression by RT-PCR. An aliquot of about 1 x 
10
6
 RA-treated cells were washed twice with PBS and RNA extracted with 500 μl of 
Trizol reagent as described above. One μg of total RNA was then DNase treated and 
reverse transcribed as described above. 
Expression of GATA4 has been evaluated by PCR using a specific set of primers 
reported in Table 1 (GATA4 primers set).  
During the differentiation, cell culture medium was changed every 24h. After 72h 
of differentiation the cell were split and about 1 x 10
6
 RA-treated cells were seeded into 
100 mm bacterial-grade Petri dishes and cultured in RPMI 1640 supplemented with 10% 
fetal bovine serum containing 2 mM L- glutamine, 100 units/ml penicillin and 100 l/ml 
streptomycin at 37°C in an atmosphere of 5% CO2.  
After cells were transferred from suspension culture to bacterial-grade Petri 
dishes, they failed to adhere and formed small aggregates. Acquisition of the 
configuration of discrete EBs started as early as 2 days after transfer to suspension 
culture. After 2 days of culture as EBs the expression of Ngn3 was started by addition of 
8 μg/ml of doxycycline for further 48 h. After 48 h the medium was changed with fresh 
one without doxycycline and the EBs maintained in culture for further 48h.  
At the end the EBs were harvested by centrifugation at 600 x g for 10 min at room 
temperature. After harvesting the pelleted cells were resuspended in 1 ml of Trizol 
reagent and total RNA extracted as described above. One μg of total RNA was then 
DNase treated and reverse transcribed as described above. The expression of Ngn3 and of 
other pancreas specific genes such as NeuroD/BETA2, Pax6, Pax4, Nkx2.2, Pdx1 and 
Isl1 and for the pancreatic hormones insulin and glucagon, have been evaluated by PCR.  
 
 
Chapter 3 Materials and Methods 
________________________________________________________________________  
 103 
3.18 PREPARATION OF AN Ngn3-RheoSwitch INDUCIBLE SYSTEM 
 
3.18.1  Cloning the mouse Ngn3-CDS into the pNEBR-X1 Hygro Vector  
 
 The complete mouse Ngn3-CDS sequence has been amplified by PCR using 
specific primer’s set reported in Table 1 (Ngn3-pNEBR-X1 Hygro) and pBS-Ngn3 as 
template. The PCR mixture was made as follow: 
 
5X Phusion HF Buffer      10 μl (1X final) 
10 mM dNTPs       1.0 μl (0.5 mM) 
10 μM 5’-primer       2.0 μl (0.4 μM) 
10 μM 3’-primer       2.0 μl (0.4 μM) 
Template (100 ng/μl)       1.0 μl 
Phusion Hot Start DNA Pol      0.5 μl (0.5 Units) 
Sterile dH2O                    To 50 μl 
 
  Following 30 cycles of amplification, 5μl of PCR product were run on a 1% 
agarose gel and analyzed by ethidium bromide staining. To the PCR mixture 445 μl of 
TE buffer were added and the solution extracted with 1 volume of 
phenol:chloroform:isoamyl alchol (24:25:1). After centrifugation at 10,000 x g for 1 
minute the upper aqueous phase was collected added with 1/10 volume of 3 M Sodium 
Acetate pH 5.2 and 0.7 volume of isopropyl alcohol. The solution was then centrifuged at 
10,000 x g for 20 min. The pellet further washed with 500 μl of 70% ethanol and 
centrifuged once more at 10,000 x g for 20 min. The pellet was air dried and dissolved in 
10 μl of dH2O. The purified PCR product and the pNEBR-X1-Hygro were digested as 
follow:  
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10X NEB Buffer 3       2.0 μl (1X final) 
100X BSA         0.2 μl (1X final 
Ngn3 PCR        10 μl  (1μg final) 
NotI         1.0 μl (10 Units) 
SalI         1.0 μl (10 Units) 
Sterile dH2O                            To 20 μl  
 
 
10X NEB Buffer 3       2.0 μl (1X final) 
100X BSA        0.2 μl (1X final) 
pNEBR-X1 Hygro       10 μl (10 μg final) 
NotI         1.0 μl (10 Units) 
SalI         1.0 μl (10 Units) 
Sterile dH2O                        To 20 μl  
 
 The reactions were gently mixed and incubated at 37°C for 1 h. The digestion 
products were run on a 1% agarose gel and analyzed by ethidium bromide staining. To 
both the reaction mixtures, 480 μl of TE buffer were added and the solution extracted 
with 1 volume of phenol:chloroform:isoamyl alchol (24:25:1). After centrifugation at 
10,000 x g for 1 minute the upper aqueous phase was collected added with 1/10 volume 
of 3 M Sodium Acetate pH 5.2 and 0.7 volume of isopropyl alcohol. The solution was 
then centrifuged at 10,000 x g for 20 min. The pellet further washed with 500 μl of 70% 
ethanol and centrifuged once more at 10,000 x g for 20 min. The pellet was air dried and 
dissolved in 10 μl of dH2O. The digestion products were run on a 1% agarose gel and 
analyzed by ethidium bromide staining and extracted using the QIAquick Gel Exctraction 
Kit as described above. The purified DNAs were quantified by using a ND-1000 
Spectrophotometer (NanoDrop Technologies). 
The ligation reaction was set up at a 3:1 insert:vector ratio. In a 200 μl tube were 
mixed: 
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10X NEB T4 DNA ligase Buffer     2.0 μl (1X final) 
pNEBR-X1 Hygro NotI/SalI      1.0 μl (50 ng final) 
Ngn3 NotI/SalI       1.0 μl (14 ng final) 
T4 DNA ligase       0.3 μl (600 Units) 
Sterile dH2O                    To 10 μl 
 
The mixture was incubated at 16°C for 16 h. The reaction was placed on ice and 
the transformation was performed as described above. Single colonies from the 
transformed bacteria plates obtained as above were inoculated into 3 ml of LB medium 
containing 10 mg/ml of ampicillin, and growth with vigorous shaking for 12-16 h. The 
plasmid DNA was then extracted as described. The plasmid mini-preps were analyzed by 
restriction analysis. In 200μl tubes were mixed: 
 
10X NEB Buffer 3       1.0 μl (1X final) 
100X BSA        0.1 μl (1X final) 
Mini-prep           5.0 μl 
NotI         0.5 μl (5 units) 
SalI         0.5 μl (5 Units) 
Sterile dH2O              To 10 μl 
 The reaction was mixed gently and incubated at 37°C for 1 h. The digestion 
products were run on a 1% agarose gel and analyzed by ethidium bromide staining. The 
positive colonies were submitted for sequencing at the NEB Sequencing Core. At least 
one positive colony containing the expected fragment size was used to set-up a DNA 
plasmid midi-prep as described before. The purified DNA (pNEBR-X1-Hygro-Ngn3) 
was quantified by using a ND-1000 Spectrophotometer (NanoDrop Technologies). 
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3.18.2  Cloning the mouse Ngn3-CDS into the pNEBR-X1-Puro Vector 
 
 The complete mouse Ngn3-CDS sequence has been amplified by PCR using 
specific primer’s set reported in Table 1 (Ngn3-pNEBR-X1-Puro) and pBS-Ngn3 as 
template. The PCR mixture was made as follow: 
 
5X Phusion HF Buffer      10 μl (1X final) 
10 mM dNTPs       1.0 μl (0.5 mM) 
10 μM 5’-primer       2.0 μl (0.4 μM) 
10 μM 3’-primer       2.0 μl (0.4 μM) 
Template (100 ng/μl)       1.0 μl 
Phusion Hot Start DNA Pol      0.5 μl (0.5 Units) 
Sterile dH2O                           To 50 μl 
 
  Following 30 cycles of amplification, 5 μl of PCR product were run on a 1% 
agarose gel and analyzed by ethidium bromide staining. To the PCR mixture 445 μl of 
TE buffer were added and the solution extracted with 1 volume of 
phenol:chloroform:isoamyl alchol (24:25:1). After centrifugation at 10,000 x g for 1 
minute the upper aqueous phase was collected added with 1/10 volume of 3 M Sodium 
Acetate pH 5.2 and 0.7 volume of isopropyl alcohol. The solution was then centrifuged at 
10,000 x g for 20 min. The pellet further washed with 500 μl of 70% ethanol and 
centrifuged once more at 10,000 x g for 20 min. The pellet was air dried and dissolved in 
10 μl of dH2O. The purified PCR product and the pNEBR-X1-Puro were digested as 
follow: 
 
10X NEB Buffer 3       2.0 μl (1X final) 
100X BSA         0.2 μl (1X final 
Ngn3 PCR        10 μl (1μg final) 
SalI         1.0 μl (10 Units) 
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Sterile dH2O                            To 20 μl  
 
 
10X NEB Buffer 3       2.0 μl (1X final) 
100X BSA        0.2 μl (1X final) 
pNEBR-X1 Puro       10 μl (10 μg final) 
SalI         1.0 μl (10 Units) 
Sterile dH2O                           To 20 μl  
 
 The reactions were gently mixed and incubated at 37°C for 1h. To the digestion 
products 435 μl of TE buffer were added and the solution extracted with 1 volume of 
phenol:chloroform:isoamyl alchol (24:25:1). After centrifugation at 10,000 x g for 1 
minute the upper aqueous phase was collected added with 1/10 volume of 3 M Sodium 
Acetate pH 5.2 and 0.7 volume of isopropyl alcohol. The solution was then centrifuged at 
10,000 x g for 20 min. The pellet further washed with 500 μl of 70% ethanol and 
centrifuged once more at 10,000 x g for 20 min. The pellet was air dried and dissolved in 
10 μl of dH2O. After that the following digestion reactions were set up: 
 
10X NEB Buffer 4       2.0 μl (1X final) 
100X BSA         0.2 μl (1X final 
Ngn3 SalI/        10 μl  (1μg final) 
ApaI         1.0 μl (10 Units) 
Sterile dH2O                           To 20 μl  
 
 
10X NEB Buffer 4       2.0 μl (1X final) 
100X BSA        0.2 μl (1X final) 
pNEBR-X1 Puro SalI/      10 μl (5 μg final) 
SalI         1.0 μl (10 Units) 
Sterile dH2O                            To 20 μl  
Chapter 3 Materials and Methods 
________________________________________________________________________  
 108 
 
 The reactions were gently mixed and incubated at 37°C for 1 h. The digestion 
products were run on a 1% agarose gel and analyzed by ethidium bromide staining. To 
both the reaction mixtures, 480 μl of TE buffer were added and the solution extracted 
with 1 volume of phenol:chloroform:isoamyl alchol (24:25:1). After centrifugation at 
10,000 x g for 1 minute the upper aqueous phase was collected added with 1/10 volume 
of 3 M Sodium Acetate pH 5.2 and 0.7 volume of isopropyl alcohol. The solution was 
then centrifuged at 10,000 x g for 20 min. The pellet further washed with 500 μl of 70% 
ethanol and centrifuged once more at 10,000 x g for 20 min. The pellet was air dried and 
dissolved in 10 μl of dH2O. The digestion products were run on a 1% agarose gel and 
analyzed by ethidium bromide staining and extracted using the QIAquick Gel Exctraction 
Kit as described above. The purified DNAs were quantified by using a ND-1000 
Spectrophotometer (NanoDrop Technologies). 
The ligation reaction was set up at a 3:1 insert:vector ratio. In a 200 μl tube were 
mixed: 
 
10X NEB T4 DNA ligase Buffer     2.0 μl (1X final) 
pNEBR-X1 Puro ApaI/SalI      1.0 μl (50 ng final) 
Ngn3 ApaI/SalI       1.0 μl (14 ng final) 
T4 DNA ligase       0.3 μl (600 Units) 
Sterile dH2O                      To 20 μl 
 
 The mixture was incubated at 16°C for 16h. The reaction was placed on ice and 
the transformation was performed as described above. Single colonies from the 
transformed bacteria plates obtained as above were inoculated into 3 ml of LB medium 
containing 10 mg/ml of ampicillin, and growth with vigorous shaking for 12-16 h. The 
plasmid DNA was then extracted as described. The plasmid mini-preps were analyzed by 
restriction analysis. In 200μl tubes were mixed: 
 
10X NEB Buffer 2       1.0 μl (1X final) 
100X BSA        0.1 μl (1X final) 
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Mini-prep           5.0 μl 
NotI         0.5 μl (5 Units) 
Sterile dH2O               To 10 μl 
 
 The reaction was mixed gently and incubated at 37°C for 1 h. The digestion 
products were run on a 1% agarose gel and analyzed by ethidium bromide staining. The 
positive colonies were submitted for sequencing at the NEB Sequencing Core. At least 
one positive colony containing the expected fragment size was used to set-up a DNA 
plasmid midi-prep as described before. The purified DNA (pNEBR-X1-Puro-Ngn3) was 
quantified by using a ND-1000 Spectrophotometer (NanoDrop Technologies). 
 
3.18.3  Removal of an aspecific ATG codon from the pNEBR-X1-Hygro- 
  Ngn3 vector 
 To remove the ATG codon located at 25bp downstream the TATA-Box, the 
pNEBR-X1-Hygro-Ngn3 vector was digested as follow: 
 
10X NEB Buffer 2       2.0 μl (1X final) 
100X BSA        0.2 μl (1X final) 
pNEBR-X1-Hygro-Ngn3      6.0 μl (6 μg final) 
NotI         1.0 μl (10 Units) 
SacI         1.0 μl (10 Units) 
Sterile dH2O                   To 20 μl 
 
 The reaction was mixed gently and incubated at 37°C for 1 h. Two μl from the 
digestion reaction was run on a 1% agarose gel, analyzed by ethidium bromide staining. 
The restriction enzymes were heat inactivated at 65°C for 10 min and to the remaining 18 
μl of digestion reaction the following components were added: 
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1 mM dNTPs Mix       0.2 μl 
Blunt Enzyme Mix       1.0 μl 
Sterile dH2O                      To 20 μl 
 
The mixture was incubated at room temperature for 30 min and immediately after 
that, the enzymes were inactivated by heating at 70°C for 10 min. 
For ligation reaction in a 200 μl tube were mixed: 
 
Blunted DNA        9.0 μl 
2X Quick Ligation Buffer      10 μl  
Quick T4 DNA ligase       1.0 μl 
 
 The reaction was incubated for 5 min at room temperature. The reaction was 
placed on ice and the transformation was performed as described above. Single colonies 
from the transformed bacteria plates obtained as above were inoculated into 3 ml of LB 
medium containing 10 mg/ml of ampicillin, and growth with vigorous shaking for 12-16 
h. The plasmid DNA was then extracted as described. The colonies were submitted for 
sequencing at the NEB Sequencing Core. At least one positive colony containing the 
expected modification was used to set-up a DNA plasmid midi-prep as described before. 
The purified DNA (pNEBR-X1-Puro-Ngn3/2) was quantified by using a ND-1000 
Spectrophotometer (NanoDrop Technologies). 
 
3.18.4  Cloning the IRES and dTomato sequences into the pNEBR-X1- 
  Hygro-Ngn3/2 Vector 
 
 The IRES sequence has been amplified by PCR using specific primer’s set 
reported in Table 1 (IRES) and pNEBR-X1-Klf4-IRES as template. Typically the PCR 
mixture contained: 
 
5X Phusion HF Buffer      10 μl (1X final) 
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10 mM dNTPs       1.0 μl (0.5 mM) 
10 μM 5’-primer       2.0 μl (0.4 μM) 
10 μM 3’-primer       2.0 μl (0.4 μM) 
Template (100 ng/μl)       1.0 μl 
Phusion Hot Start DNA Pol      0.5 μl (0.5 Units) 
Sterile dH2O                         To 50 μl 
 
  Following 30 cycles of amplification, 5μl of PCR product were run on a 1% 
agarose gel and analyzed by ethidium bromide staining. To the PCR mixture 445 μl of 
TE buffer were added and the solution extracted with 1 volume of 
phenol:chloroform:isoamyl alchol (24:25:1). After centrifugation at 10,000 x g for 1 
minute the upper aqueous phase was collected added with 1/10 volume of 3 M Sodium 
Acetate pH 5.2 and 0.7 volume of isopropyl alcohol. The solution was then centrifuged at 
10,000 x g for 20 min. The pellet further washed with 500 μl of 70% ethanol and 
centrifuged once more at 10,000 x g for 20 min. The pellet was air dried and dissolved in 
10 μl of dH2O. The purified PCR product and the pNEBR-X1-Puro-Ngn3/2 were 
digested as follow: 
 
10X NEB Buffer 3       2.0 μl (1X final) 
100X BSA         0.2 μl (1X final) 
IRES PCR        10 μl  (1μg final) 
SalI         1.0 μl (10 Units) 
NotI         1.0 μl (10 Units) 
Sterile dH2O                           To 20 μl  
 
 
10X NEB Buffer 3       2.0 μl (1X final) 
100X BSA        0.2 μl (1X final) 
pNEBR-X1-Puro-Ngn3/2      10 μl (10 μg final) 
SalI         1.0 μl (10 Units) 
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NotI         1.0 μl (10 Units) 
Sterile dH2O                            To 20 μl  
 
 The reactions were gently mixed and incubated at 37°C for 1 h. The digestion 
products were run on a 1% agarose gel and analyzed by ethidium bromide staining. To 
both the reaction mixtures, 480 μl of TE buffer were added and the solution extracted 
with 1 volume of phenol:chloroform:isoamyl alchol (24:25:1). After centrifugation at 
10,000 x g for 1 minute the upper aqueous phase was collected added with 1/10 volume 
of 3 M Sodium Acetate pH 5.2 and 0.7 volume of isopropyl alcohol. The solution was 
then centrifuged at 10,000 x g for 20 min. The pellet further washed with 500 μl of 70% 
ethanol and centrifuged once more at 10,000 x g for 20 min. The pellet was air dried and 
dissolved in 10 μl of dH2O. The digestion products were run on a 1% agarose gel and 
analyzed by ethidium bromide staining and extracted using the QIAquick Gel Exctraction 
Kit as described above. The purified DNAs were quantified by using a ND-1000 
Spectrophotometer (NanoDrop Technologies). 
The ligation reaction was set up at a 3:1 insert:vector ratio. In a 200 μl tube were 
mixed: 
 
10X NEB T4 DNA ligase Buffer     2.0 μl (1X final) 
pNEBR-X1-Hygro-Ngn3/2 NotI/SalI     1.0 μl (50 ng final) 
IRES NotI/SalI       1.0 μl (12 ng final) 
T4 DNA ligase       .3 μl (600 Units) 
Sterile dH2O                    To 20 μl 
 
 The mixture was incubated at 16°C for 16h. The reaction was placed on ice and 
the transformation was performed as described above. Single colonies from the 
transformed bacteria plates obtained as above were inoculated into 3 ml of LB medium 
containing 10 mg/ml of ampicillin, and growth with vigorous shaking for 12-16 h. The 
plasmid DNA was then extracted as described. The plasmid mini-preps were analyzed by 
restriction analysis. In 200 μl tubes were mixed: 
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10X NEB Buffer 3       1.0 μl (1X final) 
100X BSA        0.1 μl (1X final) 
Mini-prep        5.0 μl 
NotI         0.5 μl (5 Units) 
BstEII         0.5 μl (2.5 Units) 
Sterile dH2O               To 10 μl 
 The reaction was mixed gently and incubated at 37°C for 1 h. The digestion 
products were run on a 1% agarose gel and analyzed by ethidium bromide staining. The 
positive colonies were submitted for sequencing at the NEB Sequencing Core. At least 
one positive colony containing the expected fragment size was used to set-up a DNA 
plasmid midi-prep as described before. The purified DNA (pNEBR-X1-Hygro-
Ngn3/2/IRES) was quantified by using a ND-1000 Spectrophotometer (NanoDrop 
Technologies). 
 The dTomato sequence has been amplified by PCR using specific primer’s set 
reported in Table 1 (dTomato) and dTomato CDS as template. Typically the PCR mixture 
contained: 
 
5X Phusion HF Buffer      10 μl (1X final) 
10 mM dNTPs       1.0 μl (0.5 mM) 
10 μM 5’-primer       2.0 μl (0.4 μM) 
10 μM 3’-primer       2.0 μl (0.4 μM) 
Template (100 ng/μl)       1.0 μl 
Phusion Hot Start DNA Pol      0.5 μl (0.5 Units) 
Sterile dH2O                           To 50 μl 
 
  Following 30 cycles of amplification, 5μl of PCR product were run on a 1% 
agarose gel and analyzed by ethidium bromide staining. To the PCR mixture 445 μl of 
TE buffer were added and the solution extracted with 1 volume of 
phenol:chloroform:isoamyl alchol (24:25:1). After centrifugation at 10,000 x g for 1 
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minute the upper aqueous phase was collected added with 1/10 volume of 3 M Sodium 
Acetate pH 5.2 and 0.7 volume of isopropyl alcohol. The solution was then centrifuged at 
10,000 x g for 20 min. The pellet further washed with 500 μl of 70% ethanol and 
centrifuged once more at 10,000 x g for 20 min. The pellet was air dried and dissolved in 
10 μl of dH2O. The purified PCR product was used to perform a pNEBR-X1-Hygro-
Ngn3/2/IRES cloning. The dTomato sequence and the pNEBR-X1-Hygro-Ngn3/2/IRES 
were digested as follow:  
 
10X NEB Buffer 3      2.0 μl (1X final) 
100X BSA        0.2 μl (1X final) 
dTomato PCR       10 μl  (1μg final) 
SalI        1.0 μl (10 Units) 
Sterile dH2O                            To 20 μl  
 
10X NEB Buffer 3      2.0 μl (1X final) 
100X BSA       0.2 μl (1X final) 
pNEBR-X1-Hygro-Ngn3/2/IRES    10 μl (10 μg final) 
SalI        1.0 μl (10 Units) 
Sterile dH2O                          To 20 μl  
 
 The reactions were gently mixed and incubated at 37°C for 1 h. The digestion 
products were run on a 1% agarose gel and analyzed by ethidium bromide staining. The 
pNEBR-X1-Hygro-Ngn3/2/IRES SalI plasmid has been dephosphorylated by adding 1 μl 
of Calf Intestinal Phosphatase (CIP) and incubating the reaction for 1 h at 37°C. To both 
the reaction mixtures, 480 μl of TE buffer were added and the solution extracted with 1 
volume of phenol:chloroform:isoamyl alchol (24:25:1). After centrifugation at 10,000 x g 
for 1 minute the upper aqueous phase was collected added with 1/10 volume of 3 M 
Sodium Acetate pH 5.2 and 0.7 volume of isopropyl alcohol. The solution was then 
centrifuged at 10,000 x g for 20 min. The pellet further washed with 500 μl of 70% 
ethanol and centrifuged once more at 10,000 x g for 20 min. The pellet was air dried and 
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dissolved in 10 μl of dH2O. The digestion products were run on a 1% agarose gel and 
analyzed by ethidium bromide staining and extracted using the QIAquick Gel Exctraction 
Kit as described above. The purified DNAs were quantified by using a ND-1000 
Spectrophotometer (NanoDrop Technologies). 
The ligation reaction was set up at a 3:1 insert:vector ratio. In a 200 μl tube were 
mixed: 
 
10X NEB T4 DNA ligase Buffer     2.0 μl (1X final) 
pNEBR-X1-Hygro-Ngn3/2/IRES SalI/    1.0 μl (50 ng final) 
dTomato SalI/        1.0 μl (12 ng final) 
T4 DNA ligase       0.3 μl (600 Units) 
Sterile dH2O                     To 20 μl 
 
 The mixture was incubated at 16°C for 16 h. The reaction was placed on ice and 
the transformation was performed as described above. Single colonies from the 
transformed bacteria plates obtained as above were inoculated into 3 ml of LB medium 
containing 10 mg/ml of ampicillin, and growth with vigorous shaking for 12-16 h. The 
plasmid DNA was then extracted as described. The plasmid mini-preps were analyzed by 
restriction analysis. In 200μl tubes were mixed: 
 
10X NEB Buffer 3       1.0 μl (1X final) 
100X BSA        0.1 μl (1X final) 
Mini-prep        5.0 μl 
SalI         0.5 μl (5 Units) 
Sterile dH2O                      To 10 μl 
 
 The reaction was mixed gently and incubated at 37°C for 1 h. The digestion 
products were run on a 1% agarose gel and analyzed by ethidium bromide staining. The 
positive colonies were submitted for sequencing at the NEB Sequencing Core. At least 
one positive colony containing the expected fragment size was used to set-up a DNA 
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plasmid midi-prep as described before. The purified DNA (pNEBR-X1-Hygro-
Ngn3/2/IRES/dTomato) was quantified by using a ND-1000 Spectrophotometer 
(NanoDrop Technologies). 
 
 
3.18.5  Establishing of Inducible RheoSwitch F9 Cell Line 
 
 The F9 cell line was cultivated in the appropriate medium as described above. The 
day before the transfection 8 x 10
5 
cells were plated into three 60 mm cell culture dishes 
with 4 ml of medium. For the transfection in sterile microcentrifuge tubes 500 μl of 
OptiMEM, 20 μl of Lipofectamine 2000 were added and incubated for 5 min at room 
temperature. Six μg of pNEBR-R1 Regulator plasmid were added and the mixture 
incubated at room temperature for 15 min. The Lipofectamine 2000/DNA complex was 
then added to the cells in a drop-wise manner and the cells returned to the incubator. The 
culture plates were incubate at 37°C for 2 days. After that, the transfected cells were 
diluted 1:500 and plated in selection medium containing 300 μg/ml of G418 15-20 days, 
changing medium as necessary. At least 17 single colonies (F9-R1) were obtained.  
 
3.18.6  Clones Selection 
 
 F9-R1 clones were maintained in culture in selection medium containing 300 
μg/ml G418. The day before transfection 4 x 105 cells were plated into three wells of a 6-
well cell culture plate with 2 ml of medium. For the transfection in sterile microcentrifuge 
tubes 250 μl of OptiMEM and 10 μl of Lipofectamine2000 were added and incubated for 
5 min at room temperature. Two μg of pNEBR-GLuc and 2 μg of pCMV-Gal plasmid 
were added and the mixture and incubated at room temperature for 15 min. The 
Lipofectamine2000/DNA complex was then added to the cells in a drop-wise manner and 
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the cells returned to the incubator. After 6-8 h the transfection reaction was replaced with 
medium containing 0.5 μM of RSL-1 and incubated at 37°C for 12 h. 
 
 
3.18.7  Gaussia Lucifarase Assay 
 
  For the Gaussia Luciferase assay 20 μl of supernatant from the above 
transfection were collected in a 96-well black plate. 1X Gaussia Luciferase assay 
working solution was prepared by adding 50 μl of GLuc Substrate to 5 ml of the GLuc 
Assay Buffer immediately before the assay. 
Fifty μl of 1X GLuc buffer were added to each sample and immediately the plate 
was read in a luminometer programmed to perform a 2-second measurement delay 
followed by a 10-second measurement read.  
The cells transfected as above were washed twice with PBS and lysed with 250 μl 
of 1X Passive Lysis Buffer. The plates were then rocked several times to ensure complete 
coverage of the cells with lysis buffer. The cells were then scraped and all the liquid 
transferred to a microcentrifuge tube, vortexed and centrifuged at 12,000  g for 10 min 
at 4°C.  
For the assay -Galactosidase, 20 μl of cell lysates were aliquoted in a 96-well 
black plate. 100X Galacton-Plus Reagent were diluted down to 1X in Reaction Buffer 
Diluent. Seventy μl of 1X Galacton Plus Reagent were added to each sample and the 
reaction was incubated at room temparature for 30 sec. After that, 90 μl of Accelerator II 
Reagent were added to each sample. Immediately the plate was read in a luminometer 
programmed to perform a 2-second measurement delay followed by a 10-second 
measurement read. The ratio of the Gaussia/b-galactosidase activity represents the 
normalized reporter gene expression. 
The fold induction was calculated as follow: 
 
Fold-induction = +RSL1-RLU/– RSL1-RLU 
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The clones showing the highest fold-induction (highest expression with lowest 
background) were propagated. About 5 clones (F9-R1) were obtained showing about a 
10-fold induction. 
 
 
3.18.8  Establishing of Inducible RheoSwitchF9-R1-Ngn3 Cell Line 
 
 At least one of the F9 cell line showing the highest fold-induction  was cultivated 
in the appropriate medium supplemented with 200 μg/ml G418. The day before the 
transfection 8 x 10
5 
cells were plated into three 60 mm cell culture dishes with 4 ml of 
medium. For the transfection in sterile microcentrifuge tubes 500 μl of OptiMEM, 20 μl 
of Lipofectamine2000 were added and incubated for 5 min at room temperature. Six μg 
of pNEBR-X1-Hygro-Ngn3/2 plasmid were added and the mixture incubated at room 
temperature for 15 min. The Lipofectamine2000/DNA complex was then added to the 
cells in a drop-wise manner and the cells returned to the incubator. The culture plates 
were incubate at 37°C for 2 days. After that, the transfected cells were diluted 1:500 and 
plated in selection medium containing 300 μg/ml of G418 and 150 μg/ml of hygromycin 
for 15-20 days, changing medium as necessary. At least 7 single colonies (F9-R1/Ngn3) 
were obtained. 
 
 
3.18.9  Transfection and Activation of Stable Cell Line NIH-3T3-47  
  (general protocol) 
 
 The NIH-3T3-47 cell line was cultivated in the appropriate medium supplemented 
with 800 μg/ml of G418. The day before the transfection the cells were plated into 12 
well cell culture plate with 0.5 ml of medium. For the transfection, in sterile 
microcentrifuge tubes 125 μl of DMEM, 2 μl of TransPassD2 were mixed and incubated 
for 15 minutes at room temperature. At the same time 0.5 μg of pNEBR-X1-Ngn3 Hygro 
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(or pNEBR-GLuc) and 0.5 μg of control plasmid pCMV--Galactosidase were mixed 
onto sterile microcentrifuge tubes and incubated at room temperature for 15 minutes. The 
two mixtures were then mixed and incubated for additional 30 min at room temperature. 
The TransPassD2/DNA complex was then added to the cells in a drop-wise manner and 
the cells returned to the incubator. The culture plates were incubate at 37°C for 6 h. After 
that, 250 μl of medium containing 0.5 μM RSL1 activator were added to the transfected 
cells and mandained in culture for 12 h before assay for protein expression.  
 
 
3.18.10 Western-Blot Analysis 
 
The F9-R1 and NIH/3T3-47 were washed twice with PBS and lysed using 100 μl 
of Passive Lysis Buffer. The cell extracts were then transferred into microcentrifuge tubes 
and centrifuged for 5 min at 14,000  g at 4°C. The supernatants were transferred to new 
tubes and used for protein quantification as described above. 
  The protein samples were added with 1/10 of Sample Buffer and boiled for 5 min 
and 10 μg of proteins were separated onto 10-20% Tris-Glycine gel. The gels were run at 
120V (constant voltage) until the bromophenol blue dye is just off in presence of the 1X 
Electrode Buffer.  
After run, the gels were recovered and soaked for 15 min at room temperature in 
transfer buffer along with 2 sponges, 4 sheets (7.5 cm X 10 cm) of 3MM Whatman paper, 
and 1 PVDF membrane (7.5 cm X 10 cm). 
The transfer sandwiches were then set-up adding, in the order, from the negative 
side of the sandwich: one sponge, two 3MM Whatman papers, the gel, the PVDF  
membrane, two more 3MM Whatman papers, the last sponge. The sandwiches are then 
put into the tank apparatus filled with the tank buffer and blotted for 1 hr at 100V 
(constant voltage). After transfer the PVDF membranes were incubated in Blotto solution 
for 1 hr. The membranes were then incubated with rabbit anti-HA-tag (1:1000) and goat 
anti--Actin (1:5000), respectively, in Blotto solution overnight at 4ºC with gentle 
shaking. 
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The day after the membranes were washed for 10 min three times with TBST and 
then incubated with goat anti-rabbit-IgG HRP-conjugated (1:1000) and with rabbit anti-
goat-IgG HRP-conjugated (1:1000), respectively, in Blotto solution for 1 hr at room 
temperature with gentle shaking. The membranes were then washed for 15 min four times 
with TBST. The membranes were then developed for 1 min with Western Lightning 
Chemiluminescence Reagent and autoradiographed with 5 min exposure.  
 
 
3.19 Preparation of the AdNgn3-EGFP AND AdNeuroD/BETA2 viral 
 particles 
 
3.19.1  Cloning the mouse Ngn3 CDS into the pShuttle-IRES-hrEGFP2  
  vector 
  
The complete mouse Ngn3 and the complete hamster NeuroD/BETA2 CDS 
sequences have been amplified by PCR using specific set of primers reported in Table 1 
(AdNgn3 and AdNeuroD primers sets) and pBS-Ngn3 and pcDNA-NeuroD/BETA2 as 
templates, respectively.  
Following 28 cycles of amplification, 5 μl of PCR products were run on a 1% 
agarose gel and analyzed by ethidium bromide staining. To the PCR mixtures 445 μl of 
TE buffer were added and the solutions extracted with 1 volume of 
phenol:chloroform:isoamyl alchol (24:25:1). After centrifugation at 10,000 x g for 1 
minute the upper aqueous phases were collected added with 1/10 volume of 3 M Sodium 
Acetate pH 5.2 and 0.7 volume of isopropyl alcohol. The solutions were then centrifuged 
at 10,000 x g for 20 min. The pellets further washed with 500 μl of 70% ethanol and 
centrifuged once more at 10,000 x g for 20 min. The pellets were air dried and dissolved 
in 10 μl of dH2O. The purified PCR fragments were used to perform TOPO cloning 
reactions using the TOPO TA cloning kit. In two separate 200 μl tube were mixed: 
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Purified PCRs        4.0 μl 
Salt Solution        1.0 μl 
pCR2.1-TOPO vector       1.0 μl 
 
The reactions were mixed gently and incubated for 5 min at room temperature. The 
reactions were placed on ice and the transformations were performed as described above. 
Single colonies from the transformed bacteria plates obtained as above were 
inoculated into 3 ml of LB medium containing 50 μg/ml of kanamycin, and grown with 
vigorous shaking for 12–16 h. The plasmid DNAs were then extracted as described. 
The DNA plasmid mini-preps were analyzed by restriction analysis. In 200 μl tubes 
were mixed: 
 
10X NEB Buffer 3       1.0 μl 
100X BSA        0.1 μl 
Mini-prep        5.0 μl  
ScaI         0.3 μl 
XhoI         0.3 μl 
Sterile dH2O                    To 10 μl  
 
 The reactions was mixed gently and incubated for 1 h at 37ºC. The digestion 
products were run on a 1% agarose gel and analyzed by ethidium bromide staining. At 
least one positive colony containing the expected fragment size was used to set-up a 
DNA plasmid midi-prep as described before. 
The DNA plasmid midi-preps (pCR2.1-TOPO-Ngn3 and pCR2.1-TOPO-NeuroD) 
were analyzed by restriction analysis. In two 200 μl tubes were mixed: 
 
10 X NEB Buffer 3       1.0 μl 
100X BSA        0.1 μl 
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Midi-prep (100 ng/μl)       1.0 μl  
ScaI         0.3 μl 
XhoI         0.3 μl 
Sterile dH2O                     To 10 μl  
 
The reaction mixtures were gently and incubated for 1 h at 37ºC. The digestion 
products were run on a 1% agarose gel and analyzed by ethidium bromide staining. 
The Ng3 CDS and the NeuroD/BETA2 from the pCR2.1-TOPO-Ngn3 and the 
pCR2.1-TOPO-NeuroD vectors were subcloned into the pShuttle-IRES-hrEGFP2 by 
restriction digestion with ScaI and XhoI as follow. In three 1.5 ml microcentrifuge tubes 
were added respectively: 
 
10X NEB Buffer 3       10  μl (1X final) 
100X BSA        1.0 μl (1X final) 
pShuttle-IRES-hrEGFP2      20  μl (15 μg final)  
ScaI         1.5 μl (15 Units) 
XhoI         1.0 μl (20 Units) 
Sterile dH2O                 To 100 μl 
 
10X NEB Buffer 3       10 μl (1X final) 
100X BSA        1.0 μl (1X final) 
pCR2.1-TOPO-Ngn3       20 μl (15 μg final)  
ScaI         1.5 μl (15 Units) 
XhoI         1.0 μl (20 Units) 
Sterile dH2O                   To 100 μl 
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10X NEB Buffer 3       10 μl (1X final) 
100X BSA        1.0 μl (1X final) 
pCR2.1-TOPO-NeuroD      20 μl (15 μg final)  
ScaI         1.5 μl (15 Units) 
XhoI         1.0 μl (20 Units) 
Sterile dH2O                   To 100 μl 
 
 
 The reactions were gently mixed and incubated for 1 h at 37ºC. Two μl of the 
digestion products were run on a 1% agarose gel and analyzed by ethidium bromide 
staining. To the digestions mixture 348 μl of TE buffer were added and the solution 
extracted with 1 volume of phenol:chloroform:isoamyl alchol (24:25:1). After 
centrifugation at 10,000 x g for 1 minute the upper aqueous phase was collected added 
with 1/10 volume of 3 M Sodium Acetate pH 5.2 and 0.7 volume of isopropyl alcohol. 
The solutions were then centrifuged at 10,000 x g for 20 min. The pellets further washed 
with 500 μl of 70% ethanol and centrifuged once more at 10,000 x g for 20 min. The 
pellets were air dried and dissolved in 20 μl of dH2O. The digestion products were run on 
a 1% agarose gel, analyzed by ethidium bromide staining and gel extracted as described 
above. The purified DNAs were quantified by use of a ND-1000 Spectrophotometer 
(NanoDrop Technologies). 
The ligation reaction was set up at a 3:1 insert:vector ratio. In two 200 μl tube 
were mixed, respectively: 
 
10X T4 DNA ligase Buffer      2.0 μl (1X final) 
pShuttle-IRES-hrEGFP2 ScaI/XhoI     1.0 μl (25 ng final) 
Ngn3 (or NeuroD) ScaI/XhoI      1.0 μl (5 ng final) 
T4 DNA ligase       0.3 μl (600 U final) 
Sterile dH2O variable                             To 20 μl  
 
10X T4 DNA ligase Buffer      2.0 μl (1X final) 
pShuttle-IRES-hrEGFP2 ScaI/XhoI     1.0 μl (25 ng final) 
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NeuroD ScaI/XhoI       1.0 μl (5 ng final) 
T4 DNA ligase       0.3 μl (600 U final) 
Sterile dH2O variable                             To 20 μl  
 
The mixtures were incubated at 16°C for 16 h. The reactions were placed on ice 
and the transformation was performed as described above. 
Single colonies from the transformed bacteria plates obtained as above were 
inoculated into 3 ml of LB medium containing 50 μg/ml of kanamycin, and grown with 
vigorous shaking for 12–16 h. The plasmid DNAs were then extracted as described. 
The DNA plasmid mini-preps were analyzed by restriction analysis. In 200 μl tubes 
were mixed: 
 
10X NEB Buffer 3       1.0 μl (1X final) 
100X BSA        0.1 μl (1X final) 
Mini-prep        5.0 μl  
ScaI         0.3 μl (3 Units) 
XhoI         0.3 μl (6 Units) 
Sterile dH2O                      To 10 μl  
 
 The reaction was mixed gently and incubated for 1 h at 37ºC. The digestion 
products were run on a 1% agarose gel and analyzed by ethidium bromide staining. At 
least one positive colony containing the expected fragment size was used to set-up a 
DNA plasmid midi-prep as described above. The purified plasmid DNAs (pShuttle-
Ngn3-IRES-hrEGFP2 and pShuttle-NeuroD-IRES-hrEGFP2) were quantified by use of a 
ND-1000 Spectrophotometer (NanoDrop Technologies). 
The DNA plasmid midi-preps were analyzed by restriction analysis. In two 200 μl 
tubes were mixed: 
 
10 X NEB Buffer 3       1.0 μl (1X final) 
100X BSA        0.1 μl (1X final) 
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Midi-preps        1.0 μl (100 ng) 
ScaI         0.3 μl (3 Units) 
XhoI         0.3 μl (6 Units) 
Sterile dH2O                       To 10 μl  
 
The reaction mixtures were gently and incubated for 1 h at 37ºC. The digestion 
products were run on a 1% agarose gel and analyzed by ethidium bromide staining. 
Both the pShuttle-Ngn3-IRES-hrEGFP2 and pShuttle-NeuroD-IRES-hrEGFP2 
vectors were then linearized. In two 200 μl tubes were mixed respectivelly: 
 
10 X NEB Buffer 4       5.0 μl (1X final) 
100X BSA        0.5 μl (1X final) 
pShuttle-Ngn3-IRES-hrEGFP2     10 μl (10 μg final) 
PmeI         1 μl (10 Units) 
Sterile dH2O                        To 50 μl  
 
 
10 X NEB Buffer 4       5.0 μl (1X final) 
100X BSA        0.5 μl (1X final) 
pShuttle-NeuroD-IRES-hrEGFP2     10 μl (10 μg final) 
PmeI         1 μl (10 Units) 
Sterile dH2O                        To 50 μl  
 
The reactions mixtures were gently and incubated for 1 h at 37ºC. Five μl of the 
digestion product was run on a 1% agarose gel and analyzed by ethidium bromide 
staining. The mixtures were then added with 5 Units of Alkaline Calf Intestinal 
Phosphatase and incubated for 1 h at 37ºC. To the digestion mixtures 445 μl of TE buffer 
were added and the solutions extracted with 1 volume of phenol:chloroform:isoamyl 
alchol (24:25:1). After centrifugation at 10,000 x g for 1 minute the upper aqueous phases 
were collected, added with 1/10 volume of 3 M Sodium Acetate pH 5.2 and 0.7 volume 
of isopropyl alcohol. The solutions were then centrifuged at 10,000 x g for 20 min. The 
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pellets further washed with 500 μl of 70% ethanol and centrifuged once more at 10,000 x 
g for 20 min. The pellets were air dried and dissolved in 20 μl of dH2O.  The digestion 
products were run on a 1% agarose gel, analyzed by ethidium bromide staining and gel 
extracted as described above.  
The purified PmeI linearized plasmid DNAs were quantified by use of a ND-1000 
Spectrophotometer (NanoDrop Technologies) and diluted to a final concentration of 1 
μg/μl. 
 
3.19.2  Transformation of the BJ5183Ad Cells to Produce Recombinant  
  AdPlasmid 
 
The BJ5183Ad cells were transformed with the linearized pShuttle-Ngn3-IRES-
hrEGFP2 and pShuttle-NeuroD-IRES-hrEGFP2 vectors. A recombination event that 
takes place in the bacterial cells results in the production of recombinant AdEasy plasmid 
DNA. The transformation was carried out by electroporation of the competent BJ5183Ad 
cells. Just prior the transformation the BJ5183Ad cells are removed from –80°C storage 
and thawed on ice. 1 μl (1 μg) of linearized, dephosphorylated pShuttle-Ngn3-IRES-
hrEGFP2 and pShuttle-NeuroD-IRES-hrEGFP2 vectors were added to the chilled aliquot 
of BJ5183Ad cells. The cells were mixed by tapping the tube gently and kept on ice. The 
electroporator was set to the appropriate setting (200 , 2.5 kV, 25 μF) and the 
DNA/cells mixtures transferred in chilled electroporation cuvettes. The samples were 
then pulsed and immediately added with 1 ml of LB broth.  The cell suspensions were 
transferred to sterile 14-ml BD Falcon polypropylene round-bottom tubes and incubated 
at 37°C for 1 hour while shaking at 225–250 rpm. The entire volume (50 μl, 100 μl, 250 
μl, and 600 μl of cell suspension, respectively) of recovered cells was plated onto 4 LB 
agar plates containing 50 μg/ml of kanamycin and incubated overnight at 37°C. 
Single colonies from the transformed bacteria plates obtained as above were 
inoculated into 5 ml of LB medium containing 50 μg/ml of kanamycin, and grown with 
vigorous shaking for 12–16 h. 2 ml of the bacterial cells were subjected to Mini-Prep 
protocol. 
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 The DNA plasmid mini-preps were analyzed by restriction analysis. In 200 μl 
tubes were mixed: 
 
10X NEB Buffer 1       2.0 μl (1X final) 
100X BSA        0.2 μl (1X final) 
Mini-preps        10 μl  
PacI         0.5 μl (5 Units) 
Sterile dH2O                     To 20 μl  
 
The reaction was mixed gently and incubated for 1 h at 37ºC. The entire digestion 
products were run on a 0.8% agarose gel and analyzed by ethidium bromide staining. At 
least five positive colonies were selected for the subsequent amplification. The five 
selected purified recombinant Ad plasmids were quantified by use of a ND-1000 
Spectrophotometer (NanoDrop Technologies). 
For bacteria transformation, to 100 μl aliquot of XL10-Gold ultracomptetent cells, 
thawed on ice in a sterile 14-ml BD Falcon polypropylene round-bottom tube, 4 μl of -
mercaptoethanol were added and the mixture incubated on ice for 10 min. The cells were 
then added 50 ng of recombinant Ad plasmids obtained as above and incubated on ice for 
30 min. The tubes were heat-pulsed in a 42°C water bath for 30 seconds and placed on 
ice for 2 min. After addition of 900 μl of prewarmed (42°C) NZY+ into the mixture the 
cells were incubated at 37°C for 60 min with vigorous shake (250 rpm). Five μl, 25 μl, 
and 100 μl of each transformation reaction were plated on LB agar plates containing 50 
μg/ml of kanamycin and incubated overnight at 37°C. At least five colonies from 
transformations were picked and transferred into 10 ml LB broth containing 50 μg/ml of 
kanamycin and incubated overnight at 37°C while shaking at 225-250 rpm. Five ml of the 
above overnight cultures were inoculated in 500 ml of LB broth containing 50 μg/ml of 
kanamycin and incubated overnight at 37°C while shaking at 225-250 rpm and subjected 
to a plasmid Maxi-Prep protocol. The purified plasmid DNAs were quantified by use of a 
ND-1000 Spectrophotometer (NanoDrop Technologies). 
The AdNgn3 and AdNeuroD/BETA2 recombinant plasmids were them linearized. 
In 200 μl tubes were mixed, respectively: 
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10X NEB Buffer 1       5.0 μl (1X final) 
100X BSA        0.5 μl (1X final) 
AdNgn3         20 μl (25 μg) 
PacI         2.5 μl (25 Units) 
Sterile dH2O                      To 50 μl  
 
10X NEB Buffer 1       5.0 μl (1X final) 
100X BSA        0.5 μl (1X final) 
AdNeuroD/BETA2        20 μl (25 μg) 
PacI         2.5 μl (25 Units) 
Sterile dH2O                      To 50 μl  
 
The reaction mixtures were gently and incubated for 1 h at 37ºC. One μl of the 
digestion products was run on a 0.8% agarose gel and analyzed by ethidium bromide 
staining to confirm the desired restriction pattern.  
To the digestion mixtures 449 μl of TE buffer were added and the solutions 
extracted with 1 volume of phenol:chloroform:isoamyl alchol (24:25:1). After 
centrifugation at 10,000 x g for 1 minute the upper aqueous phases were collected added 
with 1/10 volume of 3 M Sodium Acetate pH 5.2 and 0.7 volume of isopropyl alcohol. 
The solutions were then centrifuged at 10,000 x g for 20 min. The pellets further washed 
with 500 μl of 70% ethanol and centrifuged once more at 10,000 x g for 20 min. The 
pellets were air dried and dissolved in 50 μl of dH2O. 
 
 
3.19.3  Preparation of Primary Adenovirus Stock 
 
 The 293Ad cell line was cultivated in Dulbecco’s Modified Eagle Medium 
(DMEM) containing 4.5 g/L glucose and 110 mg/L sodium pyruvate and 4 mM L-
glutamine, supplemented with 10% (v/v) heat-inactivated fetal bovine serum. The day 
before the transfection, 8 x 10
5 
cells were plated into two 60 mm cell culture dishes with 
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4 ml of medium. For the transfection in two sterile microcentrifuge tubes 200 μl of 
DMEM (containing 4.5 g/L glucose and 110 mg/L sodium pyruvate and 4 mM L-
glutamine), 6 μl of FuGENE 6 were added and incubated for 5 min at room temperature. 
Two μg of PacI digested AdNgn3 and AdNeuroD/BETA2 DNAs were added, 
respectively, and the mixtures incubated at room temperature for 15 min. The 
FuGENE6/DNA complexes were then added to the cells in a drop-wise manner and the 
cells returned to the incubator. The culture plates were incubated at 37°C for 7–10 days, 
replenishing the growth medium when needed. To prepare the primary viral stocks the 
growth media were removed from the adenovirus-producing 293Ad plates and the cells 
washed once with PBS. To each plate 500 μl of PBS were added and the cells collected 
by scraping. The cell suspensions were then transferred into a sterile microcentrifuge tube 
and subjected to four round of freeze/thaw by alternating the tubes between a dry ice-
methanol bath and a 37°C water bath, vortexing briefly after each thaw. The cell debris 
were collected by centrifugation at 12,000 x g for 10 min and the supernatants (primary 
virus stocks) were transferred in new microcentrifuge tubes and stored at -80°C. 
 
 
3.19.4  Amplification of the Primary Viral Stock 
 
Amplification of the primary viral stocks has been obtained by infection of 293Ad 
cells. 3.5 x 10
6
 293Ad were plated into a 100 mm culture dish in 5 ml of complete 
medium containing 200 μl of primary viral stocks. The cells were incubated for 2 h and 
then supplied with additional growth medium. The cells were then maintained in culture 
until appearance of the first signs of cytopathic effect (CPE) (cells will round up and 
detach from the plates, and the nucleus will occupy a major part of the cell). At that point 
the Adenoviral particles were collected by four round of freeze/thaw as described above. 
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3.19.5  Plaque Assay 
 
The plaque assay is used to determine the titer (pfu/ml) of the viral stocks. 5 x 10
5
 
293Ad cells were plated in two 6-well tissue culture plates overnight at 37°C. The 
adenoviral stocks obtained as above were diluted in 1 ml volumes over a 10-fold series 
from 10
-5
 to 10
-9
 in growth medium. Each dilution were then added to a separate well of 
the 6-well plates and incubated at 37°C for 2 h. The wells were overlaid with agarose as 
follow; a sterile solution of 5% agarose in dH2O was prepared by autoclaving and left to 
equilibrate at 65°C. 30 ml of growth medium equilibrated to 37°C were added and 3 ml 
of this agarose/growth medium mix was pipetted along the side of the well previously 
emptied of medium. The plates were then incubated at 37°C for about 10 days or until the 
appearance of hrEGFP expressing colonies. The titer was determined by counting the 
number of hrEGFP expressing colonies obtained with the highest viral dilution and 
multiplying that number by the dilution factor to estimate pfu/ml. 
 
 
3.20 CHROMATIN IMMUNOPRECIPITATION CLONING (ChiP-cloning)  
 
 
3.20.1  Cell culture and infection. 
 
Approximately 2 x 10
7
 AR42J and INS-1 cells were plated in 100 mm cell culture 
dishes in the appropriate medium and infected with 20 MOI of AdNgn3-EGFP and Ad-
EGFP, respectively, for 4 hr and then the medium was changed with fresh one. The cells 
were maintained in culture for two days. 
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3.20.2  In Vivo Crosslinking and Lysis 
 
For the ChiP-cloning experiments a modification of the EZ-ChiP kit has been 
used. To the cell plates prepared as above 540 μl of fresh 18.5% formaldehyde (final 
concentration is 1%) prepared dissolving 925 mg of paraformaldehyde into 4.8 ml of 
dH2O in presence of 35 μl of 1N KOH were added. The plates were gently swirled and 
incubated at room temperature for 10 min. After that 1 ml of 10X Glycine to each dish 
was added to quench unreacted formaldehyde and the plates incubated at room 
temperature for 5 min. The plates were placed on ice and the medium aspirated. The cells 
were washed twice with 10 ml of cold PBS. 1 ml cold PBS containing Protease Inhibitor 
Cocktail was added to the dish. The cells were then scraped into a microfuge tube and 
spun at 700 x g at 4°C for 2-5 min to pellet cells and the supernatant discarded. 1 ml of 
SDS Lysis Buffer containing Protease Inhibitor Cocktail was then added, the cell pellet 
resuspended and aliquoted between 300-400 μl per microcentrifuge tube. Cells in SDS 
Lysis Buffer at a cell concentration of 2 x 10
7
 per ml were sheared with 4-5 sets of 10-
second pulses on wet ice using a 60 SONIC Dismembrator (Fisher Scientific) equipped 
with a 2 mm tip and set to 30% of maximum power. The sheared cells were then spun 
down at a minimum of 10,000 x g at 4°C for 10 min to remove insoluble material and the 
supernatant collected in fresh microcentrifuge tubes in 100 μl aliquots. Each 100 μl 
aliquot contains ~2 x 10
6 
cell equivalents of chromatin. 
  
 
3.20.3  Immunoprecipitation (IP) of Crosslinked Protein/DNA 
  
To at least 2 x 100 μl aliquots (experiment + negative control) 900 μl of Dilution 
Buffer containing Protease Inhibitor Cocktail were added. Sixty μl of Protein G magnetic 
beads for each IP were then added and the tubes incubated for 1 hour at 4°C with 
rotation. The cleared supernatants were separated from the Protein G magnetic beads 
using a magnetic separation rack. Ten μl (1%) of the supernatant were collected as Input 
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and to the remaining supernatant fractions 10 μg of rabbit anti-Ngn3 and 10 μg of normal 
rabbit IgG were added to the “experiment” and “negative control” tubes, respectively. 
The tubes were incubated overnight at 4°C with rotation. To recover the 
antibody/antigen/DNA complexes 60 μl of Protein G magnetic beads were added and the 
tubes incubated for 1 hour at 4°C with rotation. The magnetic beads were recovered using 
a magnetic separation rack as above and the beads were washed as follows by 
resuspending the beads in 1 ml each of the cold buffers in the order listed below and 
incubating for 5 min on a rotating platform followed by recovery of the supernatant using 
a magnetic separation rack: 
 
a. Low Salt Immune Complex Wash Buffer, one wash. 
b. High Salt Immune Complex Wash Buffer, one wash. 
c. LiCl Immune Complex Wash Buffer, one wash. 
d. TE Buffer, two washes. 
 
 
3.20.4  Elution of Protein/DNA Complexes 
 
To each tubes (IPs and inputs) obtained as described above 100 μl of Elution 
Buffer were added mixed by flicking and incubated at room temperature for 15 min. The 
magnetic beads were pelleted using the magnetic separation rack and the supernatant 
collected. The steps were repeated with an extra 100 μl of Elution Buffer and the eluates 
combined. 
 
 
3.20.5  Reverse Crosslinks of Protein/DNA Complexes to Free DNA 
 
To all tubes (IPs and Inputs) were added 8 μl 5 M NaCl and incubated at 65°C 
overnight to reverse the DNA-Protein crosslinks. To all tubes, 1 μl of RNase A were 
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added and incubated for 30 min at 37°C. Four μl 0.5 M EDTA, 8 μl 1M Tris-HCl and 1 
μl Proteinase K were added and incubated at 45°C for 2 h. 
  
 
3.20.6  DNA Purification Using Spin Columns 
 
One ml of Bind Reagent A was added to each 200 μl DNA sample tube (IPs and 
Inputs), and the sample/Bind Reagent A. mixture transferred to the Spin Filter in 
Collection Tube and centrifuged for 30 sec at a minimum of 10,000 x g. Five hundred μl 
of the Wash Reagent B were then added to the Spin Filter in Collection Tube and 
centrifuged for 30 seconds at a minimum of 10,000 x g. The Spin Filter was put into a 
clean Collection Tube, added with 50 μl of Elution Buffer C and centrifuged for 30 sec at 
a minimum of 10,000 x g. 
 
 
3.20.7  Blunting reaction, ligation and bacteria transformation.  
 
For blunting reaction in a sterile 200 μl tube were mixed: 
 
Purified DNA         19 μl 
10X Blunting Buffer        2.5 μl 
1 mM dNTP Mix        2.5 μl 
Blunting Enzyme Mix       1.0 μl 
Sterile dH20 variable                       To 25 μl  
 
The mixtures were incubated at room temperature for 30 min. Immediately after 
that the enzymes were inactivated by heating at 70°C for 10 min. 
 
For ligation reaction a sterile 200 μl tube were mixed: 
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Blunted DNA         10 μl 
10X T4 DNA ligase Buffer         2.0 μl 
pCR-BLUNT vector        1.0 μl 
T4 DNA ligase        1.0 μl 
Sterile dH2O variable                       To 20 μl  
 
The mixtures were incubated at 16°C for 16 h. The reaction was placed on ice and 
the transformation was performed as described above. 
Single colonies from the transformed bacteria plates obtained as above were 
inoculated into 3 ml of LB medium containing 50 μg/ml of kanamycin, and grown with 
vigorous shaking for 12–16 h. The plasmid DNA was then extracted as described. 
The purified plasmid DNA was quantified by use of a ND-1000 
Spectrophotometer (NanoDrop Technologies).  
 
3.20.8  Bioinformatics analysis.  
 
About 400 ng of each mini-prep DNA samples were sequenced using the M13 
forward (-20) (5´-GTAAAACGACGGCCAG-3´) and the M13 reverse (5´-
CAGGAAACAGCTATGAC-3´) primers at the Brigham and Women’s DNA Core 
Sequencing Facility (Boston, MA, USA).  
 The sequences not belonging to the vector were used to perform BLAST 
analyses using the blastn that compares a nucleotide query sequence against a nucleotide 
sequence database.  The rat genome database 
(http://www.ncbi.nlm.nih.gov/genome/seq/BlastGen/BlastGen.cgi?taxid=10116) has 
been analyzed using the default filters setting. The output results were analyzed for 
sequences that span the 5’term in the proximity of transcription factors and that contain at 
least one DNA binding motif for the bHLH family of transcription factors (E-box, 
CANNTG). 
  
Chapter 3 Materials and Methods 
________________________________________________________________________  
 135 
3.20.9  Confirmation of the results 
 
 The sequences showing the presence of E-boxe(s) and localized at the 5’-term of 
transcription factors were confirmed by independent classical ChiP experiments. 
Approximately 2 x 10
7
 AR42J cells were plated in three 100 mm cell culture dishes in the 
appropriate medium and infected with 20 MOI of AdNgn3-EGFP, 20 MOI of AdNeuroD 
and 20 MOI of AdEGFP, respectively, for 4 hr and then the medium was changed with 
fresh one. The cells were maintained in culture for two days. The DNAs and protein 
complexes were crosslinked and immunoprecipited using anti-Ngn3 and anti-
NeuroD/BETA2 antibodies, respectively as described above. The purified DNA was 
analyzed by PCR using clone specific primer(s).  
Following 35 cycles of amplification the PCR products were run on a 1% agarose 
gel and analyzed by ethidium bromide staining. 
 
 
3.21 PREPARATION OF THE OVOl1-PROM1-LUCIFERASE REPORTER 
 SYSTEM AND TRANSACTIVATION EXPERIMENTS 
 
 
3.21.1  Cloning of the Rat 1.1 kb OVOl1 Promoter into the pGL2-Basic  
  vector 
 
The 1.1 kb sequence encompassing the 5’-flanking region from -841 to +230 of 
the rat ovol1 gene and containing the E-box 1 has been amplified by PCR using a specific 
set of primers reported in Table 1 (OVOl1Prom1 primers set) and rat genomic DNA as 
template.  
Following 30 cycles of amplification, 5 μl of PCR product was run on a 1% 
agarose gel and analyzed by ethidium bromide staining. To the PCR mixture 445 μl of 
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TE buffer were added and the solution extracted with 1 volume of 
phenol:chloroform:isoamyl alchol (24:25:1). After centrifugation at 10,000 x g for 1 
minute the upper aqueous phase was collected added with 1/10 volume of 3 M Sodium 
Acetate pH 5.2 and 0.7 volumes of isopropyl alcohol. The solution was then centrifuged 
at 10,000 x g for 20 min. The pellet further washed with 500 μl of 70% ethanol and 
centrifuged once more at 10,000 x g for 20 min. The pellet was air dried and dissolved in 
10 μl of dH2O. The purified PCR fragment was used to perform a TOPO cloning reaction 
using the TOPO TA cloning kit. In a 200 μl tube were mixed: 
 
Purified PCR        4.0 μl 
Salt Solution        1.0 μl 
pCR2.1-TOPO vector       1.0 μl 
 
The reaction was mixed gently and incubated for 5 min at room temperature. The 
reaction was placed on ice and the transformation was performed as described above. 
Single colonies from the transformed bacteria plates obtained as above were 
inoculated into 3 ml of LB medium containing 50 μg/ml of kanamycin, and grown with 
vigorous shaking for 12–16 h. The plasmid DNA was then extracted as described. 
The DNA plasmid mini-preps were analyzed by restriction analysis. In 200 μl tubes 
were mixed: 
 
10X NEB Buffer 2       1.0 μl (1X final) 
100X BSA        0.1 μl (1X final) 
Mini-prep        5.0 μl  
BamHI         0.3 μl (6 Units) 
SacI         0.3 μl (6 Units) 
Sterile dH2O                      To 10 μl  
 
 The reaction was mixed gently and incubated for 1 h at 37ºC. The digestion 
products were run on a 1% agarose gel and analyzed by ethidium bromide staining. At 
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least one positive colony containing the expected fragment size was used to set-up a 
DNA plasmid midi-prep as described before. 
The DNA plasmid midi-prep (pCR2.1-TOPO-OVOl1Prom1) was analyzed by 
restriction analysis. In 200 μl tubes were mixed: 
 
10X NEB Buffer 2       1.0 μl (1X final) 
100X BSA        0.1 μl (1X final) 
Midi-prep (100 ng/μl)       1.0 μl  
BamHI         0.3 μl (6 Units) 
SacI         0.3 μl (6 Units) 
Sterile dH2O                         To 10 μl  
 
The reaction mix was gently and incubated for 1 h at 37ºC. The digestion products 
were run on a 1% agarose gel and analyzed by ethidium bromide staining. 
The OVOl1Prom1 from the pCR2.1-TOPO-OVOl1Prom1 vector was subcloned 
into the pGL2-Basic vector by restriction digestion with BamHI and SacI as follow. In 
two 1.5 ml microcentrifuge tubes were added respectively: 
 
10X NEB Buffer 2       10 μl (1X final) 
100X BSA        1.0 μl (1X final) 
pGL2         20 μl (30 μg final)  
BamHI         1.5 μl (30 Units) 
SacI         1.5 μl (30 Units) 
Sterile dH2O                   To 100 μl 
 
10X NEB Buffer 2       10 μl (1X final) 
100X BSA        1.0 μl (1X final) 
pCR2.1-TOPO-OVOl1Prom1      20 μl (20 μg final)  
BamHI         1.0 μl (20 Units) 
SacI         1.0 μl (20 Units) 
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Sterile dH2O                         To 100 μl 
 
 The reactions were gently mixed and incubated for 1 h at 37ºC. Two μl of the 
digestion products were run on a 1% agarose gel and analyzed by ethidium bromide 
staining. To the PCR mixture 348 μl of TE buffer were added and the solution extracted 
with 1 volume of phenol:chloroform:isoamyl alchol (24:25:1). After centrifugation at 
10,000 x g for 1 minute the upper aqueous phase was collected added with 1/10 volume 
of 3 M Sodium Acetate pH 5.2 and 0.7 volume of isopropyl alcohol. The solution was 
then centrifuged at 10,000 x g for 20 min. The pellet further washed with 500 μl of 70% 
ethanol and centrifuged once more at 10,000 x g for 20 min. The pellet was air dried and 
dissolved in 20 μl of dH2O. The digestion products were run on a 1% agarose gel, 
analyzed by ethidium bromide staining and gel extracted as described above. The purified 
DNAs were quantified by use of a ND-1000 Spectrophotometer (NanoDrop 
Technologies). 
The ligation reaction was set up at a 3:1 insert:vector ratio. In a 200 μl tube were 
mixed: 
  
10X NEB T4 DNA ligase Buffer     2.0 μl (1X final) 
pGL2 BamHI/SacI       1.0 μl (25 ng final) 
OVOl1Prom1 BamHI/SacI      1.0 μl (15 ng final) 
T4 DNA ligase       0.3 μl (600 U final) 
Sterile dH2O                                     To 20 μl  
 
The mixture was incubated at 16°C for 16hr. The reaction was placed on ice and 
the transformation was performed as described above. 
Single colonies from the transformed bacteria plates obtained as above were 
inoculated into 3 ml of LB medium containing 100 μg/ml of ampicillin, and grown with 
vigorous shaking for 12–16 h. The plasmid DNA was then extracted as described. 
The DNA plasmid mini-preps were analyzed by restriction analysis. In 200 μl tubes 
were mixed: 
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10X NEB Buffer 2       1.0 μl (1X final) 
100X BSA        0.1 μl (1X final) 
Mini-prep        5.0 μl  
BamHI         0.3 μl (6 Units) 
SacI         0.3 μl (6 Units) 
Sterile dH2O                    To 10 μl  
 
 The reaction was mixed gently and incubated for 1 h at 37ºC. The digestion 
products were run on a 1% agarose gel and analyzed by ethidium bromide staining. At 
least one positive colony containing the expected fragment size was used to set-up a 
DNA plasmid midi-prep as described above. The purified plasmid DNA was quantified 
by use of a ND-1000 Spectrophotometer (NanoDrop Technologies) 
The DNA plasmid midi-prep (pGL2-OVOl1Prom1) was analyzed by restriction 
analysis. In 200 μl tubes were mixed: 
 
10X NEB Buffer 2       1.0 μl (1X final) 
100X BSA        0.1 μl (1X final) 
Midi-prep (100 ng/μl)       1.0 μl  
BamHI         0.3 μl (6 Units) 
SacI         0.3 μl (6 Units) 
Sterile dH2O                       To 10 μl  
 
The reaction mix was gently and incubated for 1 h at 37ºC. The digestion products 
were run on a 1% agarose gel and analyzed by ethidium bromide staining. 
 
 
3.21.2  Site-Directed Mutagenesis 
 
 To mutate the E-box 1 in the OVOl1Prom1 the Phusion Site-Directed 
Mutagenesis Kit has been used. This kit uses the highly processive Phusion™ Hot Start 
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High-Fidelity DNA Polymerase for exponential PCR amplification of dsDNA plasmid to 
be mutated. The mutagenesis protocol comprises only three steps: 
 
1. PCR amplificaton of target plasmid with two phosphorylated primers.  
2. Circularization of mutated PCR products. 
3. Transformation to E. coli. 
 
The point mutation for E-Box 1 has been created by designing a mismatch in the 
mutagenic primer (Table 1, EboxMut primer set). The desired mutation has been 
collocated in the middle of the primer with 10-15 perfectly matched nucleotides on each 
side. As Template the pGL2-OVOl1Prom1 has been used. The amount of plasmid 
template in the mutagenesis reaction has been titrated as down as possible to prevent 
background transformants after ligation and transformation. Typically the PCR mixture 
contained: 
 
5X Phusion HF Buffer      10 μl (1X final) 
10 mM dNTP        1.0 μl (0.5 mM) 
10 μM 5’-Primer       2.5 μl (0.5 μM) 
10 μM 3’-Primer       2.5 μl (0.5 μM) 
Template (50 pg/μl)       1.0 μl 
Phusion Hot Start DNA Pol      0.5 μl (0.5 Units) 
Sterile dH2O                           To 50 μl  
 
After PCR the product was circularized with Quick T4 DNA Ligase. For ligation 
reaction in a 200 μl tube were mixed: 
 
PCR         5.0 μl 
2X Quick Ligation Buffer      5.0 μl  
Quick T4 DNA ligase       0.2 μl 
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The reaction was incubated at room temperature for 5 min and then placed on ice 
and the transformation was performed as described above. 
Single colonies from the transformed bacteria plates obtained as above were 
inoculated into 3 ml of LB medium containing 100 μg/ml of ampicillin, and grown with 
vigorous shaking for 12–16 h. The plasmid DNA was then extracted as described and 
sequenced using a specific set of primers (Table 1, pGL2SEQ). At least two positive 
colonies containing the expected mutated fragment were used to set-up a DNA plasmid 
midi-prep as described before. The purified plasmids DNA (pGL2-OVOl1Prom1Mut) 
were quantified by use of a ND-1000 Spectrophotometer (NanoDrop Technologies). 
 
 
3.21.3  Transactivation Experiments 
 
The day before the transfection 5 x 10
5 
AR42J or INS-1 cells were plated into 6-
well cell culture plates with 2 ml of medium. For the transfection, in sterile 
microcentrifuge tubes 200 μl of DMEM (containing 4.5 g/L glucose and 1mM sodium 
pyruvate, 25 mM HEPES, 2 mM L-glutamine, 100 units/ml penicillin, 100 μg/ml 
streptomycin for AR42J) and in RPMI 1640 (containing 4.5 g/L glucose and 1 mM 
sodium pyruvate, 2 mM L-glutamine, 10 mM HEPES, 50 μM -mercaptohetanol 100 
units/ml penicillin, 100 μg/ml streptomycin for INS-1 cells), 3 μl of FuGENE 6 were 
added and incubated for 5 min at room temperature. Two μg total of the appropriate 
mixture of vectors (containing 1 μg of pGL2-OVOl1Prom1 or pGL2-OVOl1Prom1Mut, 
100 ng of pcDNA5/TO-Ngn3, 100 ng of pcDNA5/TO-NeuroD/BETA2, 100 ng of 
pCMV-MyoD, 100 ng of pcDNA-E47, 100 ng of pRL-TK and pcDNA to 2 μg) were then 
added. 
The mixtures were incubated at room temperature for 15 min. The 
FuGENE6/DNA complexes were then added to the cells in a drop-wise manner and the 
cells returned to the incubator. The culture plates were Incubate at 37°C for 2 days. 
The cells were then washed twice with PBS and lysed with 250 μl of 1X Passive 
Lysis Buffer. The plates were then rocked several times to ensure complete coverage of 
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the cells with lysis buffer. The cells were then scraped and all the liquid transferred to a 
microcentrifuge tube, vortexed and centrifuged at 12,000  g for 10 min at 4°C.  
For the Luciferase assay, 100 μl of Luciferase Assay Reagent II for each samples 
were dispensed into luminometer tubes and 20 ml of cell lysates were added. 
Immediately the tubes were read in a luminometer programmed to perform a 2-second 
measurement delay followed by a 10-second measurement read for Firefly Luciferase 
(reporter plasmid, pGL2-OVOl1Prom1) activity. Immediately after, 100l of 1X Stop & 
Glo Reagent were added and the tubes briefly to mixed. The tubes were read again with 
2-second measurement delay followed by a 10-second measurement read for Renilla 
Luciferase activity (internal control vector, pRL-TK). The ratio of the firefly:Renilla 
Luciferase activity represents the normalized reporter gene expression. 
 
 
3.21.4  Immunohistochemistry 
 
The adult rat pancreas and testis tissue were obtained from 4-week old male 
Sprague-Dawley rats. Tissues were fixed in 4% (w/v) paraformaldehyde dissolved in 
0.1M Sorensen’s buffer at room temperature for 2 h and incubated in cold PBS until use. 
The fixed tissues were then processed to make wax block and sectioned for 5 μm-
thickness slides for staining.  
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For immunohistochemistry, tissue sections were first rehydrated by sequential 
incubation in: 
 
Xylene I         7 min 
Xylene II         7 min  
100% Ethanol I        5 min 
100% Ethanol II        3 min  
95% Ethanol I         3 min 
95% Ethanol II        3 min 
70% Ethanol          10 min 
dH2O          5 min  
 
 The slides were then incubated twice in PBS containing 1% lamb serum for 5 
min. The tissues were then permeabilized with 0.3% (v/v) Triton X-100 in PBS for 20 
min. The antigen retrieval step was obtained by the incubation of slides in 10 mM citrate 
buffer for 20 min in microwave. To avoid high staining background and non-specific 
signals, endogenous peroxidase activity was quenched by incubating slides in 3% H2O2 
for 30 min and the tissues were blocked in blocking serum (Vecstastain Elite ABC), for 
30 min at room temperature. Afterwards, tissues were incubated overnight at room 
temperature with rabbit anti-OVOl1 antibody at 1:750 dilutions. As negative control, the 
OVOl1 antibody was replaced with blocking serum. On the following day, the tissues 
were washed twice with PBS for 10 min each; the biotinylated secondary antibodies were 
then added onto the slides for 30 min and washed twice with PBS for 10 min each. The 
slides were incubated with ABC reagent for 30 min and developed in solution containing 
0.5 mg/ml 3, 3'-Diaminobenzidine (DAB) and 0.015% (v/v) H2O2 until desired signal was 
observed. For counter staining for cell nuclei, the slides were incubated in filtered 
Harris’s Hematoxylin solution for 10 seconds and sequentially washed in 0.15 M Sodium 
Borate solutions for 3 times. After the final wash, slides were incubated in sodium Borate 
solution for at least for 3 min. The slides were then dehydrated as follow:  
 
70% Ethanol          5 min  
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95% Ethanol I         1 min 
95% Ethanol II        1 min 
100% Ethanol  I        1 min 
100% Ethanol II        1 min 
Xylenes I         2 min 
Xylenes II         2 min 
 
The slides were lastly mounted in Xylene-based mounting medium. The samples 
were examined under Olympus BH-2 microscope. The DIC images were photographed 
using Sony 3 CCD camera with LG-3 PCI module. Final figures were processed with 
Adobe Photoshop 7.0.  
 
3.21.5  Western-Blot Analysis 
 
The day before the transfection 5 x 10
5 
AR42J or INS-1 cells were plated into 6-
well cell culture plates with 2 ml of the appropriate medium. For the transfection in 
sterile microcentrifuge tubes 200 μl of DMEM (containing 4.5 g/L glucose and 1mM 
sodium pyruvate, 25 mM HEPES, 2 mM L-glutamine, 100 units/ml penicillin, 100 μg/ml 
streptomycin for AR42J) and in RPMI 1640 (containing 4.5 g/L glucose and 1 mM 
sodium pyruvate, 2 mM L-glutamine, 10 mM HEPES, 50 μM -mercaptohetanol 100 
units/ml penicillin, 100 μg/ml streptomycin for INS-1 cells), 6 μl of FuGENE 6 were 
added and incubated for 5 min at room temperature. 2 μg total of the appropriate mixture 
of vectors (containing 1 μg of pcDNA5/TO-Ngn3, 1 μg of pcDNA5/TO-NeuroD/BETA2, 
1 μg of pCMV-MyoD, 1 μg of pcDNA-E47 and pcDNA5/TO to 2 μg when necessary) 
were then added. 
The mixtures were incubated at room temperature for 15 min. The 
FuGENE6/DNA complexes were then added to the cells in a drop-wise manner and the 
cells returned to the incubator. The culture plates were Incubate at 37°C for 2 days. 
The cells were then washed twice with PBS and lysed with 250 μl of CytoBuster 
Protein Extraction Reagent. The cell extracts were then transferred into microcentrifuge 
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tubes and centrifuged for 5 min at 16,000  g at 4°C. The supernatants were transferred to 
new tubes and used for protein quantification. For the protein quantification the BioRad 
Protein Assay reagent was used. In a 96-well plate 5 and 10 μl of cell extracts and 10 μl 
of solutions containing 0.1, 0.2, 0.3, 0.4 and 0.5 μg/μl of BSA were pipetted. To the well 
200 μl of 1X dye reagent were added, the plates incubated at room temperature for 5 min 
and the absorbance read at 595 nm in a microplate reader. 
 Five μg of proteins were separated onto two 15% SDS-Acrylamide/Bis-
Acrylamide gel prepared as follow: 
 
Resolving Gel.  
 
30% Acrylamide/Bis Solutions, 37.5:1 mixture (30%T, 2.67% C)  5.0 ml 
1.5 M Tris-HCl, pH 8.8       2.5 ml 
10% APS (freshly prepared)       100 μl 
10% SDS         100 μl 
TEMED           10 μl 
dH2O                 To 10 ml 
 
Stacking Gel 
 
30% Acrylamide/Bis Solutions, 37.5:1 mixture (30%T, 2.67% C)  840 μl 
0.5 M Tris-HCl, pH 6.8       630 μl 
10% APS (freshly prepared)         50 μl 
10% SDS           50 μl 
TEMED          5.0 μl 
dH2O                   To 5 ml 
 
 The protein samples were added with 1/10 of Sample Buffer and boiled for 5 min. 
The gels were run gels at 200V (constant voltage) until the bromophenol blue dye is just 
off in presence of the 1X Electrode Buffer. After run the protein are transferred onto a 
nitrocellulose membrane using the Mini-Trans Blot Cell system (Bio-Rad) 
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After run, the gels were recovered and soaked for 15 min at room temperature in 
transfer buffer along with 2 sponges, 4 sheets (7.5 cm X 10 cm) of 3MM Whatman paper, 
and 1 Nitrocellulose membrane (7.5 cm X 10 cm). 
The transfer sandwiches were then set-up adding, in the order, from the negative 
side of the sandwich: one sponge, two 3MM Whatman papers, the gel, the nitrocellulose  
membrane, two more 3MM Whatman papers, the last sponge. The sandwiches are then 
put into the tank apparatus filled with the tank buffer and blotted for 1 hr at 100V 
(constant voltage). After transfer the nitrocellulose membranes were incubated in Blotto 
solution for 1 hr. The membranes were then incubated with rabbit anti-OVOl1 (1:2000) 
and goat anti--Actin (1:5000), respectively, in Blotto solution overnight at 4ºC with 
gentle shaking. 
The day after the membranes were washed for 10 min three times with TBST and 
then incubated with goat anti-rabbit-IgG HRP-conjugated (1:10000) and with rabbit anti-
goat-IgG HRP-conjugated (1:10000), respectively, in Blotto solution for 1 hr at room 
temperature with gentle shaking. The membranes were then washed for 15 min four times 
with TBST. The membranes were then developed for 1 min with Western Lightning 
Chemiluminescence Reagent and autoradiographed with 5 min exposure.  
 
 
3.22 IDENTIFICATION OF THE -CELL SPECIFIC INSULIN GENE 
 COATIVATOR A2.2 
 
3.22.1  Nuclear Protein Extract from HIT T-15 cells 
 
Nuclear extracts of HIT T-15 have been prepared using a large scale nuclear 
extract protocol as follow. About 1 x 10
12
 HIT T-15 cells were harvested from cell 
culture medium by centrifugation at room temperature for 10 min at 1000 x g. The cell 
pellet was then resuspended in five volumes of cold PBS and centrifuged again for 10 
min at 1000 x g at room temperature. The cells were resuspended in five packed cell 
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pellet volumes of buffer A and allowed to stand for 10 min. The cells were collected by 
centrifugation at 1000 x g for 10 min at 4°C, suspended in two packed cell pellet volumes 
of buffer A (referred to the cell pellet volume before the addition of buffer A)  and 
homogenized by 10 strokes of a glass Dounce homogenizer. The cell lysates were 
centrifuged for 10 min at 1000 x g and he pellet was resuspended in two pellet volumes 
of buffer A and centrifuged again for 20 min at 25,000 x g. The resulting pellet was 
resuspended in 3 ml every 10
9
 cells of buffer B and homogenized with a Dounce 
homogenizer. The resulting suspension was first stirred for 30 min at room temperature 
and then centrifuged at 25,000 x g for 30 min at 4°C. The resulting supernatant was 
dialyzed against 50 volumes of buffer C for 5 h. The protein were quantified as described 
above. 
The dialyzed nuclear extract was centrifuged at 25,000 x g for 20 min at 4°C and 
the supernatant aliquoted and stored at -80°C. 
 
3.22.2  Electrophoretic Mobility Shift Assay (EMSA) 
 
3.22.2.1 Oligonucleotides Labeling 
 
 The sequences of the oligonucleotides used as probes and competitors are 
reported in Table 1. The annealing of the probes and competitors were obtained 
dissolving each oligos (direct and complementary) in TE Buffer to a final concentration 
of 10 μM. Each strand were then mixed together in equal molar amounts and heated at 
94ºC for 10 min and gradually cooled.  
The double-stranded probes obtained as above were radiolabeled with [-
32
P]dCTP and the Klenow fragment (3´  5´) exo- of DNA polymerase I. Briefly, in a 
200 μl tube were added: 
 
NEB Buffer 2         2.0 μl 
dsProbe         4.0 μl 
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dNTPs 33 μM         1.0 μl 
[-32P]dCTP (3000 Ci/mmole)      5.0 l 
Klenow fragment (3´  5´) exo-      1.0 μl 
Sterile dH2O                     To 20 μl 
 
The reaction has been incubated at room temperature for 20 min. Radiolabeled 
double-strand oligonucleotides probes were purified by using G-50 Sephadex Columns 
TE (mini Quick Spin Columns) as described by the manufacturer. 
 
3.22.2.2 Gel Mobility Shift Assay 
 
 For the gel mobility shift assay 3-5 μg of nuclear extracts from HIT T-15 cell line 
prepared as described above were incubated in 1X DNA binding buffer with 1 μg of 
poly(dI-dC) on ice for 15 min. One hundred fmole of the radiolabeled probe were then 
added to the mixture and the extracts further incubated at room temperature for additional 
15 min. The competition experiments were performed by simultaneous addition to the 
binding reaction of an excess of unlabeled competitors along with the radiolabeled 
probes. The mixtures were separated onto a 6% Acrylamide/Bis-Acrylamide gel prepared 
as follow: 
 
30% Acrylamide/Bis Solutions, 37.5:1 mixture (30%T, 2.67% C)    10 ml 
5X TBE          5.0 ml 
10% APS (freshly prepared)       100 μl 
TEMED           37 μl 
dH2O                 To 50 ml 
 
The gel was run at 120V for 4 h at 4°C. At the end of run the gel was cast out and 
transferred on a Whatman sheets, covered with cellophane and dried for ~ 40 min at 80ºC 
under vacuum. The gel(s) is then exposed with Biomax MR Kodak films at -80°C 
overnight. The day after the film is developed.  
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For the super-shift assay prior running the gel as described above the mixtures 
were pre-incubated for 30 min with 200 ng of the appropriate antibody (anti-C/EBP and 
anti-C/EBP).  
 
3.22.3  Purification of A2.2 Coactivator 
 
For the purification of the A2.2 MafA-transcription coactivator, 25 ml of nuclear 
extract obtained as described above, were used. The purification of A2.2 has been done 
using HiTrap Heparin columns and streptavidin-agarose columns. Briefly the HiTrap 
Heparin column was first equilibrated with 10 volumes of Binding Buffer, and then the 
nuclear extract was loaded on it. The column was then washed with 5-10 volumes of 
Binding Buffer and the fractions eluted with 10 ml of Elution Buffer by increasing salt 
concentration from 1 to 2 M. The fractions were tested foir ability to form complex with 
A2.2 oligonucleotide as described above. Those showing gel-shift activity were pooled 
and further purified using an affinity chromatography on a streptavidin-agarose column.  
The pooled protein fractions obtained from the first purification diluted to 15 ml 
with streptavidin-agarose Binding Buffer and incubated with biotinylated double strand 
A2.2 sequence (5’-CCAGGCAAGTGTTTGGAAACTGCAGCTTCAGCCCCTCTG-3’) 
for 1 h on a rotating wheel at room temperature. 
 For the purification 3 ml of streptavidin-agarose resin were spun for 30 sec in at 
1000 x g and resuspended with 15 ml of streptavidin-agarose Binding Buffer containing 
500 μg/ml BSA and 200 μg of carrier DNA. The tube containing the resin was then 
gently mixed on a rotating wheel for 1 h at room temperature to block nonspecific protein 
and nucleic acid binding sites present on the streptavidin-agarose resin. The resin was 
then spun and added with the protein/biotinylated-oligonucleotides complexes, washed 
twice with strepavidin-agarose Binding Buffer. The proteins were eluted with Elution 
A2.2-Buffer containing increasing concentration of salt and collected into fractions.  
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3.22.4  Colloidal Gold Protein Staining 
 
 To confirm the presence of proteins in the eluted fractions a colloidal gold 
staining was performed. Briefly, after SDS-PAGE the proteins were transferred onto a 
nitrocellulose membrane, as describe above. The membrane was incubated twice with 
100 ml of TTBS for 20 min. After the incubation, 100 ml of dH2O were added and the 
membrane washed for 2 min. The washing was repeated twice. 50 ml of Colloidal Total 
Protein Stain were added and incubated overnight. Following the gold staining the 
membrane was washed twice with 100 ml of dH2O for 1 min.  
 
 
3.22.5  Western-Blot Analysis 
 
 About 5 μg of proteins obtained from the affinity chromatography on an 
streptavidin-agarose column were separated onto two 12% SDS-Acrylamide/Bis-
Acrylamide gel prepared as follow: 
 
Resolving Gel.  
 
30% Acrylamide/Bis Solutions, 37.5:1 mixture (30%T, 2.67% C)  4.0 ml 
1.5 M Tris-HCl, pH 8.8       2.5 ml 
10% APS (freshly prepared)       100 μl 
10% SDS         100 μl 
TEMED           10 μl 
dH2O                 To 10 ml 
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Stacking Gel 
 
30% Acrylamide/Bis Solutions, 37.5:1 mixture (30%T, 2.67% C)  840 μl 
0.5 M Tris-HCl, pH 6.8       2.5 ml 
10% APS (freshly prepared)       50 μl 
10% SDS         50 μl 
TEMED         5 μl 
dH2O               To 5 ml 
 
 The protein samples were added with 1/10 of Sample Buffer and boiled for 5 min. 
The gels were run gels at 200V (constant voltage) until the bromophenol blue dye is just 
off in presence of the 1X Electrode Buffer. After run the protein are transferred onto a 
nitrocellulose membrane using the Mini-Trans Blot Cell system (Bio-Rad) 
After run, the gels were recovered and soaked for 15 min at room temperature in 
transfer buffer along with 2 sponges, 4 sheets (7.5 cm X 10 cm) of 3MM Whatman paper, 
and 1 Nitrocellulose membrane (7.5 cm X 10 cm). 
The transfer sandwiches were then set-up adding, in the order, from the negative 
side of the sandwich: one sponge, two 3MM Whatman papers, the gel, the nitrocellulose 
membrane, two more 3MM Whatman papers, the last sponge. The sandwiches are then 
put into the tank apparatus filled with the tank buffer and blotted for 1 hr at 100V 
(constant voltage). The membranes were then incubated with mouse anti-MafF/G/K 
(1:1000) and mouse anti-MafA (1:1000), respectively, in Blotto solution overnight at 4ºC 
with gentle shaking.  
The day after the membranes were washed for 10 min three times with TBST and 
then incubated with rabbit anti-mouse-IgG HRP-conjugated (1:10000) in Blotto solution 
for 1 hr at room temperature with gentle shaking. The membranes were then washed for 
15 min four times with TBST. The membranes were then developed for 1 min with 
Western Lightning Chemiluminescence Reagent and autoradiographed with 5 min 
exposure. 
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3.22.6  TCA Protein Contentration 
 
 In a 1.5 ml microcentrifuge tube 1 volume of 100% (w/v) of trichloroacetic acid 
was added to 4 volumes of eluted fractions and incubated for 10 min at 4°C. The samples 
were then centrifuged at 14,000 x g at 4°C for 5 min and the pellet washed with 200 μl of 
cold acetone and spun again as before. The cold-acetone washing has been done twice. 
The pellet was let dry for 5 min at 95°C before resuspend it with Protein Loading Buffer. 
 
3.22.7  Mass Spectrometry Analysis 
 
 Mass spectrometry analysis was performed at the Joslin Proteomic Core by a 
microcapillary Reverse-Phase HPLC nanoelectronspray tandem mass spectrometry 
(μLC/MS/MS).  
 The results were analyzed blasting the sequences using SEQUEST database 
software. The peptide and the matching proteins coming out from the tandem mass 
spectrometry analysis and blast were blasted against different databases to confirm the 
first blast results and to select candidates with nuclear localization. The databases used 
are: 
 
MASCOT (http://www.matrixscience.com/search_form_select.html) 
OMSSA (http://pubchem.ncbi.nlm.nih.gov/omssa/) 
NCBI-BLST (http://www.ncbi.nlm.nih.gov/blast/Blast.cgi) 
EBI Protein WU-Blast2 (http://www.ebi.ac.uk/blast2/) 
Softberry (http://www.softberry.com/berry.phtml) 
Prowl Tools (http://prowl.rockefeller.edu/) 
BLSTM-LOC (http://139.91.72.10/blstm/blstm.html) 
 
Database Used For Sequence Analysis 
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DBD: Transcription factor prediction database (http://dbd.mrc-
lmb.cam.ac.uk/DBD/index.cgi?Home) 
MatInspector (http://www.genomatix.de/products/MatInspector/) 
TRANSFAC (http://www.gene-regulation.com/pub/databases.html) 
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4 RESULTS 
 
During development the formation of -cells is controlled by the activation and 
extinction of a large number of genes. Transcription factors orchestrate the intricate 
pathways of differentiation by regulating the rate of transcription of an array of genes. 
Genetic studies have begun to unravel the complex cascade of factors that control the 
proliferation and differentiation of cells in the development of the pancreas. Several 
homeodomain and bHLH transcription factors have been reported to play important roles 
in regulating the differentiation of pancreatic endocrine cell. However the general 
mechanism leading to the pancreas formation it is still unclear.  The first approach, used 
in the present Thesis work, to address the problem has been studying the genetic pathway 
leading the differentiation from undifferentiated cells to the -cell phenotype. 
Therefore, the aims of the first part of the work have been: 
 
1) To mimic the differentiation program during endocrine pancreas differentiation. 
2) To identify new genes involved in this process. 
 
Among the transcription factors involved in pancreas differentiation, Ngn3 is one 
of the essential expressed early in the differentiation of the islet cells and it is considered 
to be a marker of endocrine progenitor cell during development of the pancreas. 
Moreover, the timing of expression of this transcription factor corresponds to the specific 
developmental stage of the formation of the definitive endoderm. The subsequent 
patterning of endoderm leads to the formation of many of the major organs including 
pancreas, liver, lungs, thyroid and intestine. 
According to that, the present research project aimed to address also the following 
points: 
 
3) Is the transient expression of Ngn3 a prerequisite to have the proper molecular 
context to achieve -cells differentiation in vitro? 
4) Is the endoderm patterning a prerequisite to have the proper cellular context to 
achieve -cells differentiation?  
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5) Which are the direct downstream targets of Ngn3? 
 
The experimental strategy developed here helped answering these questions or at 
least helped to set-up strategy that needs to be refined. 
 
4.1 Mimicking the differentiation program of the pancreas and identify new 
 genes involved in endocrine development 
 
To address the first two aims a simple cell model of differentiation and a high-
throughput experimental approach have been chosen. As a model of differentiation the 
AR42J cell line was selected for their ability to differentiate into insulin-producing cells 
when treated with growing factors. In particular, the AR42J clone named B13 posses the 
highest ratio (up to 90%) of differentiation into insulin producing cells upon treatment 
with Act-A and HGF. In order to analyze the gene and protein expression profile driving 
the differentiation program during endocrine pancreas development, both microarray 
platform and two-dimensional analyses have been chosen as high-throughput assays. The 
goal of microarray and two-dimensional gel experiments is to survey the patterns of 
expression of hundred or thousands of genes and proteins in a single experiment. 
 
4.1.1  AR42J-B13 Differentiation  
 
Although the AR42J-B13 cell line is, at the moment, the best cell model to mimic 
as much as possible the physiological differentiation of -cells it shows some phenotypic 
instability, such as spontaneous differentiation in absence of growth factors stimuli. 
Therefore, it has been first necessary to stabilize the cells by treating them with 1 nM 
dexamethasone for 2 days. In that way the cells were “reprogrammed” back to their 
acinar phenotype. The cells were then maintained in culture, as described in the 
“Materials and Methods” Chapter, for 2 days, then diluted and plated in 12-well plates to 
isolate single clonal colonies. The AR42J-B13 isolated clones were then assayed before 
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and after the differentiation to confirm the efficiency of the growth factors treatment. 
Briefly 2 x 10
6
 AR42J-B13 cells were split and plated the day before the treatment in a 75 
cm
2
 cell culture flask. After 24 h, 2 nM Act-A and 500 pM HGF were added to the 
culture medium and the cells were maintained in culture for 48 h. The degree of the 
differentiation treatment has been determined evaluating the change of phenotype (Fig. 1 
A) and analyzing the gene pattern expression. 
When treated with Act-A coupled with HGF the AR42J-B13 cells change 
morphology extending three or more neurite-like processes. More detailed informations 
about the degree of differentiation were obtained by the analysis of the transcription 
factors activated during -cell development and know to be important for insulin gene 
transcription. For that purpose total RNA, from treated and untreated cells, was isolated 
using Trizol reagent. The RNA has been reverse transcribed and pancreas specific 
markers Isl-1, Nkx2.2, NeuroD/Beta2, Pax4, Ngn3, Insulin have been amplified by PCR 
(Fig. 1B).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
NT 
T 
A 
 
 
 
- + - + 
NT  T 
GAPDH 
Islet-1 1470 bp 
Nkx2.2 260 bp 
Beta-2 270 bp 
Pax4 60 bp 
Ngn3 640 bp 
Insulin 280 bp 
Pdx-1 225 bp 
B 
Fig. 1: A) The selected AR42J-B13 clone before treatment (NT) and after 48 h treatment with 500 pM HGF 
and 2 nM Act-A (T).  B) RT-PCR analysis of the markers for the cell line AR42J-B13 before treatment (NT) 
and after differentiating treatment. 30 cycles PCR amplification. 
 Amilase 700 bp 
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As shown in Figure 2, Pdx1, Nkx2.2 and NeuroD/BETA2 were detected in naive 
AR42J-B13 cells and did not show any significant changes during the differentiation 
process. On the other hand the expression of Pax4, Ngn3, and insulin genes was markedly 
increased after the differentiation treatment. Conversely the expression of amylase, a 
marker of the undifferentiated phenotype, disappears after the treatment with Act-A and 
HGF. The expression of insulin has been confirmed also at protein level through 
immunohistochemistry.  1 x 10
5
 cells have been split and cultivated on a 12- well cell 
culture plate in which were placed polyornithine-treated coverslip and treated with 2 nM 
Act-A and 500 pM HGF for 48 h. The cells were then fixed and treated with rabbit anti-
insulin antibody and then with anti-rabbit-IgG FITC-conjugated antibody as described in 
the “Materials and Methods”. The results are reported in Figure 2. Similarly to the RT-
PCR results, the insulin has been detected only in the Act-A/HGF-treated cells while any 
signal has been detected in the wild-type undifferentiated cells (Fig. 3). The positive 
signal for insulin is homogeneous with almost 100% of the treated cells appearing 
positive indicating that the step of clone selection has been efficient. The rat insulinoma 
RINm5F cell line has been used as a positive control for the immunohistochemistry (Fig. 
4).   
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 Fig. 4: RIN cells, positive control A) RIN cells stained with -Insulin antibody without -rabbit-FITC-
conjugated secondary antibody B) RIN cells stained with either -Insulin antibody and -rabbit-FITC-
conjugated secondary antibody 
 
Fig. 3: Wild type AR42J-B13 cells A) undifferentiated AR42J-B13 cells stained with -Insulin antibody 
without -rabbit-FITC-conjugated secondary antibody B) undifferentiated AR42J-B13 cells stained with 
either -Insulin antibody and -rabbit-FITC-conjugated secondary antibody 
 
Fig. 2: AR42J-B13 cells treated with 500pM HGF and 2nM Act-A A) differentiated AR42J-B13 cells 
stained with -Insulin antibody without -rabbit-FITC-conjugated secondary antibody B) differentiated 
AR42J-B13 cells stained with either -Insulin antibody and -rabbit-FITC-conjugated secondary antibody 
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To address the second point of the aims we relied on two high throughput 
methodological approaches that are the microarray and 2-D gel proteomic analyses. A 
high throughput experimental approach is necessary to obtain the higher degree of 
information in term of genes and proteins expressed per experiment. 
 
4.1.2  Microarray analysis 
 
 There are two main platforms of microarray technologies: cDNA and 
oligonuclotide arrays. cDNA microarrays are made with long double-stranded DNA 
molecules generated by enzymatic reactions such as PCR (Schena, Shalon et al. 1995). 
The cDNA arrays show the advantage that tissues- and development-specific arrays can 
be prepared offering a snap-shot of a well-defined phenotypic condition.  
According to that, the cDNA array technology has been chosen as the most 
informative tool to identify genes expressed during a differentiative event such as the 
pancreas development. One of the platforms available for the pancreas is PanChip 6.0 
from the Beta Cell Biology Consortium. The Mouse PancChip 6.0 contains 13,059 mouse 
cDNAs chosen for their expression in various stages of pancreatic development, many of 
which are not found on commercially available arrays. Total RNA isolated from 
uninduced and induced AR42J-B13 cells has been reverse transcribed and labeled using 
mono-reactive Cy3 and Cy5 dyes and hybridized to the arrays using the experimental 
strategy, as described in the Chapter 2. It is worth to mention that the results obtained 
from the microarray analyses were not straightforward and needed some adjustments to 
eliminate spurious data that could impair the identification of those genes that show a 
statistically significantly differential expression. In particular, an initial statistical analysis 
has been performed using the TIGR-MIDAS software and the results have been 
confirmed by R/Bioconductor (mArray package) analysis. The data normalization is 
shown in Fig. 5.  After the normalization of the microarray on the different slides, the 
resulting signals were used altogether to perform a t-test to find genes differentially 
expressed. For that purpose the software S.A.M. has been used. As described in the 
previous Chapter, the S.A.M. software allows for the identification of differentially 
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expressed genes through a well established statistical analysis. The results obtained using 
either R/Bioconductor coupled with S.A.M./Excel and TIGR-MIDAS coupled with 
TIGR-MeV, are shown in figure 6 and in table 1. The genes considered differential 
expressed are those with a fold of change higher then the calculated delta value in the 
S.A.M. analysis and a p-value below 0.05%.  
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A B 
C D 
E F 
G 
Fig. 5 
Raw data Background subtraction 
Mean centering Before lowess normalization 
After lowess normalization Before variance regularization 
After variance regularization 
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Number of significant genes: 65 
False Discovery Rare (0%): 0 
A 
B 
Fig. 6: S.A.M. analysis. A) S.A.M. analysis performed with TIGR-Mev after TIGR-MIDAS data 
normalization. In green the under-expressed genes while the over-expressed gene are in red. B) 
S.A.M. analysis performed with S.A.M./Excel after mArray/Bioconductor data normalization. In 
green the over-expressed gene while the under-expressed gene are in red.  
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Gene ID Gene Name Score(d) Numerator(r) Denominator(s+s0) 
q-
value(%) localfdr(%) 
1.1.7.1.5.12 2210010C04Rik 11,71558653 5,734673126 0,489490911 0 13,52871871 
1.1.11.1.5.12 Tfpi 6,273836489 6,697059654 1,067458431 0 13,49564242 
1.1.6.2.12.2 Htf9c 5,716593616 5,921854081 1,03590608 0 13,60791406 
       
       
 
Gene ID Gene Name Score(d) Numerator(r) Denominator(s+s0) 
q-
value(%) localfdr(%) 
1.1.10.1.7.1 Amy2 -7,175277349 -6,666484715 0,929090876 0 0,836338435 
1.1.5.1.11.8 Unc50 -7,086863662 -4,675675701 0,659766566 0 0,773088116 
1.1.12.1.3.4 Rab28 -6,825898549 -4,532779252 0,664056053 0 0,587670445 
1.1.5.1.11.4 Amy2 -6,295205328 -5,934221232 0,942657296 0 0,227095892 
1.1.7.2.15.7 Hnrpa3 -6,268638924 -3,685059183 0,587856348 0 0,210358263 
1.1.10.4.3.8 Gdpd5 -6,020324453 -3,106378449 0,5159819 0 0,069154865 
1.1.11.4.11.11 Amy2 -5,964818354 -5,815819082 0,975020317 0 0,042589752 
1.1.5.2.11.6 Amy2 -5,722898743 -5,604478011 0,979307561 0 0 
1.1.2.3.5.10 1110001C20Rik -5,657370628 -5,885075604 1,040249259 0 0 
1.1.2.4.3.12 Pfdn4 -5,507331417 -7,616100573 1,382902171 0 0 
1.1.5.4.1.18 4432411E13Rik -5,443818577 -8,430187332 1,548579772 0 0 
1.1.10.1.9.12 Amy2 -5,40488546 -5,760839216 1,06585778 0 0 
1.1.9.1.5.10 Amy2 -5,286223179 -7,195571173 1,361193224 0 0,065294148 
1.1.1.4.2.4 2410002O22Rik -5,283346274 -3,224254581 0,610267511 0 0,067531934 
1.1.6.2.7.6 Amy2 -5,271653467 -6,921820043 1,313026375 0 0,076893834 
1.1.1.3.10.8 Amy2 -5,268407244 -6,677313616 1,267425487 0 0,079569539 
1.1.7.3.10.16 5730472N09Rik -5,220898654 -7,817055958 1,497262536 0 0,122655536 
1.1.8.2.11.9 Amy2 -5,163916528 -9,115353675 1,765201592 0 0,184533259 
1.1.12.4.11.6 Amy2 -5,06649949 -8,778007643 1,732558675 0 0,318470635 
1.1.9.2.6.9 Amy2 -5,006615582 -8,053073651 1,608486515 0 0,420130311 
1.1.8.3.6.7 Amy2 -5,001896757 -8,208091349 1,640995756 0 0,428817253 
1.1.12.1.5.9 1110001C20Rik -4,972762494 -7,308868989 1,469780428 0 0,484741995 
1.1.9.2.7.7 Bub3 -4,956341953 -1,884672101 0,380254655 0 0,518041798 
1.1.10.3.2.4 1810009A16Rik -4,889339242 -7,19032699 1,470613233 0 0,667921141 
1.1.9.1.11.11 UNKNOWN -4,883129892 -7,912198472 1,620312924 0 0,68299528 
1.1.3.2.11.1 Amy2 -4,855960242 -7,44457794 1,533080497 0 0,751422703 
1.1.4.4.6.17 Amy2 -4,8556092 -8,044826306 1,656810912 0 0,752333534 
1.1.4.2.11.3 Myo1b -4,854935844 -7,223829028 1,487935013 0 0,754082586 
1.1.8.3.7.3 Amy2 -4,816446089 -6,667386087 1,384295799 0 0,858361792 
1.1.8.3.11.4 Amy2 -4,778805674 -8,772614573 1,83573369 0 0,968801534 
1.1.9.4.1.6 Smoc2 -4,739694294 -4,432088109 0,935099995 0 1,092868576 
1.1.6.3.11.9 Sfrs6 -4,695354249 -7,533217704 1,604398157 0 1,245578687 
1.1.8.3.11.9 Rab8b -4,672288908 -6,247306248 1,337097592 0 1,330297376 
1.1.11.2.3.15 Amy2 -4,626235782 -5,354510546 1,157422751 0 1,510727212 
1.1.6.1.6.16 Amy2 -4,62102627 -6,429889891 1,391441969 0 1,532109162 
1.1.11.4.11.6 Anapc1 -4,620766021 -3,370346259 0,72939124 0 1,533182603 
1.1.4.1.4.15 Amy2 -4,614397015 -7,386321777 1,600712239 0 1,559609779 
1.1.3.3.7.9 Amy2 -4,60955454 -6,948712007 1,507458464 0 1,579905672 
1.1.5.1.11.10 Amy2 -4,535517105 -7,272616689 1,603481262 0 1,912673616 
1.1.3.1.11.2 Amy2 -4,523265198 -6,872874015 1,519449715 0 1,971931443 
1.1.11.2.16.15 Hmgn1 -4,494280491 -2,927840419 0,65145921 0 2,117035405 
1.1.6.4.16.8 Ar -4,487229808 -2,356216718 0,525093837 0 2,153394156 
1.1.9.2.1.18 2900070E19Rik -4,439731404 -4,335612501 0,976548378 0 2,409472447 
1.1.11.1.3.13 Rps16 -4,439660158 -1,780024293 0,40093706 0 2,4098714 
1.1.12.3.5.10 Amy2 -4,390913946 -9,433323584 2,148373596 0 2,693593607 
1.1.8.3.15.2 Eif2s2 -4,377287208 -2,425929704 0,554208483 0 2,77682799 
1.1.6.1.2.18 Hmgb2 -4,305038736 -5,265659021 1,223138593 0 3,247988913 
1.1.10.3.9.12 Ppm1b -4,295759802 -4,27649024 0,995514283 0 3,31224673 
1.1.11.1.10.15 Amy2 -4,276572021 -7,601115931 1,777385227 0 3,447910523 
1.1.9.2.13.12 5230400G24Rik -4,235868946 -2,435588707 0,574991516 0 3,748376256 
1 1 6 4 6 4 Amy2 -4 204518373 -9 31540381 2 215569771 0 3 991857966
Table 1: 
 
Genes 
Over-expressed 
 
 
 
Under-expressed 
Genes 
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4.1.3  Proteomic Analysis 
 
 In a first set of experiments protein samples from treated and untreated AR42J-
B13 cells were separated according their isoelectric points using a wide range of pH 
(strips of pH 3-10) followed by the second dimension (a classical SDS- PAGE) on a 10% 
polyacrilamide gel. The completion of these first sets of experiment gave the possibility 
to gain a broad overview of total protein distribution between undifferentiated and 
differentiate condition. The results are reported in Figure 7.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 As evident the most interesting pattern of differentially expressed proteins 
accumulated on the top-left part of the gel that corresponds to the acid region of the strips 
and to the high molecular weight region for the SDS-PAGE. In the attempt to increase the 
efficiency of isoelectric separation for these proteins the pH range has been narrowed 
from pH 3-10 to pH 4-7. This pH gradient is covered with steps of 1 unit of pH allowing 
 
Fig. 7: 2D analysis. For the first dimension110μg of protein extract were separated using a 13 cm 
strip pH 3-10. For the second dimension the proteins were separated on a 10% SDS-PAGE gel. A) 
sample from untreated AR42J-B13 and B) sample from AR42J-B13 treated with 500 pM HGF and 
2 nM Act-A. 
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a more detailed resolution of the protein isolectrofocusing. At the same time the 
percentage of acrylamide has been lowered from 10% to 8%, in order to obtain a more 
efficient protein separation.  
 Following the 2-D separation and silver staining, the gel were converted into 
digital images using a scanner and analyzed using the ImageMaster
TM
 software. To 
quantify the changes, the intensity levels of each spot were normalized by expressing the 
intensity of each protein spot in a gel as a proportion of the total protein intensity detected 
for the entire gel (relative volume, % vol).  
 After normalization, the gels from individual experiments were compared to 
detect those spots differentially expressed among different assays (Fig. 8) and used for 
mass spectrometry analysis.  
Chapter 4 Results 
________________________________________________________________________ 
 166 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 8: The protein samples from undifferentiated A) and differentiated B) AR42J-B13 were 
separated using a pH range between 4-7 for the first dimension and an 8% acrylamide gel for the 
second dimension. C) After comparison and normalization,  the differentially expressed spots were 
identified and submitted to the proteomic analysis. 
C 
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For the MS protein identification, the differentially expressed spots were excised from 
gel, destained and subjected to reduction and alkylation. Once extracted, the peptides 
were loaded on LC-MS. The first separation has been performed using a C8 capillary 
column on a liquid-chromatography unit connected to a mass spectrophotometer. The 
output data (mass spectra and tandem mass spectra) have been used for the protein 
identification. Heighteen differentially over-expressed proteins were identified (Table 2) 
after Act-A/HGF treatment. Among the identified proteins from mass analysis the -actin 
all the proteins are related with cell differentiation and cellular trafficking. 
 
 
 
 
 Identified proteins Function/localization 
1 -Actin Cytoskeleton 
2 NSF Vesicular trafficking/cytoplasm 
3 VGF8a Energetic homeostasis/vesicle secretion 
4 PARK7 Oxidative stress/cytoplasm 
5 UCHL1 Ubiquitin monomers formation/cytoplasm 
6 PDIA1 Modification of disulphide bonds/cytoplasm 
7 PDIA3 Modification of disulphide bonds/cytoplasm 
8 GRP75 Oxidative stress/cytoplasm 
9 CH60 oxidative stress/cytoplasm 
10 ERp29 Protein fording/endoplasmic reticulum 
11 PRDX-2 Redox system/cytoplasm 
12 PRDX-6 Redox system/cytoplasm 
13 ENOA Plasminogen activator/cytoplasm 
14 PEBP Cell signaling/cytoplasm- 
15 GLE1 tRNA transport/nucleus-cytoplasm 
16 Calreticulin Protein folding/endoplasmic reticulum 
 
 
 
Table 2  
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4.2 Mimicking the expression of Ngn3 during the differentiation program 
 
 To address the points 3 and 4 of the aims, the F9 cell line has been used as a 
model for a controlled differentiation process. These cells can differentiate into parietal 
endoderm in the presence of retinoic acid (RA) and dibutyryl cyclic AMP. To attain at 
the same time both a high transduction efficiency and a customized activation of gene 
expression the RevTet-On transduction system have been used. The RevTet-On couples 
the efficiency of retroviral gene delivery with that of the Tetracycline-inducible gene 
expression system. 
The cells have been maintained in culture as described in “Materials and 
Methods”. The day before infection the cells have been split and plated in 100 mm 
culture dishes at a density of about 60%. The days after the cells were infected with 
about 5 MOI of RevTet-On viruses and then selected for neomycin resistance for at least 
seven days. Positive clones were expanded and selected to identify those showing the 
higher inducibility and lower background as described in “Material and Methods”. At 
least 8 colonies showing >15-fold induction were obtained. One of these stable rtTA 
expressing clones has been then infected with 5 MOI of RevTRE-Ngn3 viruses and then 
selected for hygromycin resistance. Positive clones have been selected and expanded. 
Twelve clones have been obtained. Stable clones have been then selected for 
doxycycline-induced Ngn3 expression by assaying for Ngn3 expression after treatment 
with 2, 4, 6, 8 and 10 μg/ml of doxycycline for at least 48 h. Expression of Ngn3 has 
been evaluated by RT-PCR (Fig 9). The picture shows the result obtained after the dose-
curve experiments. Unfortunately there are very slight or any differences between the 
negative control (no Dox) and the induced ones. These results have been observed for all 
the clones selected.  
According to that it has been decided to use the T-REx™ System. This system 
include an inducible expression plasmid (pcDNA5/TO) for expression of gene of interest 
under the control of the strong human CMV promoter and two tetracycline operator 2 
(TetO2) sites and a regulatory plasmid, pcDNA6/TR, which encodes the Tet repressor 
(TetR) under the control of the human CMV promoter. The mouse Ngn3 gene has been 
cloned in the response vector pcDNA5/TO as described in “Materials and Methods”.  
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Again the F9 cell line has been used as a model for a controlled differentiation. 
The cells have been maintained in culture as described in “Materials and Methods”. The 
day before transfection the cells have been split and plated in 60 mm culture dishes at a 
density of about 60%. Gene transfer has been carried out using LipofecAMINE 2000 
reagent. The pcDNA5/TO-Ngn3 has been cotransfected with the regulatory plasmid, 
pcDNA6/TR with a ratio 6:1 (w/w) pcDNA6/TR:pcDNA5/TO-Ngn3 for a total of 7 μg of 
DNA. After transfection, the target cells have been selected for hygromycin and 
blasticidin resistance, respectively. Positive clones have been selected and expanded. 
Twenty four clones have been obtained. Stable clones have been then selected for 
doxycycline-induced Ngn3 expression by assaying for Ngn3 expression after treatment 
with 2, 4, 6, 8 and 10 μg/ml of doxycycline for at least 48 h. Interestingly, as reported in 
Fig. 10, there is an increase of level of expression of the Ngn3 messenger with the 
increase of the doxycycline concentration with low basal expression in not induced 
sample. Unfortunately, the differences of induction between 2 and 10 μg/ml are not so 
dramatic.  
To establish the time needed to obtain the maximum expression of Ngn3 a time 
course experiment has been performed. As reported in Fig. 11 the maximum expression 
can be obtained after 48 h of treatment. 
Once established a cell line in which the expression of Ngn3 can be turned-on and 
off experiments of differentiation/induction have been set-up as outlined in Fig. 12. 
Briefly, the F9 cells were plated in 100 mm culture dishes at a density of about 60% and 
treated with 0.1 nM RA and 1 mM db-cAMP for 72 h and then transferred in a Petri dish 
to allow the formation of Embryod Bodies (EB) for 48 hr. From this point onward the 
EBs have been treated with 8 μg/ml of doxycycline for further 48 h. After 48 h from the 
withdrawal expression of Ngn3 and of other pancreas specific genes (NeuroD/BETA2, 
Pax6, Pax4, Nkx2.2, Pdx1 and Isl1 and for the pancreatic hormones insulin, glucagon) 
have been evaluated by RT-PCR.  The results are reported in Fig. 12. 
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Fig. 11: Time course assay. The stable clone 6TR/5TO-Ngn3-F9 was induced for 24, 48, 72 h with 8 
μg/ml of doxicycline before RNA extraction and RT-PCR analysis. As control for the retrotranscription 
-Tubulin was used. 30 cycles PCR amplification. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 10: Dose curve of the T-REx™ System. The stable clone 6TR/5TO-Ngn3-F9 was induced for 48 h 
with different concentration of doxicycline before to test the Ngn3 expression by RT-PCR. As control for 
the retrotranscription -Tubulin was used. 30 cycles PCR amplification. 
Fig. 9: Dose curve of the RevTet-On system. The stable clone Tet-On/TRE-Ngn3-F9 was induced for 48 
h with different concentration of doxicycline before to test the Ngn3 expression by RT-PCR. As control 
for the retrotranscription -Tubulin was used. 30 cycles PCR amplification. 
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Ngn3 was found to be expressed in doxycycline-treated EBs but at low level also 
in control doxycycline-not treated EBs F9/RA. A significant level of expression of the 
pancreas cell markers NeuroD/BETA2, Pax6 and Isl1 was detected only in the endoderm-
derived EBs (see Fig. 12). Slight evidence for the transcription of mRNAs of these 
factors was found in the control.  
Pdx1, Nkx2.2 and Pax4 were no detected in both doxycycline-treated EBs and 
not-treated EBs (data not shown). The RT-PCR for insulin and glucagon was negative, 
indicating that the transfected cells were unable to express pancreatic hormones (data not 
shown). 
Fig. 12: differentiation protocol for the 6TR/5TO-Ngn3-F9 double stable clone. Briefly the cells were 
plated on gelatin coated disches and kept in culture with 0.1 nM RA and 1 mM db-cAMP for 72 h. After 
that period the cells were kept in culture on Petri disches for the embryo-bodies formation. After 24 h the 
medium was changed with fresh medium containing 8 μg/ml Dox and kept in culture for 48 before the 
Dox was removed from the medium. After 48 h the embryo-bodies were assayed for the expression of 
beta-cell-development markers. As control, 6TR/5TO-Ngn3-F9 double stable clone was treated with the 
same protocol except the RA and db-cAMP treatment was skipped.  
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The presence of a low, but significant (in term of transcription factor), expression 
of Ngn3 also in the doxycycline-not treated control impaired the results.  
The leak of gene expression, even in absence of inducer, of the tetracycline-based 
systems used induced us to pursue to use new inducible system(s). One of the newest 
systems available is the RheoSwitch

 system, from New England Biolabs. 
The RheoSwitch System permits maximum control of gene expression in 
mammalian cells. Analogous to the operation of a rheostat, the RheoSwitch technology 
allows induction and adjustable control of gene expression. The induction is achieved 
through the interaction between a ligand RSL1 (a synthetic diacylhdrazine) and a 
chimeric bipartite nuclear receptor expressed by the Rheo-Receptor plasmid pNEBR-R1.  
The RheoSwitch technology offers several advantages over other inducible 
systems. Its precise control gives negligible levels of basal expression in the absence of 
inducer and greater than 10,000 fold inductions when RSL1 ligand is present because, 
unlike other systems, which rely on steroids or other drugs, the synthetic ligand RSL1 
does not exhibit cross talk with endogenous transcription factors.  
As first step stable F9 clones expressing the Rheo-Receptor plasmid have been 
created. The F9 cells were kept in culture as described in the “Materials and Methods” 
Chapter. The day before the transfection the cells were split and plated in a 60 mm cell 
culture plate at a 60% density. The day after, the cells were transfected with the pNEBR-
R1 plasmid and selected for G418 resistance for at least 10 days. Seventeen single 
colonies (F9-R1) were obtained. 
 Positive clones were expanded and selected to identify those showing higher 
inducibility. To select the clones a Luciferase assay has been performed. Briefly, the day 
before the transfection each clone was split to 4 wells of a 12-well cell culture plate. The 
day after, the cells were transiently co-transfected with pNEBR-GLuc and with pCMV--
Galactosidase. Height h after the RSL1 activator was added to the media at a final 
concentration of 0.5 μM and the cells maintained in culture for further 12 h. The results 
are shown in Fig. 13. The relative Luciferase intensities have been normalized against the 
protein concentration as well as against the -Galactosidase activity. About 8 clones 
showing the higher induction level with the lower background have been selected and 
amplified.  
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Once established the regulatory F9 cell line the target gene (Ngn3) has been 
cloned in the appropriate expression vector. In particular, the Ngn3 CDS has been cloned 
into the pNEBR-X1-Hygro plasmid as described in the “Materials and Methods”. The 
efficiency of expression of the recombinant protein has been evaluated by RT-PCR and 
western-blot analyses after transfection and induction in the NIH-3T3-47 cell line, 
expressing the Rheo-Receptor.  Twenty four h before transfection the cells were split in a 
12-well cell culture plate at a density of about 50%. The day after the cells were 
transfected with 0.75 μg of pNEBR-X1-Hygro-Ngn3, 0.75 μg of the internal transfection 
control pCMV--Galactosidase and 2 μl of TransPassD2. Height h after transfection, the 
activator RSL1 was added to the medium at a final concentration of 0.5 μM and the and 
the cells maintained in culture for further 24 h. Total RNA and proteins have been 
extracted and used to perform RT-PCR and western-blot analyses, respectively. The 
results are reported in Figure 14.   
 
 
Fig.13: Stables F9-R1 clones selected based on the relative luciferase activity. Each clone has been tested 
twice in four replicates to be statistically significant. Standard deviation has been calculated. 
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As evident at none of the incubation times examined it has been possible to detect 
a significant expression of Ngn3 both at transcription and translation level regardless the 
antibody used (anti-HA-tag or anti-Ngn3). The pNEBR-X1-Hygro backbone is 
structurally organized as reported in Figure 15. Interestingly it shows the Hygromycin 
resistance CDS with an opposite orientation with respect that of a CDS cloned into the 
MCS. This opposite orientation of the Hygromycin-resistance CDS could interfere with 
the expression of the gene of interest (Dr. George Tzertzinis, New England Biolabs, 
personal communication).  
In the attempt to overcome this problem the CDS for Ngn3 has been then cloned 
in the pNEBR-X1-Puro vector that shows the Puromycin resistance CDS in the same 
orientation of the gene of interest (Fig. 15). 
 
 
 
 
 
+ -+ - + -
HA Actin Ngn3
20
30
40
24h activation
 
 
NI I C 
 
Ngn3 370 bp 
GAPDH 550 bp 
A 
B 
Fig. 14: Transcfection of NIH 3T3-47 with pNEBR-X1-Ngn3 Hygro. A) After 24 h of activation with RSL1 
Ngn3 was detected as very faint band on western blot analysis using antibody against HAtag. Antibody against 
Ngn3 shown very low specificity. B) RT-PCR after 24 h activation with RSL1. 30 cycles of PCR amplification. 
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The expression of the recombinant protein was once again evaluated either by  
 
 
RT-PCR and western-blot analyses after transfection and induction in the NIH-
3T3-47 cells were performed as described above. The expression of Ngn3 is significantly 
improved as showed by RT-PCR and western-blot analyses (Fig. 16) even though the 
levels obtained were still below the expectation. A further sequencing analysis performed 
on the sequence of the Ngn3 did not revealed any mutation or frame-shift that could 
impair the correct expression of the recombinant protein.  
A deeper bioinformatics analysis of the boundary region immediately upstream 
the MCS of the vector pNEBR-X1-Hygro-Ngn3 revealed the presence of an ATG codon 
between the promoter region and the starting transcription ATG of the Ngn3-CDS. 
During the translation process this “proximal” ATG can compete with the legitimate 
ATG for the transcription machinery producing a transcript with a frame shift that result 
in no protein expression at all or in expression of a truncated form. The spurious ATG has 
been removed from the pNEBR-X1-Hygro-Ngn3 vector by restriction digestion, blunting 
and recircularization of the vector as described in “Materials and Methods” obtaining the 
pNEBR-X1-Hygro-Ngn3/2 vector. The new construct was used for a time course 
induction to test the ability and efficiency of the system to be turned off has been 
evaluated.  
 
 
Fig. 15: Backbone of the expression plasmids pNEBR-X1 Hygro and pNEBR-X1 Puro. 
Chapter 4 Results 
________________________________________________________________________ 
 176 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Again, NIH-3T3-47 cells were kept in culture as described and 24 h before the 
transfection split into three 12-well cell culture plates at a density around 50%. The day 
after, the cells were transfected as described in the “Materials and Methods”. The three 
set of samples were activated with 0.5 μM RSL1 for 12, 18 and 24 h. After that time the 
first set of samples were subjected to RNA and protein extraction while the others were 
kept in culture for 12, 18 and 24 h respectively without RSL1 before RNA and protein 
extraction. The result of the time-course assay is shown in Figure 17. The results show 
that the protein expression can be finely turned on and off in as much less than 24 h.  
Once obtained an efficient tunable expression vector for Ngn3 the next step has 
been evaluate its activity in the target cells. At least one of the highly inducible F9-R1 
clones selected as described above has been transiently transfected with the pNEBR-X1-
Hygro-Ngn3/2 as described in “Materials and Methods”. The F9-R1 cells were 
maintained in culture as described with 300 μg/ml of G418 and split in a 12-well cell 
culture plate the day before the transfection at a density around 50%. The day after, the 
 
 
Ngn3 370 bp 
GAPDH 550 bp 
P H 
- + CP CH - + 
  
H P H P C 
I NI 
H P H H C 
I NI 
-Actin -HA 
30 
40 
20 
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B 
Fig. 16: pNEBR X1 Puro vs pNEBR X1 Hygro. NIH 3T3-47, transfected with Puro or Hygro vector; 12 h 
induction with RSL1 A) Western blot analysis: H (pNEBR X1 Hygro); P (pNEBR X1 Puro), C (no 
transfection); I (induction with 500 nM RSL1); NI (no induction). B) RT-PCR analysis: P (pNEBR X1 Puro); 
H (pNEBR X1 Hygro); C (PCR control, Water). 30 cycles of PCR amplification for GAPDH and non-induced 
samples, 25 cycles of PCR amplification for the induced samples. 
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cells were co-transfected with same amount of pNEBR-X1-Hygro-Ngn3/2 and pCMV--
Galactosidase. The cells were incubated with the transfection mixture for 8 h and after 
that period the medium was replaced with regular medium containing 0.5, 1, 1.5, 2 μM of 
RSL1. After 12 h of activation the cells were harvested for protein extraction while 
control samples were kept in culture for further 24 h without activator. The extracts were 
normalized against protein concentration and -Galactosidase activity. The same 
normalized quantities of total protein extract were run on a 12% SDS-PAGE and blotted 
onto a PVDF membrane for immunodetection as described in the “Materials and 
Methods”. The results are showed in Figure 18. Interestingly, a significant induction is 
observed already at very low concentrations of RSL1 with a dose-dependent increment 
up to 0.5 μM when no further differences are observed. Again, no protein expression has 
been detected after 24 h of RSL1 withdrawal.  
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Fig. 17: Time course 
RheoSwitch on/off. NIH 3T3-
47 were transfected with 
pNEBR-X1-Ngn3-Hygro. 
Protein and RNA were 
extracted after 12, 18, 24 h of 
activation with 0.5 μM (on), 
after 24 and 48 h without 
RSL-1 (off). A) western blot 
assay on total protein extracts 
using -HA and -Actin 
antibodies. B) RT-PCR 
analysis, 30 cycles of 
amplification. 
A
B
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Once obtained an efficient tunable expression vector for Ngn3 the next step has 
been the establishment of a stable F9-R1-inducible cell line. At least one of the highly 
inducible F9-R1 clones selected as described above has been transfected with the 
pNEBR-X1-Hygro-Ngn3/2. The F9-R1 cells were kept in culture as described in the 
“Materials and Methods” Chapter. The day before the transfection the cells were split and 
plated in a 60 mm cell culture plate at a 60% density. The day after, the cells were 
transfected with the pNEBR-X1-Hygro-Ngn3/2 vector and selected for hygromycin 
resistance for at least 10 days. At the moment double-stable F9-R1-Ngn3 are under 
antibiotic selection. 
To improve the RheoSwitch system, a fluorescent reporter gene (dTomato) has 
been introduced along with an IRES sequence at the 3’-termini of the pNEBR-X1-Hygro-
Ngn3/2 vector. This will allow both an immediate detection of the Ngn3 expression 
during differentiation experiments and an easy purification of pure cell population Ngn3-
positive.  
To address the fifth point of the aims we relied on the use of both different cells 
model and methodological approaches. As cell models AR42J and INS-1 have been used. 
As methodology the ChiP-cloning approach has been used. As an efficient approach for 
NI 0.5 1 1.5 2 0.5 1 1.5 2 
12 h activation  
μM RSL1 
24 h after activation  
μM RSL1 
30 
40 
20 
Fig. 18: Dose curve of RSL1 
activation. F9-R1 stable clone 
was transient transfected with 
PNEBR-X1-Ngn3-Hygro 
vector. The cells were induced 
with 0.5, 1, 1.5, 2 μM RSL1 for 
12 h before protein extraction. 
Control samples were kept in 
culture for additional 24 h 
without RSL1 before protein 
extraction. NI: no-induced 
sample.  
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expressing Ngn3, an adenoviral transduction approach that is the fastest and simplest way 
to obtain specific gene expression has been used. 
 AR42J and INS-1 cell line has been maintained in culture as described in 
“Materials and Methods”. The day before infection the cells have been split and plated in 
a 2 x 100 mm culture dish at a density of about 75%. The days after the cells were 
infected with about 20 MOI of AdNgn3-EGFP and Ad-EGFP, respectively, for 4 h and 
then the medium was changed with fresh one. The cells were maintained in culture for 
two days. The progress and efficiency of infection have been monitored by hrGFP 
fluorescence. With an MOI of 20, fluorescence appeared one day post-infection and was 
uniformly distributed to all cells plated with an efficiency of infection near to 100% (Fig. 
19).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
A B 
C 
Fig. 19: Control of Ad-Ngn3 infection efficiency. The infection was carried out for 4 h and the cells checked 
for E-GFP expression 24 h after infection. A) AR42J white field. B) AR42J E-GFP positive cells. C) Merge. 
Chapter 4 Results 
________________________________________________________________________ 
 180 
 After 48 h post infection no signs of cytotoxicity were observed. At that point 
the cells were subjected to the ChiP protocol as described in “Materials and Methods” 
and the DNAs were blunted and ligated into the pCR-BLUNT vector. The ligation 
reactions were plated onto selective plated and incubated overnight at 37°C. The outputs 
obtained were genomic libraries with an average of 80 colonies from the AdNgn3-EGFP-
treated cells vs. an average of 20 colonies from the control cells treated with the Ad-
EGFP alone. Since the pCR-BLUNT vector contains the lethal E. coli ccdB gene fused to 
the C-terminus of LacZ (Bernard et al., 1994) all colonies must contain a cloned DNA 
fragment allowing for the disruption of the expression of the LacZ-ccdB gene fusion 
permitting growth of only positive recombinants upon transformation.  Cells that contain 
non-recombinant vector are killed when the transformation mixture is plated.  The 
plasmid DNA from all colonies of both the AdNgn3-EGFP- and Ad-EGFP-infected 
plates were extracted and sequenced with a specific set of primers (M13 Forward and 
M13 Reverse) that span the region of the vector containing the inserted DNA fragment. 
The average size distribution of clone insert from each library was around 840 bp. All the 
sequences not belonging to the vector, included between two EcoRI restriction sites on 
the pCR-BLUNT vector, were used to perform BLAST analyses using the blastn that 
compares a nucleotide query sequence against a nucleotide sequence database.  The rat 
genome database Blastn (www.ncbi..nlm.nih.gov/blast/Blast.cgi) has been 
analyzed using the default filters setting. The output results were analyzed for sequences 
that span the 5’ termini in the proximity of transcription factors and that contain at least 
one DNA binding motif for the bHLH family of transcription factors (E-box, CANNTG). 
Among the 80 colonies obtained from the AdNgn3-EGFP-treated cells revealed that 
about 50% of clones have at least one E-box within the sequences of their insert. On the 
contrary less than 3% of the colonies deriving from the Ad-EGFP-treated cells showed 
the presence of E-box within the sequences of their insert. 
 Among the identified sequences containing E-boxes, between 4 to 5 colonies 
belonged to the 5’ region of three known transcription factors, corresponding to the 
following proteins:  
 
1) The basic Helix-Loop-Helix neurogenic factor 4 (NeuroD4) (n= 4 colonies). 
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2) The SRY (sex determining region Y)-box 9 (campomelic dysplasia, autosomal 
sex-reversal) (Sox9) (n= 5 colonies). 
3) The zinc-finger type transcription factor OVO homolog-like 1 (OVOl1) (n= 5 
colonies). 
 
Among the 3% of sequences containing E-box deriving from the Ad-EGFP 
control, none belonged to transcription factors. 
The E-box identified for the neuroD4 gene is localized about at 18000 bp at the 
5’ side of the gene. The E-box identified for the sox9 gene is localized about at 89200 bp 
at the 5’ side of the gene whereas that one identified for the ovol1 gene maps about at 
1000 bp at the 5’ side. 
The identification of the zinc-finger type transcription factor OVO homolog-like 
1 (OVOl1) with a significant frequency (n=5 colonies) appeared interesting and 
potentially novel since no data are available regarding an involvement of this 
transcription factor in pancreas development and differentiation.  
To confirm the results obtained by ChiP-cloning approaches, classical ChiP 
experiments have been carried out as described in “Materials and Methods” but the 
purified DNA was analyzed by PCR using a specific set of primers (Table 1 Matherials 
and Methods) designed to span the region identified by ChiP-cloning. As positive control 
a PCR analysis has been performed on the same pool of DNA using a set of primers 
(Table 1 Matherials and MethodsX) encompassing functional E-boxes from the 5 
flanking regions of the rat neuroD/BETA2 gene (data not shown). As showed in Figure 20 
the ovol1 gene promoter is coimmunoprecipitated in the Ngn3-transduced cells using an 
anti-Ngn3 antibody but not by addition of IgG. Similarly, NeuroD/BETA2 is specifically 
co-precipitated by the anti-Ngn3 antibody (Fig. 20). OVOl1 and NeuroD/BETA2 are not 
precipitated in the negative control cells transduced with Ad-GFP (data not showed). 
So far neither the expression pattern of OVOl1 nor its function in the pancreas 
has been addressed directly. Therefore an extensive analysis of the expression of ovol1 
gene in pancreas-related cell line (AR42J and INS-1) and in islets has been carried out by 
RT-PCR, western blot analyses and immunohistochemistry.  
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As for RT-PCR, as shown in Fig. 21, a significant signal is present in all the 
cells analyzed along with rat testis as positive control. 
As for western blot the immunoblot analyses using anti-OVOl1 antibodies 
detected specific signals in all the samples analyzed. Interestingly an unexpected pattern 
of molecular weight distribution has been detected for AR42J (~79 kD), compared with 
INS-1 cells (~41 kD), islets (~41 kD) and rat testis protein extract used as positive control 
(~41 kD) (Fig. 22). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 20: PCR analysis of 
ChIP. Input (Input fraction); 
a-Ngn3 (fraction precipitated 
using a antibody against 
Ngn3); Normal IgG (fraction 
precipitated using a generic 
antibody); Rat Genomic 
DNA (positive control). 30 
cycles PCR amplification. 
 
Fig. 21: RT-PCR analysis 
for the presence of OVOl1 
protein in pancreatic and 
testis cell lines. 30 cycles 
of PCR amplification. 
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The subcellular localization of OVOl1 protein has been analyzed by 
immunohystochemistry on paraffin-embebbed sections of rat pancreas. In rat pancreas, 
OVOL1 is expressed strongly in luminal cells of common pancreatic ducts (CPD, Figure 
23A), cells in the evagination of CPD, small ductal and islet cells (Figure 23B & 23C). 
The expression of OVOL1 is weaker in acini than in ductal or islet cells and, in higher 
resolution, it is found that the OVOL1 is expressed heterogeneously in acini (Figure 23D, 
positive-red arrow; negative-yellow arrow). 
 
Fig. 22: Western blot analysis 
using an antibody against 
Ovol1. For the analysis protein 
extract from pancreatic cell 
lines (INS-1, AR42J) as well as 
from isolated islet were used. 
As positive control protein 
extract from rat testis was used.  
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Fig. 23: Cellular localization of the protein Ovol1 in the pancreas. A) Luminal cells of the common 
pancreatic duct. B) & C) Small duct and islet cells (alternative sections). D) Pancreatic acini E) Rat 
testis, positive control  
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According to the results so far obtained the 5 kb 5’ flanking region of the rat 
ovol1 gene, retrieved from the available database  (www.ncbi.nlm.nih.gov/blast/Blast.cgi) 
has been analyzed for the presence of E-boxes and other putative transcription factors 
DNA recognition domains by using MatInspector software. The presence of an E-box at -
697 bp (E-box 1) at the 5’ region corresponding to that identified by sequence analysis of 
the ChiP-cloning sample has been confirmed along with the identification of three more 
putative E-boxes at -1177 bp (E-box 2),  -1209 bp (E-box 3) and -1339 bp (E-box 4) at 
the 5’ side, respectively (Fig 24).  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
To determine whether Ngn3 is capable of interact with the ovol1 promoter, the 
1.1 kb sequence encompassing the 5’ flanking region from -841 to +230 of the ovol1 
gene and containing the E-box 1 has been PCR amplified using a specific set of primers 
(Table 1) and cloned into the pCR2.1-TOPO vector as described in “Materials and 
GAAAGAGTCGCCGAGGCGTGTCCACGTTCTGAGGACAGAGCGTACCAGGGACCACGCGTGGCGTTTCCAACTACGCCGAAGGTCGCCGGTGT
CCGCCGAGCGGGTGCAGTCAGGTGCACCGGGATCGGAGAAGCGCTAAGCGAGCGTCTTTCAGCTAGACTGGCGTCCCCGCGGCTGCTCGCGA
AGTCTTCAAGTGCGAGCTGGACGGACGGGTTCAAGCTTTATTGG
CTCGCGGCGGTGTGTGTTGGTGGCTCGGGCGGGGGTGGGGTAGGGGTGTTGATCTGATCTAATTAGCTTGGAGTGGCCGAGAGAGCGATGGC
GCATGCGTTGGGAAATAACGGTGACAACCCACCTATTTGTTACCTGTCGAACCGGTTTCCATTCCGCTGCGGGTGAGGTGGCCTCGCGGCCA
GGGCGGGGTGGCCCGACGGGGGCAGGGTTGGGGGGCGTGCTCTGGTCCCCACACCCAGAATCACCAGGCCCGCCCCGTACCTCCCCTGCCCG
GCGTGCTCACGTTTGCAAACTAGAGTTTCGGAGGGAGCGGGCACGGGAAGGGAGGGGAGGGCAACGTTATTTGCACCGGCGCTCGCACGCTC
TGTGGGCGATGGCACAAAACTGGCCCAACAGGCCCGGGCCCAGCCCGGCGCCCCCGGGCGCCGGGAGAGGCACAAAGCCGCGGAGCGGGAAC
CTGCGGTCCGGGCCCGAACCCAGCAGCCAGGTATCCCCAAGGCCTGGGTGAGCAATTCTTGGTTCAGTCGAGAGGTATTTGCTGGGCACCCG
ATTCCTGCGGAAAGGCACGCGAGGCGAGAGGAGCGCGTGGACCGGGAGGCTCTGATGCGCCTGTGAATCCAAAGCTCGAGCCTGCCTTCCGG
TTGCGAGGGCGTTTAAACTGCCCTAAGTCCAACCTAATC
GAGGCTAGCACCTTGGCATATGGGTGGACGTATTCGCCAAGACTCTTCTGGTCAAAAACAGCCGGATTTCAGGTTCTGAAAATCTGGAAG
ACTCTAGGATGAGGACCCTAGCTGAGTGAGATCTGATGCGGTCCTCTTCTGCCGGTTGCAACCCGTGTCCTCCCTGGCTGGGAGTTCAGCAA
GCAGCTCCCCATTCACCCTGCTGTGTTCTTCAGCAAGCCTAGTTCGGGCAACGCCCCACCCCCACTGAACTGCCCGAGAGTGTTCCGTGGCC
TTCGTGTGAGCCACTTCACTATGACACTTTGGCCGTGGCTGGGTTTCTTTTACTGGCTGACCTATTAAAGGCAGGGATGGGACCTGCAGTTA
AAGGCTACTAATATTTTAGATTCCAGACTTCAGTACACCTGTCTCACATAGTGTTAAATGTTTGCTGGAACAGACTGTTGAGGAAA
TTAGTTTGATAAATGAATTAACACAGTTCAAAAGTCAGGAGTCACAGGTGGATACGGTTCATGCTTGTGATCCCAGCACGTGGGAAG
CTGAGGTAGGAAAACCGAGTTAGAGGCCAGCCTATGTTTTTCATCGTGAATTCCTGTCTCAAACAAATAAAAGAATTAAAAGAAAGGCTGTC
GGATATGGCTCAGGAGGTATTTGTCACCAAGTGGGAAGACCTGAGTTCAACTCCCAGGACCCACAGAGTGGAGGGAGAAAACTGATCCCA
CAACTTGCTCTCTGACCCGTGGCACACCATGGAACTGGTGCGTGCTGT
E-Box 1
E-Box 2 E-Box 3
E-Box 4
+ 1
 
Fig. 24: the 5’-flancking region of the ovol1 gene. Bolded characters identify the E-Boxes binding 
elements recognized by transcription factor belonging to the bHLH family.   
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Methods”. The KpnI-SacI fragment of the pCR2.1-TOPO vector, containing the ovol1 
promoter region, has been then subcloned into the Luciferase reporter vector pGL2-basic 
as described in “Materials and Methods” to obtain the pGL2-OVOl1-Prom1 vector. 
Mouse Ngn3 has been cloned into pcDNA vector as described in “Materials and 
Methods” and cotrasfected into AR42J cell line along with the pGL2-OVOl1-Prom1 
vector. As shown in Figure 25 transient expression of Ngn3 induces a significant 
inhibition of 1.1 kb ovol1 promoter reporter construct close to 20 % (Fig 25).  
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TRANSACTIVATION EXPERIMENTS 
**<p 0.05 
A 
B 
Fig.  25: Transactivation assay. A) Schematic description of pGL2-OVOl1-Prom1 reporter construct 
containing the 1.1 kb 5’-flanking region of the ovol1 gene. B) Transactivation experiments on AR42J 
cells cotransfected using different combinations of the plasmids pGL2-OVOl1-Prom1, pcDNA-Ngn3 
and pcDNA-E47. The results from luciferase assay were performed on three replicates transfection 
experiments for the statistical significance. Standard deviation has been calculated.  
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The same cells were also transfected with the same amount of both pcDNA-
Ngn3 and pcDNA-E47 vectors alone or in combination; pcDNA-E47 cotransfected along 
with pcDNA-Ngn3 further increases the inhibition ability of Ngn3 in these cells to 80% 
(Fig 25) while when transfected alone, it had a slightly inhibitory effect on the ovol1 
promoter (about 40%; Fig 25).  
To confirm the importance of the E-box 1, a 1.1 bp promoter sequence 
containing a mutated form (CATATG  GATAGC) of the E-box 1 has been created. 
Wild-type and mutated constructs were cotransfected into AR42J cells with expression 
vectors for Ngn3 and E47. The results indicated that the mutation caused the loss of the 
Ngn3-mediated inhibition of ovol1 promoter reporter construct (Fig. 26). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The inhibitory effect of Ngn3 on the ovol1 gene expression has been 
quantitatively evaluated by real-time PCR and at level of protein expression, as well, 
using western blot analyses. AR42J and INS-1 cell lines have been transiently transfected 
with 1 μg of pcDNA-Ngn3 and 1 μg of pcDNA-E47.  
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Fig. 26: A) Schematic 
description of the mutated 
OVOl1-reporter construct. B) 
Transactivation experiments 
using the mutated construct 
pGL2-OVOl1-Prom1Mut 
AR42J cells were 
cotransfected with different 
combinations of : pcDNA-
Ngn3, pcDNA-E47, pGL2-
OVOl1-Prom1Mut. The 
luciferase activity has been 
calculated on three different 
replicate experiments for the 
statistical significance. 
Standard deviation has been 
calculated. 
A 
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One μg of RNA has been DNase treated and reverse transcribed. Sixty ng of 
cDNA has been used to perform real-time experiments as described in “Materials and 
Methods”.   The results are reported in Fig 28. Interestingly the inhibitory effect of the 
Ngn3 has been confirmed for all the cell type analyzed and quantitatively corresponds to 
a reduction of about 50% of the expression of ovol1 gene respect to that of not transfected 
cells or in those transfected with the empty vector (pcDNA) alone. 
As for the protein level expression, after extraction the protein content has been 
determined and 10 μg of total proteins have been used to run a 15% SDS-PAGE. Again, 
the inhibitory effect of Ngn3 overexpression has been detected (Fig. 27). A quantitative 
analysis of the bands revealed a reduction, respect the bands obtained from not transfect 
cells or transfected with the empty vector alone, of about 45% in good agreement with 
those obtained from quantitative PCR experiments. 
Next, the affinity of the pancreatic bHLH protein NeuroD/BETA2 and of the non-
pancreatic bHLH protein MyoD alone or in combination with their heterodimeric partner 
E47 for the E-box 1 of the ovol1 gene promoter has been tested. The results are reported 
in Fig. 28. Heterodimers of E47 with NeuroD/BETA2 significantly inhibits the activity of 
the ovol1 gene promoter. On the contrary such effect was not shown by the heterodimers 
of E47 with MyoD (Fig. 29). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 27: Inhibitory effect of 
Ngn3 on Ovol1 expression. 
Western blot analysis on protein 
extracts from the pancreatic cell 
lines AR42J and INS-1. The 
cell lines were transfected with 
different constructs (pcDNA-
Ngn3, pcDNA-E47, empty 
vector pcDNA) alone or in 
combination. -actin has been 
used as control for the 
quantitative analysis. 
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Once again the effect of bHLH proteins NeuroD/BETA2 and MyoD were 
analyzed by real-time PCR and western blot analyses. AR42J and INS-1 cell lines have 
been transiently transfected with 1 μg of pcDNA-NeuroD/BETA2 or pCMV-MyoD alone 
or with and 1 μg of pcDNA-E47. RNA and proteins have been extracted.  
One μg of RNA has been DNase treated and reverse transcribed. Sixty ng of 
cDNA has been used to perform real-time experiments as described in “Materials and 
Methods”.   As reported in Fig 30 the inhibitory effect of the NeuroD/BETA2 has been 
confirmed for all the cell type analyzed and quantitatively corresponds to a reduction of 
about 50% of the expression of ovol1 gene respect to that of not transfected cells or in 
 
Fig. 28: Inhibitory effect of 
NeuroD on Ovol1. Western blot 
analysis on protein extracts 
from the pancreatic cell lines 
AR42J and INS-1. The cell 
lines were transfected with 
different constructs (pcDNA-
NeuroD/BeTA2, pcDNA-E47, 
e.v. empty vector pcDNA) 
alone or in combination. -actin 
has been used as control for the 
quantitative analysis 
  
Fig. 29: Inhibitory effect of NeuroD 
on Ovol1. Western blot analysis on 
protein extracts from the pancreatic 
cell lines AR42J and INS-1. The cell 
lines were transfected with different 
constructs (pCMV-MyoD, pcDNA-
E47, e.v. empty vector pcDNA) 
alone or in combination. -actin has 
been used as control for the 
quantitative analysis 
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those transfected with the empty vector (pcDNA) alone. No effects have been detected 
using MyoD protein both alone and in combination with E47 partner (Fig 30). 
As for the protein level expression, again, the inhibitory effect of 
NeuroD/BETA2 overexpression has been detected (Fig. 28). A quantitative analysis of 
the bands revealed a reduction, respect the bands obtained from not transfect cells or 
transfected with the empty vector alone, of about 45% in good agreement with those 
obtained from quantitative PCR experiments. No effects have been observed using MyoD 
protein both alone and in combination with E47 partner (Fig. 30). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The ability of NeuroD/BETA2 to interact with OVOl1 promoter has been 
evaluated in vivo performing ChiP analysis as described in “Materials and Methods”. 
AR42J cell line has been and plated in 2 x 100 mm culture dish at a density of about 75% 
and with about 20 MOI of AdNeuroD-EGFP and Ad-EGFP. After 48 h post infection the 
cells were subjected to the ChiP protocol as described in “Materials and Methods” and 
the DNAs were analyzed by PCR using a specific set of primers (Table 1 Materials and 
Methods) designed to span the region identified by ChiP-cloning. As showed in Figure 31 
the ovol1 gene promoter is coimmunoprecipitated in the NeuroD/BETA2-transduced cells 
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Fig. 30: Real-time analysis on 
the inhibitory effect of Ngn3, 
NeuroD/BETA2, MyoD on 
Ovol1. The AR42J and INS-1 
cell lines were transfected as 
described with expression 
plasmid (pcDNA-Ngn3, 
pcDNA-NeuroD/BETA2, 
pCMV-MyoD, pcDNA-E47, 
e.v. empty pcDNA vector) 
alone or in combination.  
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using an anti-NeuroD/BETA2 antibody but not by addition of IgG. OVOl1 is not 
precipitated in the negative control cells transduced with Ad-GFP (data not shown). 
 
 
 
 
 
 
 
 
 
 
Fig. 31: NeuroD/BETA2 interacts 
with the promoter region of ovol1 
gene. AR42J cells were infected using 
Ad-NeuroD-EGFP and Ad-EGFP 
alone or in combination. The ChIP 
were performed using antibody against 
NeuroD/BETA2 or generic antibody 
as control. The PCR analysis was 
performed using Ovol1Chip primers 
listed in the Material and Methods. 30 
cycles of PCR amplification. 
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4.3 Purification and Characterization the -Cell Insulin Transcription   
 Factor A2.2 (All information are unpublished proprietary of Joslin Diabeted 
 Center) 
 The insulin gene is specifically expressed in -cells of the islets of Langerhans 
and its transcription is regulated by the glucose level. The molecular mechanisms of the 
-cell restricted expression of insulin has been extensively studied during the years and 
leads to the identification of different cis-regulating elements on its promoter. Among 
those, three of them appear exclusively restricted to the pancreas: E1, A3 and 
RIPE3b/C1. The transcription factors binding to the E1 and A3 sequences have been 
identified as NeuroD/BETA2 and Pdx1/IPF1/STF1/IDX1/GSF/IUF1, respectively. 
Previous studies have reported that a -cell specific nuclear factor, recently identified as 
the mammalian homologue of avian MafA (Olbrot, Rud et al. 2002), binds to the 
conserved cis-regulatory element RIPE3b/C1, spanning between the nucleotides -139 and 
-101 of the insulin promoter region. Interestingly it has been showed (Harrington and 
Sharma 2001; Nishimura, Salameh et al. 2005) that the RIPE3b/C1 (also know as Maf 
Response Element, MARE element,) binding sequence is composed of distinct 
overlapping elements. In fact the MARE element is recognized not only by MafA but 
also by transcription factors binding to an A-element that are present in the insulin-
specific MARE sequence and named A2. Three binding complexes have been found until 
now, named A2.1, A2.2 and A2.3, respectively. Among the three, only A2.2 has been 
demonstrated to be, like MafA, -cell specific. Interestingly, A2.2 element acts 
enhancing the activation potential of MafA, and not its binding activity (Nishimura, 
Salameh et al. 2005).  
Despite the importance for the cell-specific role played by A2.2 in the regulation 
of insulin gene expression its nature is still elusive. According to that it is clear that the 
fully understanding of insulin regulator elements could have an important impact on 
possibility to control the insulin gene expression as well as the pancreatic development 
and development.  
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For those reasons the aims of the present part of the Thesis have been: 
 
1) To characterize and purify the transcription factor A2.2 
2) To identify it as -cell specific transcription factor 
 
4.3.1  Characterization of the Transcription Factor A2.2 
 
 To address the first aim, EMSA assays have been set-up.  Oligonucleotides 
spanning different region of the rat insulin II promoter region and mutated in the 
sequence specific for A2.2 have been designed. These sequences have been used for 
EMSA competion experiments with HIT T-15 nuclear extracts.  
The mutated sequences that were unable to compete with the binding activity of 
the HIT T-15 nuclear extracts toward its oligonucleotide target allowed for the 
identification of the nucleotides critical for the binding properties. The sequence retrieved 
was used to perform analyses using the TRANSFAC program that compares a nucleotide 
query sequence against a nucleotide sequence database.  The rat genome database has 
been analyzed using the default filters setting. The output identified a high homology for 
bZIP binding elements. In particular the search for transcription factors binding the 
region of interest identified the C/EBP family as a possible candidate. To confirm the 
involvement of bZIP transcription factors a set of EMSA competition assays have been 
performed using HIT T-15 nuclear extract and specific oligonucleotides (Table 1 
Matherials and MethodsX) containing bZIP binding motifs. For the supershift assays 
antibody anti-C/EBP and anti-C/EBP have been used. The results are reported in 
Figure 32.  
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 As shown (Fig. 32), the bZIP cold-nucleotide sequences, used as competitors, are 
able to inhibit the formation of the A2 complexes, strongly supporting the hypothesis that 
A2-binding transcription factor could belong to the bZIP protein family. Unfortunately 
the super-shift experiments demonstrated that, even though the C/EBP is part of the 
complex binding the A2, it does not correspond to the A2.2 transcription factor. In fact 
even if the presence of the anti- C/EBP antibody induces a strong supeshift, the signal of 
the A2.2 complex (Fig. 32, lane 16) has the same intensity of that resulting from the the 
positive control (Fig. 32, lane 1). Furthermore the same EMSA assays performed in 
presence of recombinant dominant negatives of different bZIP subfamily members did 
not show different results (Dr A. Sharma, personal communication). These observations 
seem suggest that a novel bZIP protein could be involved in the binding the A2 element. 
   
 
Fig. 32: EMSA analysis. 
A2.2 wild-type and mutated 
nucleotide sequence, C/EBP, 
AP1,VBP, CREB nucleotide 
sequences were used as cold-
competitors. Super shift assay 
was performed using 
antibodies against the 
members belonging to the 
C/EBP transcription factor 
family.   
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4.3.1  Purification of A2.2 Transcription Factor 
 
 The process used for the purification of the A2.2 factor is outlined in Fig. 33. The 
HIT T-15 protein extracts were first purified on a HiTrap-Heparin column.This column 
allows for fast, simple and easy separations of nucleic acid binding proteins. Immobilized 
heparin interacts with nucleic acid-binding proteins as a cation exchanger due to its high 
content of anionic sulfate groups mimicking the polyanionic structure of the nucleic acid.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Purification of the A2.2
nuclear extract
from HIT-T15 cells
A2 probe
Biotinylated
Heparin
column
+
Streptavidin
affinity column
two rounds of each purification
have been performed
Eluted fractions
Eluted pooled
 
 
Fig. 33 
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 After extensive washing the bound proteins were eluted with an increased salt 
gradient and pooled. The eluted pooled fraction was additioned with a biotinylated A2 
oligonucleotide and subjected to an affinity chromatography step on a streptavidin-
agarose column. After extensive washing the proteins were eluted using a solution with 
increased ionic strength and collected in 30 separate fractions. Each fraction was 
analyzed for their binding activity by EMSA assay, using the A2 probe, as described 
before. The result is showed in Fig 34. 
 The A2.2 complex was not present in the flow-through and became detectable 
only within the fractions from 19 to 21.  
The protein concentration was normalized to 2 μg/ml and 20 μl from each fraction 
were run on 12% SDS-PAGE gel and then blotted on a nitrocellulose membrane. The 
nitrocellulose membrane was stained, as described in “Materials and Methods”, using 
colloidal-gold staining. The results are shown in Fig. 35. The fractions 19, 20, 21 showed 
a specific pattern compared to the control samples. In particular, as indicated by the 
arrows in Fig. 35, are present low molecular weight bands (corresponding to about 15-20 
kDa). The bands from the lanes 16, 19 and 20 were eluted from the membrane and 
checked for their binding activity by EMSA assay (Fig. 35). 
 
 
Fig. 34: EMSA assay on 
purified eluted fractions. 
Single eluted fractions 
were assayed for the 
binding activity using the 
A2.2 probe. A2.2 
complex is highlighted 
by the arrow. 
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Fig. 35: Western blot on 
selected eluted fraction. 
Selected eluted fractions were 
blotted onto a PVDF 
membrane and stained using 
colloidal gold staining 
procedure. Unique bands on 
band shift positive fraction 
are highlighted by the arrow. 
 
 
Fig. 36: Western blot and 
EMSA assay on eluted 
fractions. A) Low molecular 
weight bands were eluted 
from PVDF membrane B) 
five bands, from fraction 16 
and 19, were tested for the 
binding activity using the 
A2.2 probe. 
B 
A 
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 The result from the EMSA assay is shown in Fig. 36B. As showed only the 
eluted-band corresponding to the sample 4 was able to restore the binding activity. This 
result is in full agreement with the hypothesis that the A2.2 complex could be mediated 
by a low molecular weight protein (Dr. A Sharma personal communication). 
 The purified protein from the sample 4 has been subjected to mass spectrometry 
anaslysis at the Proteomic Core of the Joslin Diabetes Center. The results are reported in 
Fig. 37. As showed, among the proteins identified, the small Maf factors showed the 
higher score.  
 
 
 
 
 
 
 
 
 
 
 
 
To confirm the presence of small Maf factors within the A2.2 complex, western 
blot analysis using antiboby anti-MafK/G/F have been performed. For the western blot 
analysis nuclear protein extracts from MIN-6, small Maf factors from HeLa and a small 
aliquot of the concentrated sample from the 17 kDa band have been used. After TCA 
precipitation the purified nuclear extracts were run on 15% SDS-PAGE gel and blotted to 
a PVDF membrane. The membrane was cut horizontally in correspondence of the 25kDa 
protein of the ladder. The upper portion was incubated with anti-MafA while the lower 
part was incubated with antibody anti-small Maf factors (MafK/G/F).  The results of the 
western blots are shown in Fig. 38.   
 
 
 
Reference P (pro) Score
Scan(s) Peptide MH+ z P (pep) XC
IPI00117877.1|Transcription factor MafG 9,92E-12 20,22
2511 R.EPGENGTSLTDEELVTM*SVR.E 2180,00742 2 9,92E-12 4,37
2524 R.EPGENGTSLTDEELVTM*SVR.E 2180,00742 2 4,34E-06 4,05
2744 R.GPLAAGLGPLVPGK.V 1246,75232 2 3,35E-08 4,13
2753 R.GPLAAGLGPLVPGK.V 1246,75232 2 1,85E-06 3,88
IPI00126148.1|Transcription factor MafK 3,54E-09 10,26
IPI00121073.1|Cold-inducible RNA-binding protein 1,15E-07 20,24
IPI00115831.1|Histone deacetylase complex subunit SAP18 2,48E-07 20,18
IPI00225633.2|Activated RNA polymerase II transcriptional coactivator p15 precursor 6,66E-06 30,23
IPI00133583.1|Adult male kidney cDNA, RIKEN full-length enriched library, clone:0610012F23 product: 1,13E-03 10,20
IPI00355031.5|PREDICTED: cortactin binding protein 2 isoform 1 DNAJ 1,98E-03 10,10
IPI00652785.1|Adult male corpus striatum cDNA, RIKEN full-length enriched library, clone:C030004P21 2,25E-03 14,15
IPI00624384.1|4 kDa protein 1,51E-02 10,13
IPI00620640.2|PREDICTED: similar to WW domain binding protein 2 1,63E-02 2,16
IPI00131373.1|Protein Wnt-4 precursor 1,93E-02 8,14
IPI00677064.1|PREDICTED: hypothetical protein XP_920343 2,16E-02 8,10  
Fig. 37: Partial list of the identified proteins from the tandem-MS analysis of the 17 kDa band extracted 
from the PVDF membrane. 
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The presence of a faint but significant signal for the small Maf proteins is in 
agreement with the mass spectrometry analyses and identifies small Maf as members of 
the A2.2 complex.  
To test the possibility that small Maf factors could correspond to the A2.2 factor, 
EMSA and super-shift assays, using small Maf factors from HeLa and HIT-T15 nuclear 
extract, have been done. The results are reported in Figure 36. As shown in Fig. 39 the 
oligonucleotides sequences from -139 to -101, -139 to -113, -126 to -101, were used as 
probes. Small Maf were not able to form the A2.2 binding complex. Furthermore, the 
antibody used was not able to super shift the A2.2 complex.  Along with these results, 
small Maf factors are present also in cell lines not expressing A2.2 complex, as shown by 
the western blot assay. Standing the condition that the A2.2 factor “is” -cell specific it 
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Fig. 38: Western Blot analysis. Nuclear 
extract from HeLa, MIN6 cell line and 
from proteins exctracted from the 17 
kDa band were blotted onto PVDF 
membrane and stained with antibodies 
against MafA and small Maf family 
members. Blu arrow: MafA. Red arrow: 
small Maf factors. Black arrow: small 
Maf from eluted band. 
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must be excluded that small Maf is the A2.2 factor per se but cannot be excluded, as  
proved here, that small Maf could interact with it for example as dominant inhibitor. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 To select possible A2.2 candidates among the hundred proteins identified by mass 
spectrometry, a deeper bioinformatics analysis has been performed. The output of the 
mass spectrometry analysis has been analysed using the database listed in the Materials 
and Methods, using more stringent limits such as a nuclear localization and a low 
molecular weight. The possible candidates are reported in Figure 40. 
 Interestingly at least one candidate, the BATF belongs to the bZIP transcription 
factor family. The expression of all these potential candidates has been evaluated by RT-
PCR. The RNA from -TC, MIN-6, HeLa cell lines has been extracted using Trizol 
reagent as described in “Materials and Methods”. One μg of RNA was DNase treated and 
reverse transcribed.  The level of expression of the above factors was determined by PCR 
using specific sets of primers (Table 1 Materials and Methods). The results are reported 
in Fig. 41. None of the above factors were -cell specific.  
Fig. 39: EMSA and super shift 
assays. EMSA assay were 
performed using the -139-101, -
139-113, -126-101 probes. 
Super shift assay was 
performed using a antibody 
against small Maf family 
members.  
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IPI00121073.1|Cold-inducible RNA-binding protein
IPI00115831.1|Histone deacetylase complex subunit SAP18
IPI00225633.2|Activated RNA polymerase II transcriptional coactivator p15 precursor
IPI00652785.1|Adult male corpus striatum cDNA, RIKEN full-length enriched library
IPI00620640.2|PREDICTED: similar to WW domain binding protein 2
IPI00323130.3|Transcription elongation factor B polypeptide 1
IPI00662675.1|PREDICTED: similar to High mobility group protein 1
IPI00678394.1|PREDICTED: similar to Wilms tumour 1-associating protein
IPI00662975.1|PREDICTED: PHD finger protein 20-like 1 isoform 11
Fig. 40: Selected A2.2 candidates from the proteins identified by MS analysis.  
-TC MIN6 HeLa 
Histone deacetylase complex 
subunit SAP18 
Adult male corpus striatum cDNA, 
RIKEN 
Similar to WW domain binding protein 2 
Transcription elongation factor B 
polypeptide 1 
Similar to High mobility group protein 1 
Similar to Wilms tumour 1-
associating protein 
PHD finger protein 20-like 1 
isoform 11 
Cold inducible RNA binding protein 
Activated RNA polymerase II transcriptional 
coactivator 
Fig. 41: RT-PCR analysis of the A2.2 candidates. For the analysis RNA extracted, as described in 
Materials and methods, from HeLa, MIN6 and -Tc cell lines was used. The results are from 30 cycles 
of amplification 
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 Loosing further the filters, i.e considering also the proteins with the lowest 
homology score, and extending the number of databases analysed (see “Materials and 
Methods”) allowed to indentify another list of possible candidates (Fig. 42). Again the 
expression level of all these potential candidates has been evaluated in -TC, MIN-6, and 
HeLa cell lines by RT-PCR as described above. The results are shown in Fig. 43.  
Once again none of the factors identified were -cell specific. 
 
BATF basic leucine zipper transcription factor 
 
p21SNFT Jun dimerization protein 
 
HMGB4  high-mobility group box 4  
 
Csdc2 cold shock domain containing C2, RNA binding 
 
RNABP8 RNA binding protein 8 
 
C1D nuclear DNA binding protein 
 
Fig. 42: Selected A2.2-candidates after the new bioinformatic analysis.   
BATF 
-TC MIN6 HeLa 
HMGB4 
p21SNF 
Csdc2 
CD1 
RNA BP8 
Fig. 42:  RT-PCR analysis of the A2.2 candidates. For the analysis RNA extracted, as described in 
Materials and methods, from HeLa, MIN6 and -Tc cell lines was used. The results are from 30 
cycles of amplification 
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5 DISCUSSION 
 
There is a growing research interest in the potential of pancreatic stem cell in the 
treatment of type 1 diabetes. Stem cell-derived -cells may solve the problem of an 
inadequate supply of producing -cells. In this respect it should be stressed that the full 
understanding of the hierarchy of the molecular events involved in pancreas 
differentiation is probably necessary for achieving therapeutic success of ES cells 
treatment. During embryogenesis, transcription factors orchestrate intricate pathways of 
differentiation by regulating the rate of transcription of an array of genes. Genetic studies 
have begun to unravel the complex cascade of factors that control the proliferation and 
differentiation of cells in the developing of pancreas. Some of them are expressed very 
early, such as Hlxb-9 (Harrison, Thaler et al. 1999) and Pdx-1 (Jonsson, Carlsson et al. 
1994). Other transcription factors have a role in the differentiation of specific pancreas 
cell types. Pax4 (Sosa-Pineda, Chowdhury et al. 1997; Mansouri, Goudreau et al. 1999; 
Mansouri, St-Onge et al. 1999; Dohrmann, Gruss et al. 2000; Sosa-Pineda 2004) and 
Pax6 (Ahlgren, Pfaff et al. 1997; St-Onge, Sosa-Pineda et al. 1997; Hill, Asa et al. 1999; 
Mansouri, Goudreau et al. 1999; Dohrmann, Gruss et al. 2000), Isl1 (Ahlgren, Pfaff et al. 
1997), Nkx6.1, Nkx2.2 (Sussel, Kalamaras et al. 1998; Sander, Sussel et al. 2000), 
NeuroD (Naya, Huang et al. 1997) and Ngn3 (Gradwohl, Dierich et al. 2000) are all 
necessary for the differentiation of the islet endocrine cells. Nevertheless the specific 
pathway leading to the development of the insulin-secreting -cells is particularly 
important to be able to engineer new -cells from ES cells and/or progenitor cells. The 
aim of the first part of this Thesis work has been collect as much as possible information 
regarding the pathways leading to the formation of insulin producing cell from 
undifferentiated cells. To obtain the goal of the research are necessary  
 
1. A simple cell model for the differentiation. 
2. A high throughput experimental approach. 
 
As cell model for the differentiation, the cell line AR42J has been chosen. AR42J 
cells were originally derived from a chemically induced rat pancreatic tumor and posses 
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both exocrine and neuroendocrine properties. In the presence of Activin-A (Act-A) plus 
Hepatocyte Growth Factor (HGF), these cells differentiate into insulin-expressing cells.  
In particular the clone named B13 posses an efficiency >of 90% to differentiate 
into insulin producing cells when treated with Act-A and HGF (Yasuda, Tanaka et al. 
1994; Mashima, Ohnishi et al. 1996; Mashima, Shibata et al. 1996; Ogihara, Watada et 
al. 2003). For the gene expression and proteomic analyses, microarray and 2D-MS 
approaches have been used. 
 Although, the AR42J-B13 cell line is, at the present, the best cell model to mimic 
as much as possible the physiological differentiation of -cells it shows some phenotypic 
“instability” associated with spontaneous differentiation in absence of growth factors 
stimuli. To recover the original phenotype it has been necessary to expand new colonies 
from single cells. The colony showing the same characteristics of the original AR42J-B13 
clone was used to perform microarray and 2D-MS analysis.  
 The analysis of the microarray has been challenging due to the platform used for 
the scanning and the software used for the statistical analysis. In fact, the raw data 
deriving from the scanning had had to be extensively manipulated to adapt them to the 
software platform. Moreover, open-source platform requires a dept acquaintance of the 
environment system use, e.g. R-language. Once ready the data were analyzed using two 
platforms: TIGR-MIDAS/TM4 and R-mArray/S.A.M.-Excel. Although, the results from 
the two independent platforms were comparable only few genes (three genes) over- and 
(sixty genes) under-expressed were identified. None of them were specifically related to a 
pancreatic differentiation event and none of them were transcription factors. Many of the 
genes identified were, instead, putative transcripts retrieved from the Riken database 
whereas some others were identified only on the basis of a certain degree of homology 
with known sequences. Among the under-regulated genes, some were related to neuron 
phenotype, e.g. gdpd5 (glycerophosphodiester phosphodiesterase domain containing 5) 
(Yanaka, Nogusa et al. 2007) and myo1b (myosin 1b) (Ruppert, Kroschewski et al. 1993), 
just to cites two of them. These results, while disappointing, were not unexpected since 
the AR42J cells, as stated above, possess neuroendocrine properties and even during the 
growth factors-mediated differentiation they share with the neurons some molecular traits 
(Scharfmann 1997). Furthermore it is know that Act-A can induce conversion of these 
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cell into neuronlike cells (Ohnishi, Ohgushi et al. 1995). Among the gene showing a 
down-regulation it is worth to mention the amylase. Once again it is important recall the 
in the undifferentiated state the AR42J shows characteristic of acinar cells. One of the 
markers of the acinar phenotype is the expression of amylase (Mashima, Ohnishi et al. 
1996). The reduction of the expression of the amylase is a direct effect of the presence of 
Act-A (Yasuda, Tanaka et al. 1994) but it is also an important signal of the starting of a 
differentiation process. In fact it has been observed in many (trans)differentiative events 
of the AR42J such as the differentiation into insulin secreting cells (Mashima, Shibata et 
al. 1996; Zhang, Mashima et al. 2001; Kanno, Ogihara et al. 2006) and the 
transdifferentiation into hepatocytes (Shen, Slack et al. 2000; Shen, Horb et al. 2003; 
Burke, Shen et al. 2006). 
 From the 2D analysis were obtained some, but at the moment, not conclusive 
informations. Among the few proteins identified to be differentially expressed in the Act-
A/HGF-treated samples most of them were related to the response to oxidative stress such 
as PARK7 (Sekito, Koide-Yoshida et al. 2006) and CH60 (Bonior, Jaworek et al. 2005)) 
as well as related to the vesicular trafficking, (e.g.VGF8 (Snyder, Peng et al. 2003)) and 
to the protein folding (e.g. PDIA3 (Elliott, Oliver et al. 1997), GRP75 (Burkart, Liu et al. 
2000). 
 With the mass spectrometry analysis we had to face many challenges such as the 
low amount of proteins available. In fact the working hypothesis was to analyze the 
changes in the protein pattern, essentially in term of transcription factors, which occur 
during the differentiation. From a technical point of view this means to proceed with an 
important and necessary step of selective proteins extraction and enrichment. The 
protocols (or the commercial kits) available show a high efficiency of purification, when 
used as analytical tools; they loose their efficiency when are scaled-up as requested by a 
proteomics analysis. The time consuming (and high cost) process of extraction and 
purification allowed for the preparation of samples for few 2D replicates that, even 
statistically significant, were too preliminary to give conclusive answers.  
 Anyway, the identification among the genes and the proteins over-expressed of 
members involved in the response to “stress” events could be attributed to the treatment 
with growth factors and in particular to Act-A that is well know to trigger apoptosis 
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(Chen, Wang et al. 2006).  To overcome these problems can be envisaged others 
promising approaches such as the possibility to use less “aggressive” differentiation 
agents. Recently a vinca alkaloid, namely conophylline, has been identified as a potent 
differentiation agent for the AR42J (Kojima and Umezawa 2006). Conophylline-treated 
cells were found to express insulin as measured at both mRNA and protein levels. By 
RT-PCR analysis, conophylline-treated cells were shown to express Ngn3 strongly as 
well as NeuroD/BETA2, Nkx2.2 and insulin (Umezawa, Hiroki et al. 2003). 
 The difficulty to induce the differentiation process, even in a simple cell model, 
through the treatment with growth factors that could trigger unexpected epigenetic events 
prompted us to pursue a more reliable and, for some aspects easy, “molecular” strategy. 
As already stated in many part of this Thesis during the pancreas differentiation, the 
Ngn3 plays a central role placing itself at the intersection between an undifferentiated 
state (upstream the Ngn3) and the beginning of the endocrine pancreas differentiation 
(downstream the Ngn3) (Figure 3 Introduction)Therefore, all the molecular events that 
occur immediately downstream to the Ngn3 are truly pancreatic differentiation events. 
The availability of a simple experimental system in which the Ngn3 is constantly 
activated or, even better, which expression can be customized could open new interesting 
perspectives where technical approaches such as microarrays analysis and 2D may play 
import roles.    
From a physiological point of view, it is known that cells that transiently express 
the basic helix-loop-helix transcription factor Ngn3 are precursors that can become the 
endocrine pancreas. Ngn3 expression starts at E13.5 and peaks at E15.5 before 
dissipating, corresponding to the developmental stage of formation of the definitive 
endoderm. It turn out then that Ngn3 is one of the essential transcription factors expressed 
early in the differentiation of the islet cells and it is considered to be a marker of 
endocrine progenitor cell during development of the pancreas.  
Despite the important role played by Ngn3 information regarding some aspect of 
Ngn3 activity is still missing. In particular are still open the following questions;  
1) Is the transient expression of Ngn3 a prerequisite to have the proper molecular 
context to achieve -cells differentiation in vitro? In fact, most of the experimental 
approaches used have had ectopic and constitutive expression of Ngn3 driven by 
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strong promoter (Heremans, Van De Casteele et al. 2002; Gasa, Mrejen et al. 2004) 
without any possibility of a feedback regulation of its own expression as happens 
normally during pancreas differentiation. 
2) Is the endoderm patterning a prerequisite to have the proper cellular context to 
achieve -cells differentiation? Development of the pancreatic endocrine cells located 
in the dispersed islets of Langerhans is only partially characterized, and although 
some information are available a complete vision of cellular and molecular 
mechanisms involved are still missing. 
3) Which are the direct downstream targets of Ngn3? These information would provide 
valuable data to set the development of in vitro methods for the differentiation either 
of ES cells (pluripotent), of adult progenitor (multipotent) and, potentially, to drive 
transdifferentiation of non--cells towards insulin-secreting cells. 
 
Therefore the aims of this part of the PhD Thesis have been: 
 
1) To test if transient expression of Ngn3 is sufficient to act as a genetic switch that 
specifies the -cell fate in ES cells in vitro; 
2) To test if the context of endoderm patterning is a prerequisite for -cells 
differentiation. 
3) To identify those genes, mainly transcription factor(s), that lie downstream Ngn3.  
 
To attain these goals the following approaches have been used:  
 
1. Simple cell models;  
2. A "customized" gene expression for activation of expression of the target gene for 
specific times using inducible expression vectors 
3. A high-throughput experimental approach. 
 
The cell model is necessary to mimic as much as possible the physiological 
behavior of -cell differentiation. As cells models the F9, AR42J and INS-1 cell lines 
have been chosen.  
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The mouse F9 teratocarcinoma cell line is a model that can be manipulated to 
imitate one of the earliest transitions in mouse development, which is the formation of 
endoderm. The cells undergo very limited differentiation under normal culture 
conditions, but can be induced to differentiate into a) parietal endoderm in the presence of 
retinoic acid (RA) and dibutyryl cyclic AMP; b) visceral endoderm when cultured in 
suspension as aggregates and treated with RA (Strickland and Mahdavi 1978). 
The AR42J cells, as stated before, were originally derived from a chemically 
induced rat pancreatic tumor and possess both exocrine and neuroendocrine properties. In 
the presence of Activin-A (Act-A) plus Hepatocyte Growth Factor (HGF), these cells 
differentiate into insulin-expressing cells.  
INS-1 is an insulin-secreting cell line established from an x-ray-induced rat 
transplantable insulinoma (Asfari, Janjic et al. 1992). This cell line express both 
proinsulin I and II and display conversion rate of the two precursors hormones similar to 
those observed in rat islets. 
The customized gene expression has been obtained by the use of inducible 
expression system.  
An High throughput experimental approach is necessary to obtain the higher 
grade of information in term of genes expressed per experiment. 
 
5.1 Are the transient expression of Ngn3 and the endoderm patterning a   
 prerequisite to have the proper molecular context to achieve -cells   
 differentiation in vitro? 
 
During embryonic development Ngn3 appears transiently in scattered 
undifferentiated cells of endoderm origin. Several lines of evidence suggest that the 
expression of Ngn3 in endoderm progenitor cells directs them to an endocrine cell fate 
and initiates the program of islet differentiation (Heremans, Van De Casteele et al. 2002; 
Gasa, Mrejen et al. 2004). Despite this important insight, the approach used was based on 
a constant expression of Ngn3 even though it is know that Ngn3 is expressed as a pulse. 
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To ensure both an efficient and regulatable expression of the target gene we used 
tetracycline-induced transduction system both retroviral and not. 
Retroviral gene delivery will offer an efficient transduction system; it is generally 
faster, more reliable, and has broader utility than alternative gene transfer methods. 
The RevTet system used is based on the use of 1) a retroviral regulator vector and 
2) a retroviral response vector carrying the gene of interest to be regulated. The retroviral 
regulator vector express the tTA regulatory element, a fusion of the Tet repressor protein 
(TetR) and the VP16 activation domain of the Herpes simplex virus VP16 protein. The 
tTA expressed by the retroviral regulator vector binds the TRE of the response vector 
activating transcription in presence or in absence of doxycycline. With the Tet-Off 
system the gene expression is turned on when doxycycline is removed from the culture 
medium whereas in the Tet-On system the gene expression is turned on when 
doxycycline is added to the culture medium since the TetR was modified (obtaining the 
rtTA) by four amino acid changes that reverse the protein’s response to doxycycline. 
The use of viral vectors as transduction system to drive the expression of 
transcription factors in the pancreas is not novel. For example Song et al (Song, Lee et al. 
2007) developed a bi- or tri-cistronic constructs in hybrid adenovirus/adeno-associated 
virus (Ad/AAV) vectors containing Ngn3, NeuroD/BETA2, and RIPE3b1 (MafA), each 
of which plays a role in islet cell differentiation. These vectors efficiently express 
multiple transcription factors and stimulate insulin promoter activity in a combinatorial 
manner. When these multi-cistronic constructs were administered in vivo, they induced 
hepatic expression of islet-specific markers, including Pdx-1, insulin, glucagon, 
somatostatin, and islet-amyloid peptide. Administration of the Ad/AAV hybrid vectors to 
streptozotocin-induced diabetic mice reversed hyperglycemia, consistent with the 
differentiation of functional hepatic insulin-secreting cells (Song, Lee et al. 2007). 
With a similar approach Wang et al (Wang, Ehrhardt et al. 2007) delivered Pdx-1 
and Ngn3 to the livers of diabetic mice using adeno-associated virus (AAV) serotype 8, a 
vector that has been shown to result in non-toxic, persistent, high level expression of the 
transgene. However, they were unable to correct hyperglycemia in mice with 
streptozotocin-induced diabetes using AAV vectors expressing Pdx-1 and Ngn3 but, 
when they co-delivered these transcription factor expression cassettes in non-viral vectors 
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with an irrelevant adenoviral vector, they were able to correct hyperglycemia in diabetic 
animals. Further studies demonstrated that an antigen-dependent immune response 
elicited by the adenoviral capsid together with the expression of a pancreatic transcription 
factor was required for restoration of serum insulin levels by the liver.  
In both the cases described the viral transduction driven a constant gene 
expression. In any case the need of a pulsed expression has been never addressed.   
More interestingly Treff et al. (Treff, Vincent et al. 2006) have determined the 
expression profiles of murine embryonic stem cells (mESCs) uniformly induced to over- 
express Ngn3. The mESC line created was induced with doxycycline for 72 h and then a 
genome-wide microarray analysis was performed to identify genes regulated by Ngn3 in 
a variety of contexts, including undifferentiated ESCs and differentiating embryoid 
bodies (EBs). Genes regulated by Ngn3 in a context-independent manner were identified 
and analyzed using systematic gene ontology tools. This analysis revealed Notch 
signaling as the most significantly regulated signaling pathway. This result is consistent 
with the hypothesis that Ngn3 expression makes the cell competent for Notch signaling to 
be activated and, conversely, more sensitive to Notch signaling inhibition. Indeed, EBs 
induced to express Ngn3 were significantly more sensitive to -secretase inhibitor-
mediated Notch signaling inhibition when compared with uninduced EBs. Moreover, 
they found that Ngn3 induction in differentiating ESCs results in significant increases in 
insulin, glucagon, and somatostatin expression.  
These results are very interesting although they addressed only the problem of the 
Ngn3-gene pattern in term of positive regulation. Furthermore, the data need to be 
interpreted with caution because the genes identified may not be direct target genes of the 
overexpressed Ngn3, but might be the result of indirect regulation of gene expression 
patterns.  
As for the embryonic contest the importance of the endoderm patterning has been 
never considered directly in any of the report available although the experiments were 
always carried out with cell line and/or organ system already committed toward the 
appropriate phenotype. In an in vitro context O’Driscoll et al. (O'Driscoll, Gammell et al. 
2004) showed that, by using retinoic acid-derived-endoderm F9 cells as a model, ectopic 
expression of Ngn3 is able to start the differentiation pathway of endocrine pancreas. 
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Ngn3 triggers the expression of several pancreatic transcription factors following a well 
defined temporal activation sequence. The data reported demonstrated that Ngn3 is the 
first event in the temporal sequence of activation of some transcription factors 
specifically involved in the differentiation of -cells. Interestingly, gene activation 
triggered by Ngn3 was restricted to the cells that underwent endoderm differentiation 
after RA treatment. In contrast, ectopic Ngn3 expression in cells not treated with RA was 
not sufficient for inducing expression of genes involved in the signaling pathways that 
promote endocrine pancreas differentiation. 
More recently a very elegant approach demonstrating the importance of the 
embryonic context for the appropriate competence of Ngn3 in the pancreas has been 
reported by Johansson et al. (Johansson, Dursun et al. 2007). They generated transgenic 
mice expressing a tamoxifen-inducible Ngn3. In order to specifically express this 
inducible protein in the pancreas, they put it under the transcriptional control of the 
mouse pdx1 promoter. The transgene was then backcrossed into the ngn3
/
 background, 
devoid of endogenous endocrine cells. The expression of Ngn3 was induced by injecting 
the pregnant females with a single dose of tamoxifen at e8.7, e10.5, e12.5, or e14.5. 
Early activation of Ngn3-ER
TM
 (e8.7) almost exclusively induced glucagon
+
 cells, 
while depleting the pool of pancreas progenitors. As from e11.5, Pdx1
+
 progenitors 
became competent to differentiate into insulin
+
 and PP
+
 cells.  
Somatostatin
+
 cells were generated from e14.5, while the competence to make 
glucagon
+
 cells was dramatically decreased. Hence, pancreas progenitors, go through 
competence states that each allow the generation of a subset of cell types (Johansson, 
Dursun et al. 2007).  
It is important to note that most of classical inducible transduction systems, both 
viral and not, rely on the use of the Tetracycline (Tet) system.  
An alternative and most promising approach is that developed by NEB. 
Analogous to the operation of a rheostat, the RheoSwitch technology from NEB allows 
induction and adjustable control of gene expression. The precise regulation of gene 
expression is achieved through the highly specific interaction of a synthetic inducer, the 
Ligand RSL1, and a chimeric bipartite nuclear receptor. Unlike other systems, which rely 
on steroids or other drugs, the synthetic ligand RSL1 (synthetic diacylhydrazine) shows 
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no pleiotropic effects in mammalian cells and exhibits no cross talk with endogenous 
transcription factors. Moreover, RSL1 is not a steroid and it is invisible to mammalian 
nuclear receptors and has been shown to be inert within all cell lines tested to date. 
 
  
5.2 Which are the direct downstream targets of Ngn3? 
 
As already mentioned before the proendocrine basic helix-loop-helix protein
 
Ngn3 plays a critical role in the development
 
of the hormone-producing islets within the 
pancreas, including
 
the insulin-producing -cell. Deletion of ngn3 gene in mice results in 
complete loss of pancreatic endocrine cells
 
as well as development of diabetes. Despite 
numerous reports describing its role, our understanding
 
of the regulatory networks 
surrounding Ngn3 remains limited.
 
It has been reported that the expression of Ngn3 is 
directly
 
regulated by HNF6 (Jacquemin, Durviaux et al. 2000), Hes (Lee, Smith et al. 
2001), and Ngn3 itself (Smith, Gasa et al. 2003). In addition,
 
Ngn3 has been shown to 
directly regulate the expression of NeuroD/BETA2 (Huang, Liu et al. 2000), Pax4 
(Smith, Gasa et al. 2003), Nkx2.2 (Watada, Scheel et al. 2003) and IA1 (Mellitzer, Bonne 
et al. 2006). Specification and further differentiation of the islet cell types is controlled by 
target genes of Ngn3, many of which are still unknown. 
 In order to identify novel target genes of Ngn3, the transcriptome of pancreas-
derived cells ectopically expressing Ngn3 was analyzed using a ChiP-cloning approach. 
To avoid the complexity of the cell types involved present in embryonic pancreas cell 
models as simple as possible. As cell models the AR42J and INS-1 have been used.  
The AR42J cell line has been previously used as a model to study, in general, the 
changes in the expression of genes (Palgi, Stumpf et al. 2000) and in particular the 
changes in the expression of transcription factors (Zhang, Mashima et al. 2001) during 
differentiation into insulin-producing cells.  
INS-1 is an insulin-secreting cell line established from an x-ray-induced rat 
transplantable insulinoma (Asfari, Janjic et al. 1992). This cell line express both 
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proinsulin I and II and display conversion rate of the two precursors hormones similar to 
those observed in rat islets. 
AR42J and INS-1 cells are the most valuable model available with respect 
embryonic pancreata that need sophisticated technical skills to be managed. 
As technical approach to get a transcriptome analysis of the Ngn3-induced gene(s) 
the ChiP-cloning technique has been used. This is a technique for isolation and 
identification of the DNA sequences occupied by specific DNA binding proteins in cells. 
These binding sites may indicate functions of various transcriptional regulators and help 
identify their target genes during animal development and disease progression. The 
identified binding sites may also be used as a basis for annotating functional elements in 
genomes. The types of functional elements that one can identify using ChiP-cloning 
include promoters, enhancers, repressor and silencing elements, insulators, boundary 
elements, and sequences that control DNA replication.  
It has been predicted that at least 2000 transcriptional activators are encoded by 
the human genome (Tupler, Perini et al. 2001). To make use of this information, it is now 
important to determine the sets of genes regulated by each of these factors. A common 
approach used to identify the target genes that are regulated by an individual factor is to 
couple the overexpression or underexpression of that factor to cDNA microarray analysis 
(Muller, Bracken et al. 2001). Although this approach allows for the isolation of a large 
set of potential target genes, the data need to be interpreted with caution for several 
reasons. First, the genes identified may not be direct target genes of the overexpressed 
factor, but instead may be isolated as the result of indirect regulation due to overall 
alterations of gene expression patterns. In addition, it is unclear that the genes regulated 
by a factor at levels vastly greater than normal, biologically relevant concentrations are in 
fact true target genes. Therefore, many studies have focused on the development of new 
approaches designed to examine the direct targets of a site-specific transcription factor in 
the context of physiologically relevant conditions. One of the most promising methods is 
a modification of the chromatin immunoprecipitation (ChiP) procedure. ChiP has become 
a popular method in regulatory biology for studying the binding of transcription factors to 
genomic loci. The ChiP technique has been traditionally used for demonstration of the in 
vivo binding of a given transcription factor to genomic region of interest (Kuo and Allis 
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1999; Orlando 2000). In recent years, this technique has also become a useful genomic 
tool for identifying unknown target loci of transcription factors by cloning and analyzing 
the retrieved DNA fragments that have been bound by the transcription factors (Kirmizis 
and Farnham 2004). Most of the available ChiP protocols employ a similar overall 
strategy to retrieve a pool of protein-bound DNAs (Fig X). In brief, chromatin is cross-
linked by formaldehyde, fractionated by sonication and purified by the antibody raised 
against a given protein and later the bound DNAs are reverse cross-linked by heat 
treatment and phenol/chloroform extraction. Since the initial chromatin for ChiP is 
sheared with sonication, both ends of the purified DNAs are usually modified further by 
fill-in reactions to generate blunt-end DNA fragment. This modified pool of genomic 
DNAs usually becomes the starting DNA material for constructing clone libraries for the 
identification of unknown target regions for a given DNA-binding protein.  
Recent microarray studies have
 
implicated a number of additional candidate 
targets of Ngn3
 
in the developing pancreas (Gu, Dubauskaite et al. 2002) and in 
pancreatic ductal cells (Gasa, Mrejen et al. 2004). These studies were performed on 
different microarray platforms
 
and were limited to approximately 12,000 or 18,000 genes, 
respectively. Unfortunately again it is not possible to discriminate specifically those 
genes activated directly by Ngn3.  
Following this modified protocol of ChiP it has been possible to identify at least 
three genes encoding for proteins belonging to the class of transcription factors that are 
specifically regulated by Ngn3. They are: 
 
1) The basic Helix-Loop-Helix neurogenic factor 4 (NeuroD4). 
2) The SRY (sex determining region Y)-box 9 (campomelic dysplasia, autosomal 
sex-reversal) (Sox9). 
3) The zinc-finger type transcription factor OVO homolog-like 1 (OVOl1). 
 
The bHLH transcription factor neurogenic differentiation 1 (NeuroD/BETA2) or 
-cell E-box transactivator 2 (BETA2) plays a particularly prominent role in pancreatic 
-cell function. It is required for both normal islet development and regulation of insulin 
gene transcription (Naya, Huang et al. 1997). Homozygous NeuroD/BETA2/BETA2-null 
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mice show a reduction in the number of insulin-producing -cells and fail to develop 
mature islets. In addition, heterozygous mutations in the human NeuroD/BETA2/BETA2 
gene (NeuroD/BETA2) are associated with a monogenic form of diabetes that resembles 
maturity-onset diabetes of the young (MODY) in many respects except perhaps for a 
slightly later age at onset (Malecki, Jhala et al. 1999). A search for other bHLH proteins 
expressed in the developing pancreas and mature islet cells revealed the presence of 
several other members of this family, including the NeuroD/BETA2-related protein 
NeuroD4/Math-3/Ath-3. NeuroD4 is widely expressed in the developing nervous system 
and, after birth, it is expressed at its highest levels in the retina (Lee 1997; Tsuda, 
Takebayashi et al. 1998). It is also found in developing pancreas and mature rodent islet 
cells, and its expression has been confirmed in adult human islets by RT-PCR-based 
assay (Lee 1997). Interestingly, recently it has been reported that in addition to 
NeuroD/BETA2, Ngn3 also induced both NeuroD2 and NeuroD4 gene expression (Gasa, 
Mrejen et al. 2007). 
As for Sox9 much more data are available regarding its role in pancreas 
development. The sox gene family represents a group of developmentally regulated 
transcription factors, which are characterized by a highly conserved DNA-binding 
domain, the HMG-domain (Wegner 1999; Schepers, Teasdale et al. 2002). Based upon 
structural similarities, the more than 20 different vertebrate sox genes can be assigned to 
one of the seven subgroups, A-G (Schepers, Teasdale et al. 2002). Recently, several sox 
genes have been recognized as key players in the regulation of embryonic development 
and cell fate determination. The analysis of sox gene mutations in humans, mice, and 
zebrafish have demonstrated a role for sox genes in endoderm specification, as well as the 
development of gonads, lens, heart, lymphocytes, bone, and glial cells (Schilham, 
Oosterwegel et al. 1996; Britsch, Goerich et al. 2001; Dickmeis, Mourrain et al. 2001; 
Kamachi, Uchikawa et al. 2001). Specifically related to the pancreas it has been shown 
that at least eight different members of the sox gene family in the embryonic pancreas, 
and three members in adult islet cells (Lioubinski, Muller et al. 2003) were expressed. 
Among those, Sox9 was confined to the pancreatic epithelium and later to islets. The 
expression of Sox9 in the embryonic pancreatic ducts is of particular interest, because 
ducts have been suggested to contain the endocrine progenitor cells (Schwitzgebel, 
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Scheel et al. 2000; Lee and Saint-Jeannet 2003). In fact recently Sox9 has been identified 
as the first specific marker of multipotential progenitors during pancreas organogenesis. 
It acts stimulating the proliferation, survival, and persistence in an undifferentiated state 
of the multipotential progenitor cells (Lynn, Smith et al. 2007; Seymour, Freude et al. 
2007).  
Expression of Sox9 has also been reported in the human pancreas (Piper, Ball et 
al. 2002).  
Interestingly the sox9 gene shows extended regulatory cis-regulatory regions. 
Most of these elements reside within a 600-kb interval extending 350 kb 5 and 250 kb 3 
to sox9 (Wunderle, Critcher et al. 1998; Bagheri-Fam, Barrionuevo et al. 2006; Bien-
Willner, Stankiewicz et al. 2007). According to these observations we included sox9 as a 
potential gene regulated by Ngn3 even though the long range localization from the 5’ side 
of the sox9 gene (89200 bp). 
Among the genes prominently affected by Ngn3 we focused the attention on that 
encoding the protein OVO homolog-like 1 (OVOl1). So far neither the expression pattern 
of OVOl1 nor its function in the pancreas has been addressed directly.  
The molecular structure of the ovo gene product contains four C2H2 zinc finger 
motifs, characteristic of zinc-finger type transcription factor (Mevel-Ninio, Terracol et al. 
1991; Garfinkel, Wang et al. 1994; Mevel-Ninio, Terracol et al. 1995; Mevel-Ninio, 
Fouilloux et al. 1996). ovo gene has been described in Drosophila to be required for 
survival and differentiation of female germ line cells where it plays an important role in 
germ line sex determination (Oliver 1987; Oliver, Pauli et al. 1990; Oliver, Singer et al. 
1994; Horabin, Bopp et al. 1995). Homologous null mutants produce rudimentary ovaries 
in which germ cells have completely degenerated, leaving only somatic tissues (Oliver 
1987). Less severe mutations produce viable germ cells that exhibit defective oogenesis 
(Oliver 1987) or ovarian tumors with male germ line features (Oliver 1987; Oliver, Pauli 
et al. 1990). Later on (Masu, Ikeda et al. 1998) a cDNA encoding for a 274-amino acid 
protein containing an acidic amino acid and serine-rich domain and a zinc finger domain 
which shows high sequence homology to that of Drosophila Ovo protein has been 
cloned. The mRNA is predominantly expressed in testis, and the expression increases 
from 3 weeks postnatal, implying that these proteins may play important roles in the 
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development of the testes where it is present in spermatocytes and spermatids (Masu, 
Ikeda et al. 1998). To assign definitively OVO to a transcriptional factor, the DNA-
binding and transactivation properties have characterized. Random oligonucleotide 
selection, electrophoretic mobility shift assay and footprinting indicated that OVO bound 
to the sequence, 5-G(G/C/T)GGGGG-3. These motifs were found in the 5-flanking 
regions of ovo and other testis-specific genes (Unezaki, Nishizawa et al. 2004).
 
Using gene targeting, it has been show that ovo is required for proper
 
development 
of both hair and sperm. Ovo
-/-
 mice are small, produce aberrant hairs, and display 
hypogenitalism,
 
with a reduced ability to reproduce. These mice also develop 
abnormalities
 
in kidney, where ovo1 is also expressed. 
Ovol1 seems to regulate meiotic pachytene progression during spermatogenesis. 
In fact ovol1-deficient
 
germ cells are defective in progressing through the pachytene
 
stage. The pachytene arrest was accompanied by an inefficient
 
exit from proliferation, 
increased apoptosis and an abnormal
 
nuclear localization of the G2-M cell cycle regulator 
cyclin
 
B1, but was not associated with apparent chromosomal or recombination
 
defects. 
Transcriptional profiling revealed
 
reduced expression of pachytene markers in the mutant, 
providing molecular
 
evidence that pachytene differentiation was defective. In addition, 
the
 
expression of Id2 (inhibitor of differentiation 2), a known
 
regulator of 
spermatogenesis, was upregulated in ovol1-deficient
 
pachytene spermatocytes and 
repressed by Ovol1 in reporter assays (Li, Nair et al. 2005).
  
In mice, ovol1 gene is also expressed in skin, where it localizes
 
to the 
differentiating cells of epidermis and hair follicles.
 
In its absence, developing epidermis
 
fails to properly restrict the proliferative potential of progenitor
 
cells, and cultured 
keratinocytes fail to efficiently undergo
 
growth arrest in response to extrinsic growth-
inhibitory signals.
 
There are many evidences showing that c-myc expression is up-
regulated
 
in Ovol1-deficient suprabasal cells and that Ovol1 represses
 
c-myc transcription 
by directly binding to its promoter. c-Myc
 
proto-oncoprotein is one the most important 
transcription factors that control the balance between
 
proliferation and differentiation of 
keratinocytes (Nair, Teng et al. 2006).  
As for the positive regulation of the ovol1 gene, recently the wnt signal 
transduction pathway has been involved (Li, Mackay et al. 2002). Wnt proteins are a 
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family of highly conserved secreted proteins that regulate multiple developmental 
processes, including proliferation of organ-specific stem/progenitor cell populations, 
growth control and cell fate determination in diverse organs, and tissue patterning (Logan 
and Nusse 2004). In the canonical Wnt signaling pathway, binding of Wnt ligand to 
cognate membrane-spanning receptor proteins called Frizzleds (Fz), triggers a signaling 
cascade that results in the stabilization and nuclear localization of -catenin, whose 
interactions with T cell-specific factor/lymphoid enhancer-binding factor (TCF/LEF) 
transcription factors control transcription of target genes like Pitx2 (Kioussi, Briata et al. 
2002; Baek, Kioussi et al. 2003). In the absence of Wnt signaling, cytoplasmic -catenin 
in Wnt-responsive cells is targeted for proteosome-mediated degradation by a 
heteromeric protein complex that includes Axin, glycogen synthase kinase 3 (GSK-3), 
and other proteins (Rulifson, Karnik et al. 2007). 
Components of the wnt signal transduction pathway have been functionally 
implicated in multiple events during hair follicle morphogenesis and differentiation. For 
example, ectopic expression of wnt3a in mice leads to hair defects (Li, Mackay et al. 
2002). LEF1 knockout mice display a reduced number of hair follicles, and residual 
follicles fail to produce normal hair shafts (van Genderen, Okamura et al. 1994). 
Conversely, ectopic expression of LEF1 leads to hair formation in ectopic locations 
(Zhou, Byrne et al. 1995). Expression of a stable form of -catenin in skin leads to overt 
phenotypes such as de novo hair follicle morphogenesis and abnormal angling of 
protruding hairs (Gat, DasGupta et al. 1998), whereas conditional ablation of -catenin in 
the epidermis or expression of an N-terminally truncated LEF1 that cannot associate with 
-catenin results in defective hair morphogenesis (Huelsken, Vogel et al. 2001; Merrill, 
Gat et al. 2001). These and other studies suggest that wnt signaling, LEF1, and -catenin 
are required for formation of hair follicles during embryogenesis as well as for postnatal 
hair production. An analysis of the gene regulatory region of ovol1 promoter showed that 
it contains a LEF1 binding site that is activated by the ectopic expression of the LEF1/-
catenin complex (Li, Mackay et al. 2002) 
As for the negative regulation some genetic evidence suggests that Drosophila 
ovo auto-regulates (Oliver, Singer et al. 1994; Lu, Andrews et al. 1998) its own 
expression by binding to and repressing the ovol1 promoter. Ovol1 represses transcription 
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using both passive (competing with the c-Myb transcriptional activator, a known positive 
regulator of proliferation) and active (recruiting histone deacetylases 1) repression 
mechanisms (Nair, Bilanchone et al. 2007).  Furthermore, as showed above, Ovol1 
represses c-Myc and Id2 transcription by binding to their promoters (Li, Nair et al. 2005; 
Nair, Teng et al. 2006). Interestingly c-Myc is a known target of c-Myb (Evans, Moore et 
al. 1990; Nakagoshi, Kanei-Ishii et al. 1992; Cogswell, Cogswell et al. 1993), and c-Myb 
indeed binds to an Ovol1 site in the Id2 promoter. Therefore, the passive and active 
repression mechanisms of Ovol1 may apply to Ovol1-mediated regulation of its other 
target genes. 
A high number of evidences and data seem to confine the role of ovol1 gene in 
controlling the development and differentiation of hair formation and spermatogenesis, 
therefore a possible role of ovol1 gene in controlling pancreas development and 
differentiation that has even a different embryonic origin (endoderm vs. ectoderm) could 
seem improbable.  However, interestingly, some of the target genes that act downstream 
Ovol1 are a common trait of the pancreas development. Among those an interesting role 
is played by Id2 and c-Myc.  Id2 belongs to the Id family of helix-loop-helix (HLH) 
proteins, which upon heterodimerization with basic HLH proteins prevent basic HLH 
proteins from DNA binding (Norton 2000; Lasorella, Uo et al. 2001). Proteins of the Id 
family act as negative regulatory transcriptional factors, and their expression correlates 
with cell proliferation and arrested differentiation in many cell lineages.  
As for pancreas-related function it has been showed that Id2 protein inhibited 
NeuroD/BETA2 binding to its target sequence E-box inhibiting its stimulatory activity. 
As mentioned earlier (see “Introduction”) NeuroD/BETA2 regulates the survival and 
terminal differentiation
 
of pancreatic beta cells. Gene-targeting experiments revealed that 
deletion of the NeuroD/BETA2 gene resulted in defective pancreatic morphogenesis and 
abnormal enteroendocrine differentiation, which leads to the development of early 
diabetes (Naya, Huang et al. 1997). Further upstream it has been showed that Id2 in the 
pancreas could be activated by Bone Morphogenic Protein 4 (BMP-4). BMP signaling 
molecules, including SMADs
 
1, 2, and 4, are expressed in neonatal and adult pancreatic
 
islets (Brorson, Hougaard et al. 2001), and BMP4 promote the proliferation
 
and 
development of epithelial islet-like structures in vitro
 
(Jiang, Stanley et al. 2002). A 
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SMAD-binding
 
element has been found in the promoter of Id2 protein (Hollnagel, 
Oehlmann et al. 1999). In the presence of BMP4 ligand, BMP receptors transmit the 
signal that leads to phosphorylation (P) of SMAD-1 and -5 as well as co-SMAD-4. 
Activated SMADs bind to SMAD-binding elements on the Id2 promoter resulting in 
transcription of Id2 protein. This binds to NeuroD/BETA2, preventing it from binding to 
the E-box elements of endocrine-specific genes (Hua, Zhang et al. 2006). 
As for c-Myc it has been showed that it controls the inverse relationship
 
between 
proliferation and differentiation in human pancreatic
 
endocrine cells. c-Myc is expressed 
in human fetal
 
and adult pancreatic tissue (Schmid, Schulz et al. 1989), but not in 
differentiated endocrine
 
cells. c-Myc is a target gene of Wnt/ß-catenin
 
pathway (Evan and 
Littlewood 1993), which is activated during pancreas development (Amati and Land 
1994). -Catenin is identified as the component of the E-cadherin-mediated cell-cell 
adhesion system (Blackwell, Kretzner et al. 1990) and a
 
key effecter of the Wnt signaling 
pathway, which plays a critical
 
role in growth, division, and cell fate at early and late 
developmental
 
stage (Prendergast, Lawe et al. 1991; Blackwood, Luscher et al. 1992; 
Blackwell, Huang et al. 1993). In respond to Wnt signals, -catenin complexes with T 
cell factor (Tcf)/lymphoid-enhancing factors
 
and p300 to induce transcription of target 
genes known to be
 
important for normal cell proliferation, such as c-Myc (He, Sparks et 
al. 1998) and cyclin D1 (Shtutman, Zhurinsky et al. 1999).  
It is well known that during development the differentiation into hormone-
expressing
 
cells requires cell-cell contact acting in synergy with the
 
homeodomain 
transcription factor pancreatic duodenal homeobox-1
 
(Pdx-1). This event is associated 
with a decrease
 
in cell proliferation that has been showed to be mediated a down-
regulation
 
of the c-myc protooncogene (Demeterco, Itkin-Ansari et al. 2002). 
Furthermore, conditional activation of c-Myc using
 
a fusion protein between c-Myc and a 
hormone-binding domain
 
derived from the estrogen receptor leads to the ablation of
 
hormone expression and an increase in cellular proliferation.
  
From a molecular point of view recently it has been showed that this 
downregulation of c-Myc expression is mediated by Pdx-1. Pdx-1 can suppress -
catenin/Tcf-induced
 
c-Myc transcription by inhibiting the level of -catenin/Tcf and p300 
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complex formation and reducing their binding capacities
 
to endogenous c-Myc promoter 
region (Chen, Yan et al. 2007).
 
Therefore, it is believed that c-Myc, through Pdx-1, could play a role in the switch
 
mechanism that controls the inverse relationship between proliferation
 
and differentiation 
in human pancreatic endocrine cells. Proliferation of postnatal islet cells is relatively low 
compared with tissues such as intestines or bone marrow, except in states favoring robust 
 cell growth, such as pregnancy, insulin resistance, and obesity (Heit, Karnik et al. 
2006).  
The mechanism by which this equilibrium is finely tuned shows common trait 
with that one encountered in the differentiation/growth of epidermal progenitor cells.  
In both epidermal and pancreatic progenitor cells the delicate balance between 
proliferation and differentiation are mediated by the wnt signal transduction pathway. 
Multiple Wnt ligands, receptors, and signal transduction factors are expressed in the 
embryonic and adult pancreas (Murtaugh, Law et al. 2005; Papadopoulou and Edlund 
2005). Although prior studies provided evidence that pancreatic growth and 
differentiation are regulated by Wnt signaling (Heller, Dichmann et al. 2002; Heller, 
Klein et al. 2003; Pedersen and Heller 2005; Rulifson, Karnik et al. 2007) these reports 
did not present a mechanism for the Wnt-mediated action nor did they test whether Wnt 
signaling was sufficient to stimulate -cell proliferation in pancreatic islets (Rulifson, 
Karnik et al. 2007). In the seminal work of Rulifson et al. (Rulifson, Karnik et al. 2007) it 
has been shown that Wnt signaling stimulates islet - cell proliferation. In fact, the 
addition of purified Wnt3a protein to cultured -cells or islets promoted expression of 
Pitx2, a direct target of Wnt signaling, and Cyclin D2, an essential regulator of -cell 
cycle progression, and led to increased -cell proliferation in vitro. Conditional 
pancreatic -cell expression of activated -catenin, a crucial Wnt signal transduction 
protein, produced similar phenotypes in vivo, leading to -cell expansion, increased 
insulin production and serum levels, and enhanced glucose handling. Conditional -cell 
expression of Axin, a potent negative regulator of Wnt signaling, led to reduced Pitx2 and 
Cyclin D2 expression by -cells, resulting in reduced neonatal -cell expansion and mass 
and impaired glucose tolerance. Thus it turned out that Wnt signaling is both necessary 
and sufficient for islet -cell proliferation providing evidence of a mechanism governing 
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endocrine pancreas growth and function. The Wnt signaling acts, in Xenopus embryos, 
very early during the differentiation process, at level of organ patterning. It has been 
showed that Wnt/-catenin activity must be repressed in the anterior endoderm to 
maintain foregut identity and to allow
 
pancreas development. By contrast, high -catenin 
activity in the posterior endoderm inhibits foregut fate while
 
promoting intestinal 
development. Experimentally repressing
 -catenin activity in the posterior endoderm was 
sufficient
 
to induce ectopic organ buds that express early liver and pancreas
 
markers. -
Catenin acts in part by inhibiting expression
 
of the homeobox gene hhex, which is one of 
the earliest foregut
 
markers and is essential for liver and pancreas development.
 
Promoter 
analysis indicates that -catenin represses hhex transcription indirectly via the 
homeodomain repressor
 
Vent2. Later in development, -catenin activity has the opposite 
effect and enhances liver development. These results
 
illustrate that turning Wnt signaling 
off and on in the correct
 
temporal sequence is essential for organ formation, a finding
 
that 
might directly impact efforts to differentiate liver and
 
pancreas tissue from stem cells 
(Rulifson, Karnik et al. 2007). In the attempt to define precisely the topography of 
involvement of the wnt signaling in pancreas Murtaugh et al. (Murtaugh, Law et al. 2005) 
observed that that
 
the early pancreatic epithelium exhibits a specific enrichment
 
in 
unphosphorylated -catenin protein. To clarify the role of wnt signaling in pancreas 
development they specifically deleted the -catenin gene in these cells. Pancreata 
developing without -catenin are hypoplastic, although their early progenitors appear 
normal
 
and exhibit no premature differentiation or death. Surprisingly,
 
and in marked 
contrast to its role in the intestine, loss of
 -catenin does not significantly perturb islet 
endocrine
 
cell mass or function. The major defect of the -catenin-deficient pancreas is an 
almost complete lack of acinar cells, which normally
 
comprise the majority of the organ 
(Murtaugh, Law et al. 2005). 
The discovery of a hypothetical role of OVOl1 transcription factor in the pancreas 
could open new hypothesis of the molecular mechanism involved in the differentiation of 
pancreas. Previously no information of the expression pattern of OVOl1 during pancreas 
development had been known. Our data show that OVOl1 is expressed in islets and in 
pancreas-related cells (INS-1 and AR42J) and that Ngn3 seems to act as a negative 
regulator of its expression. Interestingly Ngn3 is active during a proliferative stage that 
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ends with the appearance of almost definitive islets clusters. The proliferation burst 
induced by Ngn3 seems incompatible with the differentiation one and thus should require 
a “silencing” of the factors inducing it.  
Our hypothesis is that OVOl1 is active in this time of transition to differentiation 
in the pancreas. These discoveries, albeit preliminary, suggest a new interesting scenario 
in pancreas development involving another layer of regulation by new unsuspected 
“players”. OVOl1 and Ngn3 in DNA binding and transcriptional regulation are 
particularly exciting in light of their apparently opposing biological functions. Ngn3 
positively regulates the proliferation of immature cells that are committed to 
differentiation, while OVOl1 is expressed later in a differentiation pathway and is 
necessary for efficient proliferation arrest (Dai, Schonbaum et al. 1998; Li, Dai et al. 
2002; Li, Nair et al. 2005; Nair, Teng et al. 2006). Based on the data presented here, it is 
tempting to speculate that Ngn3 and OVOl1 transcriptional regulation represent two 
consecutive steps in a relevant differentiation pathway, where the balance of the opposing 
effects of these two proteins coordinates proliferation with differentiation. Since Ngn3 is 
expressed in proliferating pancreatic progenitor cells, a possible scenario in pancreas 
development is that OVOl1 activates genes such as c-Myc and Id2 to up-regulate the 
transient proliferation of progenitor cells that have committed to differentiate, but also 
turns on the expression of its own antagonist, OVOl1, to restrict proliferation to allow 
terminal differentiation to actually occur. 
The activity of Ngn3 emerging from our experimental data appear quite unusual. 
Normally Ngn3 has been considered an activator of gene transcription. The present study 
reveals, instead, that OVOl1 is expressed in similar cells as Ngn3 during pancreatic 
development and shows that the ovol1 gene is directly negatively regulated by Ngn3.  
As mentioned earlier (see “Introduction”) ngn3 encodes a class B basic helix-
loop-helix factor, which
 
has been shown by loss-of-function studies to be required for
 
the 
development of the four endocrine cell lineages of the pancreas (Gradwohl, Dierich et al. 
2000). The pro-endocrine role of ngn3 has also been demonstrated
 
in gain-of-function 
studies. Ectopic ngn3 expression (Apelqvist, Li et al. 1999; Jensen, Pedersen et al. 2000; 
Schwitzgebel, Scheel et al. 2000),
 
as well as lineage tracing experiments (Gu, 
Dubauskaite et al. 2002), indicates that
 
ngn3 is a cell-autonomous determinant and true 
Chapter 5 Discussion 
________________________________________________________________________ 
 225 
marker of endocrine
 
progenitor cells. The adoption of each endocrine fate within
 
the islet 
(-, -, -, and PP cells) occurs preferentially at specific time points during 
embryogenesis, suggesting that
 
ngn3-positive cells adapt their responses to an evolving 
milieu
 
of signals. Premature expression of the ngn3 gene in early pancreatic
 
progenitor 
cells (e8.5–e9) results in their differentiation
 
into glucagon-producing cells (Apelqvist, Li 
et al. 1999). In all of the reports so far available the activity of Ngn3 relies as a positive 
regulator of gene expression at least for its direct known target (NeuroD/BETA2, Pax4, 
Nkx2.2 and IA1). The activation capacity of Ngn3 has been mapped at the
 
carboxyl 
terminus of the protein using one hybrid analysis that, instead, does not show any
 
significant intrinsic transcriptional repression capacity. Furthermore, studies
 
of the human 
ngn3 promoter have demonstrated that fragments
 
of the promoter itself contain a critical 
E box which presence is required for activation of the ngn3 gene (Smith, Watada et al. 
2004).  
Surprisingly in presence of exogenous Ngn3 this promoter is strongly repressed 
suggesting that a ubiquitous transcriptional
 
activator may bind to this site, when Ngn3 
expression is needed, and that Ngn3 could
 
act as a competitive inhibitor of this activator. 
This hypothesis
 
was supported by the lack of evidence for significant intrinsic
 
transcriptional repression capacity in the Ngn3 protein,
 
and by the ability of isolated 
DNA-binding basic helix-loop-helix
 
domains to repress the ngn3 promoter. Ngn3 
produced
 
additional repression, however, when the protein included an
 
intact 
transcriptional activation domain, suggesting that it
 
may also induce the expression of a 
downstream transcriptional
 
repressor (Smith, Watada et al. 2004). 
The predominant mode of action of a sequence-specific DNA-binding 
transcriptional repressor in eukaryotes is to recruit co-repressor complexes to its target 
promoters (active repression). Many sequence-specific repressors recruit histone 
deacetylases (HDACs), either directly or via adaptor proteins such as Sin3 (Burke and 
Baniahmad 2000; Thiel, Lietz et al. 2004). HDACs, opposing the function of histone 
acetylases, catalyze the deacetylation of lysine residues of core histone tails. This results 
in a more compact chromatin structure and consequently decreased accessibility for 
transcription factors. Two of the class I HDACs, HDAC1 and HDAC2, has been most 
widely implicated in transcriptional repression by myriad DNA-binding repressors 
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(Verdin, Dequiedt et al. 2003). Transcriptional repression can also occur by a passive 
mechanism, where repressors interfere with the function of transcriptional activators, for 
example by competing for binding to common DNA sequences [reviewed in (Johnson 
1995; Thiel, Lietz et al. 2004)].  
The mechanism by which Ngn3 negatively control the activity of ovol1 gene is in 
progress. 
In conclusion, the ability of Ngn3 to acts as transcriptional repressor could open a 
novel vision of the pancreas differentiation where start to appear important a correct and 
fine balance between gene activation and repression. 
 
5.3 Identification of the Transcription factor A2.2 
 
 The diabetes mellitus is one of the most common endocrine disorders today, with 
180 million people affected in the world in 2003 to approximately 220 million people in 
2010 (Zimmet 2000; Zimmet, Alberti et al. 2001). The diabetes is a group of disorders of 
multiple etiologies characterized by chronic hyperglycemia with disturbances of 
carbohydrate, fat and protein metabolism resulting from defects in insulin secretion, 
insulin action or both (WHO 1999). The two most common types of diabetes mellitus are 
the type 1 and the type 2. 
Type 1 diabetes is characterized by an absolute insulin deficiency due to an 
autoimmune destruction of the insulin producing pancreatic -cells. Patients with type 1 
Diabetes require daily injection of insulin or islet transplants to maintain blood glucose 
levels within physiological levels. Due to the shortage of islet donors, the most promising 
approach to cure type 1 Diabetes is the generation of insulin-producing cells from ES 
cells or from adult/stem cells progenitors.  
Type 2 Diabetes is, instead, characterized by a reduction in the insulin secretory 
cell population and consequently a reduction in insulin secretion that are, along with 
insulin resistance in liver, muscles and adipose tissues, the main cause of pathological 
traits of type 2 Diabetes.  
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For both the pathology the understanding of the fine molecular tuning of insulin 
gene expression is a prerequisite to envisage new therapeutic approaches.  
The molecular mechanism of the -cell-restricted expression of insulin has been 
extensively studied during the past years and many of the transcription factors involved in 
its regulation have been identified (Wang, Shen et al. 1997; Ohneda, Ee et al. 2000). 
Nevertheless many aspects of the insulin-gene regulation and hormone production are 
still unclear. For example, the restriction of the proinsulin expression to the -cell is still 
unexplained.  
The insulin gene is a small gene, located on the chromosome 11q15.5 in humans 
and consisting of three exons and two introns (Owerbach, Bell et al. 1980). The 
sequences immediately upstream of the transcription start site are important control 
elements for its expression in the -cell (Walker, Edlund et al. 1983; Edlund, Walker et 
al. 1985; Hanahan 1985). Most of the data available identified a short region of about 400 
bp in the proximal insulin promoter as responsible for the “segregation” of insulin 
expression into the -cells (Ohneda, Ee et al. 2000). Many cis-regulatory elements have 
been identified; among them the most important are the conserved E1 (-100 to -91 bp), 
A3 (-201 to -196 bp), and RIPE3b/C1-A2 (-126 to -101 bp) elements (Karlsson, Edlund 
et al. 1987; Whelan, Poon et al. 1989; Shieh and Tsai 1991). The islet-restricted 
transcription factors NeuroD/BETA2 and Pdx-1/IPF1/STF1/IDX1/GSF/IUF1, which bind 
to the E1 and A3 elements, respectively, have been identified as well. Gene disruption 
experiments in mice have revealed that both NeuroD/BETA2 and PDX-1 play critical 
roles in insulin gene expression as well as in islet development and function (Jonsson, 
Carlsson et al. 1994; Naya, Stellrecht et al. 1995; Ahlgren, Jonsson et al. 1998). 
Furthermore mutations in beta2 and pdx1, genes are found in some population of patients 
with type 2 diabetes (Stoffers, Ferrer et al. 1997; Stoffers, Zinkin et al. 1997; Malecki, 
Jhala et al. 1999).  
The third regulatory element, RIPE3b/C1, has been shown to play an important 
role in insulin gene transcription and in its glucose-regulated expression (Shieh and Tsai 
1991; Sharma and Stein 1994; Wang, Brun et al. 2007). Previous studies have identified a 
-cell-restricted RIPE3b-binding factor, called RIPE3b1 activator that appears in 
response to glucose in pancreatic nuclear extract (Sharma, Fusco-DeMane et al. 1995). 
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Using biochemical purifications and band-shift assay approaches, the transcription factor 
RIPE3b1 has been recently identified as a mammalian homologue of avian MafA/L-Maf 
(Olbrot, Rud et al. 2002). Maf family proteins belong to the basic leucine zipper (bZIP) 
family of transcription factors. To date, several maf-related genes have been identified in 
various species including human, mouse, rat, chicken, frog and zebrafish. The DNA 
consensus sequence of the Maf family of transcription factors has been determined by 
independent works (Kataoka, Noda et al. 1994; Kerppola and Curran 1994; Kerppola and 
Curran 1994) to be a palindromic sequence of 13-14 bp (TGC(N)6-7GCA), now called 
Maf Recognition Element (MARE). MARE sequences have been identified in different 
promoter regions (Kataoka, Noda et al. 1994) that turned out to be targets of the Maf 
family members (e.g. - and -globin, opsin, crystalline genes and insulin). The 
RIPE3b/C1-A2 region, within the insulin promoter region, has been characterized by 
elegant and complete studies (Harrington and Sharma 2001; Nishimura, Salameh et al. 
2005). The insulin RIPE3b/C1-A2 enhancer element contains the C1 element (-116 to 
107 bp), bound by MafA, and the A2 element (-126 to -113 bp) (Shieh and Tsai 1991; 
German, Ashcroft et al. 1995; Tomonari, Yoshimoto et al. 1996; Zhao, Guo et al. 2005). 
Furthermore, the A2 insulin enhancer element was classified, based on the sequence 
homology, as a A-elements (German, Ashcroft et al. 1995). Transcription factors 
belonging to the homeodomain transcription factor family, such PDX-1, recognize these 
sequences (Karlsson, Thor et al. 1990; Rudnick, Ling et al. 1994). In addition, the region 
RIPE3b/C1-A2 contains also an element recognized by transcription factor belonging to 
the Nkx2 family (Damante, Fabbro et al. 1994; Weiler, Gruschus et al. 1998). According 
to that it was first hypothesized that both PDX-1 and Nkx2.2 could correspond to the A2 
element. However, the work of Harrington et al. (Harrington and Sharma 2001) has 
demonstrated that neither of them were the A2-binding complex.  Instead, when analyzed 
using DNA shift assays, the RIPE3b/C1-A2 element region showed the ability to form 
five different DNA/protein complexes named RIPE3b1, RIPE3b2, A2.1, A2.2 and A2.3 
(Olbrot, Rud et al. 2002). All the complexes were formed using nuclear extracts from 
non-insulin producing cells while only RIPE3b1 (MafA) and A2.2 were formed 
exclusively using nuclear extracts from insulin-producing cells (Harrington and Sharma 
2001). Interestingly it has been demonstrated that both the C1 and A2 element share 
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overlapping nucleotides, in particular two base pairs (-122 and -121) essential for the 
binding activity of both the complexes (Nishimura, Salameh et al. 2005). Moreover, it 
emerged that C1 and A2 binding complexes can act cooperatively to regulate the insulin 
gene expression (Harrington and Sharma 2001).  
Transcriptional regulation of insulin expression results not only from the specific 
combinations of the C1 and A2.2 activators through DNA-protein and protein-protein 
interactions, but also from their relative nuclear concentrations, generating a 
cooperatively transcriptional synergism unique for the insulin gene.  
Despite the importance for the -cell-specific role played by A2.2 in the 
regulation of insulin gene expression its nature is still elusive. According to that it is clear 
that the fully understanding of insulin regulator transcription factors will have 
fundamental impact for the approaches to cure type 1 and type 2 Diabetes. 
For these reasons the aims of the present part of the Thesis have been: 
 
1) To characterize and purify the transcription factor A2.2 
2) To identify it as -cell specific transcription factor 
  
5.3.1  Characterization of A2.2 
 
The 5’ flanking region of the rat insulin II gene corresponding to the region 
containing the A2 element has been analyzed for the relative homology with the 
corresponding region of rat insulin I and human insulin. The consensus sequence 
retrieved has been then used for the identification of putative transcription factors by 
using the TRANSFAC software (Nishimura, Salameh et al. 2005). The results identified 
the A2 sequence as highly homologous to those recognized by bZIP transcription factors 
(Nishimura, Salameh et al. 2005). Furthermore among the protein identified, the higher 
scores were attributed to the proteins belonging to the C/EBP transcription factors family. 
The high homology of A2 sequence with those recognized by bZIP proteins is in 
good agreement with the observation that many bZIP domain-containing proteins play 
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important roles during pancreas development (Shih and Stoffel 2001; Wang, Webb et al. 
2003; Towle 2005; Tsuchiya, Taniguchi et al. 2006).  
This has been the starting point to develop an experimental strategy aimed to 
address the first point of the proposed aims (To characterize and purify the transcription 
factor A2.2). The band shift competition assays described in the “Materials and Methods” 
section and discussed in details in the “Results” section confirmed the originality of the 
working hypothesis. In fact, the oligonucleotide probes used (containing sequences 
recognized by several bZIP transcription factors) were able to compete with the A2 
sequence for the A2.2 binding.  
Furthermore the high score attributed by the TRANSFAC analysis to the proteins 
belonging to the C/EBP transcription factors family resulted almost “unusual” since it is 
know that C/EBP act as negative regulator of the transcription (Lu, Seufert et al. 1997; 
Seufert, Weir et al. 1998) while the A2.2 transcription factor acts, undoubtedly, as a 
positive regulator for the insulin gene expression. Nevertheless, band shift competition 
assays using the DNA binding domain for C/EBP transcription factors and super-shift 
assays, using anti-C/EBP and anti-C/EBP antibodies, were performed. Once again, the 
results confirmed the ability of oligonucleotides containing C/EBP-DNA binding 
elements to compete for the formation of the A2.2 complex. Furthermore, a strong super 
shift signal, but no the disappearance of the A2.2 complex, was observed in presence of 
anti-C/EBP and anti-C/EBP antibodies. Further experiments were performed using 
plasmids expressing dominant negative of the bZIP proteins that selectively inhibit 
transcriptional activation mediated by different bZIP sub-family members. None of these 
recombinant proteins resulted in an inhibition of the A2.2 formation.  
The first two observations strongly support the hypothesis that in the formation of 
the A2.2 complex the C/EBP transcription factors play an important role. Unfortunately 
they appear to act more as a “co-actor” rather than as a specific and unique “actor” of the 
formation of the A2.2 complex.  
The third observation open the possibility of more challenging “scenario”; the 
possibility that the A2.2 complex belongs to the C/EBP transcription factors family but 
corresponding to a “brand new” protein with new and unexpected behavior(s) 
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Although “disappointing”, from certain point of view, these observations added 
important pieces of the A2.2 puzzle prompting us to challenge the purification “from 
scratch” of the A2.2 protein. 
 
5.3.2  Purification of A2.2 
 
For the purification of the A2.2 transcription factor the cell line HIT T-15 has 
been chosen. The HIT T-15 cells derive from dispersed Syrian hamster pancreatic islets 
following transformation with SV40 (Santerre, Cook et al. 1981). This cell line was 
chosen because it shows the highest binding activity to the A2 binding element (over 10 
folds) respect other insulin producing cell lines (Harrington and Sharma 2001). To obtain 
the highest degree of purity with the lowest number of purification process a two-step 
chromatography strategy has been developed. The first chromatographic separation relies 
on the use of the HiTrap-Heparin column. The chromatographic support of the HiTrap-
Heparin column allows for fast, simple and easy separations of nucleic acid binding 
proteins. In fact, immobilized heparin interacts with nucleic acid-binding proteins as a 
cation exchanger due to its high content of anionic sulfate groups mimicking the 
polyanionic structure of the nucleic acid. The second chromatographic separation relies 
on the use of an affinity chromatography step on a streptavidin-agarose column. This 
chromatographic support is able to bind irreversibly, in mild biochemical conditions, its 
ligand, namely the biotin. For this highly selective purification step the purified and 
pooled protein fractions from the previous steps were incubated with a biotinylated A2 
oligonucleotide. This acts as a bait to “capture” the DNA binding protein(s) that 
recognize with high specificity the A2 consensus sequence. The complexes 
DNA/protein(s) are then captured by the specific interaction biotin/streptavidin. The 
highly stringent condition of washing should allow removing all spurious proteins. The 
elution of the bound proteins was obtained by competition of the protein(s) with untagged 
A2 oligonucleotides.   Each of the fraction obtained (about 30) were assayed for their 
ability to form A2.2 complexes in EMSA assays. As reported in the “results” section at 
least three fractions showed a significant A2-binding specificity. A further 
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characterization of these fractions has been obtained running a SDS-PAGE. Although the 
results showed a certain unexpected heterogeneity (at least 5 distinct bands were 
obtained) it was not so dramatic. In fact it has been possible to easily extract with high 
purity some of the bands of greater interest. In particular our attention was concentrated 
on the bands showing a low molecular weight. According to unpublished data from Dr. 
Sharma the mass range of the expected protein(s) should be between 15 and 20 kDa (Dr. 
Sharma, personal communication). Only one band present in this mass range showed a 
significant A2-binding specificity. This band has been sent to the Joslin Proteomic Core 
for mass spectrometry analysis. 
The output of the mass spectrometry analysis identified with the higher score of 
homology proteins belonging to the small Maf family factors. The small Maf proteins 
consist of only three members: MafF, MafG and MafK.  
The small Maf proteins have very similar function (Onodera, Shavit et al. 1999); 
they recognize the same MARE sequences of the Maf factors and tend to form 
homodimers or heterodimers with other bZIP factors, such as CNC (“cap’n’collar”) or 
Bach family proteins (Andrews, Erdjument-Bromage et al. 1993; Igarashi, Kataoka et al. 
1994; Itoh, Igarashi et al. 1995; Oyake, Itoh et al. 1996; Marini, Chan et al. 1997). The 
Small Maf factors lack the trans-activation domain but CNC and Bach proteins have a 
transactivation (CNC) or a repression (Bach) domain unique to each molecule. Therefore 
through heterodimerization, the small Maf proteins acquire cis-acting properties 
(activation or repression).  
The presence of small Maf factors within eluted A2.2 positive fraction has been 
experimentally confirmed. As observed for the in the C/EBP transcription factors also for 
the small Maf could be hypothesized a contribution in the formation of the A2.2 complex 
as “guest star” rather than as the only responsible for the formation of the A2.2 complex.  
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 Next the bioinformatics analysis was extended also to those proteins 
showing lower homology but retaining some constrains:  
 
1) The nuclear localization.  
2) The low molecular weight (15-20kDa).  
3) The cell specificity (-cells, if the information was available from the 
database). 
 
The expression pattern for the selected candidates was then analyzed by RT-PCR 
on insulin and non-insulin producing cells. All the candidates failed to satisfy the third 
constrain, the -cell specificity.  
In the attempt to broader the analysis the results of the mass spectrometry some 
protein database(see “Materials and Methods”) have been analyzed loosening the 
homology allowing a limited degree of degeneracy among the amino acids sequences and 
adding, to the constrains described above, the belonging to the bZIP proteins family. A 
list of nine proteins was obtained. Among them six possible candidates were selected to 
assess their expression pattern by RT-PCR on insulin and non-insulin producing cells. 
Once again the candidates failed to satisfy the -cell specificity.  
In conclusion the identification of the A2.2 factors is still an open question 
although some important information has been collected. The A2.2 complex is probably 
the result of the cooperative activity of different proteins that include member of the bZIP 
and small Maf families. A serious drawback that impaired the analysis is the lack of a 
sufficiently complete nucleotide and protein database for hamster. All the bioinformatics 
analyses have been performed assuming a good degree of homology between hamster 
and rat. Despite the close relation between the two species (both belonging to the Rodents 
order) the evolutive pressure could had act selecting protein in which the degree of 
homology (at least in term of amino acids sequences) could be low enough to complicate 
the cross-species homology analyses.  
As an alternative strategy could be worth to consider the possibility to start over 
the purification steps from nuclear extracts obtained from rat or mouse which database 
(both DNA and proteins) are as far the most complete available. 
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6 CONCLUSIONS 
 
Diabetes currently affects close to 50 million people in Europe and this number is 
expected to increase to almost 60 million by 2025.  There is, therefore, an urgent need to 
take action to address this diabetic time bomb. Apart the social and medical issues arising 
from this disease there are also challenging aspects for basic and clinical research. From a 
medical point of view maintaining glycemic control with exogenous insulin is the 
classical therapeutic approach for type 1 Diabetes. However, this approach is associated 
with an increased risk of severe hypoglycemia. One alternative treatment for type 1 
Diabetes is the whole organ pancreas transplantation. While the results of these studies 
are very encouraging, multiple donor pancreata were required to achieve insulin 
independence, and immunosuppression is still needed. 
 
Contribution from the research in the challenging field of the embryonic stem (ES) 
cells could be very important. Insulin secreting-cells derived from ES cells may offer a 
solution to the problem of an inadequate supply of insulin-producing cells. Theoretically, 
ES cells can be differentiated by the use of genetic and epigenetic manipulations.  
There is a growing research interest for possible use of pluripotent ES cells to be 
used for the treatment of type 1 Diabetes. Recent studies showed that cultured ES cells 
can differentiate, at low frequencies, into insulin-producing cells [43, 44]. Unfortunately 
these approaches are quite empirical and are based merely on a so-called “Medium 
Engineering”. This approach is based on use of media with different formulation obtained 
by addition or withdrawal of supplements, growth factors, etc. 
Almost two aspects impair the use of the “Medium Engineering” approach: 
 
1. Insulin-secreting cells obtained not always show a physiological response to the 
variation of glucose concentration.  
2. The population heterogeneity is still too high. 
 
 Inducing -cell differentiation by expression of transcription factors that are 
necessary for -cells development is a possible approach for gene therapy in diabetes. 
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The specific pathway leading to the development of the insulin-secreting -cells is 
particularly important to be able to engineer new -cells.  
It is clear that endocrine cell fate appears to be governed by the expression of the 
transcription factor Ngn3 that acts as a switch for differentiation activating, downstream, 
a molecular cascade of factors that commit the progenitor cell to the endocrine fate.  
On this aspect is based the novelty of the approach developed in this Thesis. 
Understanding the role of this molecular switch could have potential important outcomes 
for the diabetes. In fact understanding the gene pathway activated by Ngn3 during -cell 
differentiation will increase the basic knowledge on -cell function that could allow for 
development of reproducible in vitro methods for differentiation to: 
 
1. Development of reproducible in vitro methods for differentiation to: 
• Generation of glucose-responsive and insulin-secreting cells from ES cells; 
• Generation of glucose-responsive and insulin-secreting cells from adult progenitor 
cells; 
• Generation of glucose-responsive and insulin-secreting cells from non-b cells; 
2. Development of clinical and preclinical trials; 
3. Development of insulin-secreting cell lines suitable for therapeutic use in humans. 
 
 Yet, Insulin gene therapy is another approach for the possible cure of type 1 
Diabetes that might overcome the weakness of islet transplantation and -cell 
regeneration with respect their vulnerability towards autoimmune attack. Many attempts 
have been made to replace the function of -cells by introducing various components of 
the insulin secretory machinery into non -cells, which are no targets of the -cell-
specific autoimmune response. However, the simplest replacement of insulin gene 
expression by genetic engineering is not likely to be useful as a therapy for type 1 
Diabetes unless it contains an appropriate system to regulate insulin levels within 
extremely narrow physiological limits in response to glucose. Successful insulin gene 
therapy requires several important components including an effective insulin gene 
delivery system, a regulatory system tightly controlled by glucose, an appropriate 
processing system and an appropriate target cell with biochemical characteristics similar 
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to -cells. In this respect it becomes obvious that a fully understanding of insulin gene 
regulation in -cell must be achieved. Many studies have contributed to expand our 
knowledge regarding how insulin expression is restricted to pancreatic -cell and how its 
production is regulated by physiologic signals such as glucose. A picture is emerging in 
which an elaborate set of transcription factors bind to specific sequences along the 
promoter, recruiting additional “co-actors” to build a functional transcriptional-
activation-complex that is unique of the -cells. Nonetheless the complete scenario of 
insulin expression within the -cell is still full of shade. On this respect the setup of a 
reproducible method of purification and the characterization/identification of the 
A2.2 transcription factor, still “in progress”, will help so far to add a new piece to the 
puzzle on the wisdom of insulin gene regulation. 
  
 In conclusion, the project developed in this Thesis was strictly oriented to 
contribute to find a solution of an emerging social and medical problem such as Type 1 
Diabetes starting from original idea that are to mimic as much as possible physiological 
events and identify the and using innovative cell and gene therapy approaches building a 
new concept of Medicine that is the Molecular Medicine. 
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